{"meta":{"query_hash":"9bd2f9de5b61","filters":{"venue":"American Journal of Hematology"},"cohort_total":385,"direct_labels_cover":0,"predictions_cover":385,"exported":385,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9bd2f9de5b61","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Hematology"},"results":[{"id":"W1490900965","doi":"10.1002/ajh.23788","title":"Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Medicine; Internal medicine; Gastroenterology; Imatinib; Neutropenia; Dysgeusia; Adverse effect; myalgia; Myeloid leukemia; Nilotinib; Toxicity","score_opus":0.017983480108602515,"score_gpt":0.33338896278461944,"score_spread":0.3154054826760169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490900965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132485,0.011857995,0.00047915676,0.001038077,0.00022064711,0.00045161194,0.0011615998,0.0000938508,0.0033721668],"genre_scores_gemma":[0.99233776,0.0026252435,0.0005588325,0.0010715663,0.00017108422,0.00046259086,0.0016821341,0.00001722087,0.0010735762],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993618,0.00038136772,0.000035987,0.000061168335,0.00007551063,0.00008413543],"domain_scores_gemma":[0.99928916,0.0001556388,0.00025340024,0.000027446373,0.000041827498,0.00023255867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021525957,0.00047919032,0.0011483409,0.0002835309,0.00027687685,0.0008512926,0.00032146534,0.00052614295,0.0026827445],"category_scores_gemma":[0.0015001341,0.0002207025,0.0010424291,0.00027288785,0.0003236018,0.0007306722,0.00030519147,0.0018613152,0.00044143762],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77328914,0.0063913297,0.011993422,0.0010814023,0.0024392304,0.0002202389,0.00024895268,0.0028598355,0.019913841,0.00095436047,0.008473926,0.17213418],"study_design_scores_gemma":[0.59000546,0.29148415,0.08501814,0.00039414328,0.0023758481,0.00092668866,0.0001619572,0.004948336,0.0051775747,0.001309253,0.018109193,0.00008938464],"about_ca_topic_score_codex":0.0005814739,"about_ca_topic_score_gemma":0.0027115147,"teacher_disagreement_score":0.0026827445,"about_ca_system_score_codex":0.0006839018,"about_ca_system_score_gemma":0.00093849556,"threshold_uncertainty_score":0.0113841295},"labels":[],"label_agreement":null},{"id":"W1492560350","doi":"10.1002/ajh.23725","title":"A double‐blind, placebo‐controlled phase II study of the efficacy and safety of 2,2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Cairo University; Ain Shams University; Children's National Hospital; University of South Alabama; Virginia Commonwealth University; American University of Beirut","keywords":"Medicine; Fetal hemoglobin; Placebo; Internal medicine; Nausea; Gastroenterology; Adverse effect; Vomiting; Surgery; Anesthesia; Fetus; Pregnancy; Pathology","score_opus":0.012204111064161386,"score_gpt":0.29671073486938554,"score_spread":0.2845066238052242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492560350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393696,0.0022660524,0.00085751334,0.00018361247,0.00016200654,0.0016856117,0.0002918555,0.000069368114,0.00054716546],"genre_scores_gemma":[0.98867595,0.0024411143,0.0021296733,0.0006287022,0.00029886214,0.0031902415,0.00058487814,0.000022070144,0.002028536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99967134,0.00017340157,0.000021943448,0.00005888983,0.000033261047,0.00004116406],"domain_scores_gemma":[0.999318,0.00021617774,0.00018084767,0.000049039732,0.000046978264,0.00018905087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001104404,0.0011709403,0.0019004055,0.00042809334,0.00033294532,0.00043562768,0.0007135359,0.001293607,0.0023158311],"category_scores_gemma":[0.0010458286,0.00060650444,0.0006109029,0.0002647273,0.0009416932,0.00057106797,0.00018934911,0.0015780479,0.00044796016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8519498,0.046035722,0.0013102017,0.0008820681,0.00048241336,0.00010665064,0.000099532255,0.00064938545,0.05467606,0.000131174,0.00064720237,0.043029863],"study_design_scores_gemma":[0.62627673,0.36519563,0.0038875074,0.000025044028,0.00015514485,0.00007665497,0.00002271592,0.0004985452,0.00322599,0.000063194384,0.0005554817,0.000017353532],"about_ca_topic_score_codex":0.00040968892,"about_ca_topic_score_gemma":0.0006951168,"teacher_disagreement_score":0.0023158311,"about_ca_system_score_codex":0.0003551304,"about_ca_system_score_gemma":0.00068299216,"threshold_uncertainty_score":0.0077471733},"labels":[],"label_agreement":null},{"id":"W1492831809","doi":"10.1002/ajh.23712","title":"A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Covis Pharma; McGill University","keywords":"Ferumoxytol; Iron sucrose; Iron-deficiency anemia; Medicine; Clinical endpoint; Anemia; Gastroenterology; Hemoglobin; Internal medicine; Iron deficiency; Transferrin saturation; Ferritin; Randomized controlled trial; Intravenous iron; Magnetic resonance imaging","score_opus":0.021196190934312013,"score_gpt":0.30059390926182455,"score_spread":0.27939771832751253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1492831809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854417,0.0033852304,0.00091080094,0.0010099767,0.0009850999,0.0046395995,0.0009965827,0.00015541718,0.0024754712],"genre_scores_gemma":[0.98058665,0.002634612,0.0020064241,0.002022447,0.00077317486,0.006484088,0.0012121492,0.00003691239,0.0042435452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994848,0.00027720258,0.00002528086,0.00008698144,0.00003850682,0.00008724005],"domain_scores_gemma":[0.998672,0.0004909795,0.00026475458,0.000086606226,0.00008145591,0.0004041872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018242238,0.0020185,0.00318563,0.00047188005,0.00044762806,0.0010773471,0.0010828215,0.0022066315,0.0076966197],"category_scores_gemma":[0.0018746814,0.0007523656,0.0017517788,0.00036218239,0.0014229157,0.0011914166,0.0004291514,0.0035632371,0.0012073865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9809748,0.00863562,0.000175504,0.0002301228,0.00039624545,0.000030780662,0.000031705364,0.00018515237,0.0023018755,0.0000899171,0.0005413947,0.0064068045],"study_design_scores_gemma":[0.92933595,0.06913311,0.00048125768,0.000015692729,0.0001280275,0.00001890242,0.000013007721,0.00029668465,0.00022127922,0.00009039891,0.00025765764,0.000008071249],"about_ca_topic_score_codex":0.0007662665,"about_ca_topic_score_gemma":0.0017575067,"teacher_disagreement_score":0.0076966197,"about_ca_system_score_codex":0.0007738409,"about_ca_system_score_gemma":0.001242712,"threshold_uncertainty_score":0.025747776},"labels":[],"label_agreement":null},{"id":"W1505869554","doi":"10.1002/ajh.24169","title":"Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: A <scp>D</scp>anish–<scp>C</scp>anadian study of 443 patients with diffuse‐large <scp>B</scp>‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Danish; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Lymphoma","score_opus":0.011077441676237773,"score_gpt":0.23967480393728618,"score_spread":0.2285973622610484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505869554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997142,0.00010479011,0.000018515684,0.000006202823,9.801767e-7,0.000003599981,0.00008264865,5.8771883e-7,0.0000685684],"genre_scores_gemma":[0.9995858,0.00005387754,0.000025431898,0.000009701172,0.0000037005855,0.000005250887,0.00026462408,6.938879e-7,0.000051001476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973756,0.00006637222,0.000029136498,0.0000645277,0.000045522218,0.000056908368],"domain_scores_gemma":[0.99944454,0.00013455845,0.00013742792,0.000058464102,0.000045926823,0.00017912891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042493906,0.00029554009,0.00043211522,0.0003831444,0.0004047671,0.00064224034,0.00032939974,0.0004187412,0.0005913036],"category_scores_gemma":[0.00084218726,0.00035632768,0.00041422193,0.000670112,0.00033187924,0.0003327273,0.0004864181,0.00043520803,0.00020148982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068263547,0.00005288911,0.99750537,0.0000058113833,0.00003695418,0.00013919442,0.000054123517,0.00007467592,0.0003929656,0.000005303318,0.000034186847,0.001015964],"study_design_scores_gemma":[0.000054617507,0.00019483101,0.9985429,0.000003981628,0.000046838886,0.00046852737,0.00010002831,0.000312974,0.00011344857,0.00001404616,0.00014338372,0.0000044230037],"about_ca_topic_score_codex":0.008204686,"about_ca_topic_score_gemma":0.014954593,"teacher_disagreement_score":0.9917953,"about_ca_system_score_codex":0.00069742504,"about_ca_system_score_gemma":0.00042170816,"threshold_uncertainty_score":0.01631391},"labels":[],"label_agreement":null},{"id":"W1514606780","doi":"10.1002/ajh.23640","title":"Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Dosing; Pharmacology; Pharmacokinetics; Adverse effect; Drug; Pharmacodynamics","score_opus":0.017367300387844092,"score_gpt":0.31955335801566315,"score_spread":0.302186057627819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514606780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270356,0.004304918,0.00032641095,0.0002863175,0.000048275924,0.0005812865,0.0003785502,0.000055782988,0.0013148218],"genre_scores_gemma":[0.9922976,0.003427049,0.00078337634,0.0005314296,0.0001254549,0.0005176461,0.0011513738,0.000018884257,0.0011470704],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998023,0.00007365444,0.000011809945,0.000033784556,0.000031486434,0.000047035555],"domain_scores_gemma":[0.99962234,0.000061309045,0.000074731426,0.000029955707,0.000033922253,0.00017766467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007200924,0.0006353523,0.0014754491,0.0002520668,0.00026644283,0.0006576674,0.00037286105,0.0005522567,0.0014406658],"category_scores_gemma":[0.00052052445,0.0002757772,0.00073410926,0.00032635985,0.0004070144,0.00033757754,0.0001624403,0.0016252362,0.0003298617],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26693746,0.06695749,0.020536005,0.002142832,0.001957017,0.0013061677,0.00092254125,0.0026100844,0.31270725,0.00041965733,0.01119831,0.31230527],"study_design_scores_gemma":[0.20435861,0.6887486,0.06565555,0.00009636625,0.0010654068,0.0014044861,0.00016696613,0.0019434382,0.02274035,0.00022649235,0.013531627,0.00006211628],"about_ca_topic_score_codex":0.00096134335,"about_ca_topic_score_gemma":0.0021705497,"teacher_disagreement_score":0.0014754491,"about_ca_system_score_codex":0.0004883401,"about_ca_system_score_gemma":0.00082052813,"threshold_uncertainty_score":0.0048195124},"labels":[],"label_agreement":null},{"id":"W1514929400","doi":"10.1002/ajh.23868","title":"A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Janssen Scientific Affairs; Leukemia and Lymphoma Society","keywords":"Medicine; Bortezomib; Internal medicine; Multiple myeloma; Gastroenterology; Neutropenia; Placebo; Dexamethasone; Refractory (planetary science); Discontinuation; Febrile neutropenia; Oncology; Toxicity; Pathology","score_opus":0.0191206186390491,"score_gpt":0.31776368782950626,"score_spread":0.29864306919045713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514929400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872433,0.0031965498,0.0009894472,0.0008044291,0.0008230546,0.0049403533,0.00068080093,0.0001642847,0.0011578875],"genre_scores_gemma":[0.97890615,0.0024764575,0.0029059912,0.0019503168,0.0013015101,0.007859102,0.0009736832,0.000043720134,0.0035831435],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990422,0.0005258237,0.000059327478,0.00020119363,0.00006603088,0.0001054409],"domain_scores_gemma":[0.9986375,0.00040035154,0.0003450275,0.00012184104,0.00008074788,0.00041461582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028016663,0.002677911,0.0033471084,0.00076228695,0.00051663973,0.0010544258,0.0011008522,0.0022169698,0.004991469],"category_scores_gemma":[0.002082085,0.0013947238,0.001717181,0.0005166666,0.0019316236,0.001340457,0.00045604154,0.003389118,0.0010706496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9708428,0.014480826,0.00040188836,0.00034923662,0.000440731,0.000029793138,0.00005079422,0.0001967833,0.0042556645,0.000074297364,0.00034606736,0.008531064],"study_design_scores_gemma":[0.9253831,0.07295081,0.00062725344,0.000009264191,0.00015858855,0.000015023291,0.000008933013,0.00023180188,0.0002920046,0.00006185696,0.00025390155,0.0000073623005],"about_ca_topic_score_codex":0.0006575233,"about_ca_topic_score_gemma":0.0015280909,"teacher_disagreement_score":0.004991469,"about_ca_system_score_codex":0.0007160392,"about_ca_system_score_gemma":0.0012594069,"threshold_uncertainty_score":0.016698122},"labels":[],"label_agreement":null},{"id":"W1548156058","doi":"10.1002/ajh.24025","title":"Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Immunoassay; Heparin-induced thrombocytopenia; Heparin; Medicine; Platelet factor 4; False positive paradox; False Negative Reactions; Platelet; Internal medicine; Immunology; Antibody","score_opus":0.07706783411056425,"score_gpt":0.34719750561698365,"score_spread":0.2701296715064194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548156058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859891,0.0040675616,0.0026646198,0.0032083264,0.00018938453,0.000080739745,0.00008336166,0.0001246207,0.0035922884],"genre_scores_gemma":[0.99336433,0.0017710691,0.0026153917,0.0012264621,0.00018848634,0.000020535936,0.000115058756,0.000041925803,0.0006566027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877729,0.005825392,0.0014094639,0.0010683023,0.0028773062,0.0010467117],"domain_scores_gemma":[0.98309696,0.0043118373,0.0028386577,0.0011054672,0.0056893183,0.0029577108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012988805,0.0008566419,0.0005526556,0.001568262,0.0014083828,0.0024556243,0.0022161768,0.0017849674,0.00085602014],"category_scores_gemma":[0.027922004,0.0006974785,0.0006982027,0.0011130542,0.001372874,0.0022206255,0.0029848379,0.0019562545,0.0006253133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046927432,0.0010348872,0.80354315,0.00019044048,0.00008797362,0.047896437,0.01798003,0.0006906522,0.003628708,0.0001955372,0.0038380877,0.12044485],"study_design_scores_gemma":[0.0001216326,0.006841563,0.7101334,0.0008372847,0.00023369087,0.2063344,0.03025764,0.0043893848,0.008478599,0.0005756568,0.031451207,0.00034559277],"about_ca_topic_score_codex":0.006899426,"about_ca_topic_score_gemma":0.007585181,"teacher_disagreement_score":0.012988805,"about_ca_system_score_codex":0.0019819387,"about_ca_system_score_gemma":0.001699714,"threshold_uncertainty_score":0.06869221},"labels":[],"label_agreement":null},{"id":"W1565948695","doi":"10.1002/ajh.23707","title":"<i>BCR/ABL</i> level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Myeloid leukemia; Gastroenterology; Imatinib mesylate; Immunology; Surgery; Oncology","score_opus":0.012166135326978689,"score_gpt":0.3005888551829361,"score_spread":0.2884227198559574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565948695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961925,0.00012289076,0.000043183376,0.000013482816,0.000001282194,0.0000035945654,0.000029060515,0.0000013673612,0.00016588758],"genre_scores_gemma":[0.9997278,0.000042262516,0.00005706906,0.000009807824,0.000004756365,0.0000029883233,0.000083436746,0.0000010587025,0.000070787195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984324,0.000034181587,0.000020227522,0.000028120867,0.000022748292,0.00005144768],"domain_scores_gemma":[0.9994772,0.00013222558,0.00022119451,0.00002332158,0.000047957077,0.00009812134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028723967,0.00013176729,0.00028296164,0.00054042786,0.00020161012,0.00029988584,0.0001586397,0.00032647347,0.00083601585],"category_scores_gemma":[0.000756133,0.000075710515,0.0002362955,0.00032931715,0.000238632,0.00028551384,0.00022697043,0.00017884592,0.00023681064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044664467,0.00001825426,0.9939757,0.000009703331,0.000009879107,0.0004382843,0.00008118272,0.000043859327,0.0021624772,0.000013314612,0.000045031156,0.0027557174],"study_design_scores_gemma":[0.000007246148,0.00033725324,0.9966132,0.0000044506196,0.000025123049,0.0016583768,0.00029248957,0.00017305899,0.0005124994,0.00004305327,0.00032967786,0.0000036214904],"about_ca_topic_score_codex":0.00056947785,"about_ca_topic_score_gemma":0.0008763316,"teacher_disagreement_score":0.00083601585,"about_ca_system_score_codex":0.0001442761,"about_ca_system_score_gemma":0.00012499426,"threshold_uncertainty_score":0.0027967691},"labels":[],"label_agreement":null},{"id":"W1568897463","doi":"10.1002/ajh.23955","title":"Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Methotrexate; Graft-versus-host disease; Transplantation; Stem cell; Mycophenolate; Surgery; Disease; Internal medicine; Biology","score_opus":0.02844093436943884,"score_gpt":0.29789371182022495,"score_spread":0.2694527774507861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568897463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667704,0.0028094377,0.00008149252,0.00004383022,0.000012267351,0.000008354222,0.00003404067,0.000002862148,0.00033081678],"genre_scores_gemma":[0.9993529,0.00035665027,0.00008309454,0.000034516717,0.000045535744,0.0000056828203,0.00007972498,0.0000014284041,0.000040459447],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99898654,0.0004934343,0.00019417766,0.00007955033,0.0001571665,0.00008906683],"domain_scores_gemma":[0.9973628,0.0011830591,0.000964898,0.00009779245,0.00011195911,0.00027935364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012218888,0.00018527487,0.00048858405,0.0004618572,0.00021233494,0.0004874815,0.000205485,0.00040567797,0.0008749044],"category_scores_gemma":[0.004382761,0.00013758718,0.00036817472,0.0004817191,0.0002547996,0.0002630632,0.0001575121,0.00023228738,0.00019202507],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041784155,0.00014496368,0.9558818,0.00012827525,0.00023305861,0.0013124015,0.00008527463,0.00018942473,0.0034246603,0.00007952366,0.00022698299,0.034115303],"study_design_scores_gemma":[0.00048366864,0.006903843,0.9740424,0.000084579624,0.00043472488,0.013065332,0.00015194075,0.00072107697,0.0018063056,0.000110814515,0.0021811207,0.000014069071],"about_ca_topic_score_codex":0.00026431875,"about_ca_topic_score_gemma":0.0005578473,"teacher_disagreement_score":0.0012218888,"about_ca_system_score_codex":0.0002670667,"about_ca_system_score_gemma":0.00025938614,"threshold_uncertainty_score":0.006462097},"labels":[],"label_agreement":null},{"id":"W1644692312","doi":"10.1002/ajh.23690","title":"How common are myeloproliferative neoplasms? A systematic review and meta‐analysis","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University; Queen's University Belfast","keywords":"Incidence (geometry); Essential thrombocythemia; Medicine; Polycythemia vera; Meta-analysis; Publication bias; Myelofibrosis; Internal medicine; Demography","score_opus":0.03890305758919121,"score_gpt":0.3476482793114404,"score_spread":0.30874522172224916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1644692312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032108172,0.9951208,0.00043686893,0.00019447874,0.00010708328,0.00023698946,0.0005021253,0.000013226293,0.00017758342],"genre_scores_gemma":[0.109149314,0.885965,0.0018807489,0.0007294928,0.0001948499,0.0010191632,0.0008009721,0.000020833999,0.00023964708],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9898733,0.0050290045,0.002732378,0.001048205,0.001016635,0.00030056143],"domain_scores_gemma":[0.98116404,0.0139888665,0.0027013007,0.00048302778,0.0014315557,0.00023125057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013291311,0.0027376697,0.0167067,0.007999845,0.00069052697,0.0030973167,0.0020038805,0.002085085,0.004019264],"category_scores_gemma":[0.033137042,0.0014763894,0.03643112,0.009380083,0.0007458232,0.0020510938,0.001543234,0.0016578354,0.00034843117],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000944548,0.00002078958,0.0044223256,0.41676447,0.56544185,0.0001439177,0.00009238646,0.0004925241,0.00014225443,0.00014198905,0.00068770564,0.01070533],"study_design_scores_gemma":[0.00030681203,0.00015007828,0.003851232,0.03515681,0.957958,0.00014896234,0.00005470071,0.00019173056,0.00007599674,0.00020481169,0.0018773952,0.000023576413],"about_ca_topic_score_codex":0.008593269,"about_ca_topic_score_gemma":0.019381434,"teacher_disagreement_score":0.0167067,"about_ca_system_score_codex":0.0029871303,"about_ca_system_score_gemma":0.0039280457,"threshold_uncertainty_score":0.070292056},"labels":[],"label_agreement":null},{"id":"W1827459324","doi":"10.1002/ajh.24120","title":"Age and d<scp>PCR</scp> can predict relapse in <scp>CML</scp> patients who discontinued imatinib: The <scp>ISAV</scp> study","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Regione Lombardia; Associazione Italiana per la Ricerca sul Cancro","keywords":"Imatinib; Medicine; Cancer research; Myeloid leukemia","score_opus":0.014613517413403032,"score_gpt":0.26853034137151954,"score_spread":0.2539168239581165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827459324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988135,0.00046143628,0.0000641751,0.00006662001,0.000013669244,0.000011677583,0.00017581454,0.0000029908256,0.00039006342],"genre_scores_gemma":[0.9992581,0.00012552654,0.00008634333,0.000047741603,0.00003786922,0.000009442535,0.00028343088,0.000002145292,0.00014939564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960357,0.00018511774,0.000044596014,0.000060020688,0.000058715417,0.000047989903],"domain_scores_gemma":[0.99759334,0.00091730914,0.00061733584,0.00015697847,0.00014523174,0.00056977395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012835885,0.00041030877,0.00054550247,0.0004710549,0.0002095084,0.00056597276,0.00031142563,0.0006779882,0.0011122243],"category_scores_gemma":[0.0026904305,0.00018734692,0.0006132325,0.00042238366,0.00022013718,0.00044826706,0.00028581888,0.00066764525,0.00031443735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004036115,0.00012887668,0.9920013,0.000012805124,0.00010226583,0.000078156554,0.000024430074,0.00010460666,0.00049157284,0.000010693237,0.00012919393,0.0028800408],"study_design_scores_gemma":[0.0003129764,0.0026793673,0.99301404,0.00001542223,0.0002500363,0.00058629544,0.0000681821,0.0017005088,0.00042735334,0.00005517806,0.0008789019,0.000011735759],"about_ca_topic_score_codex":0.0006618469,"about_ca_topic_score_gemma":0.000965004,"teacher_disagreement_score":0.0012835885,"about_ca_system_score_codex":0.00020064227,"about_ca_system_score_gemma":0.00021769112,"threshold_uncertainty_score":0.0067883134},"labels":[],"label_agreement":null},{"id":"W1920875642","doi":"10.1002/ajh.23713","title":"Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?”","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Red blood cell distribution width; Mean corpuscular volume; Medicine; Complete blood count; White blood cell; Waist; Mean corpuscular hemoglobin; Hematocrit; Absolute neutrophil count; Body mass index; Mean corpuscular hemoglobin concentration; Internal medicine; Mean platelet volume; Hemoglobin; Hematology; Gastroenterology; Obesity; Immunology; Platelet","score_opus":0.026027793562909192,"score_gpt":0.2795449404333959,"score_spread":0.2535171468704867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920875642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.901067,0.025959084,0.04768809,0.0051787067,0.00168303,0.00024163384,0.0042206226,0.0009230311,0.013038806],"genre_scores_gemma":[0.96062404,0.0026137067,0.03059169,0.0010354266,0.00041722108,0.00023570564,0.0031715045,0.0001516429,0.0011591469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969599,0.0011122627,0.0007008066,0.00038849557,0.000739984,0.00009858269],"domain_scores_gemma":[0.985233,0.0038452365,0.0036629464,0.0021600462,0.0044721444,0.0006266165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006532518,0.0005388372,0.00083722675,0.0021160035,0.000413168,0.001031592,0.0012175934,0.0006966797,0.00064573844],"category_scores_gemma":[0.02713985,0.00022013507,0.0003405587,0.0025635785,0.00041892004,0.000721481,0.0005394966,0.00087510917,0.00054951455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013813584,0.00017165381,0.8302704,0.00037346646,0.0002105344,0.00053342653,0.00089352997,0.0009099805,0.002583043,0.0012170366,0.014062779,0.14739275],"study_design_scores_gemma":[0.00010203472,0.00070949306,0.96685666,0.00040885122,0.00021425277,0.0016073709,0.00081374205,0.003930862,0.0027335116,0.0021227293,0.02041592,0.00008450469],"about_ca_topic_score_codex":0.0032621813,"about_ca_topic_score_gemma":0.0036851766,"teacher_disagreement_score":0.006532518,"about_ca_system_score_codex":0.0002534452,"about_ca_system_score_gemma":0.00045383372,"threshold_uncertainty_score":0.034547687},"labels":[],"label_agreement":null},{"id":"W1927141198","doi":"10.1002/ajh.24183","title":"Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Fludarabine; Alemtuzumab; Transplantation; Hemoglobinopathy; Surgery; Immunosuppression; Internal medicine; Thalassemia; Cord blood; Gastroenterology; Hemolytic anemia; Cyclophosphamide; Chemotherapy","score_opus":0.00893459279584028,"score_gpt":0.2525848785514647,"score_spread":0.24365028575562445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1927141198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993837,0.00021372111,0.00013979276,0.000015322914,0.000007040596,0.000013118212,0.000024888368,0.0000058895034,0.00019652986],"genre_scores_gemma":[0.9995091,0.00014105003,0.00018775712,0.000021860811,0.0000060356842,0.0000059060767,0.00006404218,0.0000020594846,0.000062235944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975854,0.000061800965,0.00002019809,0.000029036693,0.00005991212,0.00007052375],"domain_scores_gemma":[0.99976844,0.00006009434,0.00006307233,0.000023142242,0.000013207623,0.00007208605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043075805,0.00023736763,0.00026802425,0.00024622394,0.0002988885,0.00022048483,0.0002434463,0.0002534561,0.00060146494],"category_scores_gemma":[0.001196109,0.0001659582,0.00024466397,0.00021171127,0.0003977237,0.0001679268,0.000399755,0.0002751907,0.00011235531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013418754,0.00042427424,0.8773893,0.00013876574,0.0001045379,0.034562074,0.0015030635,0.0014421905,0.013507598,0.00032029382,0.0009308556,0.068335146],"study_design_scores_gemma":[0.00050278497,0.005028085,0.90047693,0.000052490344,0.00013664948,0.07891315,0.0009165363,0.0023500985,0.008221442,0.0003103975,0.003066274,0.000025122554],"about_ca_topic_score_codex":0.0018911491,"about_ca_topic_score_gemma":0.0036755113,"teacher_disagreement_score":0.0018911491,"about_ca_system_score_codex":0.00047854922,"about_ca_system_score_gemma":0.0004918932,"threshold_uncertainty_score":0.0037602782},"labels":[],"label_agreement":null},{"id":"W1931277076","doi":"10.1002/ajh.24006","title":"The platelet serotonin‐release assay","year":2015,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet factor 4; Heparin; Platelet; Medicine; Coagulopathy; Heparin-induced thrombocytopenia; Platelet activation; Context (archaeology); Immunoassay; Immunology; Internal medicine; Antibody; Biology","score_opus":0.0590633344323724,"score_gpt":0.38027587658416717,"score_spread":0.3212125421517948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1931277076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033895942,0.99576,0.0005063615,0.00039922327,0.00030490945,0.000022372047,0.00009390873,0.000041540177,0.0025328172],"genre_scores_gemma":[0.0046727965,0.991707,0.00079435686,0.00048147107,0.00044173023,0.00004052941,0.0002488794,0.000006378145,0.0016067405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895763,0.00018999558,0.00018441486,0.00014665544,0.00046541842,0.00005584299],"domain_scores_gemma":[0.9989839,0.00040194343,0.00022619466,0.000044334876,0.00028564112,0.000057965142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012050753,0.0012690079,0.001901169,0.004839658,0.00023768331,0.0013737326,0.001344893,0.001318992,0.002583331],"category_scores_gemma":[0.0020510314,0.000330148,0.0007949167,0.0028636314,0.00071409094,0.0011267274,0.00067189167,0.0018764704,0.003082883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013996764,0.000091714435,0.0019558421,0.009158857,0.00019246248,0.0005033386,0.000044102453,0.00025712312,0.0021823556,0.0020850056,0.03829311,0.94509625],"study_design_scores_gemma":[0.00006830394,0.00036612822,0.0077198553,0.0048293862,0.00035506676,0.0124909915,0.00007894899,0.000331738,0.0036683124,0.0020783148,0.96794206,0.00007094437],"about_ca_topic_score_codex":0.0014729784,"about_ca_topic_score_gemma":0.0012362077,"teacher_disagreement_score":0.004839658,"about_ca_system_score_codex":0.00065061345,"about_ca_system_score_gemma":0.00087376515,"threshold_uncertainty_score":0.008642077},"labels":[],"label_agreement":null},{"id":"W1940067247","doi":"10.1002/ajh.23888","title":"Clinical outcomes of splenectomy in children: Report of the splenectomy in congenital hemolytic anemia registry","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Alberta Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Splenectomy; Medicine; Anemia; Adverse effect; Pediatrics; Hereditary spherocytosis; Spherocytosis; Clinical trial; Hemolytic anemia; Surgery; Internal medicine; Spleen","score_opus":0.015096725203558755,"score_gpt":0.33887633355245683,"score_spread":0.3237796083488981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940067247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960179,0.0003041957,0.00015608288,0.00008669865,0.000006245125,0.000017662447,0.0028815025,0.000008279042,0.00052131305],"genre_scores_gemma":[0.99521446,0.00037646352,0.00034352235,0.000035990342,0.0000134159045,0.000032142045,0.003915456,0.000006090934,0.00006240663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718493,0.0010528996,0.00057852676,0.00030178175,0.0006711553,0.00021064085],"domain_scores_gemma":[0.98522264,0.0033709584,0.008297644,0.00096538034,0.0015176844,0.0006257467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032350207,0.00016864904,0.00037389738,0.0014059974,0.00030300373,0.0007909208,0.0003589749,0.0002409721,0.00035059432],"category_scores_gemma":[0.009514942,0.00019190775,0.0003440224,0.0026213052,0.00035178202,0.00059116696,0.0006764595,0.00044094448,0.000106192965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025598772,0.000008420946,0.9986291,0.000007487431,0.000023457398,0.000037244434,0.00005805396,0.000046914458,0.00003300495,0.000014930777,0.00020044218,0.0009153645],"study_design_scores_gemma":[0.00000560333,0.000054648055,0.9986737,0.000011478661,0.00002566866,0.0003454595,0.00020924801,0.00014007122,0.000119263335,0.000008177341,0.00040228586,0.0000044776175],"about_ca_topic_score_codex":0.0072256178,"about_ca_topic_score_gemma":0.007620078,"teacher_disagreement_score":0.0072256178,"about_ca_system_score_codex":0.00067571306,"about_ca_system_score_gemma":0.0010895582,"threshold_uncertainty_score":0.017108679},"labels":[],"label_agreement":null},{"id":"W1964003009","doi":"10.1002/ajh.21850","title":"Comprehensive evaluation of time‐to‐response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time‐point does matter?","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Imatinib; Internal medicine; Oncology; Hazard ratio; Myeloid leukemia; Proportional hazards model; Receiver operating characteristic; Nilotinib; Survival analysis; Confidence interval","score_opus":0.014152098318423739,"score_gpt":0.31747014263009415,"score_spread":0.3033180443116704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964003009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552476,0.0005298475,0.003473402,0.00008074545,0.000008849461,0.000018096993,0.00012138889,0.000022566406,0.00022031329],"genre_scores_gemma":[0.998428,0.000070854716,0.001163455,0.000012970337,0.00001529866,0.000013972507,0.00021314238,0.0000043020027,0.000077983095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990589,0.00051079196,0.0000921262,0.000094384246,0.00015638022,0.00008736503],"domain_scores_gemma":[0.9922599,0.0045748404,0.0017930119,0.00044183046,0.00042115472,0.0005093548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003903926,0.000391798,0.0006989191,0.0009522,0.00016380953,0.0005440406,0.00026387256,0.00047181864,0.000550355],"category_scores_gemma":[0.0067377416,0.00009927875,0.0007154663,0.00073728943,0.00033427638,0.00069724757,0.0003991992,0.00074065704,0.00014076103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011293617,0.00008462587,0.97197986,0.00003962312,0.0001586431,0.00009471883,0.00010527752,0.0027728616,0.002145195,0.00012651025,0.00016194355,0.021201313],"study_design_scores_gemma":[0.000030283512,0.0019230866,0.9705043,0.00001775183,0.00026864052,0.0005451128,0.00017677927,0.022829186,0.002529018,0.00047011435,0.00066606834,0.00003976185],"about_ca_topic_score_codex":0.0004639569,"about_ca_topic_score_gemma":0.00056368177,"teacher_disagreement_score":0.003903926,"about_ca_system_score_codex":0.00019444477,"about_ca_system_score_gemma":0.00039126314,"threshold_uncertainty_score":0.020646155},"labels":[],"label_agreement":null},{"id":"W1964239136","doi":"10.1002/ajh.23235","title":"Autologous stem cell transplant for light chain deposition disease: Incorporating bortezomib to the induction therapy","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Induction therapy; Oncology; Disease; Autologous stem-cell transplantation; Stem cell; Multiple myeloma; Internal medicine; Biology; Chemotherapy; Genetics","score_opus":0.010477279161658686,"score_gpt":0.25739473633693877,"score_spread":0.24691745717528008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964239136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98293835,0.004292935,0.0071402094,0.00073122676,0.0002781258,0.00037152984,0.00007574927,0.00013256088,0.0040392983],"genre_scores_gemma":[0.99438226,0.0012285404,0.003193875,0.00033401832,0.00029121956,0.000058998794,0.00013178574,0.000012603891,0.00036667704],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99977416,0.0000322833,0.00003982732,0.000045297304,0.00004962289,0.000058906444],"domain_scores_gemma":[0.99965346,0.00006135037,0.00006668742,0.000039957707,0.000013921183,0.0001645478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034703946,0.00046152007,0.00060574134,0.0006735441,0.00096316915,0.00058461115,0.00047241198,0.00068757,0.0009541316],"category_scores_gemma":[0.00066033826,0.00016371241,0.0005022759,0.0005393012,0.00072480674,0.00030933385,0.00068797346,0.0011423124,0.00045185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032898714,0.0034994457,0.2670704,0.0004707782,0.00017020106,0.46757215,0.0016739427,0.0029234837,0.054354966,0.0017682879,0.0027512976,0.19445522],"study_design_scores_gemma":[0.0008180809,0.01279748,0.1156378,0.00013250041,0.00013809092,0.84439147,0.00032663308,0.0031352097,0.0131749,0.0010161964,0.008387588,0.00004407623],"about_ca_topic_score_codex":0.00025879726,"about_ca_topic_score_gemma":0.0006370209,"teacher_disagreement_score":0.00096316915,"about_ca_system_score_codex":0.0005852464,"about_ca_system_score_gemma":0.00042383707,"threshold_uncertainty_score":0.004246235},"labels":[],"label_agreement":null},{"id":"W1965889017","doi":"10.1002/ajh.21034","title":"Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Mitoxantrone; Medicine; Cytarabine; Internal medicine; Etoposide; Induction chemotherapy; Chemotherapy; Myeloid leukemia; Oncology; Leukemia; Regimen; Bone marrow; Surgery; Gastroenterology","score_opus":0.010878838440427353,"score_gpt":0.2888395293219061,"score_spread":0.27796069088147873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965889017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991761,0.00038357193,0.000045972192,0.00010036874,0.00000884778,0.00000810125,0.000040288356,0.000005222123,0.00023156639],"genre_scores_gemma":[0.9995191,0.00007585108,0.000047512494,0.00006763006,0.000021673022,0.00000867218,0.000176318,0.00000229279,0.00008089196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996184,0.00009818032,0.000052572694,0.0000440793,0.00009328429,0.000093400195],"domain_scores_gemma":[0.997138,0.0009653266,0.0009724557,0.000102465834,0.00020447181,0.00061732956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000534594,0.00030210867,0.00046397877,0.00039195246,0.0003497157,0.00055901514,0.0004303033,0.00085568905,0.0009879491],"category_scores_gemma":[0.0047008996,0.00016119498,0.0003911442,0.00042844363,0.00024213216,0.0003600133,0.0002540406,0.0006878898,0.00027961345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002964621,0.00004536333,0.996824,0.000005732097,0.000019731304,0.00027948778,0.000027910834,0.00015431631,0.00026593785,0.0000098436285,0.000118498305,0.0019527344],"study_design_scores_gemma":[0.000045941237,0.00054768793,0.9959431,0.00001088806,0.000051144176,0.0017711191,0.00009319595,0.0009338315,0.00019996065,0.00003347186,0.00036357608,0.000006051998],"about_ca_topic_score_codex":0.00094029907,"about_ca_topic_score_gemma":0.0013999529,"teacher_disagreement_score":0.0009879491,"about_ca_system_score_codex":0.00025188684,"about_ca_system_score_gemma":0.00026086654,"threshold_uncertainty_score":0.003305018},"labels":[],"label_agreement":null},{"id":"W1965922185","doi":"10.1002/ajh.23281","title":"A genome‐wide single‐nucleotide polymorphism‐array can improve the prognostic stratification of the core binding factor acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Research Foundation of Korea","keywords":"Core binding factor; SNP array; SNP; Single-nucleotide polymorphism; Myeloid leukemia; Internal medicine; Cytogenetics; Leukemia; Medicine; Oncology; Gastroenterology; Biology; Pathology; Genetics; Gene; Genotype; Chromosome; Transcription factor","score_opus":0.024239111791797253,"score_gpt":0.28446918928598314,"score_spread":0.26023007749418586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965922185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736124,0.0006594125,0.0011076241,0.00008042295,0.000010921402,0.0000073161054,0.00034607155,0.00002285632,0.00040407205],"genre_scores_gemma":[0.9976802,0.00019504885,0.0013939086,0.000038311147,0.000018616598,0.0000099844665,0.0004423962,0.0000036726806,0.00021781112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997309,0.000093361356,0.000024225668,0.00007238397,0.000051143754,0.00002803016],"domain_scores_gemma":[0.9997136,0.00013273006,0.00007487593,0.000020443524,0.000032893655,0.000025473453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038358165,0.00021444011,0.0002855781,0.0004312542,0.000118019314,0.0002743869,0.00010748241,0.00023582869,0.0011327891],"category_scores_gemma":[0.0008142743,0.00011260447,0.00013758875,0.00041150762,0.00007702004,0.00010710438,0.00016072764,0.00023050189,0.00026321423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002224781,0.0001304516,0.7540305,0.000073413685,0.00030083995,0.00021693646,0.000060910275,0.0011787323,0.16069227,0.00011938557,0.00088924513,0.08008245],"study_design_scores_gemma":[0.00004762062,0.0005189987,0.97243214,0.000011642632,0.0002699109,0.00096489483,0.000051307718,0.004584883,0.018963015,0.00033823043,0.0018041708,0.0000130613325],"about_ca_topic_score_codex":0.00032307807,"about_ca_topic_score_gemma":0.00072792795,"teacher_disagreement_score":0.0011327891,"about_ca_system_score_codex":0.00010348686,"about_ca_system_score_gemma":0.00012259728,"threshold_uncertainty_score":0.003789544},"labels":[],"label_agreement":null},{"id":"W1966047453","doi":"10.1002/ajh.23114","title":"Liver iron overload assessment by <i>T</i> magnetic resonance imaging in pediatric patients: An accuracy and reproducibility study","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Reproducibility; Magnetic resonance imaging; Hereditary hemochromatosis; Liver biopsy; Intraclass correlation; Hemochromatosis; Thalassemia; Liver disease; Nuclear medicine; Internal medicine; Gastroenterology; Biopsy; Radiology; Chemistry","score_opus":0.0064878308965340215,"score_gpt":0.2707239944682171,"score_spread":0.26423616357168306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966047453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975605,0.0013559551,0.007475745,0.00004732385,0.000020181498,0.000058425176,0.00019680115,0.00008460979,0.001004851],"genre_scores_gemma":[0.9966748,0.00021895798,0.0027588257,0.000031192005,0.000019803412,0.000035723497,0.00016432886,0.0000332353,0.00006305089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99188495,0.0031680781,0.0010544757,0.0017688692,0.0019096347,0.00021399042],"domain_scores_gemma":[0.9731505,0.013041808,0.005945839,0.0030652797,0.0043655583,0.0004310702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011639783,0.00065201696,0.00084736425,0.00093350234,0.0002594757,0.0009022519,0.0007080022,0.0007946187,0.00039759785],"category_scores_gemma":[0.02904836,0.00042741236,0.0005901167,0.0009463735,0.0008653636,0.00081468176,0.0007449175,0.0005377085,0.00033766814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008227858,0.000060984246,0.9724999,0.00009940364,0.00029478993,0.0002612621,0.0007004172,0.0009568059,0.004054477,0.00007246625,0.0001901554,0.019986557],"study_design_scores_gemma":[0.00006851564,0.0018524382,0.9820716,0.000043221837,0.00038950547,0.0028792773,0.00032226503,0.006019139,0.0052174213,0.000088893496,0.0010110677,0.000036721798],"about_ca_topic_score_codex":0.0009953129,"about_ca_topic_score_gemma":0.00088813365,"teacher_disagreement_score":0.011639783,"about_ca_system_score_codex":0.00034836738,"about_ca_system_score_gemma":0.00031392518,"threshold_uncertainty_score":0.06155783},"labels":[],"label_agreement":null},{"id":"W1966765074","doi":"10.1002/ajh.10423","title":"β‐thalassemia in association with a new δ‐chain hemoglobin variant [δ116(g18)Arg→Leu]: Implications for carrier screening and prenatal diagnosis","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; McMaster University; Hamilton Regional Laboratory Medicine Program; McMaster University Medical Centre","funders":"","keywords":"Hemoglobinopathy; Hydrops fetalis; Missense mutation; Genetic counseling; Thalassemia; Genetics; Medicine; Mutation; Prenatal diagnosis; Beta thalassemia; Hemolytic anemia; Pediatrics; Fetus; Gene; Biology; Internal medicine; Pregnancy","score_opus":0.007806648338934649,"score_gpt":0.25690089344622197,"score_spread":0.2490942451072873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966765074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967128,0.000447621,0.00046712597,0.00046125997,0.000027748698,0.000014016351,0.000019339743,0.000025143156,0.0018249224],"genre_scores_gemma":[0.99865556,0.0002599399,0.00047438545,0.00013027592,0.000081211554,0.000004253875,0.000018137742,0.0000061108985,0.0003701379],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998317,0.000040827643,0.000021062036,0.00003019536,0.00002726956,0.00004890704],"domain_scores_gemma":[0.99938846,0.00025011634,0.00017828157,0.000038347258,0.00002616787,0.00011862337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019746837,0.0005895082,0.00022618451,0.0005590328,0.0008403306,0.00046484914,0.00036377122,0.0010083584,0.0020339892],"category_scores_gemma":[0.0017349371,0.0002592052,0.00018112203,0.00038576283,0.0007356612,0.00034165446,0.0003563625,0.0007441736,0.0003345665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011549573,0.00007308669,0.13489032,0.000027043136,0.000013878645,0.8502936,0.0006361468,0.00015128903,0.0043960214,0.00037203167,0.00047069666,0.008560459],"study_design_scores_gemma":[0.000018049048,0.00009984771,0.034532066,0.000014277973,0.00003984536,0.96219254,0.00031263396,0.00046786325,0.0010623012,0.00028443668,0.0009643659,0.0000118014395],"about_ca_topic_score_codex":0.0015635785,"about_ca_topic_score_gemma":0.0018772876,"teacher_disagreement_score":0.0020339892,"about_ca_system_score_codex":0.00016594777,"about_ca_system_score_gemma":0.00019550032,"threshold_uncertainty_score":0.006804347},"labels":[],"label_agreement":null},{"id":"W1967239210","doi":"10.1002/ajh.23142","title":"von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Hemophilia Society; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand disease; Von Willebrand factor; Desmopressin; Medicine; Immunology; Disease; Genetic testing; Mucocutaneous zone; Pathology; Internal medicine","score_opus":0.09793278708351735,"score_gpt":0.4271209498048195,"score_spread":0.32918816272130214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967239210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028255542,0.90671444,0.004417106,0.076991454,0.004522213,0.000033605782,0.00009145895,0.000100978665,0.004303216],"genre_scores_gemma":[0.039225932,0.88561815,0.010985695,0.03019675,0.031578597,0.00006528774,0.00014215305,0.00009612925,0.0020913715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963547,0.0010475382,0.0005309486,0.00068116985,0.0012385373,0.00014714104],"domain_scores_gemma":[0.9820661,0.008263336,0.0007686547,0.001302081,0.0057744575,0.0018254095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011860662,0.0016074888,0.0025467265,0.004200566,0.0010268433,0.004612967,0.002455525,0.004882847,0.002191587],"category_scores_gemma":[0.023783702,0.00071622554,0.00093034265,0.002585885,0.006636817,0.00977832,0.002237691,0.011883923,0.0015573573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003576925,0.00045724923,0.0084423525,0.0025103542,0.0002059858,0.0018964976,0.0009135662,0.00080277375,0.0015747689,0.035651557,0.09699301,0.85019416],"study_design_scores_gemma":[0.00020942377,0.0005944518,0.0159501,0.00980276,0.0003827418,0.013181717,0.0017955563,0.0015030389,0.0014226455,0.120721966,0.8340782,0.0003572852],"about_ca_topic_score_codex":0.005708375,"about_ca_topic_score_gemma":0.0047018006,"teacher_disagreement_score":0.011860662,"about_ca_system_score_codex":0.0035513346,"about_ca_system_score_gemma":0.003498864,"threshold_uncertainty_score":0.06272596},"labels":[],"label_agreement":null},{"id":"W1967769769","doi":"10.1002/ajh.21014","title":"Azathioprine‐associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine <i>S</i>‐methyltransferase deficiency","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Thiopurine methyltransferase; Mercaptopurine; Azathioprine; Medicine; Myeloid leukemia; Leukemia; Immunology; Internal medicine; Disease; Gastroenterology; Cancer research","score_opus":0.005749631895019002,"score_gpt":0.25839464130702955,"score_spread":0.25264500941201057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967769769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965806,0.0012786775,0.00058519625,0.0018066306,0.00014643458,0.00015921403,0.00015688235,0.00005128581,0.006157629],"genre_scores_gemma":[0.9972487,0.00053295546,0.0004941291,0.0005558292,0.0002496858,0.000018882149,0.000074288175,0.000008810776,0.00081669],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995291,0.00007673586,0.00005259713,0.00012294814,0.00006618143,0.00015258987],"domain_scores_gemma":[0.9991098,0.00030659616,0.000106142485,0.00004975168,0.000043884356,0.00038391902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042646693,0.0015012488,0.0010156338,0.0019394803,0.0024773134,0.0010494451,0.0007304647,0.0036339487,0.0023574424],"category_scores_gemma":[0.0027533208,0.0010791441,0.00069964916,0.0011749777,0.0013147678,0.0013488657,0.0009290166,0.00230766,0.00060502125],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024070342,0.00011916274,0.023226786,0.0000418023,0.000017621249,0.97184384,0.00034375046,0.00007827145,0.0017498826,0.0001986219,0.0003062082,0.0018333348],"study_design_scores_gemma":[0.000088269844,0.00047136907,0.03078058,0.000026192542,0.000038402555,0.9666685,0.0002121077,0.00031411136,0.00050204527,0.00024132841,0.0006393569,0.000017739634],"about_ca_topic_score_codex":0.0027342637,"about_ca_topic_score_gemma":0.003603973,"teacher_disagreement_score":0.0036339487,"about_ca_system_score_codex":0.0009619688,"about_ca_system_score_gemma":0.0007932611,"threshold_uncertainty_score":0.007886469},"labels":[],"label_agreement":null},{"id":"W1969822989","doi":"10.1002/ajh.23127","title":"HITlights: A career perspective on heparin‐induced thrombocytopenia","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Heparin; Medicine; Platelet factor 4; Discontinuation; Thrombosis; Platelet activation; Venous thrombosis; Internal medicine; Platelet; Intensive care medicine; Immunology","score_opus":0.1102006222201683,"score_gpt":0.39364517943620486,"score_spread":0.28344455721603656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969822989","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008532674,0.42715088,0.0008958814,0.5013688,0.05055193,0.000014228251,0.000102819446,0.00008574345,0.018976364],"genre_scores_gemma":[0.016625512,0.5559218,0.0008763647,0.26571852,0.13453901,0.000051737257,0.000167748,0.00015678855,0.025942508],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971717,0.0013200986,0.0001599697,0.00031104797,0.00054559344,0.0004915961],"domain_scores_gemma":[0.99087745,0.0037166919,0.00041994953,0.00017538034,0.0014766655,0.0033338778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054014437,0.0009515641,0.00097468484,0.0036705954,0.0031931826,0.0082014315,0.0016263098,0.009460313,0.017619181],"category_scores_gemma":[0.010119391,0.0004502838,0.000750795,0.0029618246,0.0062515447,0.009761787,0.0047177984,0.013521816,0.0060479464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060270027,0.00006716871,0.0005976964,0.00051794754,0.000015759484,0.0003628292,0.0011550013,0.000079323014,0.000121041085,0.050574828,0.844925,0.10152311],"study_design_scores_gemma":[0.000013918733,0.000082414386,0.00039921008,0.0013583779,0.000007697123,0.0006482517,0.0010587557,0.000046869445,0.00002413042,0.01227135,0.9840693,0.00001982782],"about_ca_topic_score_codex":0.0036619545,"about_ca_topic_score_gemma":0.007236408,"teacher_disagreement_score":0.017619181,"about_ca_system_score_codex":0.0039905626,"about_ca_system_score_gemma":0.004140937,"threshold_uncertainty_score":0.05894208},"labels":[],"label_agreement":null},{"id":"W1969826448","doi":"10.1002/ajh.23415","title":"Sweet's syndrome in chronic myelomonocytic leukemia","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; Sweet's syndrome; Chest radiograph; Chills; Pneumonia; Erythrocyte sedimentation rate; Absolute neutrophil count; Gastroenterology; Pathology; Monocytosis; Prednisone; Leukemia; Complete blood count; Internal medicine; Bone marrow; Lung; Neutropenia; Chemotherapy","score_opus":0.007110658152241725,"score_gpt":0.2508595251202777,"score_spread":0.243748866968036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969826448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97769755,0.00624241,0.0012184024,0.0018182239,0.000233767,0.00016407706,0.00026126063,0.00010766493,0.012256746],"genre_scores_gemma":[0.9962043,0.0014634256,0.00036302584,0.0007516632,0.00018051281,0.000024262628,0.00014685585,0.0000052421897,0.00086078356],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99974185,0.000049909035,0.000033520766,0.000042571963,0.00003468372,0.00009743807],"domain_scores_gemma":[0.999652,0.000107678956,0.00008597844,0.000017742977,0.000024356606,0.00011229638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030856038,0.0012382547,0.00051686337,0.0010455098,0.00073878124,0.00053342764,0.00037100504,0.0016640289,0.0022549992],"category_scores_gemma":[0.0014172521,0.00034514707,0.00033732774,0.0010472953,0.0006515454,0.0008615539,0.00067454914,0.00093099044,0.0005299435],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031067748,0.00011429272,0.0608431,0.00013408932,0.000030778137,0.9243501,0.00022655961,0.0001928231,0.0044604028,0.0007583396,0.0018119153,0.006766946],"study_design_scores_gemma":[0.000087398825,0.0002686152,0.043057796,0.00013170112,0.000039034578,0.95097375,0.0002540238,0.00045300167,0.000722397,0.0011426826,0.0028443902,0.000025172205],"about_ca_topic_score_codex":0.0006628395,"about_ca_topic_score_gemma":0.00093170657,"teacher_disagreement_score":0.0022549992,"about_ca_system_score_codex":0.00040814097,"about_ca_system_score_gemma":0.00039406493,"threshold_uncertainty_score":0.007543683},"labels":[],"label_agreement":null},{"id":"W1970155654","doi":"10.1002/ajh.20833","title":"Imatinib mesylate responsiveness in aggressive systemic mastocytosis: Novel association with a platelet derived growth factor receptor beta mutation","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Hematopathology; Systemic mastocytosis; Medicine; Imatinib mesylate; PDGFRA; Library science; Family medicine; Imatinib; Pathology; Internal medicine; Bone marrow; Biology; Genetics; Myeloid leukemia; GiST","score_opus":0.007452370465555895,"score_gpt":0.24460344501564774,"score_spread":0.23715107455009185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970155654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239385,0.00083731825,0.0007102911,0.00094653654,0.00006208488,0.00004728712,0.00020221404,0.00006902462,0.0047314344],"genre_scores_gemma":[0.9993393,0.00008287128,0.0001889601,0.00013030457,0.00006991951,0.0000063477255,0.000041060615,0.000006061734,0.00013503544],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997203,0.000039911363,0.00004695444,0.00006529257,0.000056326735,0.00007117488],"domain_scores_gemma":[0.9992268,0.0003499581,0.00015699906,0.000036828198,0.000028476488,0.00020089526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020515024,0.0010360053,0.0005767337,0.00092096225,0.00054061133,0.0006161201,0.00065218593,0.0017273262,0.0020816035],"category_scores_gemma":[0.0011858863,0.0003086819,0.00052709994,0.00061312556,0.0006652824,0.00037446382,0.0003849974,0.0009771517,0.00042445023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006783044,0.000094058836,0.048838653,0.0000596098,0.000048090427,0.9154256,0.00015677842,0.0002910684,0.0289972,0.0003921384,0.0007554104,0.004263161],"study_design_scores_gemma":[0.00014025459,0.00047221314,0.107707284,0.000020995727,0.00011805779,0.88126904,0.00013716561,0.0019268802,0.0064798174,0.0003448626,0.0013553469,0.000027994422],"about_ca_topic_score_codex":0.00058784656,"about_ca_topic_score_gemma":0.00095791934,"teacher_disagreement_score":0.0020816035,"about_ca_system_score_codex":0.00044981707,"about_ca_system_score_gemma":0.0002976995,"threshold_uncertainty_score":0.0069636703},"labels":[],"label_agreement":null},{"id":"W1970453456","doi":"10.1002/ajh.21179","title":"Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary‐care population","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Center for Research Resources; National Human Genome Research Institute; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Deutsches Krebsforschungszentrum","keywords":"Transferrin saturation; Phlebotomy; Pacific islanders; Medicine; Ferritin; Serum ferritin; Hereditary hemochromatosis; Hemochromatosis; Serum iron; Internal medicine; Population; Gastroenterology; Physiology; Anemia; Immunology; Environmental health","score_opus":0.010090391402769428,"score_gpt":0.2761692197154976,"score_spread":0.2660788283127282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970453456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955934,0.00010543604,0.000025370107,0.000044331908,0.0000028940724,0.0000063480093,0.00007176659,0.0000020903249,0.00018238575],"genre_scores_gemma":[0.9997168,0.00004797333,0.000032190455,0.00004456412,0.000009395478,0.0000065599756,0.00008493551,7.6291315e-7,0.000056684676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992986,0.00031101183,0.00004675593,0.00013111574,0.00012501658,0.00008767071],"domain_scores_gemma":[0.99892944,0.00023304655,0.00030965355,0.000086694,0.0001631579,0.00027809918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010258099,0.0002721899,0.00034243395,0.0006511218,0.0007399551,0.00074744405,0.00027649247,0.00068446517,0.00078475714],"category_scores_gemma":[0.003382317,0.00039426144,0.0002826281,0.00066492654,0.00039434773,0.00050715945,0.00038639404,0.00058221206,0.0002272933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010225524,0.0000623841,0.99880993,0.000004100309,0.000029655725,0.00009140576,0.00016017628,0.00001321017,0.00014029958,0.0000045355127,0.00009188234,0.00049020833],"study_design_scores_gemma":[0.000018158626,0.00022509524,0.99884284,0.0000037123432,0.000026667129,0.00033793328,0.00028557982,0.00014372721,0.000030999377,0.000010981146,0.000071720955,0.0000026020496],"about_ca_topic_score_codex":0.011298728,"about_ca_topic_score_gemma":0.010957866,"teacher_disagreement_score":0.011298728,"about_ca_system_score_codex":0.00047406755,"about_ca_system_score_gemma":0.00029489893,"threshold_uncertainty_score":0.022465885},"labels":[],"label_agreement":null},{"id":"W1970526583","doi":"10.1002/ajh.10191","title":"Health status and health‐related quality of life associated with hemophilia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Regional Municipality of Niagara; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Health Utilities Index; Clotting factor; Quality of life (healthcare); Population; Cohort; Haemophilia; Disease; Pediatrics; Environmental health; Internal medicine; Health related quality of life","score_opus":0.05858427877993451,"score_gpt":0.3631025268245747,"score_spread":0.3045182480446402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970526583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943896,0.0009796098,0.00007466628,0.00025632887,0.000008207226,0.00002926515,0.0009841217,0.000003313964,0.0032749637],"genre_scores_gemma":[0.99910694,0.00026665724,0.00006680687,0.000028462728,0.0000059750855,0.0000063091493,0.00032967457,4.313968e-7,0.00018882015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948597,0.000110619905,0.00004601681,0.000046595444,0.00021824136,0.00009246712],"domain_scores_gemma":[0.99875593,0.00013670967,0.00051720836,0.000048688555,0.00024054674,0.00030100072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000533703,0.00010420598,0.00022105189,0.0005839337,0.00034747034,0.00052814727,0.00018815589,0.0002307387,0.0017131013],"category_scores_gemma":[0.0022994166,0.00007734846,0.00028238707,0.0010654868,0.00049521367,0.00033214194,0.0004183266,0.000531,0.00013634619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004855737,0.00006504712,0.99536586,0.000029171355,0.000056240682,0.00005011757,0.00013195572,0.00009835807,0.00013726053,0.000054805,0.00016573259,0.0037969088],"study_design_scores_gemma":[0.0000010289224,0.000031122352,0.9996704,0.0000042831634,0.0000052149944,0.000035846213,0.000056347562,0.000059971775,0.000008503405,0.00001661037,0.00010914128,0.0000015158446],"about_ca_topic_score_codex":0.04919855,"about_ca_topic_score_gemma":0.05285417,"teacher_disagreement_score":0.04919855,"about_ca_system_score_codex":0.00092098856,"about_ca_system_score_gemma":0.0005843341,"threshold_uncertainty_score":0.097824335},"labels":[],"label_agreement":null},{"id":"W1971844177","doi":"10.1002/ajh.20481","title":"Osteonecrosis of the jaw associated with pamidronate therapy","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Osteonecrosis of the jaw; Discontinuation; Multiple myeloma; Osteomyelitis; Bisphosphonate; Surgery; Osteoporosis; Bone pain; Adverse effect; Adjuvant therapy; Zoledronic acid; Internal medicine; Chemotherapy","score_opus":0.011706102906241462,"score_gpt":0.2782029998680319,"score_spread":0.2664968969617904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971844177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831119,0.0050814087,0.0010012584,0.0002694763,0.00006579586,0.00010096922,0.00010474355,0.00006551979,0.010199004],"genre_scores_gemma":[0.99719584,0.0013810858,0.0004551021,0.00021228919,0.00010700072,0.0000123075415,0.00006641285,0.00000742068,0.00056247815],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99907553,0.0001136317,0.000107801854,0.0001276984,0.0003117554,0.00026356342],"domain_scores_gemma":[0.99749184,0.00046750825,0.0012927924,0.00017401956,0.00023212799,0.00034169253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034965717,0.0006264317,0.00087988534,0.001183131,0.0012053789,0.0006841153,0.0003531814,0.0008885103,0.0024364558],"category_scores_gemma":[0.0022613571,0.00036200997,0.000626224,0.0013444403,0.0007841816,0.00031536203,0.0007647473,0.0010752312,0.00043637143],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058302976,0.0003291697,0.6842587,0.00036525598,0.00013445386,0.2601186,0.00077805464,0.0001805758,0.020925995,0.00022174163,0.0007847895,0.031319674],"study_design_scores_gemma":[0.0000725284,0.0008212665,0.30642632,0.000115193165,0.00015902538,0.6834428,0.00039756426,0.00031679857,0.0043891906,0.00014839105,0.0036835684,0.000027341055],"about_ca_topic_score_codex":0.0020226412,"about_ca_topic_score_gemma":0.0036361094,"teacher_disagreement_score":0.0024364558,"about_ca_system_score_codex":0.0005522362,"about_ca_system_score_gemma":0.0005567218,"threshold_uncertainty_score":0.008150756},"labels":[],"label_agreement":null},{"id":"W1973610900","doi":"10.1002/ajh.10393","title":"Case of acute lymphoblastic leukemia presenting with t(14;18)/<i>BCL2</i>, t(8;14)/cMYC, and t(1;2)/<i>FCGR2B</i>","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chromosomal translocation; BCL6; Cancer research; Lymphoma; Lymphoblastic lymphoma; Phenotype; Follicular lymphoma; Biology; Molecular biology; T cell; Antibody; Immunology; Gene; B cell; Genetics; Immune system; Germinal center","score_opus":0.009367562735246984,"score_gpt":0.2615077763345461,"score_spread":0.2521402135992991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973610900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982014,0.0024198417,0.002972305,0.0036157342,0.00030583236,0.00030578164,0.00045333544,0.00022581912,0.0076874187],"genre_scores_gemma":[0.9937562,0.0010758563,0.0016956519,0.0011703306,0.00059744436,0.000051412113,0.00017876642,0.000026583422,0.0014477754],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99942136,0.000076689474,0.000061999504,0.00012522144,0.00007061483,0.0002441094],"domain_scores_gemma":[0.99867505,0.00028213105,0.00024202357,0.00010111265,0.0000655989,0.00063401135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032947955,0.0021131327,0.0012995432,0.0020648767,0.002351286,0.0014417156,0.0011636418,0.0049008993,0.0020622911],"category_scores_gemma":[0.0022772504,0.0013524629,0.0008560194,0.0024507956,0.0016248712,0.0015872229,0.0018368714,0.0034869548,0.0009834779],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005355432,0.000047816255,0.0068884376,0.0000238933,0.000008211412,0.99081856,0.00017152916,0.000068863876,0.00059598824,0.00018399881,0.00029799753,0.0008410959],"study_design_scores_gemma":[0.000016423772,0.000051994273,0.0026713272,0.0000054870957,0.000008371468,0.9962782,0.00008125942,0.00009960557,0.00018178427,0.00016390483,0.00043460104,0.000007029892],"about_ca_topic_score_codex":0.0026919728,"about_ca_topic_score_gemma":0.003401607,"teacher_disagreement_score":0.0049008993,"about_ca_system_score_codex":0.0013159836,"about_ca_system_score_gemma":0.0010975933,"threshold_uncertainty_score":0.009548128},"labels":[],"label_agreement":null},{"id":"W1974058071","doi":"10.1002/ajh.20956","title":"Immune complex binding by immunocamouflaged [poly(ethylene glycol)‐grafted] erythrocytes","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Flow cytometry; Chemistry; Red blood cell; Ethylene glycol; PEG ratio; Immune system; Alkaline phosphatase; Biochemistry; Molecular biology; Immunology; Medicine; Enzyme; Biology","score_opus":0.009675783027959685,"score_gpt":0.27114300607176794,"score_spread":0.26146722304380826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974058071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901334,0.001672657,0.0067894086,0.00004445379,0.000020698419,0.000047395155,0.00007058255,0.00007725342,0.0011441715],"genre_scores_gemma":[0.9875994,0.0013189041,0.007990442,0.00012802806,0.000015583926,0.000044619905,0.00026666958,0.00003796334,0.0025984487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997224,0.0000625973,0.00001443198,0.00006709859,0.00006733718,0.000066157365],"domain_scores_gemma":[0.99986887,0.00005627942,0.0000298122,0.0000133526655,0.00001929505,0.000012405453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023606872,0.0004775945,0.0002837229,0.00018820129,0.0001193822,0.00031960645,0.00043633,0.000413258,0.00086399546],"category_scores_gemma":[0.00027068245,0.00016787558,0.00021180617,0.00015097066,0.00016446826,0.00021927411,0.0002861657,0.0004115412,0.00031359162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003922237,0.000008651713,0.000045709417,0.000029753757,0.0000031589107,0.000013203238,0.000010514228,0.000047666454,0.99885046,0.00004425596,0.000017587914,0.00088976556],"study_design_scores_gemma":[0.000005176878,0.00007913065,0.00065679144,0.0000034462162,0.0000070039014,0.000055901593,0.0000047171443,0.0007757675,0.997537,0.000007543318,0.0008647732,0.0000026774123],"about_ca_topic_score_codex":0.0011264435,"about_ca_topic_score_gemma":0.0010245255,"teacher_disagreement_score":0.0011264435,"about_ca_system_score_codex":0.00042791507,"about_ca_system_score_gemma":0.00012495494,"threshold_uncertainty_score":0.0031047463},"labels":[],"label_agreement":null},{"id":"W1976299049","doi":"10.1002/ajh.1102","title":"Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project","year":2001,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; U.S. Department of Health and Human Services","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Anaplastic lymphoma kinase; Medicine; Large-cell lymphoma; Null cell; Stage (stratigraphy); International Prognostic Index; Peripheral T-cell lymphoma; Internal medicine; Pathology; Non-Hodgkin's lymphoma; Not Otherwise Specified; Bone marrow; Oncology; Diffuse large B-cell lymphoma; T cell; Immunology; Biology","score_opus":0.03797715189213066,"score_gpt":0.32788348335132883,"score_spread":0.2899063314591982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976299049","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521437,0.0016510427,0.00092847814,0.0002897449,0.00006033601,0.00026054805,0.03287158,0.00008404649,0.011710483],"genre_scores_gemma":[0.9559141,0.0005691767,0.00104374,0.00007038606,0.00004231079,0.00035817607,0.04045503,0.00005539147,0.0014916327],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806803,0.0004000248,0.0002601259,0.00021855801,0.000883304,0.00017005544],"domain_scores_gemma":[0.9950571,0.00076791755,0.00108327,0.00017867246,0.0024803982,0.00043275685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022758262,0.0004049483,0.0005514559,0.0034786803,0.0003145408,0.0005927591,0.00035576388,0.00028992718,0.0022239434],"category_scores_gemma":[0.005819237,0.00014493588,0.0005946446,0.0029387302,0.00017299481,0.00047573683,0.0008590705,0.00026692133,0.0010761387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001852595,0.000019951987,0.9923968,0.000039036535,0.00005454557,0.000049006696,0.00005109287,0.00015139458,0.000132554,0.00002462325,0.002472968,0.0044227187],"study_design_scores_gemma":[0.00002553551,0.000049127848,0.9970451,0.000019429543,0.000046551388,0.0002171541,0.00012247662,0.00031515988,0.00010882124,0.00002319613,0.002022404,0.000005141329],"about_ca_topic_score_codex":0.008490681,"about_ca_topic_score_gemma":0.008570364,"teacher_disagreement_score":0.008490681,"about_ca_system_score_codex":0.0006259454,"about_ca_system_score_gemma":0.00062204583,"threshold_uncertainty_score":0.016882539},"labels":[],"label_agreement":null},{"id":"W1979470678","doi":"10.1002/1096-8652(200008)64:4<306::aid-ajh12>3.0.co;2-v","title":"Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Pancytopenia; Macrocytosis; Gastroenterology; Prednisone; Internal medicine; Danazol; Myelodysplastic syndromes; Bone marrow; Myeloid; Anemia","score_opus":0.009845085584709527,"score_gpt":0.25939139876208434,"score_spread":0.2495463131773748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979470678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843007,0.010209139,0.0018346527,0.00066986424,0.00009761731,0.00009114689,0.00014148482,0.000119565026,0.002535891],"genre_scores_gemma":[0.9964439,0.0016011453,0.00037358908,0.00035370415,0.00007557214,0.000021046075,0.00026694918,0.000009827852,0.0008542565],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99987626,0.000018812036,0.000021065385,0.000030578485,0.000021845373,0.000031399068],"domain_scores_gemma":[0.9997873,0.000039596816,0.000045430283,0.000018581854,0.000015814056,0.00009332568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014086213,0.00041192287,0.0006458548,0.00032685683,0.00045938013,0.00017771497,0.00026446165,0.0005694219,0.0005465838],"category_scores_gemma":[0.0004996155,0.00019972835,0.00040204442,0.00023418786,0.00021840402,0.00022927202,0.0002578456,0.0010063272,0.00020566335],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061088037,0.0013238954,0.104155,0.0010080339,0.0005277953,0.4579618,0.001610451,0.0019876251,0.25951827,0.0012465958,0.0035158414,0.16103598],"study_design_scores_gemma":[0.0021737362,0.012224067,0.23308748,0.00019510691,0.0006314084,0.694255,0.00027214922,0.004299694,0.026451172,0.0007384753,0.025577137,0.000094612544],"about_ca_topic_score_codex":0.00078976323,"about_ca_topic_score_gemma":0.0016347832,"teacher_disagreement_score":0.00078976323,"about_ca_system_score_codex":0.00026036883,"about_ca_system_score_gemma":0.00032162876,"threshold_uncertainty_score":0.0018891096},"labels":[],"label_agreement":null},{"id":"W1979478767","doi":"10.1002/ajh.20809","title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi‐center study of iron overload","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Deutsches Krebsforschungszentrum","keywords":"Medicine; Thalassemia; Internal medicine; Chelation therapy; Transfusion therapy; Hemoglobinopathy; Ferritin; Mortality rate; Disease; Acute chest syndrome; Gastroenterology; Sickle cell anemia; Pediatrics; Anemia; Beta thalassemia; Blood transfusion","score_opus":0.007330059617678686,"score_gpt":0.2553811969636909,"score_spread":0.2480511373460122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979478767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995216,0.00020240666,0.000022935472,0.000026786576,0.0000040942714,0.0000027508172,0.00013655494,0.0000018423501,0.00008104783],"genre_scores_gemma":[0.9994585,0.00012617455,0.000032800628,0.000025380297,0.000015359336,0.0000052695104,0.0002671999,9.603825e-7,0.00006841528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999655,0.000114479466,0.00004383776,0.000048951963,0.00008399509,0.00005366747],"domain_scores_gemma":[0.9986952,0.00017063861,0.0005478655,0.00007208349,0.00013583909,0.00037842634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004904685,0.0002628571,0.00030650187,0.0006661351,0.00044286688,0.00051509455,0.00021736299,0.00045139712,0.0005014538],"category_scores_gemma":[0.0013126539,0.0002955215,0.00031222295,0.00066331885,0.00028894038,0.00029911828,0.0002929913,0.00043667518,0.00014123549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036895883,0.000012871194,0.99935776,0.000003283809,0.000018797187,0.000045919507,0.00007244699,0.00000778257,0.00008075312,0.0000025257727,0.00005676265,0.00030429702],"study_design_scores_gemma":[0.0000033388721,0.0000388825,0.9996216,0.0000018673516,0.0000085201755,0.00017278302,0.000060035,0.000034483845,0.00001642454,0.0000023083203,0.00003842375,0.0000013083006],"about_ca_topic_score_codex":0.009251277,"about_ca_topic_score_gemma":0.010250411,"teacher_disagreement_score":0.009251277,"about_ca_system_score_codex":0.00029612813,"about_ca_system_score_gemma":0.00025293778,"threshold_uncertainty_score":0.018394828},"labels":[],"label_agreement":null},{"id":"W1979616872","doi":"10.1002/ajh.22193","title":"Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Internal medicine; Myeloid leukemia; Gastroenterology; Medicine; Leukemia; Oncology; Multiple drug resistance; Drug resistance; Biology; Genetics","score_opus":0.02171115480259071,"score_gpt":0.2723642155425807,"score_spread":0.25065306073999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979616872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995134,0.00018080421,0.00007031964,0.000017105967,0.0000019352392,0.0000023317052,0.00007587119,0.0000025162983,0.000135715],"genre_scores_gemma":[0.9997613,0.000041416763,0.00004259602,0.000005073657,0.0000051870056,0.0000016291904,0.00011200146,5.950202e-7,0.000030105653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978834,0.00004960509,0.000035666093,0.000036853955,0.00004940548,0.000040088686],"domain_scores_gemma":[0.999003,0.00017032387,0.0005522305,0.000038681846,0.000061943305,0.00017391823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023036521,0.0002170747,0.00021049334,0.0006145487,0.00015985887,0.0003042177,0.00016682163,0.00025238734,0.0011506019],"category_scores_gemma":[0.0013195995,0.0001089743,0.00016585254,0.0004868618,0.0002048209,0.00021992884,0.00028253708,0.00025040345,0.00019581261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012623887,0.0000065647473,0.9980045,0.0000031532204,0.000012593627,0.00008619455,0.000008730041,0.000030819407,0.00062428147,0.000007184993,0.000021476239,0.0010683124],"study_design_scores_gemma":[0.0000036804042,0.0000752783,0.9985624,0.0000015001433,0.000016142001,0.0008535358,0.000032656382,0.0001381923,0.00020031127,0.000024056306,0.000090415844,0.0000018880382],"about_ca_topic_score_codex":0.0005079703,"about_ca_topic_score_gemma":0.0008321833,"teacher_disagreement_score":0.0011506019,"about_ca_system_score_codex":0.00013923482,"about_ca_system_score_gemma":0.00016254178,"threshold_uncertainty_score":0.0038491488},"labels":[],"label_agreement":null},{"id":"W1980928845","doi":"10.1002/ajh.22043","title":"Chills and limb pain following administration of low‐molecular‐weight heparin for treatment of acute venous thromboembolism","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Pfizer Canada; Sanofi; Heart and Stroke Foundation of Canada; GlaxoSmithKline; Pfizer","keywords":"Medicine; Warfarin; Heparin; Thrombosis; Surgery; Aortic valve replacement; Low molecular weight heparin; Anesthesia; Stenosis; Placebo; Aortic valve; Bicuspid aortic valve; Internal medicine; Atrial fibrillation","score_opus":0.013334043417539158,"score_gpt":0.2794444136735976,"score_spread":0.2661103702560585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980928845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92690706,0.017023774,0.002583664,0.014109611,0.0014628822,0.0010104876,0.00046052816,0.00033713932,0.03610488],"genre_scores_gemma":[0.99015474,0.0026503194,0.00036664188,0.004487797,0.0006825554,0.0000478232,0.0001498456,0.000009028585,0.0014510859],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99960726,0.0001271695,0.000043808333,0.00004500077,0.00009004614,0.00008664634],"domain_scores_gemma":[0.9990746,0.00032041987,0.00020573333,0.000037132668,0.00010253352,0.00025957177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032618036,0.0006234771,0.0007031454,0.00057036517,0.00058505515,0.0003789786,0.00043261622,0.001313483,0.001819149],"category_scores_gemma":[0.003454656,0.00022237566,0.0004638691,0.00047390175,0.00037011376,0.00045703902,0.00030785604,0.001896838,0.00045313084],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019660518,0.0011293174,0.10335631,0.0003930026,0.0001981913,0.8427269,0.0006387415,0.00025599328,0.004451993,0.0003880919,0.009858762,0.03463663],"study_design_scores_gemma":[0.00066470704,0.0045436253,0.5021705,0.00041279904,0.00023291337,0.47825995,0.00063861586,0.0023048292,0.0010483616,0.0005627688,0.009102346,0.00005851219],"about_ca_topic_score_codex":0.003800051,"about_ca_topic_score_gemma":0.0075509353,"teacher_disagreement_score":0.003800051,"about_ca_system_score_codex":0.00081887137,"about_ca_system_score_gemma":0.00048562474,"threshold_uncertainty_score":0.007555902},"labels":[],"label_agreement":null},{"id":"W1981232641","doi":"10.1002/ajh.22211","title":"Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antibody; Medicine; Platelet; Immune thrombocytopenia; Autoantibody; Immune system; Immunology; Refractory (planetary science); Internal medicine; Pharmacology","score_opus":0.025032111086878472,"score_gpt":0.29517928663196097,"score_spread":0.2701471755450825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981232641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823417,0.016135933,0.00015743874,0.00016143442,0.000042028954,0.000015625832,0.00005515757,0.0000065682857,0.0010841002],"genre_scores_gemma":[0.99782014,0.0017304242,0.00006934878,0.00006818592,0.00010021925,0.000005807244,0.000067201494,0.000001686308,0.00013696244],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99919575,0.00046769826,0.000089290304,0.00006468701,0.00011028404,0.00007221411],"domain_scores_gemma":[0.99750334,0.0015521427,0.00035956377,0.00012223225,0.000092414666,0.0003703008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092041533,0.00021260112,0.00075908116,0.0004834413,0.00015357777,0.00035269975,0.00016684357,0.00035777825,0.0008352558],"category_scores_gemma":[0.003491727,0.000071184906,0.00035957136,0.000350219,0.00036467682,0.00027454313,0.0001451245,0.0003912238,0.00022990245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18857074,0.0034516386,0.31841654,0.00080796616,0.0015289998,0.003287382,0.00063045445,0.002102447,0.029317362,0.0004975633,0.0006649959,0.45072395],"study_design_scores_gemma":[0.009935856,0.14541782,0.80738896,0.00031551684,0.0020527851,0.008531165,0.000655486,0.0025367462,0.014639686,0.0005860341,0.007878393,0.00006154298],"about_ca_topic_score_codex":0.00026172528,"about_ca_topic_score_gemma":0.00034631634,"teacher_disagreement_score":0.00092041533,"about_ca_system_score_codex":0.00021404219,"about_ca_system_score_gemma":0.00017922046,"threshold_uncertainty_score":0.004867673},"labels":[],"label_agreement":null},{"id":"W1982548570","doi":"10.1002/ajh.23299","title":"Platelet count or bleeding as the outcome in ITP trials?","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Romiplostim; Medicine; Eltrombopag; Rituximab; Randomized controlled trial; Clinical trial; Surrogate endpoint; Intensive care medicine; Population; Immune thrombocytopenia; Clinical endpoint; Platelet transfusion; Thrombopoietin; Internal medicine; Platelet; Pediatrics","score_opus":0.053693725698102816,"score_gpt":0.354241109787535,"score_spread":0.30054738408943216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982548570","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032348512,0.3958626,0.01367041,0.51569486,0.061551265,0.0013548777,0.00088898535,0.00016046625,0.0075816642],"genre_scores_gemma":[0.12290724,0.08759467,0.027662955,0.629273,0.12270238,0.0064207753,0.0007611484,0.00061105826,0.0020666767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.33087417,0.56205475,0.062859975,0.010441213,0.03225261,0.0015172502],"domain_scores_gemma":[0.14169587,0.79157346,0.035934485,0.011245441,0.016784808,0.0027659533],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.45446965,0.0017072562,0.008445543,0.005267889,0.0024947857,0.013599181,0.0066005816,0.014758739,0.0055082603],"category_scores_gemma":[0.7090202,0.0012895782,0.0048071374,0.007234109,0.013132849,0.011896914,0.005355264,0.02030175,0.0016103642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013202944,0.00032460378,0.025394948,0.07185846,0.021598682,0.0005088009,0.004377116,0.0012853912,0.00033039387,0.10121489,0.34211418,0.41778952],"study_design_scores_gemma":[0.0147318095,0.004647426,0.017245447,0.18610092,0.01680554,0.001403529,0.0026829478,0.0049672252,0.0010458385,0.2384282,0.5112233,0.0007177886],"about_ca_topic_score_codex":0.0015816868,"about_ca_topic_score_gemma":0.0023927153,"teacher_disagreement_score":0.5455303,"about_ca_system_score_codex":0.0066894884,"about_ca_system_score_gemma":0.0072943275,"threshold_uncertainty_score":0.67273605},"labels":[],"label_agreement":null},{"id":"W1984359522","doi":"10.1002/ajh.22188","title":"Is HbA<sub>2</sub>level a reliable diagnostic measurement for β‐thalassemia trait in people with iron deficiency?","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Associazione Italiana per la Ricerca sul Cancro; National Natural Science Foundation of China","keywords":"Thalassemia; Medicine; Iron deficiency; Pediatrics; Hemoglobin A2; Beta thalassemia; Internal medicine; Anemia","score_opus":0.0223781394122578,"score_gpt":0.23916650008224782,"score_spread":0.21678836066999002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984359522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811451,0.010858617,0.0015997745,0.0026753815,0.0005391588,0.000028909251,0.00079470844,0.000046542085,0.0023118204],"genre_scores_gemma":[0.9959197,0.0013439889,0.0009562729,0.00074681005,0.0004477317,0.000012621693,0.00034557757,0.000011912225,0.00021552765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840623,0.00047522844,0.00020386059,0.00024846214,0.00053701916,0.00012919976],"domain_scores_gemma":[0.9930299,0.0025774087,0.0020885365,0.00061523693,0.0013335673,0.00035540247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028895908,0.00035949922,0.00082245254,0.0011790084,0.00026350474,0.00088149944,0.0008497609,0.0012384381,0.0010500867],"category_scores_gemma":[0.0118967965,0.0002659152,0.00030172928,0.001229712,0.00060481316,0.00068566675,0.00025977843,0.00084377563,0.00077249843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022095682,0.000047420046,0.9872901,0.00004394982,0.00007498209,0.00011537437,0.00006518771,0.000025931831,0.0004594393,0.000029825585,0.001057657,0.01056929],"study_design_scores_gemma":[0.000033134063,0.00040211246,0.99399984,0.00011123364,0.00021602455,0.0009752077,0.0003192834,0.0009850272,0.00084708247,0.0002887953,0.0018071032,0.000015162922],"about_ca_topic_score_codex":0.0012721525,"about_ca_topic_score_gemma":0.0013333445,"teacher_disagreement_score":0.0028895908,"about_ca_system_score_codex":0.00021397485,"about_ca_system_score_gemma":0.0002116009,"threshold_uncertainty_score":0.015281796},"labels":[],"label_agreement":null},{"id":"W1987310638","doi":"10.1002/ajh.23139","title":"New oral anticoagulants: A view from the laboratory","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Warfarin; Medicine; Clotting factor; Coagulation; Pharmacology; Intensive care medicine; Atrial fibrillation; Internal medicine","score_opus":0.10860307122521635,"score_gpt":0.4028264263322955,"score_spread":0.29422335510707914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987310638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043415304,0.99664515,0.00008492882,0.0020546934,0.00059466495,0.0000013027752,0.0000042550837,0.0000042970946,0.0005673112],"genre_scores_gemma":[0.00042501872,0.99650085,0.0001762213,0.0012320835,0.0013015971,0.0000028605475,0.0000071961845,0.0000011556997,0.00035306532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993192,0.00015817895,0.00010088602,0.00008141641,0.00029551552,0.00004479899],"domain_scores_gemma":[0.99875367,0.0005626087,0.0001429999,0.00003347084,0.00039183223,0.0001154795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014115215,0.0010757738,0.0017012189,0.0036128364,0.0004849427,0.0020986532,0.0011194918,0.002486551,0.0028230625],"category_scores_gemma":[0.0017950261,0.00035581226,0.00066572963,0.0035372623,0.0014125542,0.005542227,0.0011928941,0.005128478,0.0016669829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008250498,0.00010030428,0.00034757218,0.015398197,0.00010607579,0.0005597686,0.00025235186,0.0002567897,0.0012370916,0.012377601,0.114609234,0.8546726],"study_design_scores_gemma":[0.000015998468,0.00007514815,0.00053395797,0.0061119176,0.00006673102,0.002688273,0.00021087281,0.00006610364,0.0001394796,0.0057091904,0.98435843,0.000023952662],"about_ca_topic_score_codex":0.0011624099,"about_ca_topic_score_gemma":0.0015990882,"teacher_disagreement_score":0.0036128364,"about_ca_system_score_codex":0.0011738049,"about_ca_system_score_gemma":0.0017879913,"threshold_uncertainty_score":0.009444058},"labels":[],"label_agreement":null},{"id":"W1988316234","doi":"10.1002/ajh.23476","title":"Microfluidic analysis of cellular deformability of normal and oxidatively damaged red blood cells","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Centre for Blood Research, University of British Columbia; Michael Smith Health Research BC; University of British Columbia; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Red blood cell; Microfluidics; Chemistry; In vivo; Erythrocyte deformability; Whole blood; Biophysics; Venous blood; Biomedical engineering; Materials science; Biochemistry; Medicine; Biology; Immunology; Internal medicine; Nanotechnology","score_opus":0.007802928624233493,"score_gpt":0.23280573695972823,"score_spread":0.22500280833549474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988316234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807328,0.0011338885,0.016340798,0.00008603846,0.000053040632,0.00005248037,0.00059715856,0.000118850774,0.00088487094],"genre_scores_gemma":[0.9832023,0.0007051032,0.014638098,0.00006480973,0.000021215312,0.000119792865,0.0003785775,0.0000098436685,0.00086032547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983156,0.000014316016,0.000014925791,0.000049721948,0.00006269645,0.000026814363],"domain_scores_gemma":[0.9998198,0.000054532466,0.000057914916,0.000014999103,0.000033966448,0.000018832872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026492853,0.00021442682,0.00016472081,0.00036929187,0.00015911584,0.00023634032,0.00017507172,0.00020230007,0.00036641906],"category_scores_gemma":[0.00038699954,0.00008829122,0.00014867111,0.00023371962,0.0001784633,0.00012777574,0.00017185972,0.0002816466,0.00007644513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003677926,0.000017027045,0.0016078254,0.000026202484,0.000007201156,0.000021570519,0.000032406268,0.00020227359,0.9940759,0.000111823014,0.0000535157,0.003807494],"study_design_scores_gemma":[0.000008249842,0.00026168872,0.04534755,0.000009203004,0.000024218378,0.00018242547,0.00006363605,0.008166921,0.94425005,0.00015036881,0.0015146344,0.000021096928],"about_ca_topic_score_codex":0.00055825454,"about_ca_topic_score_gemma":0.0008429206,"teacher_disagreement_score":0.00055825454,"about_ca_system_score_codex":0.00034284015,"about_ca_system_score_gemma":0.00018993135,"threshold_uncertainty_score":0.0024875402},"labels":[],"label_agreement":null},{"id":"W1988750456","doi":"10.1002/ajh.1149","title":"Gelatinous transformation of bone marrow from a starch‐free diet","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Anorexia nervosa; Bone marrow; Wasting; Complication; Atrophy; Medicine; Hypoplasia; Internal medicine; Hematology; Endocrinology; Pathology; Surgery; Gastroenterology; Physiology; Eating disorders","score_opus":0.020442679851243654,"score_gpt":0.2557655206603293,"score_spread":0.23532284080908566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988750456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382704,0.00044911998,0.0019132606,0.000096323995,0.000021696691,0.000042878568,0.000041993077,0.000067478555,0.0035401739],"genre_scores_gemma":[0.9983139,0.00024383498,0.00045708028,0.000056242938,0.0000073855,0.000009536943,0.00005922546,0.000010050757,0.00084280415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999385,0.000010829449,0.0000068182676,0.000010683904,0.000016489095,0.000016704877],"domain_scores_gemma":[0.9998958,0.000022597802,0.000027251239,0.000021972332,0.0000052597893,0.000027025917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000673518,0.00030123722,0.00012948134,0.00034033964,0.00023926469,0.00019850778,0.00015438414,0.00030486606,0.0007397918],"category_scores_gemma":[0.0003387517,0.0001192252,0.0001753589,0.00013550851,0.0004030387,0.0001344609,0.00033799862,0.00047459977,0.00025211196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015320133,0.00026107702,0.017810125,0.00012745816,0.000056135286,0.4015263,0.00065045553,0.00039307176,0.55007195,0.0019901404,0.00041582805,0.025165467],"study_design_scores_gemma":[0.00025941682,0.0012515588,0.04863154,0.000026315622,0.00008256673,0.7588074,0.00024997158,0.0013507253,0.18045315,0.0012258681,0.0076324283,0.000028987655],"about_ca_topic_score_codex":0.00035341046,"about_ca_topic_score_gemma":0.00044297962,"teacher_disagreement_score":0.0007397918,"about_ca_system_score_codex":0.00015359608,"about_ca_system_score_gemma":0.0001243319,"threshold_uncertainty_score":0.0024748445},"labels":[],"label_agreement":null},{"id":"W1990760693","doi":"10.1002/ajh.1123","title":"Therapeutic choices for patients with hemophilia and high‐titer inhibitors","year":2001,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hemostasis; Recombinant factor VIIa; Dosing; PROTHROMBIN COMPLEX; Intensive care medicine; Prothrombin complex concentrate; Factor IX; Coagulation; Thrombosis; Surgery; Pharmacology; Internal medicine; Warfarin","score_opus":0.027118402901943242,"score_gpt":0.34546792371876234,"score_spread":0.3183495208168191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990760693","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22221723,0.118298754,0.0055082585,0.40554512,0.0067035723,0.00036283705,0.0010090956,0.00036389884,0.23999134],"genre_scores_gemma":[0.7335168,0.08125797,0.010522484,0.11914322,0.006694267,0.00045802098,0.0013143136,0.00009444804,0.046998553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996693,0.00012878797,0.000029750985,0.000025874691,0.00008058654,0.000065719774],"domain_scores_gemma":[0.99911803,0.00025621822,0.0001385205,0.000018378541,0.00006501979,0.00040387863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004890679,0.00020586682,0.00029626087,0.00042699758,0.0010366688,0.0007116392,0.00026595502,0.0015717234,0.023242401],"category_scores_gemma":[0.0034101512,0.000087891276,0.00037115838,0.00038004102,0.00033974863,0.0008045833,0.0005968784,0.0016669545,0.0029749067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012286665,0.0008405297,0.04363399,0.0008585377,0.000107818894,0.016125485,0.0022342352,0.0004971823,0.0021708403,0.010320999,0.4014605,0.5205212],"study_design_scores_gemma":[0.0007041205,0.0012433066,0.050774552,0.0016761012,0.00017268005,0.048356358,0.0055058384,0.00053163746,0.0008564937,0.020577246,0.86949736,0.000104391314],"about_ca_topic_score_codex":0.00025743977,"about_ca_topic_score_gemma":0.00089624606,"teacher_disagreement_score":0.023242401,"about_ca_system_score_codex":0.00030614354,"about_ca_system_score_gemma":0.00061161537,"threshold_uncertainty_score":0.0777536},"labels":[],"label_agreement":null},{"id":"W1991802905","doi":"10.1002/ajh.23169","title":"Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post‐ASH symposium","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Incyte; National Cancer Institute; National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Disease; Internal medicine","score_opus":0.01614833568897234,"score_gpt":0.2788131011693511,"score_spread":0.26266476548037876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991802905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017232284,0.8247697,0.0030655274,0.13249022,0.011556653,0.00006637494,0.00049544394,0.00010160775,0.010222256],"genre_scores_gemma":[0.06685524,0.84121495,0.004116787,0.025787223,0.04769935,0.00011926577,0.0006317691,0.000067876055,0.0135076055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996393,0.0000862834,0.000030550367,0.00006460905,0.00013300338,0.000046343317],"domain_scores_gemma":[0.9991763,0.00030226735,0.00008096052,0.000019923009,0.0002495796,0.00017096521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022506358,0.0005129698,0.00062441314,0.0007974067,0.00035797633,0.002596469,0.0004229328,0.0010473577,0.0028349403],"category_scores_gemma":[0.001646991,0.0002101907,0.0003125565,0.0004745086,0.00070372294,0.0012682998,0.0005923948,0.003219854,0.00057094824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006054746,0.0002467746,0.0061639347,0.0013888606,0.00014468844,0.0005378571,0.00044187767,0.00057245744,0.015047323,0.0063963947,0.32055306,0.64790136],"study_design_scores_gemma":[0.00009815879,0.000337413,0.036739796,0.0020673142,0.0002404839,0.0011187951,0.0005909791,0.0008856258,0.0053939093,0.008096048,0.94436765,0.00006387911],"about_ca_topic_score_codex":0.0010320492,"about_ca_topic_score_gemma":0.0026338226,"teacher_disagreement_score":0.0028349403,"about_ca_system_score_codex":0.0009740698,"about_ca_system_score_gemma":0.0010688611,"threshold_uncertainty_score":0.01190269},"labels":[],"label_agreement":null},{"id":"W1992703709","doi":"10.1002/ajh.21970","title":"Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B‐cell clones","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Prolymphocytic leukemia; CD5; Chronic lymphocytic leukemia; Biology; Population; Immunophenotyping; Molecular biology; Chlorambucil; Gene rearrangement; CD23; Lymphocytosis; Pathology; Leukemia; Flow cytometry; Immunology; Medicine; Antibody; Gene; Chemotherapy; Genetics","score_opus":0.009449893434788895,"score_gpt":0.2977117687352977,"score_spread":0.2882618753005088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992703709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794067,0.0024032255,0.0012070056,0.00061761716,0.00009499435,0.00017243648,0.00039367515,0.000094148556,0.007076155],"genre_scores_gemma":[0.9960006,0.0006503536,0.00057327666,0.00045086912,0.00020283346,0.000042227803,0.00035464836,0.000016494072,0.0017088526],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99946886,0.000046599045,0.00006184679,0.0001581046,0.00008371382,0.00018087687],"domain_scores_gemma":[0.9992834,0.00022102911,0.000120183366,0.00009670617,0.000070843496,0.00020789602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028131678,0.0012985466,0.0006767255,0.0010929175,0.00088837615,0.0010109672,0.00066059007,0.0019256163,0.0035397809],"category_scores_gemma":[0.0014823116,0.0007096048,0.00041411121,0.0009087408,0.00056744006,0.0009129098,0.0008897349,0.0015304828,0.0013367567],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006519466,0.00033342393,0.06752277,0.00011886221,0.000033389773,0.90334517,0.00052417215,0.000094419804,0.019068697,0.00063799747,0.0006961107,0.0069730077],"study_design_scores_gemma":[0.00013684393,0.00033805947,0.034150664,0.000022650342,0.00003456078,0.95953035,0.00016859724,0.00030722452,0.0024658218,0.00024600353,0.002584026,0.000015225761],"about_ca_topic_score_codex":0.0011081673,"about_ca_topic_score_gemma":0.0012592593,"teacher_disagreement_score":0.0035397809,"about_ca_system_score_codex":0.000740507,"about_ca_system_score_gemma":0.000439901,"threshold_uncertainty_score":0.011841714},"labels":[],"label_agreement":null},{"id":"W1993165009","doi":"10.1002/ajh.22115","title":"Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; National Cancer Institute; Children's Cancer Research Fund","keywords":"Medicine; Cyclophosphamide; Autologous stem-cell transplantation; Internal medicine; Prednisone; Gastroenterology; Melphalan; Transplantation; POEMS syndrome; Rash; Chemotherapy; Polyneuropathy","score_opus":0.006099188971106451,"score_gpt":0.2084050559448589,"score_spread":0.20230586697375244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993165009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587387,0.002167613,0.00034358216,0.0002046173,0.000040472307,0.000050212537,0.000030326468,0.000040679406,0.0012485619],"genre_scores_gemma":[0.9989103,0.00045737298,0.00020497007,0.0000685566,0.000033253924,0.000017420529,0.00007272821,0.0000030976337,0.00023228722],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999393,0.000019484864,0.0000057440816,0.0000074559994,0.000012333365,0.000015711976],"domain_scores_gemma":[0.9998491,0.00003270557,0.0000326696,0.000009525982,0.0000064228,0.00006955722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012859862,0.00030615638,0.00038969782,0.00015253472,0.00013940911,0.00019801344,0.00010737281,0.00012993267,0.00094331853],"category_scores_gemma":[0.0006409581,0.000068816924,0.0001934469,0.00012270371,0.00010016119,0.00013700356,0.00013474174,0.00045801722,0.00020495433],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0384808,0.00725672,0.14572649,0.00041334276,0.00038240608,0.0040424434,0.00044481675,0.0021644202,0.12457819,0.000391906,0.0076295636,0.6684889],"study_design_scores_gemma":[0.0066027264,0.06691298,0.87977695,0.00017954978,0.00063020416,0.008873449,0.00022027132,0.004091268,0.019915128,0.00042885586,0.0123316115,0.00003698582],"about_ca_topic_score_codex":0.00024279888,"about_ca_topic_score_gemma":0.00073262444,"teacher_disagreement_score":0.00094331853,"about_ca_system_score_codex":0.00011679097,"about_ca_system_score_gemma":0.00022413024,"threshold_uncertainty_score":0.003155768},"labels":[],"label_agreement":null},{"id":"W1993863211","doi":"10.1002/ajh.21810","title":"Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: A systematic review","year":2010,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Hemoglobin; Pulse oximetry; Hemoglobin variants; Asymptomatic; Medicine; Hemoglobinopathy; Hypoxemia; Hemoglobin A2; Hemoglobin s; Gastroenterology; Internal medicine; Anesthesia; Hemolytic anemia; Sickle cell anemia","score_opus":0.01412093847816723,"score_gpt":0.2785655720174043,"score_spread":0.26444463353923703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993863211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018604612,0.9974201,0.000065476175,0.00015871861,0.000059394453,0.000038632974,0.0002162857,0.0000043249697,0.00017669651],"genre_scores_gemma":[0.016190968,0.9827225,0.00022984743,0.00037241445,0.00010132483,0.000076232114,0.00023704137,0.0000041898325,0.00006542803],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970487,0.00050129276,0.0014668744,0.0003232835,0.0005802935,0.00007972547],"domain_scores_gemma":[0.9705382,0.020635938,0.0060338043,0.00036950555,0.0021651231,0.0002573663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027681526,0.00074529246,0.003182075,0.009421673,0.00039120403,0.0013379111,0.0011746068,0.001184931,0.0026306354],"category_scores_gemma":[0.018236464,0.0006646294,0.0025370135,0.00999326,0.0007379727,0.0013027423,0.0008217781,0.0006098214,0.00022291887],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037339033,0.000039589722,0.012627416,0.8239822,0.006282392,0.0010185378,0.00032713238,0.00015379455,0.00037908813,0.00036772224,0.0069043166,0.14754441],"study_design_scores_gemma":[0.00026827186,0.0003519255,0.060652886,0.8064169,0.06296867,0.011252953,0.0006530319,0.00023420052,0.00067363,0.0005703426,0.05585689,0.000100158635],"about_ca_topic_score_codex":0.004579343,"about_ca_topic_score_gemma":0.0102140615,"teacher_disagreement_score":0.009421673,"about_ca_system_score_codex":0.0013008242,"about_ca_system_score_gemma":0.0046195597,"threshold_uncertainty_score":0.014639616},"labels":[],"label_agreement":null},{"id":"W1994288316","doi":"10.1002/ajh.10366","title":"Thrombotic thrombocytopenic purpura associated with a prolactin‐producing pituitary adenoma","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Galactorrhea; Pituitary adenoma; Autopsy; Prolactin; Von Willebrand factor; Schistocyte; Internal medicine; Pituitary gland; Pathology; Adenoma; Pituitary tumors; Platelet","score_opus":0.012392505174086117,"score_gpt":0.25812190846937455,"score_spread":0.24572940329528845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994288316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97833496,0.0061453427,0.0017275118,0.0023421117,0.00045712056,0.00008657503,0.00016102103,0.00019909817,0.010546224],"genre_scores_gemma":[0.9964168,0.0011589861,0.00033081305,0.00036378662,0.00079983386,0.000010568919,0.00004646636,0.000011832937,0.00086096424],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99969614,0.000039814182,0.000027090986,0.00005608267,0.000045683028,0.00013531459],"domain_scores_gemma":[0.9983158,0.00057294226,0.00036431593,0.00012753,0.000079456295,0.00054000353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024789613,0.0012069662,0.0006639608,0.0013033976,0.0018963659,0.0010963331,0.00041428272,0.0021717355,0.0024422444],"category_scores_gemma":[0.0026128602,0.000731041,0.00066281273,0.0008334415,0.0010216754,0.0010296204,0.0009474755,0.0022585918,0.0007479506],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004510922,0.000021460486,0.009175928,0.000020114938,0.000010180328,0.9886995,0.00013549082,0.000045970108,0.00061562186,0.000094725234,0.00020630014,0.0009296633],"study_design_scores_gemma":[0.000015210851,0.000041833613,0.0044052606,0.000005038213,0.000013302158,0.99468094,0.000054103843,0.00008394252,0.00020733834,0.0000861368,0.00039973724,0.0000071653076],"about_ca_topic_score_codex":0.0013545771,"about_ca_topic_score_gemma":0.0012044006,"teacher_disagreement_score":0.0024422444,"about_ca_system_score_codex":0.00035198868,"about_ca_system_score_gemma":0.00046644127,"threshold_uncertainty_score":0.008170128},"labels":[],"label_agreement":null},{"id":"W1994523135","doi":"10.1002/ajh.20250","title":"Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature","year":2005,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Helicobacter pylori; Thrombocytopenic purpura; Medicine; Immunology; Immune system; Pathogenesis; Platelet; Population; Gastroenterology; Internal medicine","score_opus":0.032831262567224344,"score_gpt":0.3459523162898362,"score_spread":0.31312105372261184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994523135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010745201,0.9994505,0.000024126293,0.00013685184,0.00010511765,0.000002572357,0.000008041335,0.0000024219787,0.00016285085],"genre_scores_gemma":[0.0005273698,0.99896145,0.00008679755,0.00015027422,0.0001301618,0.000005226785,0.000012203228,5.2555527e-7,0.00012596505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997557,0.000051069037,0.0000630918,0.000035329784,0.00008094452,0.000013911073],"domain_scores_gemma":[0.9995353,0.00023734667,0.00009207341,0.00000817417,0.00009001578,0.000037088088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005091784,0.0008318492,0.0024201756,0.0028943277,0.00028236257,0.00072514225,0.0010427639,0.0010200115,0.0032632605],"category_scores_gemma":[0.0009923129,0.00027149325,0.00052458857,0.0036005995,0.0003529157,0.001330946,0.00033569417,0.0007707422,0.0011385645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019381144,0.00007938985,0.00046662186,0.06091997,0.00029175592,0.0010426894,0.000090942995,0.0002467202,0.00076960307,0.000630718,0.03956635,0.8957014],"study_design_scores_gemma":[0.00021640265,0.0005254802,0.0077332905,0.051068645,0.0018553472,0.01622951,0.0005168834,0.0003099671,0.00052772055,0.0025082508,0.9184431,0.00006547123],"about_ca_topic_score_codex":0.0012018192,"about_ca_topic_score_gemma":0.0028899726,"teacher_disagreement_score":0.0032632605,"about_ca_system_score_codex":0.00047420672,"about_ca_system_score_gemma":0.0008376721,"threshold_uncertainty_score":0.01091671},"labels":[],"label_agreement":null},{"id":"W1995133375","doi":"10.1002/ajh.10453","title":"Mcl‐1 and Bcl‐2/Bax ratio are associated with treatment response but not with Rai stage in B‐cell chronic lymphocytic leukemia","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Saskatchewan; Royal University Hospital","funders":"Saskatchewan Health Research Foundation","keywords":"Chronic lymphocytic leukemia; Chlorambucil; Prednisone; Internal medicine; Medicine; Stage (stratigraphy); Gastroenterology; Apoptosis; Complete response; Bcl-2-associated X protein; Blot; Leukemia; Immunology; Chemotherapy; Chemistry; Biology; Caspase 3; Programmed cell death; Cyclophosphamide; Gene; Biochemistry","score_opus":0.013810373300852078,"score_gpt":0.2753354294564033,"score_spread":0.26152505615555127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995133375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891937,0.00056505523,0.000084673586,0.00002510649,0.0000034413856,0.000006344175,0.00004732431,0.000010174012,0.00033848814],"genre_scores_gemma":[0.9996617,0.00004986768,0.000049707578,0.000015971824,0.000008246091,0.0000069822336,0.00008122742,0.0000029637697,0.00012336922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995739,0.00017800914,0.000046469777,0.00006269015,0.000074942545,0.00006395014],"domain_scores_gemma":[0.9978557,0.0007780024,0.00084561604,0.000086926666,0.00015981142,0.0002739808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007643189,0.00021320708,0.00038838532,0.0008916843,0.00017569179,0.00040832913,0.0002531759,0.00058007793,0.0010660148],"category_scores_gemma":[0.002315981,0.0001936355,0.00023260941,0.00039127617,0.00041239162,0.00023576662,0.00018176076,0.00039661603,0.0003444164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032046968,0.00006785369,0.97118753,0.00003697485,0.00008979137,0.00019023287,0.00018680481,0.00012349153,0.016860483,0.000029334493,0.0001250793,0.007897777],"study_design_scores_gemma":[0.000041924293,0.0005490185,0.99747235,0.0000053758163,0.000039044324,0.0008218331,0.00006436425,0.0002435307,0.00053313066,0.00002654342,0.0001975775,0.0000053118792],"about_ca_topic_score_codex":0.00057233055,"about_ca_topic_score_gemma":0.00061653304,"teacher_disagreement_score":0.0010660148,"about_ca_system_score_codex":0.00021312252,"about_ca_system_score_gemma":0.00010052479,"threshold_uncertainty_score":0.004042208},"labels":[],"label_agreement":null},{"id":"W1995158011","doi":"10.1002/ajh.10109","title":"Cytogenetic findings in reactive lymphoid hyperplasia: Significance of non‐clonal t(3;14) and t(3;22)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoid hyperplasia; clone (Java method); Chromosomal translocation; Pathology; Karyotype; Cytogenetics; Population; Immunology; Biology; Medicine; Chromosome; Genetics","score_opus":0.010786895183906534,"score_gpt":0.25618099078977613,"score_spread":0.2453940956058696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995158011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988267,0.0004224583,0.00016524736,0.000021551423,0.000002530799,0.000007645063,0.00002277589,0.000010871372,0.0005202075],"genre_scores_gemma":[0.99961925,0.00011837849,0.00012998805,0.00001648839,0.000007790703,0.0000035816752,0.000024635528,0.0000016787327,0.000078223486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998086,0.00006218902,0.000020590482,0.00003385553,0.00004129393,0.00003355764],"domain_scores_gemma":[0.9992654,0.00026570208,0.00019257392,0.000051984072,0.000076616176,0.00014777988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039687642,0.00026417538,0.00017539888,0.001045978,0.00026517213,0.00021939017,0.00021052826,0.00035226345,0.0012942079],"category_scores_gemma":[0.0019079415,0.00018534182,0.00008972878,0.00026936817,0.00046944164,0.00019268425,0.00023779189,0.00022435134,0.00029920015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062310946,0.000086846485,0.8923202,0.000099351455,0.000034294622,0.032103945,0.0005985925,0.0003263759,0.050910685,0.00015159258,0.00030036108,0.022444602],"study_design_scores_gemma":[0.00013634287,0.0018200198,0.68486816,0.000034620047,0.00010713285,0.29146338,0.00082881365,0.0014065524,0.01715524,0.00031864588,0.0018244407,0.000036680725],"about_ca_topic_score_codex":0.0009624024,"about_ca_topic_score_gemma":0.0010568121,"teacher_disagreement_score":0.0012942079,"about_ca_system_score_codex":0.00019757102,"about_ca_system_score_gemma":0.00016151345,"threshold_uncertainty_score":0.0043295026},"labels":[],"label_agreement":null},{"id":"W1995362916","doi":"10.1002/ajh.10044","title":"CD5‐negative phenotype of monoclonal B‐lymphocytosis of undetermined significance (MLUS)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Lymphocytosis; Immunophenotyping; CD5; Chronic lymphocytic leukemia; Monoclonal; Phenotype; Immunology; Pathology; Medicine; Leukemia; Monoclonal antibody; Biology; Lymphoma; Flow cytometry; Antibody; Genetics","score_opus":0.02587918797391073,"score_gpt":0.2973255777432644,"score_spread":0.27144638976935365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995362916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618906,0.0005160908,0.00070306275,0.00003847663,0.000008730856,0.000017506125,0.00005354422,0.000020190782,0.0024533605],"genre_scores_gemma":[0.9995371,0.00005680067,0.00016352891,0.000027103084,0.000006878727,0.0000027970827,0.000036901696,0.0000024517922,0.00016641284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998677,0.00001826076,0.00001025634,0.000027626122,0.000028144226,0.000047988167],"domain_scores_gemma":[0.9997924,0.00005553511,0.00004271707,0.000024871182,0.000024396273,0.000060128514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001386766,0.00030566406,0.0001676756,0.00064113614,0.00039895097,0.0003130629,0.00020614632,0.0003418468,0.0016286031],"category_scores_gemma":[0.00074994727,0.00010959163,0.00013198634,0.00024900545,0.0004373842,0.00021170481,0.00041280934,0.00024124362,0.00027669157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008538941,0.00014807397,0.5976469,0.00027005223,0.000103181206,0.12614816,0.0017463482,0.0003525484,0.19836578,0.002401875,0.0017225831,0.07024049],"study_design_scores_gemma":[0.00009595063,0.0011085673,0.45327693,0.00003992767,0.00012217062,0.50759417,0.0006155337,0.00076615077,0.024940852,0.00068762316,0.0107145505,0.000037632366],"about_ca_topic_score_codex":0.0009513756,"about_ca_topic_score_gemma":0.0011213105,"teacher_disagreement_score":0.0016286031,"about_ca_system_score_codex":0.0001609316,"about_ca_system_score_gemma":0.00012758643,"threshold_uncertainty_score":0.005448222},"labels":[],"label_agreement":null},{"id":"W1995635002","doi":"10.1002/ajh.23210","title":"Controversies in heparin monitoring","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heparin; Medicine; Intensive care medicine; Internal medicine","score_opus":0.013570675991604159,"score_gpt":0.29891386127132147,"score_spread":0.2853431852797173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995635002","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012422148,0.43634868,0.0021826304,0.53417856,0.019347262,0.00003756945,0.000079934136,0.00006512527,0.006517967],"genre_scores_gemma":[0.04272604,0.34166923,0.006515242,0.43805605,0.16884634,0.00018014241,0.0001748368,0.000109545384,0.0017225256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9753711,0.010237218,0.005028355,0.0030032054,0.0056661377,0.0006939716],"domain_scores_gemma":[0.7828633,0.1821046,0.0066271075,0.0044471826,0.019393362,0.0045644655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039102357,0.00097198726,0.0027271865,0.0029660182,0.003092331,0.007153188,0.005301508,0.020911057,0.0049975542],"category_scores_gemma":[0.13686675,0.0008317965,0.0019357852,0.0035443015,0.013945518,0.015439586,0.0038880778,0.031268425,0.0022859962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049624284,0.000170998,0.0030924655,0.0056511904,0.00034236396,0.0018499893,0.0010792358,0.0006443585,0.00039495504,0.09520705,0.26596236,0.62510884],"study_design_scores_gemma":[0.00021943454,0.000303815,0.0024593286,0.018808814,0.00037412287,0.0058651925,0.0018051477,0.00086428307,0.00056300097,0.08387561,0.88471746,0.00014376137],"about_ca_topic_score_codex":0.003476228,"about_ca_topic_score_gemma":0.003996943,"teacher_disagreement_score":0.039102357,"about_ca_system_score_codex":0.0072328043,"about_ca_system_score_gemma":0.0059902673,"threshold_uncertainty_score":0.20679551},"labels":[],"label_agreement":null},{"id":"W1997569947","doi":"10.1002/ajh.20882","title":"Inv (11)(p15q21) in donor‐derived Ph‐negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Imatinib mesylate; Medicine; Myeloid leukemia; Transplantation; Philadelphia chromosome; Hematopoietic stem cell transplantation; Internal medicine; Imatinib; Stem cell; Dysplasia; Oncology; Gastroenterology; Immunology; Chromosomal translocation; Biology","score_opus":0.005524933062993245,"score_gpt":0.2350075105700737,"score_spread":0.22948257750708045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997569947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927487,0.00057071744,0.00051568996,0.0014068611,0.00008362555,0.00014724197,0.00011847031,0.000047076806,0.0043616393],"genre_scores_gemma":[0.99803346,0.0002505808,0.0003022671,0.00045990926,0.00011429987,0.000014235046,0.000060226343,0.000012344762,0.0007526348],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995709,0.000049726863,0.00004116016,0.00012350918,0.00006923811,0.0001454586],"domain_scores_gemma":[0.99916255,0.00019640695,0.0001315376,0.00005531033,0.00005746293,0.00039688236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044042277,0.0012311741,0.000956135,0.0016829354,0.0021880006,0.00085348065,0.0010197933,0.0031892345,0.0021883931],"category_scores_gemma":[0.0016471659,0.0006987805,0.0007307561,0.0008634001,0.0011555755,0.0009206632,0.00076629716,0.0020719436,0.0006493008],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018749114,0.00015913563,0.017142609,0.000024686376,0.000010839886,0.9775374,0.000375967,0.0000888482,0.0024273677,0.00017150749,0.0002277898,0.0016464202],"study_design_scores_gemma":[0.00007066461,0.00080313446,0.03519861,0.000020062596,0.000038455535,0.96099114,0.0002513889,0.00056145724,0.0012501364,0.00020802052,0.00058552774,0.000021381713],"about_ca_topic_score_codex":0.0034139436,"about_ca_topic_score_gemma":0.0038122842,"teacher_disagreement_score":0.0034139436,"about_ca_system_score_codex":0.0011153787,"about_ca_system_score_gemma":0.00076620874,"threshold_uncertainty_score":0.008092701},"labels":[],"label_agreement":null},{"id":"W1998550373","doi":"10.1002/ajh.22094","title":"Published guidelines versus real‐life practice in the diagnosis and treatment of essential thrombocythemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Essential thrombocythemia; Medicine; Thrombocytosis; Myeloproliferative neoplasm; Bone marrow; Internal medicine; Hydroxycarbamide; Thrombosis; Biopsy; Hematologist; Gene mutation; Anagrelide; Oncology; Surgery; Myelofibrosis; Polycythemia vera; Mutation; Chemotherapy; Platelet; Disease; Gene","score_opus":0.07414932893291384,"score_gpt":0.37263746025234146,"score_spread":0.29848813131942764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998550373","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09048107,0.10101981,0.022833955,0.67335737,0.013385525,0.0015353189,0.00116331,0.0005503261,0.09567335],"genre_scores_gemma":[0.6801032,0.07161943,0.07867765,0.15063216,0.006785744,0.001991723,0.0022854968,0.00045198447,0.0074525937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9167587,0.049159255,0.016393213,0.0027609926,0.013232621,0.0016952564],"domain_scores_gemma":[0.813175,0.07268137,0.034509342,0.008134817,0.061626308,0.009873119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055577353,0.000285359,0.0005305014,0.002396626,0.0014453889,0.0050897077,0.0026767408,0.0044424264,0.002951722],"category_scores_gemma":[0.18621,0.00043529828,0.0005442908,0.0032499232,0.0030772241,0.0026535604,0.0030848812,0.0045189452,0.001315037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003307019,0.0007887455,0.06691156,0.005198198,0.00026113124,0.0020558103,0.008027669,0.002203997,0.0010511939,0.020355526,0.24741055,0.64540505],"study_design_scores_gemma":[0.0007616946,0.00091421674,0.09437589,0.033969797,0.00037356105,0.0067623653,0.013883706,0.004463221,0.0023929884,0.023034263,0.8187023,0.00036597604],"about_ca_topic_score_codex":0.007989011,"about_ca_topic_score_gemma":0.010316647,"teacher_disagreement_score":0.055577353,"about_ca_system_score_codex":0.0062181735,"about_ca_system_score_gemma":0.014394387,"threshold_uncertainty_score":0.29392463},"labels":[],"label_agreement":null},{"id":"W2000138691","doi":"10.1002/ajh.23506","title":"Pregnancy outcomes in women with thalassemia in North America and the United Kingdom","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; New England Research Institutes; University Health Network; Harvard Catalyst","keywords":"Medicine; Pregnancy; Thalassemia; Obstetrics; Childbirth; Infertility; Pediatrics; Advanced maternal age; Blood transfusion; Fetus; Internal medicine","score_opus":0.006265726617148967,"score_gpt":0.23683291516407767,"score_spread":0.2305671885469287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000138691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963799,0.0014806029,0.00003593873,0.00028248652,0.000009421669,0.000009502749,0.0008438269,0.0000035279916,0.00095481204],"genre_scores_gemma":[0.9984479,0.00086124166,0.00003251814,0.000082061095,0.0000052449395,0.000008101757,0.0004202335,0.0000015526783,0.00014111194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935263,0.00024388693,0.000113715694,0.00009312217,0.000083798164,0.0001128668],"domain_scores_gemma":[0.9984969,0.00030599255,0.0008007006,0.00007491114,0.00013240869,0.00018912608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055114855,0.00012089517,0.00021848232,0.0007783644,0.00039898368,0.00052756816,0.00021061781,0.000261622,0.001249957],"category_scores_gemma":[0.0037601746,0.00020355212,0.00020789499,0.0014095751,0.0002914951,0.00032431772,0.000734435,0.00031788103,0.00015022309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040917243,0.000007490879,0.9966413,0.00001288888,0.0000136184335,0.00022460532,0.0004078169,0.00003194781,0.00006668136,0.00004534697,0.00034941363,0.0021579803],"study_design_scores_gemma":[0.0000039567744,0.00001728596,0.9984823,0.00002285946,0.000007252527,0.0004421036,0.000654367,0.000049024755,0.00002019947,0.000014655316,0.00028277523,0.000003131434],"about_ca_topic_score_codex":0.12143279,"about_ca_topic_score_gemma":0.1296341,"teacher_disagreement_score":0.8785672,"about_ca_system_score_codex":0.0009877312,"about_ca_system_score_gemma":0.00066807715,"threshold_uncertainty_score":0.24145192},"labels":[],"label_agreement":null},{"id":"W2001481776","doi":"10.1002/ajh.21768","title":"Phosphatidylserine exposure and other apoptotic‐like events in Bernard‐Soulier syndrome platelets","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Institut National de la Santé et de la Recherche Médicale; Heart and Stroke Foundation of Canada","keywords":"Platelet; Phosphatidylserine; Annexin; Platelet activation; Annexin A5; Thrombin; Chemistry; Flow cytometry; Apoptosis; Cell biology; Immunology; Biophysics; Molecular biology; Biochemistry; Biology; Membrane","score_opus":0.005256162202560619,"score_gpt":0.23025639797588737,"score_spread":0.22500023577332676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001481776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920374,0.00033368877,0.00022727554,0.000012157627,0.0000018064943,0.000005223019,0.000029033425,0.000007029145,0.00018005742],"genre_scores_gemma":[0.99940383,0.0002222327,0.00016912507,0.0000108987015,0.000005330241,0.000007464539,0.00007580364,0.0000020557986,0.00010322123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989414,0.000027766739,0.000014700916,0.000019231222,0.000030187228,0.000014000288],"domain_scores_gemma":[0.9998234,0.000051858864,0.00006533873,0.000011933215,0.000019964373,0.000027504606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001060146,0.00021665683,0.00015449707,0.0005860938,0.00015124919,0.00021363665,0.00009655334,0.00036549228,0.00061027845],"category_scores_gemma":[0.00043001605,0.00009285585,0.00011751813,0.00032560277,0.0002356664,0.00017193954,0.00016610608,0.00021934228,0.000098186814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310983,0.000074375894,0.11299447,0.00013022777,0.00006008869,0.010630978,0.00069077977,0.00025146166,0.86257327,0.0002794537,0.00011818142,0.00986573],"study_design_scores_gemma":[0.000077387354,0.0016467717,0.7516695,0.000014699879,0.00008477449,0.043229483,0.00044949833,0.0013128144,0.19878726,0.00044844375,0.0022551457,0.000024268938],"about_ca_topic_score_codex":0.00032286407,"about_ca_topic_score_gemma":0.00017288169,"teacher_disagreement_score":0.00061027845,"about_ca_system_score_codex":0.00015334904,"about_ca_system_score_gemma":0.000040435858,"threshold_uncertainty_score":0.002041638},"labels":[],"label_agreement":null},{"id":"W2004178456","doi":"10.1002/ajh.20034","title":"Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Rituximab; Medicine; Hemolysis; Cold Agglutinin; Autoimmune hemolytic anemia; Prednisone; Hemolytic anemia; Hemoglobin; Cyclophosphamide; Haptoglobin; Autoantibody; Gastroenterology; Anemia; Immunology; Antibody; Internal medicine; Chemotherapy","score_opus":0.004869729385145392,"score_gpt":0.24358144924755717,"score_spread":0.23871171986241177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004178456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687076,0.005645312,0.0036843473,0.00685314,0.0006043974,0.00032826437,0.00009171345,0.00037593726,0.013709188],"genre_scores_gemma":[0.99517846,0.00060040026,0.00059889484,0.001800489,0.0005086086,0.000033864533,0.00007922518,0.000015296377,0.0011847516],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99938774,0.00017488904,0.00007881039,0.00008559112,0.00009578313,0.0001770608],"domain_scores_gemma":[0.99854326,0.00060058746,0.00012990598,0.00010849838,0.00010322366,0.000514566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078130537,0.0010264013,0.0010738459,0.0005235189,0.0007360542,0.00053507497,0.00045411976,0.0028850029,0.0009140161],"category_scores_gemma":[0.003285415,0.00048185105,0.0005921899,0.00022034234,0.00040053145,0.00045114697,0.00033482592,0.002522266,0.00042160327],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038289707,0.0009497721,0.03484187,0.00025186286,0.0001204096,0.8857373,0.00046208582,0.000874647,0.026273407,0.00044781723,0.004268553,0.04194333],"study_design_scores_gemma":[0.0015408141,0.0058951736,0.08285198,0.000115028655,0.00015468513,0.8813871,0.00027886024,0.0028969918,0.014904077,0.0007375906,0.009177119,0.000060647762],"about_ca_topic_score_codex":0.00060683605,"about_ca_topic_score_gemma":0.0010482341,"teacher_disagreement_score":0.0028850029,"about_ca_system_score_codex":0.0006161923,"about_ca_system_score_gemma":0.00043184718,"threshold_uncertainty_score":0.004470825},"labels":[],"label_agreement":null},{"id":"W2007715200","doi":"10.1002/ajh.10327","title":"Health status and health‐related quality of life associated with von Willebrand disease","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Regional Municipality of Niagara; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Health Utilities Index; Quality of life (healthcare); Von Willebrand disease; Disease; Population; Cohort; Cross-sectional study; Cohort study; Pediatrics; Health related quality of life; Immunology; Von Willebrand factor; Environmental health; Internal medicine; Pathology","score_opus":0.019486218808333317,"score_gpt":0.31730413778056066,"score_spread":0.2978179189722273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007715200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997785,0.0005254606,0.00003684284,0.00010526192,0.000004541518,0.000016783815,0.0005059694,0.0000012424892,0.0010188903],"genre_scores_gemma":[0.9995011,0.000106723855,0.00004353805,0.000018338851,0.000003268535,0.0000048042616,0.00021355244,2.7901126e-7,0.000108450826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999566,0.0000981251,0.000042168598,0.000046468347,0.00015241776,0.00009475131],"domain_scores_gemma":[0.99879754,0.00017150401,0.0005313699,0.00004267436,0.00017444737,0.00028243108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006556542,0.00011010322,0.00019712787,0.0006014059,0.0003469209,0.0005212081,0.00020099554,0.00029028038,0.0011773822],"category_scores_gemma":[0.0029542237,0.00009544213,0.00039979542,0.0008967501,0.0003508832,0.00029934992,0.00041044748,0.0005296675,0.000086336564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004797198,0.000038502072,0.997954,0.0000144344785,0.000043286156,0.0000282944,0.000117125244,0.000061300714,0.00008767801,0.000026799229,0.00006526429,0.0015152291],"study_design_scores_gemma":[0.0000013755015,0.000033550612,0.99973744,0.0000030510143,0.000005551286,0.000024643658,0.00005526141,0.000054196225,0.0000071846316,0.000010803341,0.00006561316,0.0000012582553],"about_ca_topic_score_codex":0.048900995,"about_ca_topic_score_gemma":0.059634577,"teacher_disagreement_score":0.048900995,"about_ca_system_score_codex":0.00088031223,"about_ca_system_score_gemma":0.0004392538,"threshold_uncertainty_score":0.0972327},"labels":[],"label_agreement":null},{"id":"W2012542492","doi":"10.1002/ajh.10220","title":"Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera","year":2002,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Queen (butterfly); Tumor lysis syndrome; Medicine; Citation; Polycythemia vera; Classics; Family medicine; History; Library science; Internal medicine; Biology; Computer science; Chemotherapy","score_opus":0.01617246754057505,"score_gpt":0.26341960910665413,"score_spread":0.24724714156607908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012542492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7405441,0.012123065,0.006461052,0.13488017,0.0096563585,0.00045750703,0.0004076155,0.0007250925,0.09474498],"genre_scores_gemma":[0.967527,0.0020162228,0.00090913445,0.01653205,0.0062804054,0.000060613696,0.00017605149,0.000050236147,0.0064483243],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992631,0.00025500654,0.00009594268,0.00006399675,0.00014123079,0.00018068035],"domain_scores_gemma":[0.99721754,0.00165358,0.0002742838,0.00014387208,0.00015269936,0.00055797445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071331393,0.0010261617,0.0012308945,0.00095924956,0.00168188,0.0011632224,0.0011314728,0.00861888,0.0021839049],"category_scores_gemma":[0.005595319,0.0005328102,0.0014223624,0.0006987083,0.0012176613,0.0010714593,0.0006251256,0.0059746406,0.00088132644],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005504489,0.0001219796,0.0076478655,0.000061455925,0.000054645123,0.97932374,0.00015445525,0.0001855129,0.0016922161,0.0008662118,0.005467151,0.0038742088],"study_design_scores_gemma":[0.0008187413,0.001123021,0.025621135,0.000104082836,0.00020829307,0.9410737,0.00026106578,0.004318022,0.0035004644,0.0019261389,0.020995723,0.000049527236],"about_ca_topic_score_codex":0.002728934,"about_ca_topic_score_gemma":0.0038188396,"teacher_disagreement_score":0.00861888,"about_ca_system_score_codex":0.0019475474,"about_ca_system_score_gemma":0.0008753868,"threshold_uncertainty_score":0.014130533},"labels":[],"label_agreement":null},{"id":"W2014034847","doi":"10.1002/ajh.20263","title":"A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful?","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Alberta Hospital Edmonton; Dalhousie University; University of Toronto; University Health Network; University of Alberta Hospital; University of Calgary; Western University; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Liver biopsy; Cirrhosis; Liver disease; Hepatitis C; Biopsy; Clotting factor; Internal medicine; Population; Gastroenterology; Asymptomatic; Surgery","score_opus":0.014837403998793042,"score_gpt":0.304212387585317,"score_spread":0.28937498358652397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014034847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977804,0.00048372903,0.00007231994,0.00012103068,0.000007143368,0.000035209374,0.0002568272,0.00000384146,0.0012395451],"genre_scores_gemma":[0.9992193,0.0002524621,0.00010744826,0.00011712877,0.00001278921,0.000008755276,0.00018782694,0.0000031091179,0.00009123973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985507,0.00019737295,0.00009998675,0.00020997143,0.000582823,0.0003590869],"domain_scores_gemma":[0.9957995,0.00042643538,0.0014594002,0.00020789361,0.0011650525,0.0009417255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00103999,0.0004656503,0.0005124205,0.0010152686,0.0017014593,0.0008466956,0.00071207876,0.00061914255,0.0014777299],"category_scores_gemma":[0.0038036592,0.00045596695,0.00044849407,0.0027226484,0.0011419246,0.0003850044,0.00053741544,0.00075204845,0.0001939757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007140845,0.00001937034,0.99823546,0.000013351451,0.000019645995,0.00031709,0.00013433788,0.000015303076,0.00013001934,0.000017057118,0.000111749505,0.00091510493],"study_design_scores_gemma":[0.000014389356,0.00013055638,0.9974316,0.000016657088,0.000034722045,0.0011108136,0.000695576,0.00010432038,0.00006774914,0.000010081503,0.0003744092,0.000009097271],"about_ca_topic_score_codex":0.70818186,"about_ca_topic_score_gemma":0.73176926,"teacher_disagreement_score":0.29181814,"about_ca_system_score_codex":0.006581692,"about_ca_system_score_gemma":0.008916362,"threshold_uncertainty_score":0.58707345},"labels":[],"label_agreement":null},{"id":"W2017949613","doi":"10.1002/ajh.21584","title":"A young woman with episodic angioedema, papilledema, and eosinophilia","year":2009,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hyperviscosity syndrome; Thrombocytosis; Organomegaly; Eosinophilia; Angioedema; Surgery; Internal medicine; Gastroenterology; Polyneuropathy; Multiple myeloma","score_opus":0.005367527602862001,"score_gpt":0.24313264080198763,"score_spread":0.23776511319912563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017949613","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41632977,0.016295694,0.0041278964,0.42387053,0.025049988,0.00044044605,0.00048096842,0.00033033724,0.113074325],"genre_scores_gemma":[0.8357347,0.009525161,0.0025013548,0.106773846,0.029874535,0.00007568977,0.00017125525,0.00005640138,0.015286969],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99941087,0.00014927973,0.00008003959,0.00011167652,0.000108522356,0.00013956026],"domain_scores_gemma":[0.99863213,0.0007909463,0.00014781501,0.00004195039,0.00011040847,0.00027673613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057084404,0.00069764606,0.0006540845,0.0008091785,0.0022696434,0.0010469576,0.000701288,0.0070148073,0.0036731234],"category_scores_gemma":[0.0049446225,0.0005058132,0.0005449745,0.0006905405,0.0010579828,0.0020196692,0.00068950345,0.0049997503,0.001030405],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048642643,0.000052032137,0.009082771,0.000047304286,0.000011209981,0.96898043,0.0006061809,0.000059973445,0.0003998033,0.00067541265,0.016989738,0.0030464276],"study_design_scores_gemma":[0.000038728314,0.00012142931,0.008721742,0.0002088994,0.000030560634,0.967449,0.0015807302,0.0004081468,0.00029318978,0.0013547097,0.019764889,0.000027974136],"about_ca_topic_score_codex":0.003278072,"about_ca_topic_score_gemma":0.0069886264,"teacher_disagreement_score":0.0070148073,"about_ca_system_score_codex":0.00095759955,"about_ca_system_score_gemma":0.0012334872,"threshold_uncertainty_score":0.012287855},"labels":[],"label_agreement":null},{"id":"W2018664064","doi":"10.1002/ajh.21293","title":"Laboratory testing for fibrinogen abnormalities","year":2008,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Fibrinogen; Fibrin; Medicine; Afibrinogenemia; Coagulation; Abnormality; Coagulation Disorder; Internal medicine; Pathology; Immunology","score_opus":0.06458634447870937,"score_gpt":0.33575130189687086,"score_spread":0.2711649574181615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018664064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005218725,0.9724378,0.0043605412,0.001780957,0.00089393684,0.000093367096,0.0003031086,0.00018791585,0.014723699],"genre_scores_gemma":[0.040058635,0.94350576,0.00587401,0.0021597513,0.0009732399,0.00008006206,0.0008540405,0.000024534678,0.006469963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992754,0.00015243521,0.00008035622,0.000082436316,0.00036503546,0.00004438712],"domain_scores_gemma":[0.99923635,0.00026492515,0.00014564155,0.000034807836,0.00027903065,0.000039290135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077345676,0.0010808216,0.0014970567,0.0036218008,0.0002066517,0.0005194591,0.0009623088,0.00082725583,0.002746483],"category_scores_gemma":[0.0022923704,0.00017132748,0.00058351894,0.0024492096,0.00033312914,0.00050473894,0.000360908,0.0009696484,0.0026585802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001739698,0.00016798014,0.013662584,0.003772328,0.00025991577,0.0059357123,0.00012535154,0.00020236627,0.0065820534,0.0011594914,0.07118872,0.8967695],"study_design_scores_gemma":[0.00012244466,0.00044354238,0.05505392,0.012907358,0.00082666584,0.15239114,0.00030921446,0.0006219365,0.011166884,0.0045037232,0.7615535,0.00009967904],"about_ca_topic_score_codex":0.0011705344,"about_ca_topic_score_gemma":0.0009128529,"teacher_disagreement_score":0.0036218008,"about_ca_system_score_codex":0.00026188552,"about_ca_system_score_gemma":0.00036021022,"threshold_uncertainty_score":0.009187937},"labels":[],"label_agreement":null},{"id":"W2019023281","doi":"10.1002/ajh.23220","title":"No association between cigarette smoking and incidence of plasma cell myeloma: A meta‐analysis of 17 observational studies","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Incidence (geometry); Internal medicine; Plasma Cell Myeloma; Observational study; Bone marrow; Meta-analysis; Oncology; Pathology","score_opus":0.18598639532587363,"score_gpt":0.4185439652328027,"score_spread":0.23255756990692905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019023281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14045441,0.84941435,0.0032974666,0.00069151324,0.0005284512,0.0002167163,0.0042028325,0.000108317705,0.0010859185],"genre_scores_gemma":[0.84290457,0.14902747,0.002350831,0.0012061631,0.00030017257,0.00040834644,0.0032356125,0.000093783005,0.00047315873],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9858247,0.0067113754,0.00358192,0.0023544969,0.0010152034,0.0005123174],"domain_scores_gemma":[0.96068585,0.028877474,0.0051875347,0.002845503,0.0018982452,0.0005054563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01466207,0.0020173322,0.009018663,0.0033304114,0.00088442944,0.0037508763,0.0020764826,0.0023116672,0.0027817925],"category_scores_gemma":[0.031449318,0.0020273256,0.04281808,0.0064677107,0.00067645084,0.0013915959,0.0012958816,0.0025051855,0.00030156708],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038513,0.000034570963,0.0893463,0.023109315,0.87767327,0.00022743212,0.000051727384,0.0009945895,0.00027801594,0.00010147298,0.0005812395,0.0037507357],"study_design_scores_gemma":[0.00063364697,0.00018983774,0.031005513,0.0016267085,0.9643052,0.00018858653,0.000037023572,0.00067776645,0.00015957061,0.00025057961,0.00089926796,0.000026234848],"about_ca_topic_score_codex":0.006789855,"about_ca_topic_score_gemma":0.008638863,"teacher_disagreement_score":0.01466207,"about_ca_system_score_codex":0.001177182,"about_ca_system_score_gemma":0.001523578,"threshold_uncertainty_score":0.07754135},"labels":[],"label_agreement":null},{"id":"W2019593279","doi":"10.1002/ajh.20737","title":"Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; AIDS Vancouver; University of British Columbia","funders":"","keywords":"Lamivudine; Medicine; Virology; Hepatitis B; Drug resistance; Hepatitis B virus; Chemotherapy; Cirrhosis; Gastroenterology; Internal medicine; Virus; Biology; Microbiology","score_opus":0.005732124867826355,"score_gpt":0.23810466213588025,"score_spread":0.2323725372680539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019593279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921335,0.0008326899,0.0008338422,0.0007998833,0.00008530908,0.000048594025,0.00005520142,0.00009234541,0.005118701],"genre_scores_gemma":[0.99864155,0.00019312662,0.00011829644,0.00036865345,0.00012163894,0.0000057080356,0.000038673163,0.000007949067,0.00050428975],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99950683,0.000110498426,0.0000548321,0.00006953673,0.000049966777,0.00020838263],"domain_scores_gemma":[0.99833703,0.0004879199,0.00029166485,0.0002037971,0.00008473195,0.0005948306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039146515,0.0009290184,0.00062805304,0.0009277991,0.0023069836,0.0009114863,0.0005254043,0.0021339494,0.0023858014],"category_scores_gemma":[0.0027169408,0.0006545257,0.0007360059,0.00037822014,0.0010964188,0.00091093313,0.000856668,0.0016576429,0.0009770892],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027228956,0.00012009975,0.042545903,0.000026433738,0.000015942307,0.9527912,0.00035442927,0.00008889607,0.0011972317,0.00019562684,0.0003062958,0.0020856925],"study_design_scores_gemma":[0.00006223823,0.00060135394,0.020976543,0.000014923263,0.000021778567,0.97552115,0.00020848439,0.00041881937,0.0013480445,0.00018741516,0.00062397745,0.000015309857],"about_ca_topic_score_codex":0.0013974534,"about_ca_topic_score_gemma":0.0015107896,"teacher_disagreement_score":0.0023858014,"about_ca_system_score_codex":0.00079215853,"about_ca_system_score_gemma":0.00065274123,"threshold_uncertainty_score":0.0079813},"labels":[],"label_agreement":null},{"id":"W2021706185","doi":"10.1002/ajh.21670","title":"Pain as an emergent issue in thalassemia","year":2010,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Thalassemia; Medicine; Intensive care medicine; Internal medicine","score_opus":0.005991613823772109,"score_gpt":0.2732161678628304,"score_spread":0.26722455403905826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021706185","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.554979,0.04024086,0.004109366,0.28113776,0.015085407,0.0003267904,0.00038762527,0.00051928154,0.10321387],"genre_scores_gemma":[0.89484334,0.008509798,0.0012733171,0.06339482,0.024435906,0.000062210675,0.000098665456,0.00004701303,0.0073349327],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994456,0.00015908964,0.00006226078,0.00007903188,0.00008534544,0.00016863157],"domain_scores_gemma":[0.9987581,0.00056376966,0.00023452095,0.000056165507,0.00012967964,0.00025774265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048788943,0.00079604087,0.0007860523,0.00080953026,0.0018178722,0.0012637669,0.000720848,0.0076062325,0.0024897594],"category_scores_gemma":[0.003913749,0.00047761502,0.0005893759,0.0009273995,0.001325663,0.0013318267,0.00052745355,0.0050925505,0.0010925141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001176065,0.00009695132,0.027354209,0.00014425632,0.000036411016,0.9370018,0.00038812053,0.00019966181,0.0007551632,0.0012778721,0.021077046,0.011550945],"study_design_scores_gemma":[0.000086659034,0.00014461443,0.016396621,0.00014916199,0.000034299766,0.969933,0.00039007873,0.00078692747,0.00023841704,0.0017482941,0.010069915,0.000022097747],"about_ca_topic_score_codex":0.00203364,"about_ca_topic_score_gemma":0.0035177274,"teacher_disagreement_score":0.0076062325,"about_ca_system_score_codex":0.0017973817,"about_ca_system_score_gemma":0.0007022052,"threshold_uncertainty_score":0.01304096},"labels":[],"label_agreement":null},{"id":"W2024979995","doi":"10.1002/ajh.21108","title":"Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV‐positive men: A case series","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Montreal General Hospital","funders":"","keywords":"Rituximab; Medicine; Immunosuppression; Chemotherapy; Oncology; Internal medicine; Disease; CD20; Castleman disease; Immunology; Lymphoma","score_opus":0.005309175492526143,"score_gpt":0.25668893642208007,"score_spread":0.25137976092955394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024979995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893416,0.003204464,0.0012711812,0.00080716395,0.00025361992,0.00016279871,0.00007211257,0.0000652696,0.0048217527],"genre_scores_gemma":[0.9967295,0.00077208184,0.0005474833,0.0004005099,0.0003134074,0.00002419522,0.000038396713,0.000014262973,0.0011601745],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991738,0.00013175138,0.00007422962,0.00017513348,0.00012231873,0.00032274917],"domain_scores_gemma":[0.99876475,0.00028624706,0.00024532928,0.000103431244,0.000059847942,0.0005403499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004517858,0.002223263,0.0012905919,0.0021046065,0.0039724866,0.0015143652,0.0013356692,0.0036948463,0.0028974449],"category_scores_gemma":[0.0025368917,0.0015097319,0.0014089665,0.0011603698,0.0019677202,0.0011591181,0.0014804016,0.0022542654,0.0007361486],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008108719,0.0003886062,0.016858187,0.000032993303,0.000048924343,0.9788012,0.0003950262,0.00012478564,0.00048516583,0.00011751348,0.00022932731,0.0024371198],"study_design_scores_gemma":[0.00005212849,0.00027814895,0.011825469,0.000012947166,0.000034153458,0.9862748,0.00024872762,0.0002488171,0.0003321314,0.00006337744,0.0006063919,0.000022835711],"about_ca_topic_score_codex":0.003879203,"about_ca_topic_score_gemma":0.0046607605,"teacher_disagreement_score":0.0039724866,"about_ca_system_score_codex":0.0012439456,"about_ca_system_score_gemma":0.00089736545,"threshold_uncertainty_score":0.009692907},"labels":[],"label_agreement":null},{"id":"W2025604364","doi":"10.1002/ajh.20821","title":"Very severe thrombocytopenia and fragmentation hemolysis mimicking thrombotic thrombocytopenic purpura associated with a giant intracardiac vegetation infected with <i>Staphylococcus epidermidis</i>: Role of monocyte procoagulant activity induced by bacterial supernatant","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Staphylococcus epidermidis; Hemolysis; Thrombotic thrombocytopenic purpura; Thrombocytopenic purpura; Intracardiac injection; Monocyte; Immunology; Microbiology; Staphylococcus aureus; Platelet; Bacteria; Internal medicine; Biology","score_opus":0.006352346136597916,"score_gpt":0.23443646606140475,"score_spread":0.22808411992480684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025604364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957777,0.0012762354,0.0010009194,0.00015750779,0.000020256066,0.000023661805,0.000036216046,0.00004501129,0.0016623839],"genre_scores_gemma":[0.99925715,0.00026721263,0.00021214432,0.000072556264,0.000060051523,0.000003594439,0.000027689835,0.0000029096832,0.00009670584],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99982244,0.0000347589,0.000022634145,0.00002982074,0.00003156039,0.000058776965],"domain_scores_gemma":[0.99931633,0.00026683978,0.00020408943,0.000042694,0.0000186293,0.00015143456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001614497,0.0006820571,0.0005020483,0.00054583506,0.00041016878,0.00051317643,0.00033100208,0.0012530873,0.0007202977],"category_scores_gemma":[0.0012670091,0.00036162348,0.00031672153,0.00038322256,0.00051459373,0.00030012924,0.00037664524,0.00079937075,0.0002233904],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032458905,0.00006150693,0.06312315,0.00008807739,0.000033326312,0.9172604,0.0002564872,0.00014443498,0.013934153,0.0001642047,0.0003181404,0.004291579],"study_design_scores_gemma":[0.000020180396,0.0003853976,0.045631494,0.000008877904,0.000022152584,0.95137143,0.00006673641,0.0003527435,0.0017911725,0.000081656275,0.00025951947,0.000008664948],"about_ca_topic_score_codex":0.00039679752,"about_ca_topic_score_gemma":0.00054539955,"teacher_disagreement_score":0.0012530873,"about_ca_system_score_codex":0.00026696207,"about_ca_system_score_gemma":0.0001303802,"threshold_uncertainty_score":0.002409637},"labels":[],"label_agreement":null},{"id":"W2029430078","doi":"10.1002/ajh.21273","title":"Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fondaparinux; Heparin; Medicine; Heparin-induced thrombocytopenia; Low molecular weight heparin; Platelet factor 4; Anticoagulant; Platelet; Immunology; Internal medicine; Gastroenterology; Anesthesia; Thrombosis","score_opus":0.01221561422676701,"score_gpt":0.2602082745691867,"score_spread":0.2479926603424197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029430078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992796,0.0015298169,0.0015132324,0.00039251344,0.000058898386,0.000044984747,0.000053612916,0.0000709254,0.0035399713],"genre_scores_gemma":[0.9988921,0.00029665904,0.00021416022,0.0001390068,0.00007974706,0.000005783985,0.00003517919,0.000004285261,0.00033305385],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998072,0.000030733776,0.000019707633,0.000035889843,0.000027064272,0.00007952356],"domain_scores_gemma":[0.9993579,0.00023055138,0.00016985871,0.000049234386,0.000036054258,0.00015634752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012786522,0.00073917734,0.0006225265,0.0005413394,0.0005671378,0.00053289655,0.00038199627,0.0014373529,0.0012924063],"category_scores_gemma":[0.0013267475,0.0003431884,0.00040659614,0.00043339573,0.00038332908,0.00054918963,0.00027560027,0.0011759491,0.00027790532],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040815113,0.00011039404,0.04998201,0.000055168046,0.000017140701,0.93738127,0.0001789959,0.00011282802,0.006377171,0.0003530159,0.0002394458,0.0047844313],"study_design_scores_gemma":[0.00006759301,0.000504346,0.0214392,0.000012131711,0.00003795615,0.973905,0.000051950603,0.00037251183,0.0027813443,0.000159504,0.000657832,0.000010674418],"about_ca_topic_score_codex":0.0008497078,"about_ca_topic_score_gemma":0.0006777676,"teacher_disagreement_score":0.0014373529,"about_ca_system_score_codex":0.00037267536,"about_ca_system_score_gemma":0.00030153376,"threshold_uncertainty_score":0.004323542},"labels":[],"label_agreement":null},{"id":"W2029627784","doi":"10.1002/ajh.10440","title":"Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis","year":2003,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Warfarin; Heparin-induced thrombocytopenia; Surgery; Thrombosis; Argatroban; Gangrene; Heparin; Aortic valve; Internal medicine; Cardiology; Thrombin; Atrial fibrillation; Platelet","score_opus":0.026236921263214284,"score_gpt":0.2847006454334744,"score_spread":0.2584637241702601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029627784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930409,0.002834458,0.0010374252,0.00031837786,0.000069313384,0.000040731655,0.000029204672,0.000045715107,0.0025838509],"genre_scores_gemma":[0.99893373,0.00044632296,0.00014801047,0.00011939216,0.00010564192,0.0000041475187,0.000017180859,0.0000028932345,0.0002226412],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99961,0.00007296637,0.000055174434,0.000074604744,0.000059469872,0.00012781547],"domain_scores_gemma":[0.9990854,0.00029159745,0.00026517254,0.00010216957,0.000038581216,0.0002170654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026800254,0.00077188405,0.0007175981,0.00090089726,0.0007819612,0.0008469151,0.0004502424,0.001716461,0.0012639102],"category_scores_gemma":[0.001705349,0.0005256041,0.00054945116,0.0005683551,0.00074869615,0.0006221021,0.0006033743,0.0010701836,0.00036783438],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001333811,0.00005460091,0.04298406,0.000042678792,0.000025046633,0.95236325,0.0001637405,0.0000591752,0.0017835338,0.00008754807,0.00010936863,0.0021935906],"study_design_scores_gemma":[0.000041352694,0.00020169336,0.031921558,0.000015044593,0.000035926885,0.96624523,0.000111579255,0.00027705688,0.00076080573,0.00007916048,0.00030070197,0.00000987831],"about_ca_topic_score_codex":0.00065745343,"about_ca_topic_score_gemma":0.0007289404,"teacher_disagreement_score":0.001716461,"about_ca_system_score_codex":0.000382402,"about_ca_system_score_gemma":0.0002712521,"threshold_uncertainty_score":0.0042282343},"labels":[],"label_agreement":null},{"id":"W2029918987","doi":"10.1002/1096-8652(200009)65:1<25::aid-ajh4>3.0.co;2-8","title":"Pneumococcal vaccine administration associated with splenectomy: The need for improved education, documentation, and the use of a practical checklist","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kelowna General Hospital; Canadian Blood Services; BC Cancer Agency","funders":"","keywords":"Splenectomy; Medicine; Checklist; Vaccination; Pneumococcal vaccination; Documentation; Audit; Pneumococcal vaccine; Pediatrics; General surgery; Surgery; Internal medicine; Immunology; Streptococcus pneumoniae; Spleen","score_opus":0.01597655908146362,"score_gpt":0.32452005635841985,"score_spread":0.30854349727695624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029918987","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97846496,0.0032915624,0.003515528,0.007673027,0.00015705134,0.0013466625,0.0004620889,0.00040167852,0.004687534],"genre_scores_gemma":[0.97811335,0.004394207,0.014278984,0.0010634784,0.00009814358,0.00049059436,0.00068697747,0.000038408332,0.0008357462],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.97462535,0.012488832,0.0066107954,0.00040407223,0.005112623,0.0007584415],"domain_scores_gemma":[0.85549015,0.060684297,0.051706485,0.006422101,0.021147065,0.004549834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019595677,0.0003602753,0.00058838923,0.0036562001,0.0011958901,0.0015832447,0.001029238,0.000768773,0.0012810633],"category_scores_gemma":[0.13128527,0.0005942094,0.0003270557,0.0030364476,0.0010366357,0.0018596044,0.0018575292,0.0014673595,0.00032450794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038384576,0.000378119,0.80937535,0.0016158138,0.000037463244,0.0017636894,0.0073118587,0.00058441306,0.0011785738,0.00018936998,0.0049273213,0.17225419],"study_design_scores_gemma":[0.00008484283,0.0017097291,0.96321803,0.0022749119,0.000066999295,0.0072998614,0.010480739,0.0019404631,0.0017774233,0.00017121814,0.0108678555,0.000107894215],"about_ca_topic_score_codex":0.009443544,"about_ca_topic_score_gemma":0.012556219,"teacher_disagreement_score":0.019595677,"about_ca_system_score_codex":0.002014575,"about_ca_system_score_gemma":0.007045245,"threshold_uncertainty_score":0.103633106},"labels":[],"label_agreement":null},{"id":"W2030527052","doi":"10.1002/ajh.21782","title":"Coagulopathy in a patient with nephrotic syndrome","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Coagulopathy; Nephrotic syndrome; Medicine; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.0033025653591573782,"score_gpt":0.2279215170942125,"score_spread":0.2246189517350551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030527052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839243,0.004224758,0.0008132469,0.0016659138,0.00023166992,0.000089679714,0.00012806016,0.00009848911,0.008823991],"genre_scores_gemma":[0.99774617,0.0008162088,0.00020197548,0.000506445,0.00022702843,0.000010506642,0.00007926115,0.0000073422925,0.00040495628],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99958545,0.00006681777,0.000069929396,0.00007541668,0.00009077784,0.0001116317],"domain_scores_gemma":[0.99922526,0.00024044709,0.00019667494,0.000038624574,0.000069781774,0.00022921905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000349656,0.0010418206,0.00075504504,0.0020282944,0.0012764302,0.0007506519,0.00043151816,0.0015863042,0.0021433767],"category_scores_gemma":[0.0034084937,0.0004998942,0.0006540633,0.0010730149,0.0006507796,0.00078356534,0.00053121644,0.0012220494,0.00040324946],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019328196,0.000068855115,0.13267824,0.000060739225,0.000043710414,0.8613321,0.00028261708,0.00010471154,0.001411328,0.00022435922,0.0007714946,0.0028285868],"study_design_scores_gemma":[0.0000484435,0.00024425998,0.058227967,0.000052059742,0.00007138166,0.93881,0.00018101039,0.00038412816,0.00034600642,0.0002596417,0.0013552709,0.00001972068],"about_ca_topic_score_codex":0.0012167402,"about_ca_topic_score_gemma":0.0012894776,"teacher_disagreement_score":0.0021433767,"about_ca_system_score_codex":0.0005093196,"about_ca_system_score_gemma":0.00043289777,"threshold_uncertainty_score":0.0071703196},"labels":[],"label_agreement":null},{"id":"W2033671580","doi":"10.1002/ajh.20246","title":"Megakaryocyte‐like giant myeloma cells","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Library science; Citation; Medicine; Medical laboratory; Family medicine; Pathology; Computer science","score_opus":0.013793857266544172,"score_gpt":0.29687643815796017,"score_spread":0.28308258089141597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033671580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.937096,0.008452427,0.0068212897,0.001889129,0.0006927321,0.0003291827,0.004992721,0.00088236795,0.038844116],"genre_scores_gemma":[0.97331774,0.0020556976,0.0051690093,0.0004414056,0.00022512866,0.00010447014,0.0022039057,0.000052709634,0.01643003],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99989295,0.000015321455,0.000009929098,0.000022151402,0.000034294044,0.000025379033],"domain_scores_gemma":[0.9997447,0.00005462893,0.000042083888,0.000047957743,0.000047627214,0.0000629015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012765737,0.00025259797,0.00022163078,0.0005082178,0.00022125474,0.0003526102,0.00019061497,0.0005420175,0.00557568],"category_scores_gemma":[0.00029298375,0.00014240415,0.00019869505,0.00044505295,0.00013895138,0.00022074375,0.0004156867,0.00050032063,0.0019246845],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015592754,0.0001433954,0.01518809,0.00046038104,0.000119388074,0.013762677,0.00039081252,0.00036356933,0.902119,0.0050728605,0.009063792,0.051756795],"study_design_scores_gemma":[0.0011855554,0.0020712705,0.14737692,0.00016277283,0.00044091526,0.07747162,0.00083288597,0.003610421,0.4945174,0.004941628,0.26731786,0.00007083295],"about_ca_topic_score_codex":0.00034823755,"about_ca_topic_score_gemma":0.00063809275,"teacher_disagreement_score":0.00557568,"about_ca_system_score_codex":0.00024526095,"about_ca_system_score_gemma":0.00010385243,"threshold_uncertainty_score":0.018652558},"labels":[],"label_agreement":null},{"id":"W2034363241","doi":"10.1002/ajh.1106","title":"An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Plasmacytoma; Medicine; Presentation (obstetrics); Subcutaneous tissue; Soft tissue; Pathology; Nasal cavity; Extramedullary plasmacytoma; Anatomy; Radiology; Multiple myeloma; Internal medicine","score_opus":0.020835054313758636,"score_gpt":0.35760829905816316,"score_spread":0.3367732447444045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034363241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900255,0.0009899022,0.0027517427,0.00038924045,0.00009831043,0.00008278126,0.00014224097,0.00013354175,0.005386624],"genre_scores_gemma":[0.99784195,0.00022295106,0.00093203137,0.00015629598,0.00021993455,0.000013737036,0.000076065575,0.000012563855,0.00052446144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996039,0.000053002044,0.00004571494,0.00009075225,0.000058613223,0.00014797156],"domain_scores_gemma":[0.997954,0.00049179833,0.00042760238,0.00016845073,0.00009750779,0.00086059724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023606334,0.0013299197,0.0011811969,0.001536411,0.0011366421,0.0012395321,0.0008990381,0.0023560366,0.0031795728],"category_scores_gemma":[0.0026817445,0.0009867765,0.00054256985,0.0013121669,0.00078427984,0.0015415709,0.0014311055,0.001772314,0.0009030488],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008128455,0.00003477026,0.016271174,0.00002265893,0.000011772059,0.9791727,0.00008692097,0.00008297633,0.0027206708,0.00014250654,0.00014386632,0.0012287081],"study_design_scores_gemma":[0.000046301288,0.00008494923,0.0065485304,0.0000049490586,0.0000120252325,0.9917783,0.000067933855,0.00023508802,0.0008732489,0.00012179211,0.00021894294,0.000007859116],"about_ca_topic_score_codex":0.0005541988,"about_ca_topic_score_gemma":0.00078159245,"teacher_disagreement_score":0.0031795728,"about_ca_system_score_codex":0.00043753625,"about_ca_system_score_gemma":0.00045138464,"threshold_uncertainty_score":0.010636747},"labels":[],"label_agreement":null},{"id":"W2035386216","doi":"10.1002/ajh.23136","title":"Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Mechanical heart; Stroke (engine); Antithrombotic; Intensive care medicine; Vitamin K antagonist; Cardiology; Internal medicine; Surgery","score_opus":0.11380909070893624,"score_gpt":0.4265956618241217,"score_spread":0.31278657111518543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035386216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007184508,0.9990908,0.000043185457,0.00013382909,0.000099235884,0.000006967978,0.000010970817,0.000003934573,0.0005390998],"genre_scores_gemma":[0.0006813707,0.9985655,0.00015249263,0.00013663499,0.00012090271,0.00000770947,0.00002530602,9.589627e-7,0.00030910797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964905,0.00008155364,0.00006394178,0.000035195873,0.00014765965,0.000022504146],"domain_scores_gemma":[0.99951994,0.00022844458,0.00011087504,0.00001432327,0.00010092467,0.000025430973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000576523,0.00077860366,0.0017773311,0.0030774816,0.0002874413,0.0006888158,0.00071848114,0.0009900611,0.0048246477],"category_scores_gemma":[0.0010650804,0.000204701,0.0008566856,0.0032380787,0.0003808919,0.0007475623,0.0004889251,0.0014286354,0.0017636201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058068217,0.00008951672,0.00022272901,0.028687295,0.0002433096,0.00012676856,0.00004678428,0.00014131294,0.00058377464,0.001344548,0.029427245,0.9390287],"study_design_scores_gemma":[0.00013625034,0.00019661462,0.003748677,0.023774676,0.00082675525,0.0036429046,0.000112683825,0.00015296147,0.00044733429,0.0034518675,0.96347946,0.000029866984],"about_ca_topic_score_codex":0.0013043464,"about_ca_topic_score_gemma":0.0025796979,"teacher_disagreement_score":0.0048246477,"about_ca_system_score_codex":0.0004244711,"about_ca_system_score_gemma":0.0009432543,"threshold_uncertainty_score":0.016140044},"labels":[],"label_agreement":null},{"id":"W2035790980","doi":"10.1002/ajh.23194","title":"In multiple myeloma, bone‐marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Chromosomal translocation; Bone marrow; Fluorescence in situ hybridization; CD20; Multiple myeloma; Pathology; Biology; Abnormality; Chromosome abnormality; Peripheral blood mononuclear cell; Lymphocyte; Immunology; Karyotype; Medicine; Lymphoma; Chromosome; Genetics; Gene","score_opus":0.018378740826383563,"score_gpt":0.281875947007928,"score_spread":0.26349720618154443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035790980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991303,0.00043993056,0.000079572106,0.000030241648,0.0000036420463,0.000002937015,0.00008750861,0.0000054028587,0.00022038617],"genre_scores_gemma":[0.99964654,0.000086614054,0.00004266683,0.000012802699,0.00000760386,0.0000026637235,0.00013470609,8.0217427e-7,0.000065700726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998362,0.00002997066,0.000018950721,0.0000419183,0.000043359938,0.000029599747],"domain_scores_gemma":[0.9994455,0.00014953884,0.00020545263,0.000034661665,0.00004644985,0.00011846836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028784334,0.00035993112,0.0002734989,0.00072819885,0.0002910691,0.00043428363,0.00019328577,0.0005018196,0.001294815],"category_scores_gemma":[0.0012971807,0.00014187205,0.00018357196,0.00057716406,0.00030629095,0.00026084864,0.00028222828,0.00033188524,0.00032015142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016768719,0.000013710444,0.9950663,0.000012213211,0.000026319121,0.00016904817,0.000035055346,0.00008893442,0.0019796484,0.000010325299,0.000070399634,0.0023604212],"study_design_scores_gemma":[0.000008799991,0.00012719164,0.9966503,0.0000047150106,0.00004986005,0.0019992678,0.000069551184,0.00027872258,0.0005463002,0.000045167053,0.00021803682,0.0000021744709],"about_ca_topic_score_codex":0.0010531101,"about_ca_topic_score_gemma":0.001453462,"teacher_disagreement_score":0.001294815,"about_ca_system_score_codex":0.00013937693,"about_ca_system_score_gemma":0.00013483556,"threshold_uncertainty_score":0.0043315887},"labels":[],"label_agreement":null},{"id":"W2036000990","doi":"10.1002/ajh.23105","title":"Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities","year":2011,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Sickle cell anemia; Stroke (engine); Anemia; Transfusion therapy; Pediatrics; Blood transfusion; Intensive care medicine; Internal medicine; Disease","score_opus":0.007949468046258895,"score_gpt":0.2369195214378361,"score_spread":0.2289700533915772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036000990","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313474,0.0028432284,0.00038809585,0.0006868894,0.000025659583,0.00009001723,0.0012897146,0.000046705045,0.0014948992],"genre_scores_gemma":[0.99499255,0.0018616964,0.0018240901,0.00014452994,0.00004049187,0.00008799545,0.00080343406,0.000005834152,0.00023951055],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901736,0.00033134228,0.00018856641,0.00008781773,0.00027051775,0.00010445196],"domain_scores_gemma":[0.9955493,0.00068215927,0.0027801234,0.00012733972,0.00047725465,0.00038376328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010925302,0.00017569061,0.00023932492,0.00095428515,0.00046586228,0.00038452516,0.0003914506,0.0003004602,0.00207747],"category_scores_gemma":[0.0045669544,0.0001447678,0.00025951603,0.0014777327,0.00021369716,0.00034903325,0.00025417967,0.00046009754,0.00020383237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008444086,0.000102651225,0.9870302,0.00004615527,0.000014134095,0.000047428453,0.00018506355,0.00005322348,0.000107751395,0.00003467204,0.0009878682,0.011306259],"study_design_scores_gemma":[0.000019662672,0.00024835317,0.9982712,0.00006358978,0.000018625371,0.00017903262,0.00016533717,0.00024036325,0.0001538102,0.000019646553,0.0006171218,0.0000032536566],"about_ca_topic_score_codex":0.017764125,"about_ca_topic_score_gemma":0.034608424,"teacher_disagreement_score":0.017764125,"about_ca_system_score_codex":0.0010865683,"about_ca_system_score_gemma":0.0020310683,"threshold_uncertainty_score":0.035321474},"labels":[],"label_agreement":null},{"id":"W2038661096","doi":"10.1002/ajh.20118","title":"Echocardiographic abnormalities in sickle cell disease","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dartmouth General Hospital; Dalhousie University; Royal University Hospital","funders":"","keywords":"Medicine; Disease; Internal medicine; MEDLINE; Cardiology; Intensive care medicine; Pediatrics; Biology","score_opus":0.004141990782277265,"score_gpt":0.22762596931486084,"score_spread":0.2234839785325836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038661096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986966,0.00070048147,0.00006732078,0.00003789941,0.0000061063033,0.000003842429,0.00006548886,0.000004176458,0.00041814163],"genre_scores_gemma":[0.9995468,0.00019451312,0.00006739692,0.000029505487,0.000019392162,0.0000031580817,0.00008622351,7.498655e-7,0.000052196458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968016,0.00007746019,0.00005434492,0.000051466868,0.00007878611,0.000057768604],"domain_scores_gemma":[0.998818,0.00032928423,0.0004574498,0.000035227105,0.00011752428,0.0002425208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033033438,0.00020085511,0.00026341155,0.0008829819,0.00029579038,0.0003068115,0.0001589554,0.00038553216,0.0010925053],"category_scores_gemma":[0.0021889159,0.00016840015,0.00011345724,0.00047101834,0.00025249083,0.000309755,0.00026540863,0.00028062967,0.00016609991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057232995,0.000013638763,0.99664044,0.0000091359425,0.000007664704,0.0009732393,0.00007035793,0.000022824997,0.00049054995,0.0000096439135,0.0000736613,0.0016316009],"study_design_scores_gemma":[0.000005448129,0.00009987238,0.9933523,0.0000090608855,0.000008927883,0.0060207467,0.0001159047,0.00011431592,0.00011507129,0.000015718611,0.00014028163,0.000002329177],"about_ca_topic_score_codex":0.00088564376,"about_ca_topic_score_gemma":0.001100254,"teacher_disagreement_score":0.0010925053,"about_ca_system_score_codex":0.00018263493,"about_ca_system_score_gemma":0.00014244435,"threshold_uncertainty_score":0.003654778},"labels":[],"label_agreement":null},{"id":"W2038906686","doi":"10.1002/ajh.23408","title":"Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic‐phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Adverse effect; Dasatinib; Myeloid leukemia; Rash; Phases of clinical research; Imatinib; Chemotherapy","score_opus":0.012338075314130881,"score_gpt":0.3062197094384318,"score_spread":0.2938816341243009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038906686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971464,0.0003765926,0.00033113075,0.00017433098,0.00004807659,0.0012159783,0.0002343543,0.00003120873,0.00044195782],"genre_scores_gemma":[0.9941075,0.00049545494,0.0011109408,0.00038395045,0.00012559158,0.0017577779,0.00097461825,0.000011875749,0.0010322358],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996877,0.00013808651,0.000017544518,0.000048614034,0.000031513493,0.00007671803],"domain_scores_gemma":[0.99949527,0.00008641021,0.00009948761,0.00004697217,0.00003403089,0.0002377454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011768709,0.0012516391,0.0016350999,0.0003259643,0.00028921434,0.0005879609,0.00052665826,0.0008685076,0.002002772],"category_scores_gemma":[0.0006717863,0.00039764293,0.00082726683,0.00023895875,0.0005192853,0.0005749311,0.0002650177,0.001791315,0.0004538266],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54084074,0.15688671,0.012038294,0.0006821837,0.00080455357,0.00083010393,0.0005150007,0.0036767973,0.15455255,0.00046542322,0.0034878096,0.12521976],"study_design_scores_gemma":[0.36428306,0.6122928,0.012411086,0.000020456104,0.00015073342,0.0005546114,0.000063902444,0.0018900654,0.006483038,0.0001273629,0.0016994537,0.000023362049],"about_ca_topic_score_codex":0.0006156274,"about_ca_topic_score_gemma":0.0011762438,"teacher_disagreement_score":0.002002772,"about_ca_system_score_codex":0.00050166895,"about_ca_system_score_gemma":0.0010341075,"threshold_uncertainty_score":0.0066999793},"labels":[],"label_agreement":null},{"id":"W2038935774","doi":"10.1002/ajh.20221","title":"Dissociation between the level of von Willebrand factor‐cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thrombotic thrombocytopenic purpura; ADAMTS13; Medicine; Von Willebrand factor; Splenectomy; Coagulopathy; Gastroenterology; Internal medicine; Immunology; Platelet; Atypical hemolytic uremic syndrome; Antibody; Spleen; Complement system","score_opus":0.026551036004678813,"score_gpt":0.2712749913259103,"score_spread":0.2447239553212315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038935774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991258,0.00023927011,0.00020243923,0.00009250787,0.0000046317987,0.0000032688567,0.00003047062,0.000009794864,0.00029189166],"genre_scores_gemma":[0.9995384,0.00008303828,0.0001772186,0.0000428656,0.000014190385,0.0000031597963,0.000042249274,0.0000035179683,0.00009534731],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997067,0.00005480981,0.0000412504,0.00008641629,0.000052946718,0.000057888872],"domain_scores_gemma":[0.9990827,0.00031573165,0.00020649553,0.00006848105,0.00006543613,0.0002611384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000281962,0.00046083514,0.00040189957,0.000960876,0.00083666015,0.00050669,0.00027331512,0.0010429239,0.0005943219],"category_scores_gemma":[0.0022099116,0.00032875285,0.00029579745,0.00060056266,0.0005291856,0.00053524,0.00028679584,0.0009967098,0.00015999337],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011160973,0.00050496426,0.77689964,0.00006526558,0.00010982233,0.15149537,0.0032698694,0.00059343944,0.045231782,0.0004579648,0.00050087715,0.019754903],"study_design_scores_gemma":[0.000098560085,0.0020624592,0.48262936,0.000025692427,0.00016302028,0.50407696,0.00039065376,0.0016863106,0.0069719744,0.00034767605,0.0014861423,0.00006115983],"about_ca_topic_score_codex":0.001227038,"about_ca_topic_score_gemma":0.00084273703,"teacher_disagreement_score":0.001227038,"about_ca_system_score_codex":0.00031853723,"about_ca_system_score_gemma":0.0002880484,"threshold_uncertainty_score":0.0024397373},"labels":[],"label_agreement":null},{"id":"W2039127104","doi":"10.1002/ajh.21585","title":"Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study","year":2009,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Center for Research Resources; National Human Genome Research Institute; University of California, Irvine; Deutsches Krebsforschungszentrum; National Heart, Lung, and Blood Institute; University of Minnesota; National Cancer Institute; National Institutes of Health; Wake Forest University; Kaiser Permanente","keywords":"Heritability; Transferrin saturation; Hemochromatosis; Proband; Medicine; Internal medicine; Serum iron; Hereditary hemochromatosis; Population; Genotype; Serum ferritin; Ferritin; Genetics; Anemia; Biology; Gene","score_opus":0.014196600630362557,"score_gpt":0.2828052952023827,"score_spread":0.26860869457202013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039127104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976896,0.00019459492,0.0006302074,0.000056475936,0.000010477211,0.000019485444,0.00060591486,0.000015632242,0.00077766436],"genre_scores_gemma":[0.9992866,0.00006260678,0.00018612276,0.000012128686,0.0000062300724,0.000010284396,0.0002020908,0.0000022051017,0.00023182842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898344,0.0004820231,0.000060548304,0.00021338648,0.00015402609,0.000106621075],"domain_scores_gemma":[0.99903774,0.00033787207,0.0002627363,0.00015578019,0.00011065511,0.00009531355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018303345,0.00038898966,0.00047389473,0.00049657427,0.00047166646,0.00041240812,0.00024685272,0.00027080142,0.0016072509],"category_scores_gemma":[0.0027809395,0.00022534757,0.00034213165,0.00043089315,0.0003194965,0.00020578597,0.00038172837,0.00037446935,0.00014619593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047113653,0.00009328592,0.98784757,0.000018158613,0.00041033246,0.0010315028,0.0006248093,0.0005766892,0.0013243388,0.0003915933,0.0014844605,0.005726068],"study_design_scores_gemma":[0.000020953485,0.0000725871,0.9975999,0.000014820008,0.00010183821,0.00078221783,0.0001716097,0.0005903555,0.00012213957,0.00017325627,0.00034273937,0.000007573384],"about_ca_topic_score_codex":0.014004614,"about_ca_topic_score_gemma":0.010664397,"teacher_disagreement_score":0.014004614,"about_ca_system_score_codex":0.00026234935,"about_ca_system_score_gemma":0.00024332355,"threshold_uncertainty_score":0.027846217},"labels":[],"label_agreement":null},{"id":"W2039735377","doi":"10.1002/ajh.22090","title":"Myeloma ASH 2010 highlights","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine","score_opus":0.03226952994917358,"score_gpt":0.30281670643244657,"score_spread":0.270547176483273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039735377","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020230634,0.1058902,0.0007270163,0.29179728,0.38758144,0.00023605509,0.0034949807,0.00047101043,0.20777898],"genre_scores_gemma":[0.014386318,0.11892563,0.0013901355,0.15704894,0.31615493,0.00023550756,0.0068697655,0.0002963503,0.38469252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991067,0.0001020617,0.00007222351,0.00013622217,0.00043927896,0.00014357419],"domain_scores_gemma":[0.99776375,0.00017816837,0.00010223087,0.000057524885,0.001001888,0.0008965086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012844134,0.0010165031,0.00065843697,0.0008094743,0.0011861117,0.0038389114,0.0011905914,0.0045308312,0.09581074],"category_scores_gemma":[0.0023321041,0.0002897401,0.00088033656,0.00074710004,0.00035077968,0.0017137978,0.0015453589,0.0041369414,0.04987178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003843698,0.000017573213,0.000103785984,0.00017430182,0.000005937255,0.00012130781,0.000005426645,0.000021573307,0.00012146813,0.00045268264,0.95961654,0.039320964],"study_design_scores_gemma":[0.000016337268,0.000016653772,0.00047530312,0.00014877926,0.000006758122,0.0003202297,0.000016787622,0.00001626929,0.00009299338,0.0002521372,0.99863404,0.0000037064594],"about_ca_topic_score_codex":0.0026523303,"about_ca_topic_score_gemma":0.006459244,"teacher_disagreement_score":0.09581074,"about_ca_system_score_codex":0.0027230901,"about_ca_system_score_gemma":0.0036618656,"threshold_uncertainty_score":0.32051885},"labels":[],"label_agreement":null},{"id":"W2039971449","doi":"10.1002/ajh.23172","title":"Referrals for suspected hematologic malignancy: A survey of primary care physicians","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Institute of Nursing Research; Centers for Disease Control and Prevention","keywords":"Medicine; Hematologic malignancy; Primary care; Hematologic Neoplasms; Malignancy; Hematological malignancy; Hematologic tests; Family medicine; Intensive care medicine; Internal medicine; Cancer; Environmental health; Health services","score_opus":0.04210755597494975,"score_gpt":0.2763084119615964,"score_spread":0.23420085598664664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039971449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966073,0.0008009426,0.0000667056,0.00076765375,0.000011881044,0.000026485392,0.000572974,0.000009269218,0.0011368528],"genre_scores_gemma":[0.9986663,0.00047895598,0.00006484095,0.0004571058,0.00002505359,0.000016719685,0.00019965008,0.0000019462461,0.00008935012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789184,0.0006897111,0.00025878302,0.0002910786,0.0006386504,0.00023002113],"domain_scores_gemma":[0.99228436,0.0022267378,0.0033035395,0.00018891238,0.00078409124,0.0012122482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011936169,0.00013970412,0.0003406787,0.0010621136,0.0005843012,0.0007181547,0.00042651757,0.00091320527,0.0019760751],"category_scores_gemma":[0.0072510084,0.00041821046,0.00023025696,0.0017602,0.000488344,0.000887599,0.0005722598,0.00060478545,0.00044494495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019530931,0.000041330266,0.9973053,0.000029792023,0.000014516066,0.00018940005,0.0005185774,0.000011952529,0.00010038558,0.0000091713,0.0005115199,0.0012484266],"study_design_scores_gemma":[0.0000041403828,0.000092387076,0.99812275,0.00002529755,0.000006070242,0.00051761203,0.0009110094,0.0000599212,0.00001625811,0.0000054942775,0.00023665145,0.0000024701717],"about_ca_topic_score_codex":0.01983837,"about_ca_topic_score_gemma":0.024687434,"teacher_disagreement_score":0.01983837,"about_ca_system_score_codex":0.0009408363,"about_ca_system_score_gemma":0.0007524413,"threshold_uncertainty_score":0.039445758},"labels":[],"label_agreement":null},{"id":"W2040267768","doi":"10.1002/ajh.20680","title":"Waldenstrom's macroglobulinemia presenting with spinal cord compression: A case report","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Hepatosplenomegaly; Waldenstrom macroglobulinemia; Bone marrow; Cytopenia; Pathology; Lymphoplasmacytic Lymphoma; Macroglobulinemia; Spinal cord compression; Hyperviscosity syndrome; Back pain; Spinal cord; Lymphoma; Internal medicine; Disease; Multiple myeloma","score_opus":0.014939438870727854,"score_gpt":0.3321530409717257,"score_spread":0.31721360210099786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040267768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983264,0.0049326434,0.0018211707,0.0013063819,0.0002537137,0.00023391913,0.0001827041,0.00014121899,0.007864081],"genre_scores_gemma":[0.9955142,0.0015454795,0.0008620297,0.00040448955,0.0007409209,0.00004187273,0.00008187094,0.000015027863,0.000794059],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99900264,0.00012818053,0.00010004878,0.00019190168,0.00013060674,0.00044663946],"domain_scores_gemma":[0.99831116,0.00049044157,0.00043448352,0.00015694764,0.000091750226,0.00051523175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048652268,0.0032654046,0.0016549196,0.0029000002,0.0038708986,0.0025890442,0.0013115217,0.0062989327,0.002915944],"category_scores_gemma":[0.00400817,0.0018816672,0.00097185106,0.0021741467,0.0021234197,0.0025756373,0.0019261021,0.00254944,0.0015496735],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029546549,0.0000870183,0.005736749,0.0000306579,0.000009545336,0.9922501,0.0001662064,0.000036219975,0.00045936424,0.00007638217,0.0001873777,0.0009309443],"study_design_scores_gemma":[0.000021006088,0.0000714227,0.002590991,0.000008363042,0.000009383348,0.9966186,0.000089258465,0.00010183113,0.00018952577,0.000062351915,0.00022836441,0.000008796455],"about_ca_topic_score_codex":0.002693868,"about_ca_topic_score_gemma":0.0032183607,"teacher_disagreement_score":0.0062989327,"about_ca_system_score_codex":0.0011689278,"about_ca_system_score_gemma":0.0010328818,"threshold_uncertainty_score":0.009754837},"labels":[],"label_agreement":null},{"id":"W2041029933","doi":"10.1002/ajh.20368","title":"Congenital methemoglobinemia caused by Hb‐M<sub>Ratnagiri</sub> (β‐63CAT→TAT, His→Tyr) in an Indian family","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methemoglobinemia; Methemoglobin; Hemoglobinopathy; Medicine; Hemoglobin; Pediatrics; Thalassemia; Internal medicine; Hemolytic anemia; Anesthesia","score_opus":0.006810323150346666,"score_gpt":0.25666667657975023,"score_spread":0.24985635342940357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041029933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976649,0.00028632313,0.00047078615,0.00012685366,0.00001909266,0.00001178162,0.000038997936,0.000041452164,0.001339813],"genre_scores_gemma":[0.99886334,0.00019424372,0.00042501406,0.00007594103,0.00003460601,0.000004425381,0.000028880291,0.00000791745,0.00036559865],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997824,0.00003786965,0.000019383879,0.00006753603,0.00004160576,0.000051163515],"domain_scores_gemma":[0.9997191,0.00009525139,0.00007365871,0.000021905813,0.00001697098,0.00007316618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001213515,0.0009474584,0.00028703437,0.0006723471,0.0009672104,0.00026962074,0.00040953566,0.0005040978,0.0018925158],"category_scores_gemma":[0.0007838984,0.0004077002,0.00023817786,0.0005513913,0.00071555324,0.00023772752,0.00047728253,0.000610446,0.00033094845],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023238317,0.00026768702,0.19500986,0.00012693075,0.00009775801,0.7265897,0.004060423,0.00023834906,0.04366807,0.0009776693,0.0013154014,0.027415777],"study_design_scores_gemma":[0.000031644446,0.00034709563,0.15063873,0.00003124424,0.000116596464,0.8413819,0.00073154527,0.00042589108,0.0037587283,0.0002160708,0.002280954,0.00003951013],"about_ca_topic_score_codex":0.003507848,"about_ca_topic_score_gemma":0.005083381,"teacher_disagreement_score":0.003507848,"about_ca_system_score_codex":0.00026949611,"about_ca_system_score_gemma":0.0002656527,"threshold_uncertainty_score":0.006974876},"labels":[],"label_agreement":null},{"id":"W2041622724","doi":"10.1002/(sici)1096-8652(200001)63:1<54::aid-ajh12>3.0.co;2-b","title":"PCR-based diagnosis of the Filipino (??FIL) and Thai (??THAI) ?-thalassemia-1 deletions","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Thalassemia; Medicine; Beta thalassemia; Genetics; Internal medicine; Biology","score_opus":0.005600731001218741,"score_gpt":0.23767255593268427,"score_spread":0.23207182493146553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041622724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8925354,0.004081958,0.09046632,0.0005021279,0.00020403386,0.0010982193,0.0011304916,0.0005105755,0.0094708325],"genre_scores_gemma":[0.8772967,0.003209377,0.114925586,0.00032659882,0.000058920246,0.00037597516,0.0016807844,0.00004691103,0.0020792587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990089,0.00024785622,0.00014733755,0.00020144977,0.00027431519,0.0001201782],"domain_scores_gemma":[0.998495,0.0008618463,0.00023448265,0.00007715181,0.00023789961,0.000093576265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006857302,0.0005207391,0.00032734923,0.0013457361,0.00018104346,0.0003388746,0.00049258576,0.00057009695,0.0009139542],"category_scores_gemma":[0.002490835,0.00031108677,0.00027451172,0.00030229308,0.00045892736,0.00030892095,0.0003014633,0.0006025198,0.0006808765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037950007,0.00014237213,0.02021047,0.0003157873,0.000028559984,0.0020121979,0.0004265282,0.00041909376,0.9268999,0.00050687016,0.00029943898,0.048359312],"study_design_scores_gemma":[0.000084306535,0.0012643142,0.045753215,0.00018732803,0.00018908159,0.014295815,0.00072522974,0.0063702096,0.9213433,0.00058892224,0.009139736,0.00005843849],"about_ca_topic_score_codex":0.000525035,"about_ca_topic_score_gemma":0.0011132732,"teacher_disagreement_score":0.0013457361,"about_ca_system_score_codex":0.00016415304,"about_ca_system_score_gemma":0.00016809854,"threshold_uncertainty_score":0.003626585},"labels":[],"label_agreement":null},{"id":"W2041712143","doi":"10.1002/ajh.20699","title":"Thymoma followed by paroxysmal nocturnal hemoglobinuria: A unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Thymoma; Myasthenia gravis; Hemoglobinuria; Medicine; Context (archaeology); Immunology; Autoimmune hemolytic anemia; Pathology; Biology; Antibody","score_opus":0.005345291744602563,"score_gpt":0.26713961190231555,"score_spread":0.261794320157713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041712143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959372,0.0006289787,0.0004394102,0.0002777182,0.000043817654,0.00003596839,0.00006232307,0.000026744203,0.0025478182],"genre_scores_gemma":[0.9992223,0.00014967105,0.00014872996,0.000092856324,0.00009241699,0.0000058253954,0.00003056163,0.0000038403987,0.00025380458],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99967754,0.000050082614,0.00003138906,0.00008594399,0.000035964982,0.00011905907],"domain_scores_gemma":[0.9988148,0.0003144602,0.00026127437,0.00007421937,0.00006948892,0.00046571682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027347048,0.0009280784,0.0007035908,0.0010435157,0.0014918341,0.0006574829,0.0004921596,0.0018427419,0.0013490173],"category_scores_gemma":[0.001584679,0.0005541684,0.00042249158,0.00067508355,0.0010574597,0.0006344812,0.00072430616,0.001245864,0.00030864953],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020686303,0.000064366395,0.06573166,0.000030075078,0.000019797137,0.9286272,0.00032089112,0.00008494557,0.0032104063,0.00016750729,0.00019492285,0.0013413971],"study_design_scores_gemma":[0.00003043151,0.00026055516,0.04439931,0.000009130141,0.000024399316,0.9539348,0.00016029025,0.00016857525,0.00063156185,0.00008402914,0.000282738,0.0000141853825],"about_ca_topic_score_codex":0.0011675523,"about_ca_topic_score_gemma":0.0018244757,"teacher_disagreement_score":0.0018427419,"about_ca_system_score_codex":0.00041416113,"about_ca_system_score_gemma":0.00039327051,"threshold_uncertainty_score":0.0045129657},"labels":[],"label_agreement":null},{"id":"W2042544679","doi":"10.1002/ajh.20653","title":"ADAMTS13 activity in sickle cell disease","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mach-Gaensslen Foundation of Canada; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Disease; ADAMTS13; Internal medicine; Thrombotic thrombocytopenic purpura","score_opus":0.003780845232269668,"score_gpt":0.23214474781064134,"score_spread":0.22836390257837166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042544679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719524,0.0023002767,0.00020337559,0.000017423505,0.000005328092,0.00000385882,0.000097985954,0.0000110494175,0.00016542977],"genre_scores_gemma":[0.9991328,0.00041038884,0.00017885951,0.000009334489,0.000012498599,0.0000040736913,0.00014911372,0.0000020997904,0.00010078316],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970967,0.00008289313,0.000051842435,0.000053468968,0.00007392134,0.000028213539],"domain_scores_gemma":[0.9993674,0.00014266714,0.0002987842,0.000026947466,0.00008011813,0.00008404912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036436057,0.00028604898,0.0003118511,0.000974352,0.00012996898,0.00036797172,0.00011739099,0.0002649985,0.00045210507],"category_scores_gemma":[0.0013486936,0.00010433126,0.00015304112,0.0006474871,0.00018918543,0.00012163486,0.00016607917,0.00018983847,0.00010976012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025214243,0.00012098071,0.7350831,0.0002105611,0.00021557766,0.0026477564,0.0004526994,0.0004749317,0.227658,0.0001725146,0.00041216274,0.03003023],"study_design_scores_gemma":[0.00002914795,0.00045686014,0.97092515,0.00001963863,0.0001003544,0.006165451,0.00005556804,0.0008958367,0.02030631,0.00011330994,0.0009227367,0.0000095517735],"about_ca_topic_score_codex":0.00045916648,"about_ca_topic_score_gemma":0.00021120219,"teacher_disagreement_score":0.000974352,"about_ca_system_score_codex":0.00018218967,"about_ca_system_score_gemma":0.00008456602,"threshold_uncertainty_score":0.0019269586},"labels":[],"label_agreement":null},{"id":"W2043355737","doi":"10.1002/ajh.21896","title":"Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Thalassemia; Cohort; Medicine; Quality of life (healthcare); Pediatrics; Beta thalassemia; Internal medicine","score_opus":0.014940780160300413,"score_gpt":0.3136953777836498,"score_spread":0.2987545976233494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043355737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667597,0.0009056689,0.00020930156,0.0001720855,0.000026604683,0.000017950131,0.0012990509,0.000006966148,0.0006863379],"genre_scores_gemma":[0.9977023,0.00023770261,0.00014554767,0.000049059254,0.000011734337,0.000021761112,0.0017484911,0.0000033607448,0.000079991354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987686,0.00039012294,0.0001901699,0.00017699464,0.00035706046,0.00011697226],"domain_scores_gemma":[0.99717087,0.0008298747,0.0010074544,0.00016058891,0.0005799311,0.00025123626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031680865,0.0002313906,0.0003421075,0.0017233029,0.00026721926,0.0008099164,0.000313294,0.00029765238,0.00069845596],"category_scores_gemma":[0.008905809,0.00014405066,0.00064603734,0.001645412,0.00024366831,0.00058983895,0.0007729465,0.00050386484,0.000109254914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021442425,0.00003491638,0.9944419,0.00002919176,0.0002492729,0.000025082642,0.00023469004,0.000097143704,0.00007492451,0.00004472752,0.0004636489,0.004089934],"study_design_scores_gemma":[0.00001218149,0.000099378856,0.9989513,0.000014463159,0.000043806693,0.000065713924,0.0002517506,0.0001665672,0.00002281937,0.000025807476,0.00034131948,0.0000048622924],"about_ca_topic_score_codex":0.007504804,"about_ca_topic_score_gemma":0.008043423,"teacher_disagreement_score":0.007504804,"about_ca_system_score_codex":0.0006757363,"about_ca_system_score_gemma":0.00033698892,"threshold_uncertainty_score":0.016754687},"labels":[],"label_agreement":null},{"id":"W2043595799","doi":"10.1002/ajh.20747","title":"Aberrant expression of T‐cell‐associated markers CD4 and CD7 on B‐cell chronic lymphocytic leukemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Chronic lymphocytic leukemia; CD5; Fluorescence in situ hybridization; CD20; Biology; Trisomy; Cancer research; Leukemia; Gene rearrangement; Pathology; Immunology; Flow cytometry; Antibody; Medicine; Chromosome; Gene; Genetics","score_opus":0.006723992156853539,"score_gpt":0.2558490728327741,"score_spread":0.24912508067592054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043595799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955331,0.00038470703,0.0010079815,0.00013486193,0.000007731071,0.000015680784,0.00004606861,0.00003662218,0.0028332223],"genre_scores_gemma":[0.99862707,0.0001352635,0.0008393189,0.00003131101,0.000013627103,0.000010402011,0.00007835472,0.0000050200347,0.00025966318],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975306,0.00004320963,0.00002317413,0.00004932568,0.000045162808,0.000086088294],"domain_scores_gemma":[0.99969363,0.0001319676,0.000031965286,0.00004606365,0.000036944064,0.00005951593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019802875,0.00040038372,0.00017578379,0.0014302601,0.00066153606,0.00060318457,0.00024956898,0.0008830185,0.0017202762],"category_scores_gemma":[0.00087593286,0.00022717609,0.00013920083,0.00041958046,0.0007406348,0.00045412776,0.00031087178,0.0003944077,0.00037811702],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00108697,0.00029905318,0.14988983,0.00019609208,0.00008212058,0.14605312,0.0014300008,0.0006919023,0.6573696,0.003304218,0.0011456951,0.038451392],"study_design_scores_gemma":[0.00024454558,0.0008767525,0.14736764,0.00007869947,0.0002582517,0.6547386,0.0010511162,0.01030062,0.1686732,0.003095213,0.013247715,0.000067626206],"about_ca_topic_score_codex":0.0013525712,"about_ca_topic_score_gemma":0.0012118708,"teacher_disagreement_score":0.0017202762,"about_ca_system_score_codex":0.0005975654,"about_ca_system_score_gemma":0.00020900642,"threshold_uncertainty_score":0.005754888},"labels":[],"label_agreement":null},{"id":"W2046186673","doi":"10.1002/ajh.23202","title":"Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors","year":2012,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; McMaster University","funders":"Daiichi Sankyo Europe; Grifols; Astellas Pharma; Eisai; Sanofi; CSL Behring; GlaxoSmithKline; Pfizer","keywords":"Dabigatran; Rivaroxaban; Medicine; Apixaban; Prothrombin complex concentrate; Intensive care medicine; Warfarin; Drug; Hemostasis; Antidote; Activated charcoal; Expert opinion; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.1318674564263781,"score_gpt":0.398016953624913,"score_spread":0.2661494971985349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046186673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009301357,0.992577,0.0002305529,0.0030238472,0.0007113897,0.000022045033,0.000081534155,0.000015802063,0.0032448445],"genre_scores_gemma":[0.00051471073,0.9956448,0.00086983526,0.0012943691,0.0002715621,0.000020743446,0.00013962937,0.0000025413135,0.0012417241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917763,0.00017826709,0.00016003747,0.00006728829,0.0003752102,0.00004154207],"domain_scores_gemma":[0.99865544,0.00055706524,0.0002566835,0.000025393545,0.00043625874,0.00006907436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013113861,0.00085109106,0.001539775,0.0033691959,0.00030590984,0.00079939695,0.0014866522,0.0019680883,0.0056309616],"category_scores_gemma":[0.0025111386,0.0003191911,0.0011832973,0.0030967467,0.00047106462,0.00124629,0.0005226964,0.0020469998,0.0030997999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041764946,0.00006286551,0.00014839388,0.024119888,0.00012081539,0.0003865226,0.00009223393,0.00016450365,0.00044599737,0.0026389163,0.20747511,0.7643029],"study_design_scores_gemma":[0.000032693388,0.000045704495,0.00070384046,0.01572355,0.0001346345,0.0019396653,0.00004882667,0.000046433626,0.00011773093,0.0011961244,0.9799973,0.000013455063],"about_ca_topic_score_codex":0.003691723,"about_ca_topic_score_gemma":0.0066447225,"teacher_disagreement_score":0.0056309616,"about_ca_system_score_codex":0.00093446305,"about_ca_system_score_gemma":0.0028332397,"threshold_uncertainty_score":0.018837452},"labels":[],"label_agreement":null},{"id":"W2047177706","doi":"10.1002/ajh.21053","title":"Characteristics of participants with self‐reported hemochromatosis or iron overload at HEIRS study initial screening","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Hemochromatosis; Medicine; Hereditary hemochromatosis; Internal medicine","score_opus":0.02664994957869372,"score_gpt":0.3279629238013846,"score_spread":0.3013129742226909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047177706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633586,0.0002833866,0.00013460072,0.000051887957,0.000013001181,0.00009735266,0.0015916913,0.000009356365,0.0014829503],"genre_scores_gemma":[0.9973628,0.00014770895,0.00018797621,0.00010598367,0.0000129611835,0.0001981798,0.0011716419,0.000005389804,0.0008073804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995383,0.00008407744,0.000069376634,0.00012363147,0.00010460275,0.0000800685],"domain_scores_gemma":[0.9989182,0.00022622033,0.0003187153,0.000073164825,0.00023057194,0.00023328073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094042893,0.00022627144,0.00043118163,0.0008518975,0.0007772901,0.00048224392,0.00031396706,0.00044596792,0.0028083792],"category_scores_gemma":[0.002695151,0.00020270438,0.00035671584,0.0007355448,0.00022389233,0.00045077814,0.00030644168,0.00035328243,0.0004888638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022718955,0.00015573374,0.9952761,0.00003502347,0.000044798053,0.00023035257,0.00062263,0.000023316692,0.0006137632,0.00001870696,0.00042088694,0.0023316315],"study_design_scores_gemma":[0.000012909001,0.00024010648,0.99781835,0.000022020584,0.000027800574,0.0003636827,0.00073324185,0.00007636119,0.00008417035,0.00002154156,0.00059254636,0.000007281715],"about_ca_topic_score_codex":0.008200195,"about_ca_topic_score_gemma":0.007164464,"teacher_disagreement_score":0.008200195,"about_ca_system_score_codex":0.00023519457,"about_ca_system_score_gemma":0.00031405748,"threshold_uncertainty_score":0.01630491},"labels":[],"label_agreement":null},{"id":"W2048360052","doi":"10.1002/ajh.10255","title":"Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry","year":2003,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; CancerCare Manitoba","funders":"Amgen","keywords":"Medicine; Neutropenia; Filgrastim; Internal medicine; Absolute neutrophil count; Congenital Neutropenia; Leukopenia; Granulocyte colony-stimulating factor; Adverse effect; Gastroenterology; Pediatrics; Surgery; Chemotherapy","score_opus":0.01105449617154365,"score_gpt":0.280331050174908,"score_spread":0.26927655400336437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048360052","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823267,0.0009784175,0.00038641365,0.00028580066,0.000027908598,0.00019047219,0.011984359,0.000032868185,0.003787116],"genre_scores_gemma":[0.9764114,0.0006787116,0.00065034354,0.0002639981,0.000057421385,0.0004388944,0.020744916,0.000014392372,0.0007400254],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989072,0.00025166967,0.0002656841,0.00017582465,0.00022737369,0.00017235518],"domain_scores_gemma":[0.99505264,0.0004553252,0.0027678383,0.00039034116,0.000637698,0.00069612387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013795333,0.00015177144,0.0003598282,0.0010438672,0.000592469,0.0007027368,0.00043927477,0.00037678477,0.0010127549],"category_scores_gemma":[0.0032363937,0.00015582865,0.00031967807,0.0021422543,0.00015264166,0.00066448626,0.000599128,0.00061718305,0.00029787325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002461365,0.000077630575,0.9935355,0.000018793195,0.000021833297,0.00010589753,0.00006942665,0.00006513328,0.00012990575,0.000032015312,0.0011020117,0.004595842],"study_design_scores_gemma":[0.000054228174,0.00028740265,0.99483263,0.000030308978,0.000033684144,0.0006873508,0.0001996044,0.0003578896,0.00019839454,0.000035496072,0.0032719998,0.000011069],"about_ca_topic_score_codex":0.006100366,"about_ca_topic_score_gemma":0.0048359022,"teacher_disagreement_score":0.006100366,"about_ca_system_score_codex":0.0004945884,"about_ca_system_score_gemma":0.0009928785,"threshold_uncertainty_score":0.012129724},"labels":[],"label_agreement":null},{"id":"W2049540913","doi":"10.1002/ajh.21308","title":"Hemoglobin Kenya composed of α‐ and (<sup>A</sup>γβ)‐fusion‐globin chains, associated with hereditary persistence of fetal hemoglobin","year":2008,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; McGill University","keywords":"Fetal hemoglobin; Globin; Hemoglobinopathy; Compound heterozygosity; Hemoglobin; Asymptomatic; Gene; Genetics; Mutation; Biology; Fetus; Molecular biology; Hemolytic anemia; Medicine; Immunology; Internal medicine; Pregnancy; Biochemistry","score_opus":0.017567806367920345,"score_gpt":0.2635372216025085,"score_spread":0.24596941523458812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049540913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002804792,0.9977865,0.00013331295,0.00016451687,0.00012126446,0.0000040700884,0.000022339593,0.000013289906,0.0014742053],"genre_scores_gemma":[0.0022962457,0.99591064,0.00027520926,0.00020009968,0.0001641512,0.0000053464687,0.00007888562,0.0000027867432,0.0010666066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998373,0.000021374055,0.00002525006,0.00004242302,0.00005843556,0.00001521919],"domain_scores_gemma":[0.9997576,0.000084354935,0.00006253262,0.0000096373715,0.00005448826,0.000031380318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032471435,0.00077378005,0.0013211104,0.0035229847,0.00029113123,0.0006536489,0.0005542699,0.0006180509,0.0020277626],"category_scores_gemma":[0.0005293932,0.00025175622,0.00024222916,0.0029916223,0.00065437757,0.001074254,0.00047942335,0.00091801863,0.0021123085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006503124,0.00004827774,0.00078920985,0.0066569773,0.00007042648,0.001567899,0.000058957896,0.00014526321,0.002516246,0.0013461725,0.03735552,0.94938004],"study_design_scores_gemma":[0.000024496452,0.00008925233,0.005037244,0.0020874534,0.00013244615,0.034847047,0.00011605549,0.00006802981,0.0009972063,0.0010504221,0.9555265,0.000023896337],"about_ca_topic_score_codex":0.0016410962,"about_ca_topic_score_gemma":0.0022864365,"teacher_disagreement_score":0.0035229847,"about_ca_system_score_codex":0.000537481,"about_ca_system_score_gemma":0.00073925377,"threshold_uncertainty_score":0.0067834854},"labels":[],"label_agreement":null},{"id":"W2052482483","doi":"10.1002/ajh.20601","title":"Chronic eosinophilic leukemia presenting with autoimmune hemolytic anemia and erythrophagocytosis by eosinophils","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University; Grand River Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Immunology; Eosinophilic; Hemolytic anemia; Leukemia; Anemia; Eosinophilia; Eosinophil; Pathology; Internal medicine; Antibody; Asthma","score_opus":0.004466520734331537,"score_gpt":0.22946762718537334,"score_spread":0.2250011064510418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052482483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914625,0.0025284928,0.00065772864,0.0003397775,0.00004180042,0.000072803756,0.00007635817,0.00005603397,0.0047644777],"genre_scores_gemma":[0.9973959,0.000991886,0.0003397796,0.00033487487,0.00018904658,0.000018142908,0.00007060249,0.000010095852,0.000649651],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99965334,0.000051049396,0.000037955328,0.000049039492,0.000044121338,0.00016452096],"domain_scores_gemma":[0.99924767,0.00023190322,0.00021504499,0.000050609557,0.00003889662,0.00021586215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021848128,0.0010953523,0.00055770675,0.0010901392,0.0010196606,0.0006910823,0.00031214705,0.001905799,0.0019148963],"category_scores_gemma":[0.0013965387,0.0005868079,0.00028282948,0.0009279807,0.0008227367,0.00082984264,0.0006553337,0.0009978575,0.0007291353],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018456792,0.0000902616,0.07388356,0.00005733225,0.000015460595,0.9178469,0.00024009327,0.000058538175,0.0031776417,0.00016554598,0.00043078285,0.0038493054],"study_design_scores_gemma":[0.000053513682,0.00015048428,0.02065646,0.00002063331,0.000015552307,0.97758716,0.00017058005,0.00011162945,0.00046041817,0.000103838946,0.0006628871,0.0000068614204],"about_ca_topic_score_codex":0.001312267,"about_ca_topic_score_gemma":0.0022185135,"teacher_disagreement_score":0.0019148963,"about_ca_system_score_codex":0.00030714396,"about_ca_system_score_gemma":0.00035057412,"threshold_uncertainty_score":0.0064059496},"labels":[],"label_agreement":null},{"id":"W2053625299","doi":"10.1002/ajh.20305","title":"Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Ticlopidine; Platelet; Platelet activation; Heparin-induced thrombocytopenia; Heparin; Pharmacology; Ex vivo; Adenosine diphosphate; Internal medicine; Immunology; Chemistry; In vitro; Platelet aggregation; Biochemistry","score_opus":0.015692945655562212,"score_gpt":0.28432171746085916,"score_spread":0.26862877180529693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053625299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577147,0.0007907585,0.00012690897,0.00013956272,0.000017894123,0.000022997376,0.00002538869,0.000009272987,0.003095707],"genre_scores_gemma":[0.99953794,0.00015267766,0.00004922429,0.00009504486,0.00004051957,0.0000050204035,0.00003488388,8.739625e-7,0.000083939936],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9993912,0.00019273965,0.00006786962,0.00005623081,0.00015083664,0.00014108869],"domain_scores_gemma":[0.998833,0.0004329727,0.00038439088,0.00006081138,0.00006457578,0.00022437418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003162481,0.00035128603,0.0004760571,0.0005071829,0.0005341483,0.00051010423,0.00016472221,0.00070015376,0.0013661771],"category_scores_gemma":[0.0034084274,0.00025499475,0.00036439844,0.00051919895,0.00028235262,0.00038410877,0.00029066476,0.0005909838,0.0002295463],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009041324,0.00017796172,0.9735527,0.000043739852,0.00010600861,0.011494283,0.00017291382,0.00005817962,0.0025347432,0.00009792363,0.00033143646,0.0105260415],"study_design_scores_gemma":[0.000065505454,0.0013366796,0.9482448,0.000026115924,0.00019497526,0.04772553,0.00019012565,0.0004240402,0.0007525221,0.00009893462,0.00092999026,0.000010863091],"about_ca_topic_score_codex":0.0005877357,"about_ca_topic_score_gemma":0.0010734643,"teacher_disagreement_score":0.0013661771,"about_ca_system_score_codex":0.00022165275,"about_ca_system_score_gemma":0.00023511653,"threshold_uncertainty_score":0.0045703053},"labels":[],"label_agreement":null},{"id":"W2053912111","doi":"10.1002/ajh.10057","title":"Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C)","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto; St. Michael's Hospital","funders":"Ipsen; Canadian Hemophilia Society","keywords":"Platelet; Prothrombinase; Coagulation; Platelet activation; Hemostasis; Tissue factor; Von Willebrand factor; In vivo; Chemistry; Internal medicine; Immunology; Platelet factor 4; Medicine; Endocrinology; Thrombin; Biology","score_opus":0.03100185183279867,"score_gpt":0.3006443947065569,"score_spread":0.2696425428737582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053912111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873894,0.00047937516,0.00014432771,0.000031239026,0.0000046228047,0.000014138216,0.000059281872,0.0000041082053,0.0005240343],"genre_scores_gemma":[0.9995503,0.00010526569,0.00010366236,0.000028105014,0.000008213246,0.0000076043243,0.0001051495,9.070506e-7,0.00009078468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997844,0.000057992675,0.000026898102,0.0000485117,0.00003786182,0.000044218752],"domain_scores_gemma":[0.9996244,0.00011662652,0.00010426475,0.000024441864,0.00002935027,0.00010092203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017271494,0.00022928294,0.00039341394,0.00035454228,0.0005046911,0.00039730096,0.000112729416,0.0004036695,0.00074078655],"category_scores_gemma":[0.0006929167,0.000120219665,0.0002259696,0.00034898316,0.00032854264,0.00010733115,0.00021653436,0.00034876648,0.00013625938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041725817,0.00062464393,0.91218746,0.000107990614,0.0001396057,0.013369009,0.0012643897,0.0003453028,0.025504928,0.0001720038,0.00058594166,0.041526116],"study_design_scores_gemma":[0.00027442083,0.008981619,0.9492754,0.000013755499,0.000112488015,0.031813595,0.00040368788,0.00050990767,0.0056689624,0.00010824895,0.0028174324,0.000020489224],"about_ca_topic_score_codex":0.0010258509,"about_ca_topic_score_gemma":0.000681614,"teacher_disagreement_score":0.0010258509,"about_ca_system_score_codex":0.00034594542,"about_ca_system_score_gemma":0.00017817953,"threshold_uncertainty_score":0.0025100112},"labels":[],"label_agreement":null},{"id":"W2054534658","doi":"10.1002/ajh.23205","title":"The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institutes of Health","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Medicine; Peripheral T-cell lymphoma; T-cell lymphoma; Internal medicine; Anaplastic lymphoma kinase; Not Otherwise Specified; Natural killer cell; Gastroenterology; Pathology; T cell; Immunology; Biology; Immune system; Cytotoxic T cell; Pleural effusion","score_opus":0.012272677754966764,"score_gpt":0.2720979502373004,"score_spread":0.2598252724823336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054534658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989976,0.0004032609,0.000098561446,0.000011729644,0.000003564303,0.000011012194,0.00022942816,0.0000034078219,0.00024141814],"genre_scores_gemma":[0.998315,0.0002315911,0.000119093114,0.000013148147,0.000019910354,0.000026537304,0.0011624544,0.000004841202,0.000107480286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927765,0.00017149058,0.000105543826,0.00020045781,0.00013207707,0.00011273301],"domain_scores_gemma":[0.99857116,0.00032224244,0.0004274547,0.00015510096,0.00017005812,0.00035384693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010080703,0.0005084831,0.00061682693,0.0016850717,0.0004830979,0.0006566588,0.00041573387,0.0004509563,0.0009390031],"category_scores_gemma":[0.0023704458,0.00037904183,0.0003836206,0.001508323,0.0005325807,0.00048720185,0.0007618727,0.000388469,0.0003994775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020795816,0.000012963849,0.99749374,0.000009714254,0.000029297436,0.00026727887,0.000059625465,0.00003797152,0.0002660939,0.000005680596,0.00008035521,0.0015293458],"study_design_scores_gemma":[0.000024142893,0.00016929276,0.9967417,0.000008683504,0.000041279185,0.0021136366,0.00014771878,0.00018633805,0.00012408315,0.00001538851,0.0004213138,0.000006439225],"about_ca_topic_score_codex":0.0017787893,"about_ca_topic_score_gemma":0.0012304274,"teacher_disagreement_score":0.0017787893,"about_ca_system_score_codex":0.0003166877,"about_ca_system_score_gemma":0.00020964027,"threshold_uncertainty_score":0.0053312182},"labels":[],"label_agreement":null},{"id":"W2054820765","doi":"10.1002/1096-8652(200101)66:1<42::aid-ajh1006>3.0.co;2-v","title":"EBV-associated perianal Hodgkin's disease in an HIV-positive individual","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"CD15; Lymphoma; Pathology; Medicine; Reed–Sternberg cell; Biopsy; CD20; Population; CD30; Incidence (geometry); Disease; Hodgkin lymphoma; Biology; CD34","score_opus":0.008123888830586136,"score_gpt":0.2742044161890516,"score_spread":0.2660805273584655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054820765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952113,0.0008617851,0.00013886424,0.00020750923,0.000024310997,0.000019022178,0.000034673507,0.000017085555,0.0034854566],"genre_scores_gemma":[0.99853945,0.00061278295,0.00011493883,0.00013967826,0.0000700398,0.0000050026288,0.000020180369,0.0000024989693,0.000495522],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998994,0.000017453167,0.000007381078,0.00001924945,0.000018055389,0.00003847565],"domain_scores_gemma":[0.99981207,0.00004992825,0.000034153345,0.000010277624,0.000011649816,0.000081896185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013932073,0.00041427664,0.00028501236,0.0007737594,0.0013554565,0.0005689109,0.00016668091,0.000725595,0.0029979884],"category_scores_gemma":[0.00079115713,0.00040227213,0.00018804899,0.00047034732,0.00046034472,0.0007221369,0.0004293102,0.00062836707,0.00047092585],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023568927,0.000180117,0.62201273,0.000083617575,0.000041142797,0.36021775,0.0013083026,0.00013043659,0.003700115,0.00020605822,0.00077233155,0.011111656],"study_design_scores_gemma":[0.000023328015,0.0005153548,0.35200685,0.00006979007,0.00009743331,0.6420957,0.00199164,0.00029845312,0.0005515589,0.0002462716,0.002074453,0.00002920519],"about_ca_topic_score_codex":0.0014970725,"about_ca_topic_score_gemma":0.0022763147,"teacher_disagreement_score":0.0029979884,"about_ca_system_score_codex":0.00017988576,"about_ca_system_score_gemma":0.000227829,"threshold_uncertainty_score":0.010029316},"labels":[],"label_agreement":null},{"id":"W2056903619","doi":"10.1002/ajh.23138","title":"A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Thrombopoietin; Essential thrombocythemia; Medicine; Mutation; Plateletpheresis; Thrombopoietin receptor; Myelofibrosis; Platelet; Immunology; Internal medicine; Genetics; Biology; Haematopoiesis; Gene; Bone marrow","score_opus":0.014848053300557865,"score_gpt":0.30426786043168563,"score_spread":0.28941980713112775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056903619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968202,0.0004109768,0.0012711195,0.0001516199,0.000042343323,0.00004082036,0.00026721662,0.00008068115,0.0009149655],"genre_scores_gemma":[0.9987534,0.00010715661,0.0004959008,0.00005045733,0.000020350124,0.000007434412,0.00011105394,0.000012421715,0.0004417288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998828,0.000013966496,0.000016722437,0.000033904053,0.000031449625,0.000021193298],"domain_scores_gemma":[0.99986565,0.00004453358,0.000029973831,0.0000063026782,0.0000074722343,0.000046058616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089241286,0.0005254423,0.00022837707,0.00048880925,0.00027280537,0.00020419633,0.00025817644,0.00075411244,0.0013626206],"category_scores_gemma":[0.00028135433,0.0001301159,0.00037780986,0.00019501608,0.0003604146,0.00014787469,0.0002620731,0.0003338464,0.00034837952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052776805,0.00018559967,0.01922987,0.00012449537,0.00011751237,0.2970581,0.0003891061,0.0010023074,0.66518277,0.0006496005,0.0011747763,0.014358011],"study_design_scores_gemma":[0.00021134291,0.0011696691,0.12655666,0.00003854782,0.00018930812,0.59521663,0.00018852692,0.0039035461,0.2638114,0.0004123829,0.008222252,0.00007976888],"about_ca_topic_score_codex":0.0006976218,"about_ca_topic_score_gemma":0.0008359107,"teacher_disagreement_score":0.0013626206,"about_ca_system_score_codex":0.00027187323,"about_ca_system_score_gemma":0.00013855538,"threshold_uncertainty_score":0.004558444},"labels":[],"label_agreement":null},{"id":"W2056966986","doi":"10.1002/ajh.21209","title":"Pure red cell aplasia in a patient with adult‐onset Still's disease","year":2008,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"University of Illinois at Urbana-Champaign","keywords":"Hematopathology; Library science; Columbia university; Medicine; Family medicine; Sociology; Media studies; Computer science","score_opus":0.0070040966609197725,"score_gpt":0.24407631142626096,"score_spread":0.23707221476534118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056966986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93636525,0.004561693,0.0025919292,0.028921645,0.002837467,0.00015842452,0.0003201518,0.0004048609,0.023838628],"genre_scores_gemma":[0.98468035,0.0011317641,0.0009745936,0.0063195177,0.0035795164,0.000022986022,0.00013933203,0.00007844448,0.0030735475],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99905235,0.00016738875,0.00015336128,0.00019805452,0.00015925057,0.00026953165],"domain_scores_gemma":[0.99591345,0.002299345,0.0004672176,0.00032172087,0.00024471825,0.0007535827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007731911,0.0016925466,0.0015390738,0.0017676683,0.0020505073,0.0016270123,0.0018501229,0.010092769,0.0025532902],"category_scores_gemma":[0.006828604,0.00087107933,0.0015762699,0.0011312017,0.0018877983,0.0017921268,0.00088428403,0.0042804517,0.000964464],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071286486,0.000025663454,0.0035857134,0.000018581653,0.000013964132,0.9938465,0.000144127,0.0000478972,0.00046418246,0.00016067585,0.00089195813,0.00072943885],"study_design_scores_gemma":[0.00005452446,0.00022577484,0.007362575,0.000021587135,0.00005373676,0.98933893,0.00019176856,0.0006436326,0.0006095014,0.0002726933,0.0012088591,0.00001635339],"about_ca_topic_score_codex":0.0029198076,"about_ca_topic_score_gemma":0.002767863,"teacher_disagreement_score":0.010092769,"about_ca_system_score_codex":0.001972391,"about_ca_system_score_gemma":0.0009833168,"threshold_uncertainty_score":0.014310777},"labels":[],"label_agreement":null},{"id":"W2058115183","doi":"10.1002/ajh.21032","title":"What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Regional Medical Associates of Hamilton; Sanofi; Heart and Stroke Foundation of Canada; GlaxoSmithKline","keywords":"Overdiagnosis; Heparin-induced thrombocytopenia; Medicine; Heparin; Intensive care medicine; Internal medicine","score_opus":0.024266096464233326,"score_gpt":0.3335324730200309,"score_spread":0.3092663765557976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058115183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6922298,0.090610735,0.02738336,0.16961093,0.0040607243,0.0004723868,0.0016227857,0.00040879173,0.013600569],"genre_scores_gemma":[0.95777595,0.009767068,0.011285787,0.01539929,0.004827663,0.00013711526,0.00044632555,0.000049282327,0.00031141719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9464775,0.03338479,0.006455606,0.0035285575,0.009067428,0.0010862137],"domain_scores_gemma":[0.4991273,0.36246547,0.059520707,0.01630156,0.05629432,0.0062906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08136345,0.00085028814,0.0019330878,0.004939253,0.00095554435,0.004127646,0.0034248175,0.005729804,0.0019801473],"category_scores_gemma":[0.37445852,0.0007949747,0.0018089286,0.0033951406,0.0043958784,0.0059475186,0.0017429605,0.002107361,0.00095679285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038451198,0.0000688792,0.8999355,0.0008703905,0.00052406103,0.0017344466,0.00037825818,0.0005500793,0.00013966733,0.0009731595,0.004226773,0.09021438],"study_design_scores_gemma":[0.0002448772,0.0015081809,0.8526056,0.005506365,0.0016570287,0.07721368,0.004690303,0.019990519,0.0009910115,0.015232507,0.019971125,0.00038878803],"about_ca_topic_score_codex":0.0032550802,"about_ca_topic_score_gemma":0.0037320342,"teacher_disagreement_score":0.08136345,"about_ca_system_score_codex":0.0015893119,"about_ca_system_score_gemma":0.0016631711,"threshold_uncertainty_score":0.43029618},"labels":[],"label_agreement":null},{"id":"W2059259609","doi":"10.1002/ajh.20098","title":"Risk of thrombosis in patients with malignancy and heparin‐induced thrombocytopenia","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Malignancy; Thrombosis; Heparin-induced thrombocytopenia; Pulmonary embolism; Heparin; Internal medicine; Odds ratio; Venous thrombosis; Retrospective cohort study; Medical record; Surgery; Gastroenterology","score_opus":0.01067983743953367,"score_gpt":0.26095656197278605,"score_spread":0.2502767245332524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059259609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983284,0.00080528355,0.0000796516,0.000106776984,0.000008755215,0.0000062697573,0.00008483535,0.0000036149997,0.0005763472],"genre_scores_gemma":[0.9995326,0.00020807363,0.000057722627,0.000033540255,0.000026075975,0.0000035934208,0.00007839466,7.9184747e-7,0.0000592518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950373,0.00017524461,0.000051369723,0.000064141954,0.000104723396,0.00010083144],"domain_scores_gemma":[0.99839693,0.00048069516,0.0006461154,0.00006673978,0.00010266479,0.0003067727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033906137,0.0001534728,0.00037549014,0.00090364646,0.0004306942,0.0005207505,0.00021242019,0.0006017932,0.0021384007],"category_scores_gemma":[0.0029409858,0.00022477057,0.00026884477,0.0010843911,0.00030217637,0.00039159186,0.00025607453,0.000636796,0.00019117228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076298435,0.000015908807,0.99838746,0.0000057096154,0.000015650443,0.00045488414,0.00003485058,0.00001722802,0.00007772972,0.000016854181,0.00006501259,0.0008323902],"study_design_scores_gemma":[0.00001848872,0.00027642207,0.9908242,0.00001812503,0.000051876934,0.007833557,0.0002442333,0.00026031124,0.000094187446,0.00007853124,0.00029284947,0.0000072970515],"about_ca_topic_score_codex":0.0015061091,"about_ca_topic_score_gemma":0.0013873118,"teacher_disagreement_score":0.0021384007,"about_ca_system_score_codex":0.00017560871,"about_ca_system_score_gemma":0.00029897632,"threshold_uncertainty_score":0.00715369},"labels":[],"label_agreement":null},{"id":"W2060391786","doi":"10.1002/ajh.20436","title":"Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Thrombotic thrombocytopenic purpura; Cardiac surgery; Coronary artery bypass surgery; Platelet; Artery; Cardiology; Internal medicine; Population; Thrombocytopenic purpura; Purpura (gastropod); Surgery","score_opus":0.025804920280501076,"score_gpt":0.3048463944160927,"score_spread":0.2790414741355916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060391786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869164,0.0012745551,0.0010038699,0.001359849,0.00012559688,0.0000633186,0.00007267978,0.000066131404,0.009117574],"genre_scores_gemma":[0.997881,0.00042101293,0.000407002,0.0003991152,0.0003187535,0.000014467847,0.00004059985,0.000008679513,0.0005092928],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991443,0.00018490797,0.00011625078,0.00014608173,0.00016062356,0.00024774944],"domain_scores_gemma":[0.99746007,0.0011614013,0.0004570231,0.00015443318,0.0001355083,0.0006314652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053389254,0.0012481997,0.0010384183,0.0020499278,0.0020984465,0.0013960752,0.0006322252,0.0029914635,0.0043499344],"category_scores_gemma":[0.0046696016,0.0011716562,0.00068293884,0.00109666,0.0012288503,0.002623504,0.0010651519,0.002328644,0.0009416524],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114411145,0.00015642475,0.10643413,0.000025348156,0.000024983627,0.88881826,0.00034427494,0.000077899545,0.0010155342,0.00023090141,0.0004138875,0.0023439412],"study_design_scores_gemma":[0.000014630338,0.00012596665,0.016105682,0.000010300781,0.00002262875,0.9826362,0.00024480178,0.00021441856,0.00025642308,0.000082726125,0.00027451658,0.000011642652],"about_ca_topic_score_codex":0.0015914866,"about_ca_topic_score_gemma":0.0015249068,"teacher_disagreement_score":0.0043499344,"about_ca_system_score_codex":0.0005731251,"about_ca_system_score_gemma":0.00075642456,"threshold_uncertainty_score":0.014551997},"labels":[],"label_agreement":null},{"id":"W2060522135","doi":"10.1002/ajh.20024","title":"Nodular regenerative hyperplasia of the liver: An under‐recognized cause of portal hypertension in hematological disorders","year":2004,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Nodular regenerative hyperplasia; Medicine; Portal hypertension; Cirrhosis; Pathology; Lymphoproliferative disorders; Fibrosis; Differential diagnosis; Myeloproliferative Disorders; Portopulmonary hypertension; Internal medicine; Gastroenterology; Lymphoma","score_opus":0.03380239150716408,"score_gpt":0.3139588351083652,"score_spread":0.2801564436012011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060522135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006560687,0.9976659,0.00016005264,0.00021889896,0.00013590488,0.0000038033254,0.0000068554723,0.000009583579,0.0011430148],"genre_scores_gemma":[0.00468181,0.99383354,0.0002769807,0.00023712142,0.0002960255,0.000004548367,0.000020319967,0.0000014443622,0.00064825173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998171,0.000036138383,0.000032933065,0.000028140841,0.00006771554,0.000018059638],"domain_scores_gemma":[0.9996506,0.00014198807,0.000080143276,0.000011818586,0.00008112372,0.000034204117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028385196,0.0005451433,0.0011822506,0.002147177,0.00024622088,0.0005557047,0.00055470056,0.0008235006,0.0015271069],"category_scores_gemma":[0.0006901947,0.00017189035,0.00025521926,0.0024543223,0.00041853025,0.0010356806,0.00028952444,0.0007648421,0.0013451626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008065639,0.000073242496,0.0027965351,0.011003772,0.000092404945,0.0064500715,0.000096122145,0.00021881,0.0027828868,0.00091024366,0.016246103,0.95924914],"study_design_scores_gemma":[0.00006133612,0.00027654436,0.020505268,0.005821734,0.0003413542,0.22663862,0.00042497934,0.00024680744,0.0018873577,0.0026875613,0.74105823,0.00005011759],"about_ca_topic_score_codex":0.00080214243,"about_ca_topic_score_gemma":0.0014089698,"teacher_disagreement_score":0.002147177,"about_ca_system_score_codex":0.00029704854,"about_ca_system_score_gemma":0.0007322982,"threshold_uncertainty_score":0.0051086545},"labels":[],"label_agreement":null},{"id":"W2063827970","doi":"10.1002/ajh.20812","title":"Pathological splenic rupture: A rare complication of chronic myelomonocytic leukemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chronic myelomonocytic leukemia; Medicine; Complication; Pathological; Spleen; Pathology; Internal medicine; Bone marrow; Myelodysplastic syndromes","score_opus":0.015037321804729647,"score_gpt":0.2978919273949417,"score_spread":0.282854605590212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063827970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783805,0.009319243,0.0032442668,0.0012196845,0.0003337836,0.00009384159,0.00018135892,0.00026466753,0.0069626677],"genre_scores_gemma":[0.9964593,0.0013281548,0.000572074,0.0003752,0.00071434275,0.000018189317,0.00011051972,0.000012103786,0.0004100348],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994642,0.0001463899,0.000075866876,0.00006515766,0.000086694105,0.00016163169],"domain_scores_gemma":[0.9952809,0.0015602951,0.0014516474,0.0006677253,0.00019119114,0.0008482118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051315734,0.001022266,0.00063913234,0.0016301406,0.0012198874,0.0012539141,0.00078785396,0.0036168003,0.0026380685],"category_scores_gemma":[0.008367133,0.00067883066,0.00041899976,0.0010902513,0.0014572894,0.0013787558,0.0012913708,0.0018641781,0.0013639851],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002482856,0.000059947466,0.0552674,0.000118849806,0.00002070751,0.9356125,0.00020554331,0.00012433124,0.0014769996,0.0005611158,0.0008453149,0.0054590963],"study_design_scores_gemma":[0.00003849458,0.00008901737,0.009977928,0.000015561673,0.000013403377,0.9880945,0.00009054344,0.00017576224,0.0005470985,0.000237195,0.00071242463,0.000008119873],"about_ca_topic_score_codex":0.0002931908,"about_ca_topic_score_gemma":0.00027650117,"teacher_disagreement_score":0.0036168003,"about_ca_system_score_codex":0.00035868087,"about_ca_system_score_gemma":0.00046826157,"threshold_uncertainty_score":0.0088252425},"labels":[],"label_agreement":null},{"id":"W2064117411","doi":"10.1002/ajh.20104","title":"Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Serology; Thrombopoietin; Immunology; Platelet; Antibody; Anti-nuclear antibody; Prospective cohort study; Internal medicine; Autoantibody; Population; Gastroenterology; Biology","score_opus":0.030242953654040304,"score_gpt":0.2774411999630983,"score_spread":0.24719824630905798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064117411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993988,0.00008788847,0.00007745552,0.000010839615,0.0000028448014,0.00002128967,0.00018031943,0.0000029551732,0.0002175298],"genre_scores_gemma":[0.99904925,0.000075125194,0.0001426764,0.000051213345,0.0000151524155,0.000027436172,0.0004903171,0.000002332824,0.00014649122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994351,0.00013691619,0.00006375695,0.00013808733,0.00009900263,0.00012705378],"domain_scores_gemma":[0.99894065,0.00030491763,0.0003250961,0.000091036134,0.000102169,0.00023609307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037325046,0.00057113817,0.0005029871,0.00093783985,0.0008365521,0.000602039,0.00020438216,0.0005086411,0.0013502679],"category_scores_gemma":[0.0019468257,0.00068140455,0.00030628336,0.0009016851,0.00041074576,0.0006133877,0.00042717205,0.00058451836,0.0004588442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018356212,0.00013029049,0.99736893,0.00000794377,0.000015047923,0.000585641,0.00010462257,0.000037263755,0.00041573207,0.000012246038,0.00007456822,0.0010642065],"study_design_scores_gemma":[0.000041883388,0.0016723297,0.9934948,0.000009590517,0.00003673705,0.003470785,0.00025298257,0.00022610376,0.00034582824,0.00002427286,0.0004154772,0.000009204298],"about_ca_topic_score_codex":0.0030359381,"about_ca_topic_score_gemma":0.0034999663,"teacher_disagreement_score":0.0030359381,"about_ca_system_score_codex":0.0003672011,"about_ca_system_score_gemma":0.00036327273,"threshold_uncertainty_score":0.00603652},"labels":[],"label_agreement":null},{"id":"W2064153027","doi":"10.1002/ajh.22268","title":"Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Neutropenia; Cohort; Chemotherapy; Bacteremia; Internal medicine; Leukemia; Mortality rate; Febrile neutropenia; Pediatrics; Intensive care medicine; Antibiotics","score_opus":0.020949786045548778,"score_gpt":0.2901529863597842,"score_spread":0.26920320031423545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064153027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999292,0.00029049296,0.00006138032,0.000029251918,0.0000054719685,0.000007287165,0.000017266568,0.0000025009529,0.00029432226],"genre_scores_gemma":[0.9993895,0.000196374,0.00018741499,0.000045725803,0.00002295535,0.000007611582,0.000073643765,0.0000016240651,0.00007506383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999757,0.00011249093,0.000025171483,0.00002270656,0.000048558184,0.000034112403],"domain_scores_gemma":[0.9988722,0.00025216944,0.00045093033,0.000058392183,0.000094796866,0.00027144878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000523573,0.000106495565,0.00028088875,0.000146629,0.00013392758,0.00029474375,0.00007753678,0.0001358625,0.0010196966],"category_scores_gemma":[0.0024853814,0.000060168593,0.00016309292,0.00014110007,0.00009548336,0.00021972867,0.00021228839,0.00026461526,0.00010641151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061100316,0.00072932907,0.8963766,0.000063885425,0.00004656828,0.0005017958,0.0002294833,0.00027550157,0.007972617,0.00007703563,0.00040951255,0.08720766],"study_design_scores_gemma":[0.00023901164,0.010611142,0.9834479,0.000029554092,0.00008716969,0.0015157621,0.00035016818,0.0008829511,0.0014278382,0.00005940331,0.0013408822,0.000008286441],"about_ca_topic_score_codex":0.0007661146,"about_ca_topic_score_gemma":0.0014712176,"teacher_disagreement_score":0.0010196966,"about_ca_system_score_codex":0.00024351433,"about_ca_system_score_gemma":0.0002682431,"threshold_uncertainty_score":0.0034111738},"labels":[],"label_agreement":null},{"id":"W2064429031","doi":"10.1002/ajh.10065","title":"Anti‐D (WinRho SD<sup>™</sup>) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; St. Michael's Hospital","funders":"","keywords":"Cytokine; Medicine; Chemokine; Immunology; Platelet; Thrombocytopenic purpura; Internal medicine; Inflammation","score_opus":0.011145003135141635,"score_gpt":0.2483333806694292,"score_spread":0.23718837753428756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064429031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975266,0.0014054021,0.00032602806,0.00004163499,0.0000099964955,0.00006415999,0.00009011822,0.00002651503,0.00050954905],"genre_scores_gemma":[0.99748236,0.000671463,0.0010168653,0.000058882382,0.000017487175,0.000071743314,0.0002252715,0.0000049486407,0.00045107462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983954,0.000053604275,0.000014096962,0.000020890306,0.000030081836,0.00004182045],"domain_scores_gemma":[0.99977106,0.000057902038,0.00007558154,0.000018571172,0.000012762331,0.00006410565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022945399,0.00024697583,0.00045095585,0.00013737376,0.00011189471,0.00016167355,0.00022757935,0.00023283152,0.00087144173],"category_scores_gemma":[0.00022747325,0.0001063973,0.00019521348,0.00010997269,0.0002855664,0.00015036152,0.00016000956,0.00044300596,0.00027074566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0314509,0.006553048,0.08157792,0.0010285773,0.0003149033,0.004102119,0.00043710243,0.000906516,0.6348808,0.00031471762,0.0018678216,0.23656556],"study_design_scores_gemma":[0.005925914,0.35545486,0.36032015,0.00009445172,0.00038960946,0.016223866,0.0003781481,0.0012113467,0.24320896,0.00014133677,0.016625943,0.000025447362],"about_ca_topic_score_codex":0.0006290223,"about_ca_topic_score_gemma":0.0012361971,"teacher_disagreement_score":0.00087144173,"about_ca_system_score_codex":0.00016010446,"about_ca_system_score_gemma":0.0002690371,"threshold_uncertainty_score":0.0029152632},"labels":[],"label_agreement":null},{"id":"W2064616188","doi":"10.1002/ajh.23124","title":"Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Von Willebrand disease; Medicine; Platelet disorder; Coagulation testing; Von Willebrand factor; Coagulation Disorder; Partial thromboplastin time; Coagulation; Intensive care medicine; Prothrombin time; Platelet; Internal medicine","score_opus":0.1283962994660094,"score_gpt":0.3634657347021734,"score_spread":0.23506943523616403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064616188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856711,0.003394598,0.0018446809,0.0031914564,0.000049895378,0.00018477294,0.0004895081,0.000055618806,0.0051183896],"genre_scores_gemma":[0.9924759,0.0018167109,0.0037591485,0.0010654287,0.000045892026,0.00014100787,0.000407604,0.0000119335555,0.0002763703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9841467,0.006320666,0.0033054405,0.0011072167,0.004508373,0.00061152666],"domain_scores_gemma":[0.9329828,0.014998617,0.029393341,0.0019503688,0.01774278,0.002932053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015470363,0.00020626055,0.00033192735,0.0036742177,0.0009271721,0.0013971113,0.00089652924,0.0005589054,0.0008428431],"category_scores_gemma":[0.03280488,0.00026596567,0.0005240948,0.0045544617,0.00080879853,0.002084974,0.0019630643,0.0005945454,0.00015676203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004293232,0.000052073698,0.9812773,0.00012140786,0.000054213964,0.000066353234,0.0023056495,0.000092679344,0.00018631385,0.00011288141,0.00070451415,0.014983709],"study_design_scores_gemma":[0.000009437459,0.00018796476,0.98737085,0.00022454702,0.000045741475,0.00048068384,0.007158201,0.00079058757,0.00016408371,0.00014845205,0.0034004338,0.000019040517],"about_ca_topic_score_codex":0.010677823,"about_ca_topic_score_gemma":0.019073583,"teacher_disagreement_score":0.015470363,"about_ca_system_score_codex":0.0017281282,"about_ca_system_score_gemma":0.0037224211,"threshold_uncertainty_score":0.08181614},"labels":[],"label_agreement":null},{"id":"W2066067246","doi":"10.1002/ajh.1073","title":"CD34‐positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Hamilton Health Sciences","keywords":"CD34; Acute promyelocytic leukemia; Medicine; Internal medicine; Gastroenterology; Immunophenotyping; Cohort; Immunology; Oncology; Retinoic acid; Biology; Stem cell; Flow cytometry; Cell culture","score_opus":0.0041231751177709846,"score_gpt":0.22577286097071583,"score_spread":0.22164968585294484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066067246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759954,0.0009766192,0.0004233381,0.000027480513,0.0000041530625,0.000018561594,0.00013701367,0.000026533262,0.00078679854],"genre_scores_gemma":[0.99892586,0.00028739346,0.00029285587,0.00001609439,0.000012024794,0.000008555512,0.0001750845,0.0000026690195,0.00027938752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998481,0.000027116483,0.000016489194,0.000044416243,0.000039913426,0.000023909817],"domain_scores_gemma":[0.9996182,0.00005432258,0.00020609278,0.000024664323,0.000029718554,0.00006712231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013378717,0.0003041084,0.00024498446,0.0005454531,0.00022992396,0.0002500916,0.00017358336,0.00019345188,0.0016062465],"category_scores_gemma":[0.00078078517,0.00013389769,0.00008012085,0.0006056576,0.00035537223,0.00013849356,0.0003834939,0.00017359776,0.00046051107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043376893,0.00006293392,0.8940042,0.00010674917,0.00007484187,0.012264659,0.00018925867,0.00018964623,0.062080186,0.0002725013,0.0009524173,0.029368775],"study_design_scores_gemma":[0.000023956443,0.00039195525,0.8756606,0.0000218559,0.000061035644,0.11324507,0.00015554443,0.00030796096,0.0051697926,0.0002834203,0.004667711,0.000011126404],"about_ca_topic_score_codex":0.00035090093,"about_ca_topic_score_gemma":0.00048169246,"teacher_disagreement_score":0.0016062465,"about_ca_system_score_codex":0.00015048559,"about_ca_system_score_gemma":0.00013801461,"threshold_uncertainty_score":0.005373478},"labels":[],"label_agreement":null},{"id":"W2067279861","doi":"10.1002/ajh.21266","title":"Hydroxycarbamide‐induced changes in E/beta thalassemia red blood cells","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Center for Research Resources; National Institutes of Health; National Heart, Lung, and Blood Institute; Georgia Clinical and Translational Science Alliance","keywords":"Hydroxycarbamide; Beta thalassemia; Thalassemia; Medicine; Hemoglobinopathy; BETA (programming language); Internal medicine; Hemolytic anemia; Chemotherapy; Computer science","score_opus":0.01077056067768401,"score_gpt":0.24414454370764802,"score_spread":0.233373983029964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067279861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993856,0.0002344359,0.00007242311,0.000005209031,0.0000020356044,0.000006661848,0.000032640753,0.0000045341512,0.0002565245],"genre_scores_gemma":[0.999683,0.00007045288,0.00006313706,0.000011638408,0.0000025418306,0.0000033862013,0.000058678048,0.0000010950997,0.00010621736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998723,0.00004597041,0.000010659363,0.000023803326,0.00002333683,0.000023868113],"domain_scores_gemma":[0.9997147,0.0000815821,0.00010316593,0.000026668067,0.000027313577,0.00004656781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016532959,0.00012006249,0.00013088644,0.0001959101,0.00012549789,0.00015290386,0.00007643252,0.00013816723,0.0006933758],"category_scores_gemma":[0.00053475477,0.000065644745,0.0001426621,0.00014263409,0.00020134867,0.00010819163,0.000093924136,0.00022729051,0.00008942409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007400482,0.0011525047,0.31653988,0.00016391386,0.00020201252,0.0037854814,0.00062205404,0.0007834422,0.5901249,0.00020557376,0.00026003827,0.078759626],"study_design_scores_gemma":[0.00022829788,0.015100842,0.826205,0.00001154881,0.0001344187,0.00451022,0.00018622258,0.00091097306,0.15124096,0.00008208517,0.0013725805,0.000016919374],"about_ca_topic_score_codex":0.00068927056,"about_ca_topic_score_gemma":0.00062133657,"teacher_disagreement_score":0.0006933758,"about_ca_system_score_codex":0.00015740143,"about_ca_system_score_gemma":0.00006231829,"threshold_uncertainty_score":0.0023195744},"labels":[],"label_agreement":null},{"id":"W2067456806","doi":"10.1002/ajh.1062","title":"Thalidomide‐associated hepatitis: A case report","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Thalidomide; Medicine; Plasmacytosis; Multiple myeloma; Pomalidomide; Hepatitis; Aplastic anemia; Immunology; Internal medicine; Gastroenterology; Dermatology; Bone marrow","score_opus":0.022045487208967048,"score_gpt":0.3384723653067485,"score_spread":0.31642687809778147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067456806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257906,0.0077756383,0.003045675,0.002568556,0.00057799154,0.00018591215,0.00015094744,0.00020535645,0.012910937],"genre_scores_gemma":[0.9930479,0.0020354846,0.0011839833,0.00078795326,0.0011893213,0.000039157778,0.000074540505,0.000025357502,0.0016162873],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992938,0.00009202009,0.00006296494,0.00014288306,0.00009517138,0.00031303675],"domain_scores_gemma":[0.998596,0.0003424968,0.00034757063,0.00016080862,0.00007547715,0.00047759365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041711674,0.0023418309,0.0011438853,0.0019840563,0.0040587033,0.002227316,0.0009878202,0.005041038,0.003384047],"category_scores_gemma":[0.0028768869,0.0014946316,0.0010456932,0.0014226929,0.0014794504,0.0025124145,0.0017996174,0.0028681103,0.0015657814],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025159557,0.000072668765,0.005073688,0.00002230153,0.000009456265,0.9925069,0.00023114533,0.000033374512,0.00041513416,0.00013245652,0.00026673437,0.0012108932],"study_design_scores_gemma":[0.000014591196,0.000044768996,0.001362176,0.000005531949,0.000007910438,0.99778676,0.0001079341,0.000079690195,0.00012842183,0.00008626151,0.00037050247,0.0000053784647],"about_ca_topic_score_codex":0.001461437,"about_ca_topic_score_gemma":0.0018756498,"teacher_disagreement_score":0.005041038,"about_ca_system_score_codex":0.0008960885,"about_ca_system_score_gemma":0.00071527914,"threshold_uncertainty_score":0.01132077},"labels":[],"label_agreement":null},{"id":"W2069783144","doi":"10.1002/ajh.20937","title":"Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white <i>HFE</i> C282Y homozygotes in the hemochromatosis and iron overload screening study","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Center for Research Resources; National Human Genome Research Institute; National Heart, Lung, and Blood Institute","keywords":"Mean corpuscular volume; Transferrin saturation; Internal medicine; Hemochromatosis; Hereditary hemochromatosis; Medicine; Mean corpuscular hemoglobin; Serum iron; Gastroenterology; Mean corpuscular hemoglobin concentration; Confidence interval; Ferritin; Hemoglobin; Iron deficiency; Endocrinology; Anemia","score_opus":0.006403469100026115,"score_gpt":0.25860959348162926,"score_spread":0.25220612438160317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069783144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953604,0.00006362549,0.00004381925,0.000019777837,0.0000038295625,0.0000042078414,0.00014001795,0.0000018855441,0.00018684707],"genre_scores_gemma":[0.9996189,0.000016328071,0.000032249303,0.00001531251,0.000006999381,0.0000051509646,0.00020492327,0.0000021325034,0.00009799422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961853,0.00010481776,0.000035747165,0.00010156719,0.00007438032,0.00006497907],"domain_scores_gemma":[0.9984957,0.0003823589,0.00043351288,0.00008754775,0.00015816078,0.0004427116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005541764,0.0003305133,0.0004684578,0.0006440053,0.00030873663,0.0004567513,0.000331182,0.00059375254,0.0012881143],"category_scores_gemma":[0.0024466387,0.00023453488,0.00032228345,0.00066014915,0.00027461405,0.0002535223,0.00024386263,0.0005261237,0.00024994975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017772282,0.00003442913,0.9987686,0.0000023297546,0.00003297376,0.00009261001,0.00003989536,0.000033390836,0.0002948621,0.000013330368,0.00009072624,0.0004191064],"study_design_scores_gemma":[0.0000069169496,0.000095877826,0.9992287,0.000001950548,0.000015817088,0.00022855995,0.000052781732,0.00024777555,0.00003807324,0.00001736644,0.00006345114,0.0000027018486],"about_ca_topic_score_codex":0.0053759865,"about_ca_topic_score_gemma":0.0037409428,"teacher_disagreement_score":0.0053759865,"about_ca_system_score_codex":0.00015536588,"about_ca_system_score_gemma":0.00015323242,"threshold_uncertainty_score":0.010689378},"labels":[],"label_agreement":null},{"id":"W2069848482","doi":"10.1002/(sici)1096-8652(200005)64:1<53::aid-ajh9>3.0.co;2-9","title":"Familial myelodysplastic syndrome with early age of onset","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bone marrow; Sepsis; Disease; Family member; Bone marrow failure; Myelodysplastic syndromes; Bone marrow transplantation; Leukemia; Pathogenesis; Internal medicine; Pediatrics; Immunology; Stem cell; Genetics; Biology; Haematopoiesis","score_opus":0.00852336114054926,"score_gpt":0.2665449508785553,"score_spread":0.25802158973800604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069848482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899766,0.0022373926,0.001926502,0.00028286246,0.00005290645,0.00003465315,0.00020722288,0.000099241326,0.005182752],"genre_scores_gemma":[0.99615806,0.00090381166,0.0007249664,0.00013265642,0.000057973804,0.000015344061,0.0001263561,0.000009739262,0.0018711381],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99981767,0.000041109193,0.000013884023,0.000040715982,0.00002780399,0.000058924965],"domain_scores_gemma":[0.9995634,0.0001213108,0.00011148274,0.000022535247,0.000038630424,0.00014254931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015559865,0.0010255451,0.0005135248,0.0007381538,0.001272738,0.00030578417,0.00017828253,0.0007088769,0.0026870589],"category_scores_gemma":[0.0010409203,0.00026887606,0.0002318223,0.0005140015,0.00044705626,0.00024725526,0.0003949943,0.0005933424,0.0004945837],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004932597,0.00027358482,0.26413122,0.00010649589,0.00006262649,0.6762866,0.0020777292,0.0003092259,0.01852194,0.0019277554,0.0025760315,0.033233523],"study_design_scores_gemma":[0.00004889982,0.00047095498,0.107364714,0.00006175659,0.000082476465,0.8809435,0.00031773263,0.00024166213,0.001853472,0.00075452897,0.007830625,0.0000297348],"about_ca_topic_score_codex":0.0012446868,"about_ca_topic_score_gemma":0.0022420243,"teacher_disagreement_score":0.0026870589,"about_ca_system_score_codex":0.00027618214,"about_ca_system_score_gemma":0.00035510468,"threshold_uncertainty_score":0.008989155},"labels":[],"label_agreement":null},{"id":"W2070009478","doi":"10.1002/ajh.20765","title":"Absence of FTL3 mutations in patients with <i>JAK2<sup>V617F</sup></i> mutation negative essential thrombocythemia","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Essential thrombocythemia; Myeloproliferative Disorders; Mutation; Haematopoiesis; Janus kinase 2; Point mutation; Cancer research; Medicine; Tyrosine kinase; Myelofibrosis; Biology; Internal medicine; Immunology; Receptor; Genetics; Polycythemia vera; Gene; Stem cell; Bone marrow","score_opus":0.004263649426485132,"score_gpt":0.24554761506339826,"score_spread":0.24128396563691312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070009478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771225,0.000354411,0.00010920376,0.00010790001,0.00001121122,0.000009768533,0.00007371351,0.000010614985,0.0016109851],"genre_scores_gemma":[0.9997024,0.00006188212,0.000057822028,0.000029540714,0.00001578731,0.0000022983338,0.000039087416,0.00000221383,0.00008903083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999778,0.000036841415,0.000032329026,0.00005506164,0.000050760238,0.000047045225],"domain_scores_gemma":[0.99940705,0.00023652788,0.0001446942,0.00003728781,0.000042368185,0.0001320103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002664113,0.00043232023,0.0004554952,0.0010068968,0.0005298056,0.00045028445,0.0002680199,0.0008457264,0.0018028489],"category_scores_gemma":[0.0021063976,0.00029224448,0.00016620322,0.00040735325,0.00058161997,0.00043032382,0.0001853473,0.0003916279,0.00027420383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025999632,0.00018862172,0.86642104,0.000069989,0.0000526228,0.08819925,0.0005394904,0.00030801888,0.02577024,0.00042497405,0.0007685165,0.014657243],"study_design_scores_gemma":[0.00017776374,0.0011745887,0.7129193,0.000035573266,0.00012918265,0.27724943,0.0003806945,0.000999647,0.0048289225,0.00049458275,0.0015749198,0.000035459798],"about_ca_topic_score_codex":0.00089516095,"about_ca_topic_score_gemma":0.000990297,"teacher_disagreement_score":0.0018028489,"about_ca_system_score_codex":0.00024379634,"about_ca_system_score_gemma":0.00024078079,"threshold_uncertainty_score":0.0060311556},"labels":[],"label_agreement":null},{"id":"W2075346227","doi":"10.1002/ajh.20127","title":"<i>Cardiobacterium hominis</i> endocarditis associated with very severe thrombocytopenia and platelet autoantibodies","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Autoantibody; Endocarditis; Medicine; Platelet; Immune thrombocytopenia; Immunology; Internal medicine; Antibody","score_opus":0.00800485734598445,"score_gpt":0.25264153283738494,"score_spread":0.2446366754914005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075346227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98020977,0.0022826805,0.0017580199,0.0014035037,0.00014211918,0.000045802382,0.00009426043,0.00012353004,0.013940366],"genre_scores_gemma":[0.99829715,0.00029532137,0.00027012432,0.00042149625,0.00020019601,0.000003523851,0.000040944633,0.000008118236,0.000463215],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996525,0.000083185354,0.000049166214,0.000052649546,0.000049943854,0.00011247081],"domain_scores_gemma":[0.9990632,0.00033725065,0.00026660968,0.0000757932,0.000054292217,0.00020279271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020531793,0.0006301128,0.00035385246,0.00067541655,0.0007308944,0.0005697341,0.00026443545,0.0012821638,0.0011015108],"category_scores_gemma":[0.0016365413,0.00030826754,0.00033882502,0.00038341768,0.00061451615,0.00032906263,0.00041217174,0.0010217772,0.00035378448],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014154769,0.000057474426,0.06763833,0.00006859764,0.000027123815,0.9193994,0.00022909381,0.00009276446,0.0056238985,0.0002911036,0.0015922043,0.004838545],"study_design_scores_gemma":[0.000014473582,0.0001382313,0.033831704,0.000017047803,0.000024823481,0.96205866,0.00008878159,0.00023566512,0.0019780195,0.0001451593,0.0014570494,0.000010402168],"about_ca_topic_score_codex":0.00089860783,"about_ca_topic_score_gemma":0.0009349657,"teacher_disagreement_score":0.0012821638,"about_ca_system_score_codex":0.00026379456,"about_ca_system_score_gemma":0.00017771023,"threshold_uncertainty_score":0.003684938},"labels":[],"label_agreement":null},{"id":"W2075973291","doi":"10.1002/ajh.23569","title":"Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two‐year results including pharmacokinetics and concomitant hydroxyurea","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Novartis Pharma","keywords":"Deferasirox; Medicine; Internal medicine; Adverse effect; Concomitant; Renal function; Gastroenterology; Nausea; Pharmacokinetics; Thalassemia","score_opus":0.01025141505907404,"score_gpt":0.26232099904511985,"score_spread":0.2520695839860458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075973291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966928,0.0024127369,0.00025899865,0.00010944104,0.00003628391,0.00017233445,0.0001314098,0.00001617689,0.00016990551],"genre_scores_gemma":[0.99715364,0.0010731994,0.00046314998,0.0001941444,0.00012670452,0.00016749947,0.00037136843,0.000007706503,0.00044255928],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99866855,0.0007531306,0.00010279492,0.00016519078,0.00015398899,0.00015644723],"domain_scores_gemma":[0.9974923,0.0008002579,0.00075677095,0.00021738416,0.00016891061,0.0005644418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037810276,0.0009536626,0.00242834,0.0004325313,0.0003927265,0.0009419521,0.0006265168,0.0011836783,0.000914744],"category_scores_gemma":[0.0020450007,0.0005153087,0.0025386408,0.00032086615,0.00088206114,0.0008329501,0.00028983763,0.0022027052,0.00022891424],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8648919,0.027360292,0.010602031,0.0004828549,0.002114195,0.00016937198,0.0003066689,0.0013438832,0.033365417,0.00009119027,0.0004300978,0.058842108],"study_design_scores_gemma":[0.20614617,0.76388127,0.02210502,0.000025176869,0.0014693685,0.00017349538,0.000054629,0.0008949599,0.004421724,0.000076464275,0.00071061944,0.000041092444],"about_ca_topic_score_codex":0.0008840734,"about_ca_topic_score_gemma":0.0010493681,"teacher_disagreement_score":0.0037810276,"about_ca_system_score_codex":0.00055714307,"about_ca_system_score_gemma":0.00087095355,"threshold_uncertainty_score":0.019996166},"labels":[],"label_agreement":null},{"id":"W2076592061","doi":"10.1002/ajh.22256","title":"A basis for updating our approach to resistant acute leukemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Occult; Oncology; Leukemia; Disease; Breast cancer; Acute leukemia; Minimal residual disease; Incidence (geometry); Bone marrow; Cancer; Surgery; Pathology","score_opus":0.037725766569255546,"score_gpt":0.32343155262773143,"score_spread":0.2857057860584759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076592061","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058434997,0.025758224,0.09628949,0.8012126,0.039404787,0.00039518005,0.00007971623,0.0008435079,0.030173004],"genre_scores_gemma":[0.1372222,0.06143233,0.2773299,0.38735047,0.10194679,0.0015641754,0.00038112293,0.00089233485,0.031880714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890878,0.0054868255,0.0015949857,0.00096705946,0.0022646694,0.0005986503],"domain_scores_gemma":[0.9608266,0.011228471,0.0018922195,0.004678529,0.015486255,0.005887911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030617114,0.0009187278,0.0012542163,0.0029749125,0.0029419484,0.0073846243,0.0042536254,0.008108858,0.0055562784],"category_scores_gemma":[0.042204864,0.00048059283,0.0015822456,0.0010522988,0.0089614615,0.007754385,0.006210332,0.025317317,0.0032090277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022305235,0.00069680513,0.004593023,0.0012007526,0.00020877655,0.0013735731,0.0026859962,0.0026228945,0.0020753515,0.1380061,0.2087991,0.6375146],"study_design_scores_gemma":[0.00012597154,0.00034784578,0.001734275,0.001494568,0.000100915146,0.0019655987,0.0017000103,0.0014184198,0.0007014281,0.10773687,0.88256973,0.0001044043],"about_ca_topic_score_codex":0.0020296867,"about_ca_topic_score_gemma":0.0053818333,"teacher_disagreement_score":0.030617114,"about_ca_system_score_codex":0.004977785,"about_ca_system_score_gemma":0.009342455,"threshold_uncertainty_score":0.16192073},"labels":[],"label_agreement":null},{"id":"W2077100867","doi":"10.1002/ajh.23557","title":"The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review","year":2013,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Calgary","funders":"Health Canada; Canada Research Chairs","keywords":"Medicine; Mutation; MEDLINE; National database; Database; Family medicine; Genetics; Biology; Computer science; Gene","score_opus":0.09550155514808802,"score_gpt":0.4310969407563657,"score_spread":0.3355953856082777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077100867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059006247,0.97877574,0.00033895313,0.0045491667,0.00065548305,0.00015205471,0.009530476,0.00009671141,0.0053113247],"genre_scores_gemma":[0.00462331,0.9762039,0.0014607336,0.0020146046,0.00029205214,0.00015957857,0.013433124,0.000043737207,0.0017688993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99702567,0.0002542633,0.0005054171,0.00022040358,0.0017911467,0.000203171],"domain_scores_gemma":[0.98008543,0.002281575,0.0016318843,0.00039145502,0.014444881,0.0011647455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049551725,0.0011629022,0.0024425013,0.02069474,0.0011926759,0.002509511,0.0042675617,0.0014544707,0.0123296175],"category_scores_gemma":[0.014949649,0.00063842855,0.00092585717,0.029097872,0.0011685665,0.0020746873,0.0013403695,0.0011819246,0.003715155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010573084,0.000027332935,0.0024337862,0.019220462,0.00017902101,0.00018726758,0.000090080015,0.000114658375,0.00017867035,0.0012685203,0.4288238,0.5473707],"study_design_scores_gemma":[0.00003526848,0.000025224339,0.015124416,0.025044005,0.00043328956,0.0008549457,0.000114355564,0.0001285923,0.00017783482,0.00031547435,0.9576935,0.000053119704],"about_ca_topic_score_codex":0.5083007,"about_ca_topic_score_gemma":0.5567398,"teacher_disagreement_score":0.49169928,"about_ca_system_score_codex":0.014545836,"about_ca_system_score_gemma":0.050100926,"threshold_uncertainty_score":0.98919},"labels":[],"label_agreement":null},{"id":"W2077500782","doi":"10.1002/ajh.20547","title":"Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; University of British Columbia; Children's & Women's Health Centre of British Columbia; Vancouver General Hospital","funders":"","keywords":"Hemolysis; Medicine; Concomitant; Methemoglobinemia; Drug; Methylene blue; Pharmacology; Internal medicine; Anesthesia; Biology; Biochemistry","score_opus":0.010023601895487438,"score_gpt":0.2827916983463329,"score_spread":0.27276809645084543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077500782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895107,0.0019578794,0.0011827489,0.004128696,0.00014245718,0.00008987138,0.00005957234,0.000086305736,0.0028416838],"genre_scores_gemma":[0.99718696,0.0007734239,0.0006222069,0.0007109534,0.00015768543,0.000012855096,0.00004433158,0.000008261873,0.00048337912],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998005,0.000030905394,0.000038906634,0.000037326867,0.000038120503,0.000054239306],"domain_scores_gemma":[0.9995258,0.00010675549,0.000092615635,0.000020797746,0.000038697548,0.00021537107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002011397,0.0005549529,0.0006139828,0.0008393928,0.001312537,0.00053137465,0.00048781317,0.0021671744,0.0006022235],"category_scores_gemma":[0.0014305183,0.00037531246,0.00042875228,0.00035794542,0.0005278068,0.0007224714,0.0005001492,0.0022076387,0.00020072341],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057862484,0.00025145468,0.04789946,0.00007154117,0.000022136377,0.9328195,0.00043515078,0.00019379184,0.010033469,0.00020638973,0.0006666429,0.006821776],"study_design_scores_gemma":[0.00006703722,0.0010709341,0.032976676,0.000042389984,0.00003777571,0.9568159,0.00037005145,0.0012230596,0.0057182726,0.00033442475,0.0013180497,0.000025348401],"about_ca_topic_score_codex":0.0011590371,"about_ca_topic_score_gemma":0.0015141519,"teacher_disagreement_score":0.0021671744,"about_ca_system_score_codex":0.0005608751,"about_ca_system_score_gemma":0.00053874915,"threshold_uncertainty_score":0.004069507},"labels":[],"label_agreement":null},{"id":"W2078398393","doi":"10.1002/ajh.21349","title":"Novel 27.9 kb α<sup>0</sup>‐thalassemia deletion in a Filipino woman","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Citation; Medicine; Family medicine; Gerontology; Library science; Law; Political science; Computer science","score_opus":0.009475106342141194,"score_gpt":0.24912051913002453,"score_spread":0.23964541278788334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078398393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935595,0.000248138,0.00056988746,0.0011118536,0.000087895954,0.000034194603,0.0005355056,0.000052939162,0.0038000636],"genre_scores_gemma":[0.9961119,0.00019653149,0.000382655,0.00027935632,0.00011584183,0.000008915435,0.0002151983,0.000023905654,0.0026655656],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99984455,0.000014863485,0.000011844463,0.00005463209,0.000020279507,0.000053824308],"domain_scores_gemma":[0.9995995,0.00016165618,0.0000790179,0.000021710926,0.00003058075,0.00010753753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009683383,0.0011538524,0.0004757076,0.001280276,0.001322622,0.000493083,0.00087458186,0.0014530849,0.004238127],"category_scores_gemma":[0.00086372386,0.00032115044,0.00037639096,0.00068516086,0.0008327077,0.00034171046,0.0004052333,0.0009381737,0.0008994923],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001934341,0.00008676886,0.014432275,0.000020339836,0.000010762755,0.96958804,0.00053483184,0.00010809233,0.011962917,0.00022179993,0.00060358987,0.0022371102],"study_design_scores_gemma":[0.000048374564,0.0003275093,0.083274156,0.000042284726,0.0001342246,0.9018877,0.0014272364,0.00082018983,0.008224543,0.00037504002,0.0034047253,0.000033954384],"about_ca_topic_score_codex":0.0042033554,"about_ca_topic_score_gemma":0.002539771,"teacher_disagreement_score":0.004238127,"about_ca_system_score_codex":0.00041418424,"about_ca_system_score_gemma":0.00041188402,"threshold_uncertainty_score":0.014177978},"labels":[],"label_agreement":null},{"id":"W2079914174","doi":"10.1002/ajh.20499","title":"Transient monoclonal gammopathy in a patient withBartonella quintana endocarditis","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Gammopathy; Monoclonal gammopathy; Endocarditis; Medicine; Monoclonal antibody; Hypergammaglobulinemia; Pathology; Monoclonal; Immunology; Antibody; Internal medicine","score_opus":0.004856152783218267,"score_gpt":0.2315188954570349,"score_spread":0.22666274267381664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079914174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242145,0.001782729,0.00053801906,0.00082773896,0.00011477274,0.00003587093,0.00005583035,0.000074370895,0.0041492307],"genre_scores_gemma":[0.99906284,0.0002821983,0.00008626268,0.00022520064,0.00010527106,0.000003431179,0.000016671842,0.0000034268953,0.00021468762],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99973303,0.000038272596,0.000029796553,0.000058577316,0.000040756666,0.00009955314],"domain_scores_gemma":[0.99927753,0.0002629641,0.0001093707,0.00004867804,0.00005050808,0.000250992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030969357,0.00081174955,0.00061971194,0.0012111126,0.0015215208,0.0007079604,0.0004580028,0.0022317085,0.0015503361],"category_scores_gemma":[0.0021375297,0.0006024055,0.00053986773,0.0006398832,0.0007478537,0.00075201585,0.00048357795,0.0011729386,0.00032270866],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018519646,0.00010750001,0.07023786,0.000048369144,0.00002070897,0.9234942,0.0006131171,0.00008404965,0.0022632477,0.00012580701,0.00032898187,0.0024910406],"study_design_scores_gemma":[0.000045421606,0.00040506007,0.06763856,0.000036025256,0.000053617,0.9293763,0.00034690512,0.000388011,0.0007753569,0.0001438599,0.000770052,0.000020733783],"about_ca_topic_score_codex":0.00187428,"about_ca_topic_score_gemma":0.0015199641,"teacher_disagreement_score":0.0022317085,"about_ca_system_score_codex":0.00050042674,"about_ca_system_score_gemma":0.00034838813,"threshold_uncertainty_score":0.0051864386},"labels":[],"label_agreement":null},{"id":"W2080106923","doi":"10.1002/ajh.21916","title":"Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Overdiagnosis; Gangrene; Catastrophic antiphospholipid syndrome; Adverse effect; Internal medicine; Intensive care medicine; Surgery; Thrombosis","score_opus":0.00734004925804221,"score_gpt":0.2482622453945034,"score_spread":0.24092219613646118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080106923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912815,0.00091380137,0.0005824773,0.0022528572,0.00016385445,0.00007712807,0.00009971294,0.000057117,0.0045713587],"genre_scores_gemma":[0.99784565,0.0003925471,0.0003295103,0.0007520484,0.00036561262,0.000007266895,0.00006853985,0.0000061508167,0.00023272245],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99942976,0.00011109354,0.000082093306,0.00010288838,0.00010150589,0.0001726665],"domain_scores_gemma":[0.9986933,0.0003885402,0.0002580961,0.000085159525,0.00009662851,0.0004782195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004665598,0.0011055608,0.00079809356,0.0017526211,0.0019001295,0.001177108,0.00070197636,0.0028494624,0.0016165207],"category_scores_gemma":[0.0042313463,0.000828916,0.00067426055,0.001023782,0.0009790396,0.0011558754,0.0008596011,0.0025203007,0.0004766158],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011615959,0.00007961543,0.099512696,0.00001795886,0.000016976792,0.8975151,0.00021539752,0.00008816255,0.00037916945,0.0001221144,0.0003663181,0.0015703057],"study_design_scores_gemma":[0.00004021049,0.00025210678,0.049568415,0.00002703624,0.000029872384,0.94802344,0.00032132104,0.0007458032,0.0002890369,0.00024563013,0.00043796079,0.000019106876],"about_ca_topic_score_codex":0.0030553916,"about_ca_topic_score_gemma":0.0042214612,"teacher_disagreement_score":0.0030553916,"about_ca_system_score_codex":0.0010566299,"about_ca_system_score_gemma":0.0007496536,"threshold_uncertainty_score":0.007666409},"labels":[],"label_agreement":null},{"id":"W2080451014","doi":"10.1002/ajh.21105","title":"Treatment of acquired factor X inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids","year":2007,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Partial thromboplastin time; Concomitant; Medicine; Antibody; Gastroenterology; Thromboplastin; Coagulopathy; Fresh frozen plasma; Internal medicine; Coagulation; Immunology; Anesthesia","score_opus":0.015583202790570934,"score_gpt":0.2898794670456788,"score_spread":0.27429626425510784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080451014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9295399,0.032947645,0.007921197,0.0057816757,0.0009540415,0.0004819669,0.00016225674,0.00037621148,0.02183505],"genre_scores_gemma":[0.9903307,0.004742269,0.0015725,0.001072895,0.0005441932,0.00009378389,0.000103713515,0.00001389312,0.0015261257],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997336,0.00007960755,0.0000305673,0.000033478827,0.000064030486,0.000058808746],"domain_scores_gemma":[0.9997695,0.00007974368,0.000040651634,0.000014522542,0.000021044103,0.00007451453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031685774,0.0005764211,0.0007193036,0.0004843218,0.00061772205,0.00028173978,0.00035904252,0.000849051,0.00090169924],"category_scores_gemma":[0.0011534777,0.00012664606,0.00043932523,0.00032409796,0.0003687485,0.0002344566,0.00026377823,0.0011898205,0.00030292053],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007986291,0.0033714296,0.09718972,0.0013737839,0.00088244776,0.4033922,0.0007454282,0.003553212,0.05917324,0.0035575721,0.013673366,0.40510133],"study_design_scores_gemma":[0.004937715,0.019424219,0.13082919,0.00064077915,0.0006584895,0.75345266,0.00044339107,0.008651254,0.022498423,0.002598514,0.055744383,0.00012108617],"about_ca_topic_score_codex":0.000961276,"about_ca_topic_score_gemma":0.001489416,"teacher_disagreement_score":0.000961276,"about_ca_system_score_codex":0.00040669172,"about_ca_system_score_gemma":0.00051190157,"threshold_uncertainty_score":0.0030164719},"labels":[],"label_agreement":null},{"id":"W2080733157","doi":"10.1002/ajh.22190","title":"Unintended benefit of anabolic steroid use in hemophilia B leiden","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Anabolic steroid; Medicine; Emergency department; Pediatrics; Leukocytosis; Internal medicine; Surgery; Anabolism","score_opus":0.04994917088565148,"score_gpt":0.3110085813182417,"score_spread":0.26105941043259023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080733157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390408,0.04633679,0.0012968694,0.003636203,0.00033349366,0.00003738292,0.00013601959,0.000091388065,0.0090911575],"genre_scores_gemma":[0.99457353,0.0035854888,0.0001558041,0.00060141686,0.00037536092,0.0000036340205,0.000052917036,0.000005859083,0.0006460752],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99980396,0.000056713954,0.00002112774,0.000019016516,0.00005094153,0.000048391128],"domain_scores_gemma":[0.9992366,0.00031868796,0.00015288308,0.000037830283,0.00003159082,0.00022248962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020701694,0.00019450058,0.00042976672,0.0002701673,0.00034190842,0.00031171733,0.00016873125,0.0005786576,0.0018812885],"category_scores_gemma":[0.0014207338,0.00004912258,0.0002818889,0.0001569424,0.00028994848,0.0001800697,0.00020359152,0.00072131737,0.00030116024],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003564365,0.0005768825,0.2190307,0.0004833468,0.00029155004,0.5990495,0.00047866834,0.00029999495,0.01522773,0.0012559416,0.0029164949,0.15682481],"study_design_scores_gemma":[0.000252342,0.005109336,0.26961708,0.00025946827,0.00028908427,0.69529206,0.00039078298,0.0010607523,0.005277832,0.0015410514,0.02086535,0.00004493232],"about_ca_topic_score_codex":0.00035826635,"about_ca_topic_score_gemma":0.00068528985,"teacher_disagreement_score":0.0018812885,"about_ca_system_score_codex":0.00025616025,"about_ca_system_score_gemma":0.00017994236,"threshold_uncertainty_score":0.006293595},"labels":[],"label_agreement":null},{"id":"W2082486060","doi":"10.1002/ajh.24032","title":"“Bleeding in the jungle”","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Lawrence College","funders":"British Heart Foundation","keywords":"Medicine; Hemostasis; Gastrointestinal bleeding; Surgery; Hemarthrosis; Von Willebrand disease; Medical history; Von Willebrand factor; Internal medicine","score_opus":0.02516470293026253,"score_gpt":0.30800015069586073,"score_spread":0.2828354477655982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082486060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7359381,0.0770238,0.0053758277,0.067438826,0.0081775915,0.00032719396,0.000860317,0.0006387275,0.10421965],"genre_scores_gemma":[0.9340295,0.022412468,0.0024251393,0.021210846,0.0025928405,0.000058339687,0.0003400176,0.00008689537,0.016843919],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996916,0.000073457326,0.000023104189,0.00005238935,0.000042764652,0.00011661746],"domain_scores_gemma":[0.99967015,0.000057151494,0.00006432141,0.000016793987,0.000034051656,0.00015751737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023634551,0.00095406245,0.0004188264,0.0017195352,0.0028149595,0.0012640577,0.00053425215,0.0018217458,0.0045761117],"category_scores_gemma":[0.0016681508,0.00036693327,0.00045607128,0.0013844353,0.0012746365,0.0020126605,0.0015653425,0.0030114485,0.0010145004],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095174575,0.00009454603,0.015291791,0.00019746413,0.000039981416,0.9170361,0.0037981998,0.00010964205,0.0012466557,0.0063858507,0.031687614,0.02401699],"study_design_scores_gemma":[0.000010980172,0.000084465064,0.0058250926,0.0002645568,0.00001551542,0.9620235,0.0028765008,0.000110010355,0.00015965707,0.0027892487,0.02580895,0.000031554977],"about_ca_topic_score_codex":0.0032578954,"about_ca_topic_score_gemma":0.0046613645,"teacher_disagreement_score":0.0045761117,"about_ca_system_score_codex":0.00067737367,"about_ca_system_score_gemma":0.00050811,"threshold_uncertainty_score":0.015308619},"labels":[],"label_agreement":null},{"id":"W2083967734","doi":"10.1002/ajh.20102","title":"Adherence to deferoxamine therapy: Heeding Hippocrates and Osler","year":2004,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Deferoxamine; Thalassemia; Medicine; Citation; Pediatrics; Family medicine; Library science; Internal medicine; Computer science","score_opus":0.01662437718712059,"score_gpt":0.27333741492243707,"score_spread":0.2567130377353165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083967734","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001593429,0.002354198,0.000068432826,0.9850205,0.009240221,0.0000035806622,0.000008210675,0.000008201378,0.0017031917],"genre_scores_gemma":[0.0255038,0.005108931,0.0003739314,0.922006,0.04341345,0.000012464147,0.000014292643,0.000024714886,0.0035422975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997919,0.0007144075,0.0003124869,0.00025091314,0.00047116887,0.00033193576],"domain_scores_gemma":[0.98987514,0.0050678933,0.0008350111,0.00027508222,0.0020464917,0.0019003432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025778385,0.0006063068,0.0011409025,0.00071608025,0.005083955,0.0032143232,0.0012897251,0.04008343,0.0025094242],"category_scores_gemma":[0.027808538,0.0006395598,0.0007360076,0.00069514406,0.0026706946,0.004536674,0.0014033447,0.03750115,0.0013723545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092783004,0.00007353577,0.003159308,0.00007658348,0.00004738603,0.015851812,0.0010061857,0.00009133896,0.00016146802,0.0039965576,0.9534488,0.02199425],"study_design_scores_gemma":[0.00027629494,0.00022843527,0.004796213,0.0017780829,0.00018683661,0.046127003,0.0043548974,0.0012770876,0.000379601,0.016332906,0.92406034,0.00020222017],"about_ca_topic_score_codex":0.011767812,"about_ca_topic_score_gemma":0.025018279,"teacher_disagreement_score":0.04008343,"about_ca_system_score_codex":0.004531866,"about_ca_system_score_gemma":0.004594119,"threshold_uncertainty_score":0.03288108},"labels":[],"label_agreement":null},{"id":"W2085785612","doi":"10.1002/ajh.21713","title":"Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge","year":2010,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Cutaneous Mastocytosis; Pathology; Biopsy; Urticaria pigmentosa; Leukemia; Bone marrow; Myeloid; Myeloid leukemia; Mastocytoma; Skin biopsy; Internal medicine; Cancer research","score_opus":0.016733704035326,"score_gpt":0.2547730907563595,"score_spread":0.2380393867210335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085785612","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7416523,0.10192101,0.025960693,0.092451595,0.0039054938,0.0011990065,0.001033755,0.0006177592,0.03125845],"genre_scores_gemma":[0.94584465,0.019819163,0.010518443,0.0091253305,0.012664368,0.00020346824,0.0005501361,0.00005247115,0.0012219731],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986663,0.00027693092,0.00022174344,0.00020065412,0.00026409488,0.00037025413],"domain_scores_gemma":[0.997755,0.00093658373,0.00030507514,0.00009720149,0.00031881477,0.0005874189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022504432,0.0015320919,0.0021871773,0.002642834,0.0019847967,0.0026949893,0.0024842715,0.006003542,0.0027105634],"category_scores_gemma":[0.0069185332,0.0006803864,0.0007313323,0.0014312664,0.0019179217,0.0052496702,0.0023218377,0.005221552,0.001877857],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006569255,0.00033473977,0.11746592,0.00054043456,0.000054144642,0.808698,0.0007331658,0.0006409195,0.0034163534,0.0045994776,0.013630836,0.04922907],"study_design_scores_gemma":[0.00008956529,0.00020613626,0.017303277,0.0005003361,0.00006507183,0.9629624,0.0019386949,0.0032205663,0.00065540214,0.0067230216,0.0062912065,0.0000443292],"about_ca_topic_score_codex":0.00065358286,"about_ca_topic_score_gemma":0.0008287932,"teacher_disagreement_score":0.006003542,"about_ca_system_score_codex":0.0012098571,"about_ca_system_score_gemma":0.00075837434,"threshold_uncertainty_score":0.011901677},"labels":[],"label_agreement":null},{"id":"W2086036138","doi":"10.1002/ajh.10466","title":"Hepatosplenic γδ T‐cell lymphoma in a 10‐year‐old boy successfully treated with hematopoietic stem cell transplantation","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lymphoma; Hematopoietic stem cell transplantation; Medicine; Transplantation; Chemotherapy; Stem cell; T-cell lymphoma; Haematopoiesis; Oncology; Internal medicine; Biology","score_opus":0.006172396217719142,"score_gpt":0.22689735442727116,"score_spread":0.220724958209552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890554,0.0015822982,0.0011321831,0.0022119735,0.0002218936,0.00008810843,0.0001580572,0.0001299734,0.005420095],"genre_scores_gemma":[0.9961355,0.0012851178,0.00058736425,0.0005451122,0.00026826846,0.00001973553,0.00011246816,0.000020768637,0.0010256938],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99954885,0.000067085784,0.00004464515,0.00008157907,0.0000677992,0.00018995942],"domain_scores_gemma":[0.99860233,0.00031992132,0.00023312357,0.000047753518,0.00006948865,0.0007273564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033220783,0.0014769307,0.0011838384,0.001311302,0.0021126934,0.001039578,0.0007073214,0.003036462,0.0014198135],"category_scores_gemma":[0.0016398592,0.0009745419,0.0010638898,0.0007936187,0.0013826387,0.0010931165,0.00072790927,0.00293135,0.00062276],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007184762,0.0001197807,0.018398952,0.000033528755,0.000014702504,0.9776964,0.00034288142,0.00011903107,0.0013035645,0.00013721576,0.0003189373,0.0014431257],"study_design_scores_gemma":[0.0000808769,0.0007863574,0.03182034,0.000044493132,0.000050496816,0.9639718,0.0004911639,0.00042627967,0.0011086086,0.00009030466,0.0011073907,0.000021891923],"about_ca_topic_score_codex":0.0046525854,"about_ca_topic_score_gemma":0.0060653705,"teacher_disagreement_score":0.0046525854,"about_ca_system_score_codex":0.0010171506,"about_ca_system_score_gemma":0.0010571842,"threshold_uncertainty_score":0.0092509985},"labels":[],"label_agreement":null},{"id":"W2087051409","doi":"10.1002/ajh.10092","title":"Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Badan Riset dan Inovasi Nasional","keywords":"Angiogenesis; Bone marrow; Endostatin; Vascular endothelial growth factor; Neovascularization; Pathology; Myeloid; In vivo; CD34; Cancer research; Biology; Medicine; Stem cell; Cell biology","score_opus":0.005133358588388156,"score_gpt":0.21614664697858763,"score_spread":0.21101328839019948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087051409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765678,0.020727491,0.0011742843,0.00012287417,0.000018695335,0.00002171269,0.0000897471,0.00003698476,0.0012402884],"genre_scores_gemma":[0.994843,0.0039307475,0.0006804653,0.00003246718,0.000026896529,0.000015945212,0.00006598564,0.0000032117164,0.00040120565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998976,0.00004256398,0.000006046582,0.000010731666,0.0000192876,0.000023692863],"domain_scores_gemma":[0.9999379,0.000012820775,0.000020230826,0.0000035950288,0.0000051775082,0.000020349637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014954765,0.00018078212,0.00015283114,0.00020515903,0.00011732017,0.00025508789,0.00006513324,0.00013810124,0.0005249057],"category_scores_gemma":[0.00014776927,0.000087468296,0.00009018127,0.0000736756,0.00014488655,0.00015416098,0.00021703518,0.00015757924,0.0001419152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007399166,0.000049803366,0.0062288716,0.00016876645,0.000010451046,0.0005827372,0.000044962835,0.00019487113,0.97639436,0.00042275773,0.00012151305,0.0150409425],"study_design_scores_gemma":[0.00021075712,0.0040919837,0.3351806,0.000120701654,0.00012253183,0.007961521,0.00031256376,0.003242219,0.62293935,0.001580854,0.02421463,0.000022160673],"about_ca_topic_score_codex":0.00014375975,"about_ca_topic_score_gemma":0.00022993273,"teacher_disagreement_score":0.0005249057,"about_ca_system_score_codex":0.00014606926,"about_ca_system_score_gemma":0.000097973374,"threshold_uncertainty_score":0.0017560124},"labels":[],"label_agreement":null},{"id":"W2087600599","doi":"10.1002/ajh.21993","title":"Iron chelation adherence to deferoxamine and deferasirox in thalassemia","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Deferoxamine; Thalassemia; Deferiprone; Medicine; Beta thalassemia; Chelation therapy; Chelation; Internal medicine; Chemistry","score_opus":0.017729159517385556,"score_gpt":0.267995170969387,"score_spread":0.25026601145200145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087600599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970078,0.00080574217,0.000094150775,0.000080484904,0.000006260126,0.000031398155,0.0011827175,0.0000036461925,0.0007878721],"genre_scores_gemma":[0.9985089,0.0002475784,0.00014054182,0.000048067635,0.000009183139,0.00002366431,0.0008379144,0.000001078072,0.00018308341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848014,0.0005206486,0.0003036702,0.00019611057,0.0003713771,0.0001280446],"domain_scores_gemma":[0.9973935,0.000556796,0.0014824207,0.00011186543,0.0002712538,0.00018414983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017763247,0.0001119642,0.00027346212,0.00086684705,0.00022559782,0.00035645932,0.00019747346,0.00025284835,0.00046368342],"category_scores_gemma":[0.0041208244,0.00015545807,0.00031091776,0.0011054692,0.0001058783,0.00022504377,0.00029134811,0.0004563533,0.00008746554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067112436,0.000032418404,0.99629444,0.000019469424,0.00004085287,0.000027131395,0.000101055426,0.00003547528,0.00004969426,0.000008918224,0.00018006182,0.0031434423],"study_design_scores_gemma":[0.000006019774,0.00005015184,0.99942446,0.000015314672,0.000014401024,0.00007872239,0.000036805388,0.0001560789,0.000035092962,0.0000067826036,0.00017394582,0.0000022830275],"about_ca_topic_score_codex":0.010042608,"about_ca_topic_score_gemma":0.011797206,"teacher_disagreement_score":0.010042608,"about_ca_system_score_codex":0.0004826484,"about_ca_system_score_gemma":0.0002616574,"threshold_uncertainty_score":0.01996833},"labels":[],"label_agreement":null},{"id":"W2088730430","doi":"10.1002/ajh.21806","title":"Iron chelation therapy for patients with sickle cell disease and iron overload","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chelation therapy; Medicine; Deferoxamine; Deferasirox; Anemia; Ferritin; Internal medicine; Sickle cell anemia; Transfusion therapy; Blood transfusion; Gastroenterology; Pallor; Surgery; Disease; Thalassemia","score_opus":0.0026561151064067806,"score_gpt":0.22031226074461893,"score_spread":0.21765614563821215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088730430","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7556596,0.21458638,0.0017192397,0.0075703682,0.000588362,0.0002190129,0.0001818008,0.0001507548,0.019324472],"genre_scores_gemma":[0.95945346,0.032158002,0.001822205,0.002468935,0.0008250171,0.000085645675,0.0002771154,0.00001010462,0.0028995771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999138,0.000026992866,0.000013223081,0.000007522115,0.000019379737,0.0000190499],"domain_scores_gemma":[0.9998603,0.000037265643,0.000030945284,0.0000031835727,0.000011133537,0.00005717556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017844819,0.0001999027,0.00052097713,0.0003866072,0.0004946287,0.00019042531,0.00013754376,0.0005558414,0.0011507439],"category_scores_gemma":[0.0005672124,0.000060448387,0.00024830346,0.00025901277,0.00012221864,0.00015731981,0.0002036156,0.00039069713,0.00033436783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068963324,0.0021035704,0.15100807,0.00315552,0.00029977033,0.14492907,0.0016540822,0.00045852966,0.031681336,0.0011447307,0.043178197,0.61349076],"study_design_scores_gemma":[0.0022723305,0.016645297,0.26464492,0.001737953,0.0005550895,0.4626267,0.0009977646,0.0018154111,0.00915897,0.0017859027,0.23767571,0.000083918465],"about_ca_topic_score_codex":0.00040902905,"about_ca_topic_score_gemma":0.0009144834,"teacher_disagreement_score":0.0011507439,"about_ca_system_score_codex":0.00015503366,"about_ca_system_score_gemma":0.00024725858,"threshold_uncertainty_score":0.0038496852},"labels":[],"label_agreement":null},{"id":"W2088900228","doi":"10.1002/ajh.20359","title":"Anaplastic large‐cell lymphoma presenting as acute leukemia","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphoma; Leukemia; Anaplastic large-cell lymphoma; Cancer research; Oncology; Internal medicine","score_opus":0.005965687940182669,"score_gpt":0.27116655238889104,"score_spread":0.2652008644487084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088900228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8453756,0.00885114,0.0060365633,0.0027639826,0.00046414422,0.000844829,0.0012893209,0.0012981078,0.13307637],"genre_scores_gemma":[0.98729825,0.0021793866,0.0013875595,0.0011097246,0.00042294204,0.0000647523,0.00057225773,0.000045933153,0.0069191437],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997701,0.000038422713,0.000018281718,0.000044357497,0.00004204881,0.00008680016],"domain_scores_gemma":[0.99972755,0.000063344436,0.000060998907,0.000027424863,0.000030528627,0.00009017179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019822673,0.0011919593,0.0005425887,0.0008813828,0.00075807236,0.0006358575,0.00047998005,0.0014418892,0.008624031],"category_scores_gemma":[0.00084,0.00031594676,0.00029413938,0.0008698384,0.00033895829,0.0011356376,0.00041769884,0.0009292786,0.0033076406],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041276237,0.0002189137,0.033715375,0.00017814574,0.000021954645,0.9312063,0.00030678193,0.00024304278,0.013371027,0.001791429,0.0039993785,0.01453482],"study_design_scores_gemma":[0.0001726398,0.00053260033,0.044249695,0.000076151875,0.000053713782,0.9266654,0.0002949675,0.0011995588,0.0021932023,0.0017368835,0.022796834,0.00002836435],"about_ca_topic_score_codex":0.0006579047,"about_ca_topic_score_gemma":0.0007179302,"teacher_disagreement_score":0.008624031,"about_ca_system_score_codex":0.00038579502,"about_ca_system_score_gemma":0.000341351,"threshold_uncertainty_score":0.028850198},"labels":[],"label_agreement":null},{"id":"W2089751232","doi":"10.1002/ajh.22236","title":"If at first you don't succeed: Try, try again","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chills; Rash; Gastroenterology; Erythrocyte sedimentation rate; Internal medicine; Elevated transaminases; Physical examination; Anemia; Surgery","score_opus":0.013043811899042468,"score_gpt":0.2567291399702445,"score_spread":0.24368532807120202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089751232","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04043383,0.022500033,0.0058860034,0.5985721,0.059050843,0.0005311463,0.0006610544,0.0025494562,0.2698156],"genre_scores_gemma":[0.13431612,0.019119171,0.01117364,0.3429399,0.012349506,0.0005254697,0.0006751735,0.00066446123,0.47823653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923086,0.00021960518,0.000026390508,0.00007085674,0.0001534061,0.00029878807],"domain_scores_gemma":[0.9971923,0.00016859351,0.00011288207,0.000058590995,0.00044609886,0.002021447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077347335,0.0006941497,0.0005940033,0.00050566765,0.003145408,0.0020459897,0.0010481616,0.003630358,0.08938614],"category_scores_gemma":[0.004966494,0.00027676387,0.0006287226,0.00018264992,0.0010794912,0.0033401216,0.0019863283,0.0055419407,0.053161066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008627914,0.0004743308,0.004211361,0.00014678718,0.000021586124,0.0028920295,0.0011348255,0.000038761642,0.00034926363,0.0007962982,0.9014143,0.08843419],"study_design_scores_gemma":[0.0000815334,0.00032108714,0.006678709,0.0010158387,0.000048422295,0.014723732,0.011122879,0.00025089824,0.00045402962,0.0051644337,0.96002793,0.000110510955],"about_ca_topic_score_codex":0.004080856,"about_ca_topic_score_gemma":0.010209932,"teacher_disagreement_score":0.08938614,"about_ca_system_score_codex":0.00060887507,"about_ca_system_score_gemma":0.0013227981,"threshold_uncertainty_score":0.29902643},"labels":[],"label_agreement":null},{"id":"W2090247704","doi":"10.1002/ajh.20205","title":"Prognostic variables in newly diagnosed childhood immune thrombocytopenia","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; University of Saskatchewan","funders":"","keywords":"Medicine; Prodrome; Internal medicine; Multivariate analysis; Mean platelet volume; Odds ratio; Univariate analysis; Immune thrombocytopenia; Pediatrics; Disease; Family history; Platelet","score_opus":0.006553087029186502,"score_gpt":0.2548230655183501,"score_spread":0.2482699784891636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090247704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916375,0.00049535633,0.000067766094,0.000033382643,0.00000561539,0.0000033893552,0.000076697484,0.0000043533464,0.00014974894],"genre_scores_gemma":[0.99943477,0.00020757505,0.000083211264,0.000009062779,0.000012684531,0.0000037619582,0.00022051662,0.0000019122144,0.000026524083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996215,0.000105699124,0.00004684773,0.000055048717,0.00008747185,0.000083471794],"domain_scores_gemma":[0.9961576,0.0011414284,0.0018604734,0.00007817677,0.00020673189,0.00055562786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046258813,0.00030795205,0.00036066293,0.0007741219,0.0002692619,0.000459605,0.0003210831,0.0004785967,0.00083803886],"category_scores_gemma":[0.0048257723,0.00019601082,0.0002636422,0.0010293572,0.00038406978,0.00050172204,0.00034973855,0.00068631634,0.00012269703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037758808,0.0000042871516,0.998944,0.0000036892197,0.0000049614673,0.00020294455,0.000013798293,0.000041731466,0.00004135694,0.000004948836,0.000033176235,0.00066734245],"study_design_scores_gemma":[0.0000065808904,0.00009596142,0.9961259,0.000008888529,0.000017458016,0.0031539586,0.00007840139,0.0003241513,0.000079408295,0.000015835123,0.00009009748,0.0000033619049],"about_ca_topic_score_codex":0.0020750347,"about_ca_topic_score_gemma":0.0024565472,"teacher_disagreement_score":0.0020750347,"about_ca_system_score_codex":0.0002680437,"about_ca_system_score_gemma":0.00036149923,"threshold_uncertainty_score":0.004125893},"labels":[],"label_agreement":null},{"id":"W2092734676","doi":"10.1002/ajh.23163","title":"Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Romiplostim; Medicine; Splenectomy; Immune thrombocytopenia; Quality of life (healthcare); Rituximab; Internal medicine; Clinical trial; Platelet; Immunology; Spleen; Thrombopoietin; Lymphoma","score_opus":0.01916317450765705,"score_gpt":0.339096856106367,"score_spread":0.31993368159870994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092734676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865425,0.0008541839,0.000044849778,0.000045064662,0.000010644682,0.00007533514,0.000068609064,0.0000036194574,0.000243402],"genre_scores_gemma":[0.999385,0.00018476036,0.0001025556,0.00006454926,0.000009071069,0.00007655938,0.00010040811,4.8493337e-7,0.00007656515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995521,0.00022639218,0.000039700888,0.000046201865,0.00006789602,0.00006773007],"domain_scores_gemma":[0.9993987,0.00014343874,0.00020097427,0.000029574187,0.000042822878,0.00018452974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009037047,0.0002819553,0.0010962037,0.00025995684,0.0002229699,0.00032458713,0.00018895126,0.0003690566,0.0008643809],"category_scores_gemma":[0.0013330207,0.00016578725,0.00070853677,0.00030558306,0.00020759668,0.00030607727,0.00025802536,0.00061139243,0.00008576994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2846354,0.026950676,0.45647946,0.0012819049,0.0038984756,0.0003888932,0.0008349895,0.002356305,0.01723618,0.00017667956,0.0018223895,0.20393862],"study_design_scores_gemma":[0.024704099,0.20585082,0.7630362,0.00007464437,0.0009777807,0.00033178358,0.00017908115,0.002082022,0.0016057211,0.000089926056,0.0010349015,0.000033048174],"about_ca_topic_score_codex":0.0005306954,"about_ca_topic_score_gemma":0.0006190484,"teacher_disagreement_score":0.0010962037,"about_ca_system_score_codex":0.00027315412,"about_ca_system_score_gemma":0.00023453777,"threshold_uncertainty_score":0.004779339},"labels":[],"label_agreement":null},{"id":"W2094170436","doi":"10.1002/ajh.22144","title":"Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Hemophagocytosis; Gastroenterology; Internal medicine; Pancytopenia; Mean corpuscular volume; Proteinuria; Reference range; Bone marrow; Hemoglobin; Kidney","score_opus":0.01753851498276794,"score_gpt":0.2590140491020947,"score_spread":0.24147553411932676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094170436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803571,0.0025801626,0.00092436053,0.0013686005,0.00009657379,0.0001453887,0.00023698059,0.00010058091,0.014190272],"genre_scores_gemma":[0.9975223,0.00073635945,0.00025076413,0.00026735736,0.0002050209,0.000014089435,0.00012287367,0.000005680585,0.000875595],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99959236,0.000069431226,0.000054085052,0.00008757548,0.000081156984,0.0001153624],"domain_scores_gemma":[0.9992047,0.00023606472,0.0002044734,0.000045978202,0.00006615199,0.00024263181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034197967,0.0012707586,0.00059918454,0.0019351818,0.0009299505,0.00054427347,0.0004926621,0.0015041921,0.0037887336],"category_scores_gemma":[0.0014474936,0.00048764443,0.00043221907,0.0008374402,0.000637095,0.0006864223,0.00055469264,0.0014777868,0.0006760744],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027901225,0.00024099568,0.14695431,0.00011946318,0.00003981747,0.84192616,0.0002666699,0.000107795044,0.0042868056,0.00022867376,0.0006714039,0.0048788083],"study_design_scores_gemma":[0.00007464105,0.00054673053,0.14267892,0.00007648832,0.00004569143,0.8538565,0.00018931422,0.00041113314,0.00064792065,0.00021863182,0.0012395217,0.0000145613185],"about_ca_topic_score_codex":0.0012505829,"about_ca_topic_score_gemma":0.0018735495,"teacher_disagreement_score":0.0037887336,"about_ca_system_score_codex":0.000458919,"about_ca_system_score_gemma":0.0004335697,"threshold_uncertainty_score":0.01267457},"labels":[],"label_agreement":null},{"id":"W2094319690","doi":"10.1002/ajh.10181","title":"Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia","year":2002,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Lepirudin; Warfarin; Medicine; Gangrene; Heparin-induced thrombocytopenia; Heparin; Direct thrombin inhibitor; Venous thrombosis; Discovery and development of direct thrombin inhibitors; Thrombosis; Surgery; Platelet; Internal medicine; Thrombin; Atrial fibrillation","score_opus":0.028807812887572896,"score_gpt":0.26928670193862575,"score_spread":0.24047888905105286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094319690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971716,0.0005647093,0.00052563654,0.00015197451,0.00002082874,0.00002808716,0.000017610624,0.000016759697,0.0015028706],"genre_scores_gemma":[0.9993155,0.00013809673,0.00018394932,0.00014828026,0.00005593603,0.000006758053,0.000023572138,0.0000029217322,0.00012494098],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99935895,0.00016893017,0.00006188541,0.00008529695,0.00008538965,0.00023954219],"domain_scores_gemma":[0.99845374,0.00053698407,0.00049444597,0.0001026396,0.000060505696,0.00035179383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033228166,0.00082086003,0.00054202706,0.00063226797,0.0011119954,0.00088497513,0.00033664986,0.001518203,0.0007728541],"category_scores_gemma":[0.0039878455,0.00049605203,0.0005553846,0.00047729025,0.0006872853,0.00066049275,0.00071495987,0.0010988609,0.0001541601],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008006226,0.00040541438,0.33573353,0.00008274046,0.00009860969,0.643001,0.0017427062,0.0003154392,0.0036019224,0.00032976666,0.00040126394,0.013486971],"study_design_scores_gemma":[0.00018444825,0.0012581811,0.08504753,0.00002007167,0.00008238375,0.909961,0.00037716035,0.0007311507,0.0012097347,0.00018207001,0.00092079386,0.000025524558],"about_ca_topic_score_codex":0.0012734273,"about_ca_topic_score_gemma":0.0013228089,"teacher_disagreement_score":0.001518203,"about_ca_system_score_codex":0.00044364837,"about_ca_system_score_gemma":0.0003343197,"threshold_uncertainty_score":0.0032189488},"labels":[],"label_agreement":null},{"id":"W2094729938","doi":"10.1002/ajh.22225","title":"Clinical trial opportunities in hemostasis and thrombosis: NHBLI State‐of‐the‐science symposium","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clinical trial; Medicine; Biostatistics; Intensive care medicine; Family medicine; Hemostasis; Public health; Clinical research; Alternative medicine; Internal medicine; Nursing; Pathology","score_opus":0.1257868202256539,"score_gpt":0.3609994473338326,"score_spread":0.2352126271081787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094729938","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008301418,0.11885102,0.0025354382,0.7121373,0.13415068,0.0008756493,0.00081176846,0.00023608834,0.029571954],"genre_scores_gemma":[0.01319186,0.16752617,0.016060265,0.47141838,0.24607284,0.003378109,0.0025107015,0.00036028295,0.07948142],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9656451,0.015832657,0.0027187904,0.002165801,0.0110081835,0.0026295313],"domain_scores_gemma":[0.89700985,0.038569205,0.0068685077,0.0032427472,0.021619935,0.032689754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15061568,0.002158912,0.0019077619,0.0028630174,0.0033575452,0.015306088,0.0038804952,0.026494982,0.025129287],"category_scores_gemma":[0.067328915,0.0011464882,0.0029101851,0.0026782064,0.0032733649,0.00830214,0.0074989703,0.0236284,0.011570282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003579654,0.00020513473,0.00026579513,0.00093897595,0.00005556628,0.0001385625,0.00012592447,0.00014490128,0.00033438738,0.005349328,0.9073834,0.08470014],"study_design_scores_gemma":[0.0002812582,0.00015234335,0.0011662599,0.0035776985,0.0000618902,0.00010748511,0.00009453233,0.00024236055,0.00014460062,0.0054254667,0.9887029,0.000043299173],"about_ca_topic_score_codex":0.0042971023,"about_ca_topic_score_gemma":0.008542937,"teacher_disagreement_score":0.15061568,"about_ca_system_score_codex":0.010804108,"about_ca_system_score_gemma":0.04468946,"threshold_uncertainty_score":0.79654133},"labels":[],"label_agreement":null},{"id":"W2094956732","doi":"10.1002/1096-8652(200102)66:2<130::aid-ajh1030>3.0.co;2-b","title":"Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Prothrombinase; Platelet; Factor V; Thrombin; Internal medicine; Chemistry; Endocrinology; Medicine; Thrombosis","score_opus":0.06502370894220214,"score_gpt":0.3033249035902591,"score_spread":0.23830119464805696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094956732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97913367,0.0019116837,0.0020210466,0.0010720005,0.00014147688,0.00008639495,0.00065891794,0.00008367723,0.014891205],"genre_scores_gemma":[0.99018466,0.0004253042,0.0012954426,0.00021285612,0.000027673765,0.000016050446,0.0003249329,0.000021789334,0.0074914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981993,0.000019711251,0.000011141903,0.00004694103,0.000050396116,0.0000519353],"domain_scores_gemma":[0.9997532,0.00007542754,0.000044990255,0.000010803377,0.000048077945,0.00006761069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001350162,0.0006378134,0.00018895396,0.00058558874,0.0005441245,0.00045522518,0.00034560624,0.0005244294,0.0062890733],"category_scores_gemma":[0.0006488774,0.00013484276,0.00017154898,0.00041022376,0.0005071993,0.00024531872,0.00026149405,0.0005292872,0.00034608183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011545245,0.00038931976,0.09414767,0.00039237962,0.00026907946,0.20388187,0.0021311042,0.0008279106,0.60738796,0.014204378,0.0066512157,0.068562575],"study_design_scores_gemma":[0.00040477145,0.0014435647,0.56735754,0.00014935751,0.00041225285,0.30495524,0.0009187238,0.0060565504,0.06581299,0.0015720818,0.050765637,0.00015132476],"about_ca_topic_score_codex":0.2333023,"about_ca_topic_score_gemma":0.26343563,"teacher_disagreement_score":0.2333023,"about_ca_system_score_codex":0.0015554485,"about_ca_system_score_gemma":0.001595514,"threshold_uncertainty_score":0.46388865},"labels":[],"label_agreement":null},{"id":"W2095227834","doi":"10.1002/ajh.23181","title":"Introductory remarks for the THSNA meeting proceedings: Hemostasis and thrombosis at the cutting edge","year":2012,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hemostasis; Medicine; Multidisciplinary approach; Medical education; Thrombosis; Family medicine; Political science; Internal medicine; Law","score_opus":0.01882364038494134,"score_gpt":0.30327249930597816,"score_spread":0.28444885892103683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095227834","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019675623,0.006939728,0.00056134304,0.31512135,0.65221447,0.00026201984,0.0005931195,0.00025227526,0.023858964],"genre_scores_gemma":[0.0022387814,0.011276966,0.0014855429,0.31005448,0.5153091,0.00061373477,0.00095349905,0.0003155004,0.15775236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997086,0.0007220269,0.0003454452,0.00039570773,0.0011103926,0.00034045303],"domain_scores_gemma":[0.9895013,0.0023360224,0.0005891063,0.00027669244,0.004880236,0.0024166203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051310235,0.0020547672,0.0012772705,0.0018475023,0.003314495,0.006790752,0.0023870412,0.013397872,0.10042386],"category_scores_gemma":[0.020222802,0.0007209854,0.002219961,0.0012104835,0.0011085185,0.0038222459,0.0024795048,0.015623629,0.0749349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014751833,0.0000101546175,0.000022219316,0.000043680946,0.0000013357613,0.000021584223,0.000011769199,0.000007754892,0.000027397658,0.00015035036,0.99657226,0.0031167718],"study_design_scores_gemma":[0.000020591448,0.000027137145,0.00031151623,0.00019009474,0.000007105587,0.000058140722,0.00009518157,0.000025339534,0.00005034185,0.0005388491,0.99866045,0.000015097285],"about_ca_topic_score_codex":0.0041115186,"about_ca_topic_score_gemma":0.007181501,"teacher_disagreement_score":0.10042386,"about_ca_system_score_codex":0.0032456364,"about_ca_system_score_gemma":0.0036891513,"threshold_uncertainty_score":0.33595127},"labels":[],"label_agreement":null},{"id":"W2095402186","doi":"10.1002/ajh.21470","title":"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention","year":2009,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin k; Vitamin K antagonist; Intensive care medicine; Internal medicine; Warfarin","score_opus":0.07649233109302077,"score_gpt":0.39506578345155235,"score_spread":0.3185734523585316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095402186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009483136,0.95762736,0.0007754617,0.020566933,0.001019997,0.0004554037,0.00054929475,0.000026836848,0.009495553],"genre_scores_gemma":[0.0707519,0.91455704,0.0048075896,0.0056608156,0.001936717,0.00062167685,0.0006086,0.000012283368,0.0010434308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940481,0.0026976082,0.0016116059,0.0003166507,0.0011240597,0.00020189522],"domain_scores_gemma":[0.9851403,0.007934382,0.004277128,0.00025930366,0.0019158442,0.00047297322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055071637,0.00037005325,0.0014380703,0.0021613971,0.0004451743,0.0018972902,0.00061558274,0.0013901513,0.0047041443],"category_scores_gemma":[0.038363483,0.00036429407,0.001963608,0.0020575467,0.00038125066,0.0011976555,0.00091868144,0.001630797,0.00054395525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000837856,0.00029620595,0.015941564,0.090926036,0.0015107959,0.00023457846,0.0008102707,0.00030421672,0.00036141256,0.0022319134,0.04243381,0.84411144],"study_design_scores_gemma":[0.001980799,0.0020557372,0.12885767,0.5052228,0.010982244,0.0031130677,0.0012482014,0.0007303691,0.0009835393,0.005432135,0.33925465,0.00013870186],"about_ca_topic_score_codex":0.0047088414,"about_ca_topic_score_gemma":0.007078566,"teacher_disagreement_score":0.0055071637,"about_ca_system_score_codex":0.0013269394,"about_ca_system_score_gemma":0.004923417,"threshold_uncertainty_score":0.029124975},"labels":[],"label_agreement":null},{"id":"W2098169365","doi":"10.1002/ajh.21826","title":"Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort","year":2010,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Anxiety; Psychosocial; Depression (economics); Medicine; Thalassemia; Quality of life (healthcare); Cohort; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.0026935431080394394,"score_gpt":0.2160993894289988,"score_spread":0.21340584632095938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098169365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974727,0.00022416521,0.000041655338,0.001097371,0.00001827066,0.0000112202915,0.00024159646,0.000004325887,0.00088859047],"genre_scores_gemma":[0.998648,0.00021427353,0.00007512517,0.00049837906,0.00006170024,0.000014632272,0.00017106444,0.0000014575052,0.00031551966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996928,0.000113081405,0.00003935388,0.000041928037,0.00007306851,0.00003987291],"domain_scores_gemma":[0.9989599,0.00029356775,0.00029260846,0.000043766355,0.00016522732,0.00024497646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004162603,0.00014688661,0.00026380364,0.0005354561,0.00060184684,0.00047597705,0.00026110766,0.00074617966,0.0015129282],"category_scores_gemma":[0.0020843004,0.00022544556,0.00013835868,0.00063255004,0.00025913428,0.00047855606,0.00019885844,0.0008249768,0.00029201023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005347159,0.00005947356,0.99792504,0.000003302869,0.000008146927,0.00038619371,0.00008833092,0.000009288469,0.0001170362,0.00000836528,0.00042730404,0.0009139034],"study_design_scores_gemma":[0.000013017391,0.000118307136,0.9962947,0.000008434538,0.00001283779,0.002684036,0.0003233463,0.00017049572,0.000031308296,0.000023935503,0.00031445513,0.000005027734],"about_ca_topic_score_codex":0.005024777,"about_ca_topic_score_gemma":0.00737425,"teacher_disagreement_score":0.005024777,"about_ca_system_score_codex":0.0002971389,"about_ca_system_score_gemma":0.0002485164,"threshold_uncertainty_score":0.009991109},"labels":[],"label_agreement":null},{"id":"W2098215007","doi":"10.1002/ajh.24098","title":"Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Public Health Agency; Queen's University Belfast","keywords":"Medicine; Myeloproliferative neoplasm; Internal medicine; Polycythaemia; Myelofibrosis; Quality of life (healthcare); Population; Gastroenterology; Bone marrow","score_opus":0.05208725393675259,"score_gpt":0.3397715469331797,"score_spread":0.28768429299642706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098215007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993869,0.00013593808,0.000020482503,0.000017926835,0.0000033884346,0.0000042961506,0.00012119896,0.0000018202605,0.00030809653],"genre_scores_gemma":[0.9997316,0.00003275457,0.000017586799,0.000009336307,0.000004031358,0.0000043802943,0.00013964472,4.2912006e-7,0.000060237697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996176,0.00009283081,0.000043674172,0.00009927448,0.00008552006,0.00006097423],"domain_scores_gemma":[0.9990971,0.00014125541,0.00039114247,0.00004737202,0.000096040436,0.00022714166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000418758,0.0002762743,0.0004428483,0.00094887527,0.0003082496,0.00054382614,0.0002048996,0.0003846487,0.0018221863],"category_scores_gemma":[0.0021956468,0.00012462556,0.0002418456,0.0005474602,0.0002606286,0.00045762776,0.00063279364,0.00031286923,0.0001944036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005898282,0.00013885526,0.9956529,0.000020933383,0.00009250248,0.00016474852,0.00019421933,0.000039817318,0.00036822414,0.000020355226,0.00010636416,0.002611241],"study_design_scores_gemma":[0.000015638,0.00031638972,0.99896085,0.000003763518,0.000020905552,0.00030042575,0.00017010924,0.00008014176,0.000033353048,0.000016996708,0.00007884918,0.0000026319105],"about_ca_topic_score_codex":0.0017751743,"about_ca_topic_score_gemma":0.0010516684,"teacher_disagreement_score":0.0018221863,"about_ca_system_score_codex":0.00021438143,"about_ca_system_score_gemma":0.000098423516,"threshold_uncertainty_score":0.006095767},"labels":[],"label_agreement":null},{"id":"W2100083745","doi":"10.1002/ajh.24089","title":"Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Magnetic resonance imaging; Anemia; Sickle cell anemia; Transcranial Doppler; Stroke (engine); Clinical trial; Internal medicine; Radiology","score_opus":0.014282315929319318,"score_gpt":0.24310120521185946,"score_spread":0.22881888928254016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100083745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631834,0.0018969884,0.0001795969,0.00014472516,0.000008866047,0.00005396227,0.0007780812,0.000010622529,0.0006087816],"genre_scores_gemma":[0.9962214,0.0006568567,0.0005393385,0.00014685837,0.00003741784,0.00011529212,0.0020257083,0.0000133447575,0.00024364224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899036,0.0005546488,0.000113866074,0.00013311888,0.00014478636,0.000063241496],"domain_scores_gemma":[0.99683833,0.0010233154,0.0011566508,0.00029823018,0.00036434547,0.00031914888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002768666,0.00032984756,0.000742186,0.00017423306,0.00019324098,0.0005582333,0.00022130937,0.0004939768,0.0006001507],"category_scores_gemma":[0.0057584993,0.00017646796,0.00035977128,0.00037361003,0.00028130255,0.000518644,0.00028958463,0.0006204217,0.00017945438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100514196,0.00073290674,0.834834,0.00048790884,0.0020934138,0.00020607922,0.00048538524,0.000738305,0.006013031,0.00016000668,0.0031353193,0.05059951],"study_design_scores_gemma":[0.0067647113,0.016057052,0.96935064,0.000113515234,0.0016258417,0.00064737507,0.00014964904,0.0007225935,0.0022478302,0.00017047809,0.0021174124,0.000032838878],"about_ca_topic_score_codex":0.0011830088,"about_ca_topic_score_gemma":0.002047936,"teacher_disagreement_score":0.002768666,"about_ca_system_score_codex":0.0003329301,"about_ca_system_score_gemma":0.00028181152,"threshold_uncertainty_score":0.014642298},"labels":[],"label_agreement":null},{"id":"W2100618811","doi":"10.1002/ajh.1142","title":"Hemoglobin H (Hb H) disease in Canada: Molecular diagnosis and review of 116 cases","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Hydrops fetalis; Vietnamese; Compound heterozygosity; Disease; Genetics; Point mutation; Population; Medicine; Hemoglobinopathy; Gene; Biology; Mutation; Internal medicine; Pregnancy; Fetus","score_opus":0.006932173537876715,"score_gpt":0.25130158236865874,"score_spread":0.244369408830782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100618811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41983968,0.5407437,0.001522013,0.0024671985,0.0005286903,0.00023744936,0.0032906223,0.00023804045,0.031132616],"genre_scores_gemma":[0.5336626,0.45430574,0.0024741732,0.0010668875,0.00031176698,0.000051938823,0.003745377,0.00005950444,0.004321997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936074,0.000027580903,0.00010094757,0.000090348265,0.0003042376,0.00011616225],"domain_scores_gemma":[0.998811,0.00025019175,0.00020688736,0.000049775048,0.000450706,0.00023138401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033198684,0.00085747207,0.00042862396,0.007877302,0.0017112732,0.0011874269,0.0017013364,0.0008564036,0.0018850887],"category_scores_gemma":[0.0019010765,0.00044719692,0.00028425033,0.009393322,0.0013862844,0.00049180904,0.00067061506,0.000514066,0.00065566105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036685506,0.00015007005,0.2448988,0.0033005527,0.00019050458,0.16284968,0.00282264,0.0008000008,0.0070646736,0.00090976316,0.03454654,0.54209995],"study_design_scores_gemma":[0.000046042023,0.00013017333,0.41885298,0.0023708905,0.00032240615,0.4570016,0.0030233578,0.00047433094,0.002401424,0.00038013916,0.114889964,0.00010675087],"about_ca_topic_score_codex":0.5679408,"about_ca_topic_score_gemma":0.5622117,"teacher_disagreement_score":0.43205923,"about_ca_system_score_codex":0.006822724,"about_ca_system_score_gemma":0.009301361,"threshold_uncertainty_score":0.86920744},"labels":[],"label_agreement":null},{"id":"W2103541791","doi":"10.1002/ajh.24082","title":"Gray zone lymphoma with features intermediate between classical<scp>H</scp>odgkin lymphoma and diffuse large<scp>B</scp>‐cell lymphoma:<scp>C</scp>haracteristics, outcomes, and prognostication among a large multicenter cohort","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Internal medicine; Rituximab; CHOP; Gastroenterology; Hazard ratio; Dacarbazine; Oncology; Lymphoma; Prednisone; Cyclophosphamide; Diffuse large B-cell lymphoma; B symptoms; Surgery; Chemotherapy; Confidence interval","score_opus":0.008092142052280111,"score_gpt":0.24796022870251758,"score_spread":0.23986808665023746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103541791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99987733,0.000025223826,0.000013047019,0.0000041906246,4.5073875e-7,0.0000028708807,0.000023813143,7.107325e-7,0.00005234075],"genre_scores_gemma":[0.99984086,0.000013834211,0.000018911524,0.000009275503,0.0000027929316,0.0000028057407,0.0000773571,4.9505707e-7,0.000033653912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998394,0.000031416424,0.000014980814,0.00005125659,0.000021268486,0.00004159421],"domain_scores_gemma":[0.9997116,0.000034614466,0.00009325117,0.000022248109,0.000020325364,0.00011796453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024965944,0.00020797252,0.00018217006,0.00047948892,0.0003148438,0.00037498592,0.00015585792,0.00022949597,0.0010753326],"category_scores_gemma":[0.00048970117,0.00018546787,0.00012489644,0.00031370498,0.00026301856,0.00035466332,0.0004083159,0.00021258228,0.00017657231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009476789,0.000020700818,0.9982584,0.000001999196,0.000007918422,0.00019721473,0.000044125325,0.00001028707,0.00068866945,0.00000480965,0.000029384948,0.0006417128],"study_design_scores_gemma":[0.000017946102,0.00019111573,0.99717283,0.0000023850696,0.000011804458,0.001979921,0.000225737,0.0000960087,0.0001404861,0.000010553512,0.0001492755,0.0000018421605],"about_ca_topic_score_codex":0.0014821388,"about_ca_topic_score_gemma":0.0022104417,"teacher_disagreement_score":0.0014821388,"about_ca_system_score_codex":0.00023856196,"about_ca_system_score_gemma":0.00015848789,"threshold_uncertainty_score":0.0035973191},"labels":[],"label_agreement":null},{"id":"W2112472918","doi":"10.1002/ajh.20145","title":"Cavernous sinus thrombosis presenting with diplopia in an allogeneic bone marrow transplant recipient","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Diplopia; Thrombosis; Autopsy; Surgery; Bone marrow transplant; Cavernous sinus; Bone marrow; Radiological weapon; Radiology; Transplantation; Bone marrow transplantation; Pathology","score_opus":0.01606951148575644,"score_gpt":0.27424067262381535,"score_spread":0.25817116113805894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112472918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951663,0.0008140967,0.00058914535,0.0005574061,0.00006101921,0.0000496917,0.000066302855,0.000045570585,0.0026504567],"genre_scores_gemma":[0.9986112,0.00050239614,0.0002729198,0.00016023057,0.00013735813,0.000008920518,0.000036892165,0.0000062282616,0.000263777],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99967635,0.000050031475,0.000033962286,0.00004830219,0.000059245795,0.0001320858],"domain_scores_gemma":[0.9991061,0.00029706914,0.00019290438,0.000050420782,0.00003986817,0.00031350311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031646193,0.0011381578,0.0007055619,0.0016568485,0.0013520289,0.0008980848,0.0008597784,0.0025941394,0.0014026486],"category_scores_gemma":[0.0021148217,0.0006838053,0.00047302007,0.0012256602,0.0011289755,0.000822203,0.00076346577,0.002017361,0.0004118045],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009611699,0.0001048597,0.030805156,0.000022193855,0.000014497579,0.9654199,0.0001810977,0.00013327989,0.0012686289,0.000111806665,0.00026447495,0.0015779189],"study_design_scores_gemma":[0.000028985329,0.00026619,0.020510722,0.0000116947585,0.000018285577,0.97807133,0.00016311348,0.00031390582,0.0003146362,0.00008977708,0.00019825056,0.000013133644],"about_ca_topic_score_codex":0.0030948895,"about_ca_topic_score_gemma":0.0034364033,"teacher_disagreement_score":0.0030948895,"about_ca_system_score_codex":0.00073893083,"about_ca_system_score_gemma":0.0006723938,"threshold_uncertainty_score":0.0061537623},"labels":[],"label_agreement":null},{"id":"W2120300273","doi":"10.1002/ajh.23805","title":"Silent cerebral infarction, income, and grade retention among students with sickle cell anemia","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Quartile; Medicine; Demography; Anemia; Logistic regression; Psychological intervention; Sickle cell anemia; Educational attainment; Household income; Odds ratio; Pediatrics; Gerontology; Internal medicine; Confidence interval; Psychiatry","score_opus":0.003714131595690591,"score_gpt":0.229604361980888,"score_spread":0.2258902303851974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120300273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998466,0.00003231028,0.000014225942,0.00001611133,0.0000010678497,0.0000014245459,0.000030367262,6.345853e-7,0.00005718099],"genre_scores_gemma":[0.99984276,0.000025056805,0.000014216937,0.0000071560644,0.0000043359128,0.0000018233255,0.000069407295,3.233713e-7,0.000034944005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996592,0.000119664284,0.000031313404,0.000040923227,0.00006163762,0.000087270506],"domain_scores_gemma":[0.99793565,0.00039280587,0.001008886,0.00007469852,0.00012349068,0.00046443817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078101916,0.00022891969,0.0002702889,0.00063662976,0.00031764532,0.0005211428,0.0003181703,0.00031433694,0.0013230477],"category_scores_gemma":[0.0031575644,0.000194051,0.00027530824,0.00053454685,0.00034069218,0.00040990885,0.00040465832,0.00057528605,0.00020281786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041137457,0.000032007494,0.9995332,0.0000015495455,0.000008801801,0.000015987356,0.000025344294,0.0000095207015,0.000027557184,0.0000037508714,0.000016690066,0.00028453793],"study_design_scores_gemma":[0.000004006703,0.00013692591,0.999529,0.000002495546,0.000009447364,0.00005944379,0.00009680321,0.00010591506,0.000026241503,0.00000932325,0.000019256475,0.000001226557],"about_ca_topic_score_codex":0.0041256,"about_ca_topic_score_gemma":0.005300944,"teacher_disagreement_score":0.0041256,"about_ca_system_score_codex":0.00019393631,"about_ca_system_score_gemma":0.00024555577,"threshold_uncertainty_score":0.008203149},"labels":[],"label_agreement":null},{"id":"W2125406455","doi":"10.1002/ajh.20236","title":"Compound heterozygosity for a novel nine-nucleotide deletion and the Asn45Ser missense mutation in the glycoprotein IX gene in a patient with Bernard-Soulier syndrome","year":2004,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Bernard–Soulier syndrome; Compound heterozygosity; Missense mutation; Mutation; Genetics; Molecular biology; Biology; Asparagine; Gene; Point mutation; Platelet membrane glycoprotein; Glycoprotein; Amino acid","score_opus":0.007550369079298915,"score_gpt":0.24034967625414705,"score_spread":0.23279930717484815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125406455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971084,0.00035466987,0.00079749187,0.00032889497,0.000045950048,0.00002388905,0.00009645217,0.00004309015,0.0012011161],"genre_scores_gemma":[0.99866045,0.00013117967,0.0005407549,0.00009670959,0.000045620036,0.000005392588,0.00005447214,0.000011952153,0.0004534497],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996369,0.000057165238,0.000039524315,0.00012125032,0.00008208707,0.000063014195],"domain_scores_gemma":[0.9994992,0.00017532153,0.00011615263,0.000017965647,0.000025455996,0.00016583539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000270999,0.0015024216,0.00070650654,0.00093948725,0.0009004621,0.00047744636,0.00033396768,0.0016993111,0.0018321171],"category_scores_gemma":[0.0012188258,0.00039975022,0.00030520165,0.00063813897,0.00090337836,0.00043465203,0.0004837342,0.000713285,0.00035806268],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034234568,0.00013267748,0.020188864,0.00006665866,0.000071724324,0.912134,0.0011537673,0.00034758734,0.05765089,0.0013418045,0.00058286084,0.005986854],"study_design_scores_gemma":[0.000096584336,0.00057080516,0.031436004,0.000018616292,0.00009135504,0.9521636,0.00021645433,0.0009750339,0.011804635,0.00063014845,0.001957815,0.000039020175],"about_ca_topic_score_codex":0.00087069056,"about_ca_topic_score_gemma":0.00082299113,"teacher_disagreement_score":0.0018321171,"about_ca_system_score_codex":0.00032023812,"about_ca_system_score_gemma":0.00033526766,"threshold_uncertainty_score":0.006129086},"labels":[],"label_agreement":null},{"id":"W2127359693","doi":"10.1002/ajh.20518","title":"Isolated pulmonary amyloidosis: Case report and review of the literature","year":2006,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Amyloidosis; Medicine; Intensive care medicine; Dermatology; Pathology","score_opus":0.003966870314583004,"score_gpt":0.24881852142103272,"score_spread":0.2448516511064497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127359693","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45747462,0.4983666,0.006911764,0.005503661,0.004388776,0.00043720097,0.0008939234,0.0006644304,0.02535903],"genre_scores_gemma":[0.73760116,0.23801109,0.0039694887,0.00392829,0.0100172,0.00017194379,0.00075499876,0.00007948208,0.0054663485],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99946994,0.00006461819,0.00013468126,0.00012680424,0.000097080105,0.00010687859],"domain_scores_gemma":[0.9988587,0.00038986278,0.00028031744,0.000080926286,0.00014334416,0.0002468142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004173104,0.0011925634,0.0014793307,0.0041269856,0.00081588555,0.0012766789,0.0017476045,0.0023697456,0.003864755],"category_scores_gemma":[0.0017848739,0.0005121026,0.0005692068,0.002857807,0.0010033285,0.001816765,0.0007313531,0.000826896,0.002814043],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011235785,0.0003090995,0.012417415,0.0013952159,0.0001378345,0.91337425,0.00036563698,0.00021461437,0.0020631696,0.00018717747,0.008909005,0.06051422],"study_design_scores_gemma":[0.000028208824,0.000100721954,0.008444672,0.00020977325,0.00008550533,0.98061633,0.00025120442,0.00013910038,0.0002466687,0.00020796263,0.009644203,0.000025597934],"about_ca_topic_score_codex":0.00082347513,"about_ca_topic_score_gemma":0.001491143,"teacher_disagreement_score":0.0041269856,"about_ca_system_score_codex":0.00048699198,"about_ca_system_score_gemma":0.0006862041,"threshold_uncertainty_score":0.012928903},"labels":[],"label_agreement":null},{"id":"W2130548892","doi":"10.1002/ajh.21781","title":"Necrosis following skull base irradiation and stem cell transplant for multiple myeloma","year":2010,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Multiple myeloma; Skull; Necrosis; Medicine; Stem cell; Pathology; Immunology; Surgery; Biology","score_opus":0.014132465732123279,"score_gpt":0.28194197702822843,"score_spread":0.26780951129610514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130548892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734779,0.0063294047,0.0013521014,0.0024060544,0.0005646902,0.00028078526,0.000322755,0.00025068122,0.015015608],"genre_scores_gemma":[0.9955065,0.0014178574,0.00025021227,0.0009987628,0.0003752028,0.000022544395,0.00017155918,0.000017349003,0.0012398981],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99970263,0.000025576337,0.000027584629,0.00005672021,0.00007796628,0.00010956038],"domain_scores_gemma":[0.9992471,0.00011733976,0.00019608704,0.000072900104,0.000054130654,0.00031260063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026379808,0.0008782776,0.0010775133,0.0017842785,0.0016430614,0.0009972883,0.00067600777,0.0018954212,0.001974729],"category_scores_gemma":[0.0012804157,0.00053684483,0.0010621703,0.0012922918,0.0008239555,0.0006413107,0.0007751878,0.0020693687,0.00097164186],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023341467,0.00009083202,0.011812377,0.000032511525,0.000033333497,0.9826972,0.00009393447,0.00008419686,0.0015749052,0.00010301661,0.0003127493,0.0029314323],"study_design_scores_gemma":[0.00009568923,0.0005108756,0.034135617,0.00003886375,0.00006465902,0.96141773,0.00015535318,0.0005382872,0.0012533984,0.0002539785,0.0015214381,0.000014170945],"about_ca_topic_score_codex":0.002396625,"about_ca_topic_score_gemma":0.0037009616,"teacher_disagreement_score":0.002396625,"about_ca_system_score_codex":0.0021001427,"about_ca_system_score_gemma":0.0008583921,"threshold_uncertainty_score":0.015237629},"labels":[],"label_agreement":null},{"id":"W2132432381","doi":"10.1002/ajh.24223","title":"Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Statistic; Oncology; Population; Anthracycline; Framingham Risk Score; Disease; Lymphoma; Cancer; Clinical trial; Statistics; Mathematics; Breast cancer","score_opus":0.009678997285731131,"score_gpt":0.24355383513251344,"score_spread":0.2338748378467823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132432381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801994,0.0007538523,0.01688573,0.0005733485,0.000023028138,0.000039352057,0.0009432158,0.00014984974,0.0004323792],"genre_scores_gemma":[0.9953982,0.00010605338,0.00318679,0.0000666602,0.000021169048,0.000022662955,0.0010487287,0.000011787406,0.0001380407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989349,0.0005972064,0.00005480062,0.0002261357,0.00010674888,0.00008025503],"domain_scores_gemma":[0.99640876,0.0023991815,0.00062477466,0.00027186092,0.0001421489,0.0001532453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003427841,0.00054652937,0.00074924965,0.0007962848,0.00018441,0.0009542647,0.00060683925,0.0004896268,0.0004564275],"category_scores_gemma":[0.008089807,0.00022538968,0.0008056198,0.0005126836,0.00020631247,0.0004053229,0.0006422128,0.0011258546,0.00014871563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011906072,0.0001617312,0.82864136,0.00004437563,0.00052974554,0.00022234098,0.000096960415,0.11716165,0.0006471747,0.00041178716,0.001537784,0.049354542],"study_design_scores_gemma":[0.00012715884,0.00044276856,0.21960512,0.000023844568,0.0002332234,0.00036934522,0.000065411456,0.7739174,0.00078895036,0.00302043,0.0013604587,0.000045824487],"about_ca_topic_score_codex":0.0033756143,"about_ca_topic_score_gemma":0.0033759577,"teacher_disagreement_score":0.003427841,"about_ca_system_score_codex":0.00055127323,"about_ca_system_score_gemma":0.0005630809,"threshold_uncertainty_score":0.018128395},"labels":[],"label_agreement":null},{"id":"W2132940313","doi":"10.1002/ajh.24018","title":"Non–injection‐site necrotic skin lesions complicating postoperative heparin thromboprophylaxis","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Thrombosis; Complication; Rash; Thrombus; Surgery; Coagulopathy; Amputation; Necrosis; Anticoagulant; Internal medicine","score_opus":0.03589062673312375,"score_gpt":0.32067901952675026,"score_spread":0.2847883927936265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132940313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97763467,0.004668713,0.0024864278,0.0020457818,0.00039187886,0.00039416616,0.00018034432,0.00015831766,0.012039741],"genre_scores_gemma":[0.9963605,0.0010499217,0.00037155836,0.00080259895,0.00035971243,0.00002881908,0.0000643269,0.000008924143,0.00095358444],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996785,0.000045325032,0.000036397323,0.00006308249,0.000052679043,0.00012404022],"domain_scores_gemma":[0.9991173,0.0002931898,0.00018353508,0.00006981909,0.00004758643,0.00028852434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031592627,0.0013737752,0.0008764058,0.0009747215,0.0010739865,0.000790384,0.0006790209,0.002323136,0.0022150595],"category_scores_gemma":[0.002076714,0.0006351643,0.00065213814,0.000733983,0.00068095204,0.00074240845,0.00042168322,0.0019156403,0.00060268864],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013101091,0.00016694103,0.014414403,0.000045738747,0.000014532797,0.98165053,0.00007522807,0.00009395566,0.00092014496,0.00007175431,0.00026123147,0.0021545282],"study_design_scores_gemma":[0.000090009235,0.0007521536,0.032038327,0.00004177296,0.000033576882,0.96488047,0.00013093631,0.0006726135,0.00057011767,0.00014170194,0.00063361874,0.0000146895545],"about_ca_topic_score_codex":0.0010036161,"about_ca_topic_score_gemma":0.0017351947,"teacher_disagreement_score":0.002323136,"about_ca_system_score_codex":0.0005163582,"about_ca_system_score_gemma":0.0004259792,"threshold_uncertainty_score":0.007410109},"labels":[],"label_agreement":null},{"id":"W2136426334","doi":"10.1002/ajh.24204","title":"Rituximab with high‐dose methotrexate in primary central nervous system lymphoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Rituximab; Methotrexate; Lymphoma; Dosing; Internal medicine; Chemotherapy; Retrospective cohort study; Surgery; Gastroenterology","score_opus":0.01188359765193602,"score_gpt":0.25186790290450295,"score_spread":0.23998430525256692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136426334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9269268,0.06761765,0.00051840645,0.00038731456,0.000087186636,0.00012573363,0.00014791451,0.000029870933,0.0041591185],"genre_scores_gemma":[0.9885794,0.010169219,0.000199963,0.00037884695,0.00013695723,0.000032386066,0.00016754988,0.0000049458004,0.0003307098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922574,0.00039815548,0.00007420092,0.00011869707,0.00010587747,0.000077260716],"domain_scores_gemma":[0.9989158,0.00035005593,0.0003428336,0.00013962714,0.000085043524,0.00016665662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093845575,0.0001304246,0.00053328124,0.00031652473,0.00026450705,0.00060598244,0.00029714825,0.0004424645,0.0010171017],"category_scores_gemma":[0.002173367,0.00018196658,0.00033966187,0.00074291555,0.00042000087,0.00030818465,0.0003664697,0.00042699598,0.00034613314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004275099,0.0003797802,0.857179,0.0009915564,0.0006494327,0.010177887,0.00025016093,0.0003131769,0.003183427,0.00014748014,0.0026646503,0.11978838],"study_design_scores_gemma":[0.0008982206,0.007764017,0.8980765,0.00065272977,0.0011716732,0.07304093,0.00035447595,0.00062917237,0.0017256989,0.0002640021,0.01540206,0.00002061598],"about_ca_topic_score_codex":0.002042373,"about_ca_topic_score_gemma":0.0034072336,"teacher_disagreement_score":0.002042373,"about_ca_system_score_codex":0.00068746385,"about_ca_system_score_gemma":0.00055222434,"threshold_uncertainty_score":0.004987955},"labels":[],"label_agreement":null},{"id":"W2136749314","doi":"10.1002/ajh.20253","title":"Intravascular T-cell lymphoma with bowel involvement: Case report and literature review","year":2005,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lymphoma; Abdomen; Immunophenotyping; Abdominal pain; Laparotomy; Autopsy; Pathology; Surgery; Immunology","score_opus":0.00534744552747374,"score_gpt":0.2481279740461677,"score_spread":0.24278052851869397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136749314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4955281,0.4497054,0.009084902,0.0041669244,0.0025944123,0.0009380365,0.0011533542,0.0007125906,0.03611622],"genre_scores_gemma":[0.79807943,0.18383159,0.004953646,0.0024861232,0.004903775,0.00025183512,0.0009666827,0.000057584617,0.0044691833],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99948126,0.00006347571,0.00015651947,0.0000948942,0.00007735472,0.00012655498],"domain_scores_gemma":[0.9990527,0.0002515527,0.00035484094,0.000060342896,0.000109356726,0.00017130669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003099423,0.0014608741,0.0010989389,0.0057853484,0.0010319405,0.0013949509,0.0016420034,0.00238678,0.0030649316],"category_scores_gemma":[0.0012035558,0.0004897999,0.0005310238,0.004494487,0.0010885311,0.0018304364,0.0010148261,0.000978625,0.0025447153],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000584777,0.0001917282,0.017119467,0.001192981,0.00006558724,0.92795104,0.0004214633,0.0002430975,0.0017145055,0.00023371927,0.0056072166,0.045200754],"study_design_scores_gemma":[0.000014723227,0.000057409125,0.009884002,0.00034448135,0.000065178494,0.9770653,0.0003241502,0.00015946582,0.00032468265,0.00015743659,0.011580792,0.00002232636],"about_ca_topic_score_codex":0.0014052925,"about_ca_topic_score_gemma":0.0019340483,"teacher_disagreement_score":0.0057853484,"about_ca_system_score_codex":0.0007882696,"about_ca_system_score_gemma":0.00081982306,"threshold_uncertainty_score":0.010253191},"labels":[],"label_agreement":null},{"id":"W2137499479","doi":"10.1002/ajh.10009","title":"Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T‐cell lymphoma: Case study and review","year":2001,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lymphoma; Autologous stem-cell transplantation; Lymphoproliferative disorders; Transplantation; Stem cell; Peripheral T-cell lymphoma; Chemotherapy; T-cell lymphoma; Aggressive lymphoma; Oncology; Internal medicine; Immunology; T cell; Rituximab; Immune system; Biology","score_opus":0.014032784262379428,"score_gpt":0.29158919180393983,"score_spread":0.2775564075415604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137499479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49455673,0.46098754,0.009027645,0.0033948235,0.0018400496,0.00033599843,0.00036243888,0.00037981456,0.029115064],"genre_scores_gemma":[0.7609779,0.22463603,0.004386929,0.0022003427,0.0035185895,0.00010765477,0.00032119016,0.0000460214,0.003805319],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996201,0.00006943619,0.000111580965,0.000056859368,0.00007319697,0.00006891154],"domain_scores_gemma":[0.9993593,0.0003047828,0.0001412068,0.000041584743,0.0000690482,0.00008406616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004057801,0.00077988347,0.00093317736,0.0021143348,0.00060470967,0.0010241775,0.000970533,0.002264853,0.0018601046],"category_scores_gemma":[0.001113794,0.00027578216,0.00048051728,0.0014838701,0.0007959635,0.0010350621,0.0003574009,0.0007868313,0.0013884697],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006434035,0.00012923147,0.009875183,0.0009063494,0.000057945894,0.94752324,0.0002581985,0.00012858213,0.0023739925,0.0002469607,0.0024451793,0.03599077],"study_design_scores_gemma":[0.000008108093,0.00007241608,0.004101168,0.00010238986,0.00004609447,0.9890842,0.00015176479,0.00010835399,0.0004600712,0.00008002592,0.0057749567,0.000010414166],"about_ca_topic_score_codex":0.00058662024,"about_ca_topic_score_gemma":0.0007505267,"teacher_disagreement_score":0.002264853,"about_ca_system_score_codex":0.00034775797,"about_ca_system_score_gemma":0.0005774744,"threshold_uncertainty_score":0.0062226653},"labels":[],"label_agreement":null},{"id":"W2148765840","doi":"10.1002/ajh.23623","title":"Haptoglobin testing in hemolysis: Measurement and interpretation","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haptoglobin; Hemolysis; False positive paradox; Medicine; Gold standard (test); Immunology; Intensive care medicine; Internal medicine; Computer science; Artificial intelligence","score_opus":0.029832926257660746,"score_gpt":0.3126879756436792,"score_spread":0.2828550493860184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148765840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018533811,0.99661046,0.0005521266,0.000723348,0.0003824823,0.000016624543,0.000027711789,0.000014791338,0.0014870685],"genre_scores_gemma":[0.00195261,0.9955605,0.001105471,0.0004378991,0.00038974176,0.000018014489,0.00005092414,0.000004381284,0.00048036143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883574,0.00029719842,0.00024630062,0.000117196534,0.0004539668,0.000049457547],"domain_scores_gemma":[0.99775094,0.0011475425,0.00031805577,0.000060051538,0.00065754214,0.00006590328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018721465,0.0011133654,0.0015924332,0.0054410035,0.00031000937,0.0014342566,0.0011359341,0.0014447937,0.0021980864],"category_scores_gemma":[0.0040883045,0.0003263253,0.00068965,0.0033027804,0.0010278916,0.0016465207,0.00076667004,0.0018576371,0.0015950553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007259245,0.00006138976,0.0016363711,0.024177529,0.00015684917,0.00081826403,0.00017473711,0.00029255872,0.0014332877,0.0032664202,0.038077336,0.92983276],"study_design_scores_gemma":[0.000023825864,0.00012281716,0.006462265,0.027075104,0.00038746712,0.01982838,0.0004009126,0.00030186132,0.0019081198,0.0058164936,0.9376108,0.000061946215],"about_ca_topic_score_codex":0.0013271556,"about_ca_topic_score_gemma":0.0016621224,"teacher_disagreement_score":0.0054410035,"about_ca_system_score_codex":0.000716613,"about_ca_system_score_gemma":0.0013275241,"threshold_uncertainty_score":0.009900987},"labels":[],"label_agreement":null},{"id":"W2150604072","doi":"10.1002/ajh.23728","title":"Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Bristol-Myers Squibb","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Dasatinib; Nilotinib; Nausea; Adverse effect; Gastroenterology; Myeloid leukemia; Oncology; Rash; Tyrosine-kinase inhibitor; Cancer","score_opus":0.010508573516696769,"score_gpt":0.2926125195130662,"score_spread":0.28210394599636945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150604072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925195,0.003214944,0.0008319627,0.00011266964,0.000025162326,0.00012880538,0.0009951202,0.00005152443,0.0021202802],"genre_scores_gemma":[0.997127,0.0002584136,0.00016550934,0.00008851325,0.000030753807,0.00009412136,0.0016436409,0.000007267134,0.0005846919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910283,0.00022886836,0.00011406269,0.00012297895,0.00021748424,0.00021378211],"domain_scores_gemma":[0.9974994,0.0005851708,0.0008230389,0.00021176755,0.0005080916,0.00037260138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032886127,0.00048907,0.0016526727,0.0006156948,0.0007705454,0.00074682315,0.00038528306,0.0006278038,0.0014951029],"category_scores_gemma":[0.0030758858,0.00016557414,0.0010880915,0.0005253667,0.00029346012,0.0006244616,0.00038874685,0.0010704354,0.0005710002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07072018,0.0032014046,0.6728738,0.0004703967,0.0013321749,0.0024423406,0.0007723556,0.0029046708,0.043111786,0.00015159769,0.003004391,0.19901489],"study_design_scores_gemma":[0.001223015,0.026378332,0.9567372,0.000037911832,0.0008791213,0.0016546177,0.00008657191,0.0012855539,0.008474256,0.00010856139,0.0030847983,0.000050092087],"about_ca_topic_score_codex":0.0007291632,"about_ca_topic_score_gemma":0.0008612908,"teacher_disagreement_score":0.0032886127,"about_ca_system_score_codex":0.000513162,"about_ca_system_score_gemma":0.00033713516,"threshold_uncertainty_score":0.01739204},"labels":[],"label_agreement":null},{"id":"W2152551343","doi":"10.1002/ajh.23582","title":"Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Covis Pharma; McGill University","keywords":"Ferumoxytol; Clinical endpoint; Medicine; Placebo; Anemia; Adverse effect; Hemoglobin; Iron-deficiency anemia; Internal medicine; Gastroenterology; Iron deficiency; Randomized controlled trial; Pathology; Magnetic resonance imaging","score_opus":0.008095242062402119,"score_gpt":0.2712025239910979,"score_spread":0.26310728192869576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152551343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758185,0.009231934,0.00053334516,0.0004324243,0.00012378357,0.00043257486,0.00018424906,0.000029177021,0.0014508019],"genre_scores_gemma":[0.9961313,0.001902011,0.0005841687,0.00038543687,0.00016808695,0.00021758623,0.00016473308,0.000003711025,0.00044287334],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965763,0.00018692149,0.000030012181,0.000041103554,0.000044061486,0.000040229737],"domain_scores_gemma":[0.99938166,0.00024061733,0.00018710937,0.000023667386,0.000044033066,0.000122827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010503863,0.00035627827,0.00095527945,0.00016448364,0.000191987,0.00030312277,0.00021954438,0.00096664234,0.001219263],"category_scores_gemma":[0.001497121,0.00018383504,0.0007015931,0.00012110955,0.00030059458,0.00029678558,0.00014030421,0.0009580097,0.00021316338],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63724035,0.012367592,0.0069122813,0.0011808316,0.00080338935,0.00022830485,0.00020489543,0.00061154616,0.04006743,0.00022353785,0.0014079445,0.29875192],"study_design_scores_gemma":[0.3036573,0.6493077,0.031904757,0.00022303991,0.00083139073,0.00051322056,0.00009958105,0.0015056013,0.008401732,0.00022834472,0.0032976603,0.00002975725],"about_ca_topic_score_codex":0.00028763292,"about_ca_topic_score_gemma":0.00048618214,"teacher_disagreement_score":0.001219263,"about_ca_system_score_codex":0.000253451,"about_ca_system_score_gemma":0.00026820268,"threshold_uncertainty_score":0.0055550337},"labels":[],"label_agreement":null},{"id":"W2157580101","doi":"10.1002/ajh.23287","title":"Immune thrombocytopenia: Getting back to basics","year":2012,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Splenectomy; Rituximab; Thrombocytopenic purpura; Immune system; Immune thrombocytopenia; Immunology; Pediatrics; Platelet; Antibody; Spleen","score_opus":0.016265217894813878,"score_gpt":0.2846585623433377,"score_spread":0.2683933444485238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157580101","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006823863,0.8047189,0.0014122756,0.15017849,0.03390258,0.000016123902,0.00010596346,0.00017723045,0.008805989],"genre_scores_gemma":[0.010150343,0.7993502,0.0018433928,0.097647354,0.0838383,0.000038228238,0.00017232222,0.000121141646,0.006838727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977597,0.00067676196,0.0002204893,0.00027442587,0.00085963577,0.00020892356],"domain_scores_gemma":[0.99167144,0.0047430024,0.00030166213,0.00036167057,0.0019735312,0.0009487764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00399046,0.0010303677,0.0015730627,0.0025820264,0.001349521,0.0050075036,0.001533549,0.00555042,0.010760477],"category_scores_gemma":[0.012726266,0.00039383565,0.0006892778,0.0012335323,0.005700945,0.00921879,0.0024838522,0.016527858,0.005771336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022326598,0.00014913626,0.0011655616,0.0028526376,0.000080122045,0.0012567966,0.0009040005,0.0002172509,0.0007350572,0.046589043,0.5000626,0.44576454],"study_design_scores_gemma":[0.000028393464,0.00009990897,0.0006725099,0.0045368522,0.000032170607,0.003414437,0.0006564287,0.00011514761,0.00020655374,0.06670539,0.92348385,0.00004838129],"about_ca_topic_score_codex":0.0016925008,"about_ca_topic_score_gemma":0.0017321934,"teacher_disagreement_score":0.010760477,"about_ca_system_score_codex":0.0029066175,"about_ca_system_score_gemma":0.0024519674,"threshold_uncertainty_score":0.03599739},"labels":[],"label_agreement":null},{"id":"W2163744485","doi":"10.1002/ajh.24060","title":"Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences","keywords":"Depression (economics); Repeatable Battery for the Assessment of Neuropsychological Status; Beck Depression Inventory; Medicine; Internal medicine; Thrombotic thrombocytopenic purpura; Montreal Cognitive Assessment; Psychiatry; Cognition; Neuropsychology; Pediatrics; Cognitive impairment; Psychology; Anxiety; Platelet","score_opus":0.019180272897131517,"score_gpt":0.285127697248539,"score_spread":0.26594742435140745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163744485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991617,0.00024736064,0.000021078073,0.000046288147,0.0000037827106,0.000006630607,0.00004847386,0.000001772855,0.000462876],"genre_scores_gemma":[0.9996325,0.00013666273,0.00001621424,0.00003554475,0.00000797147,0.0000023870568,0.00006324716,4.199213e-7,0.00010498319],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99970514,0.00006288078,0.000036878944,0.00003726512,0.0000702872,0.000087518645],"domain_scores_gemma":[0.9993249,0.00009549447,0.0003625009,0.000027010847,0.000066470355,0.00012362134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035755424,0.00016701852,0.00029782098,0.0005278863,0.0005023937,0.00044100397,0.00019860736,0.00027260857,0.000635973],"category_scores_gemma":[0.0015414746,0.000120817145,0.00019205785,0.0004902058,0.00028368342,0.00027226622,0.00031884472,0.00045606043,0.00018749307],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026027183,0.00007822474,0.99213505,0.000013993978,0.000032033575,0.0018164187,0.00023215626,0.00002954163,0.0003213254,0.000011220879,0.00015269704,0.00491709],"study_design_scores_gemma":[0.000006287543,0.000083783714,0.9977062,0.0000049785444,0.000008280771,0.001866836,0.00016258431,0.000036480735,0.000036774254,0.000009837974,0.00007566759,0.0000022631418],"about_ca_topic_score_codex":0.005867435,"about_ca_topic_score_gemma":0.008081256,"teacher_disagreement_score":0.005867435,"about_ca_system_score_codex":0.00045509613,"about_ca_system_score_gemma":0.00027818847,"threshold_uncertainty_score":0.011666536},"labels":[],"label_agreement":null},{"id":"W2174145330","doi":"10.1002/ajh.24240","title":"Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open‐label, 6‐month extension study","year":2015,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Covis Pharma; McGill University","keywords":"Ferumoxytol; Medicine; Anemia; Iron-deficiency anemia; Transferrin saturation; Internal medicine; Placebo; Iron deficiency; Kidney disease; Gastroenterology; Ferritin; Adverse effect","score_opus":0.031461872049836,"score_gpt":0.30947648988227017,"score_spread":0.2780146178324342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174145330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8676035,0.07862068,0.0018285691,0.03046193,0.011456657,0.0026760518,0.002824071,0.00021623568,0.004312344],"genre_scores_gemma":[0.9299448,0.01826752,0.0029700943,0.026798343,0.014853303,0.0013167665,0.0013832415,0.000057354926,0.004408639],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928385,0.00036113305,0.000092181755,0.00008653046,0.0001272147,0.00004910231],"domain_scores_gemma":[0.99396944,0.003047482,0.0012163759,0.0002281872,0.0009000302,0.0006383673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056454916,0.0005805226,0.0021655373,0.00016489367,0.000412191,0.0009072035,0.0007932444,0.0026110564,0.0035586315],"category_scores_gemma":[0.0056437813,0.00031249187,0.0014445267,0.0002230877,0.0005683221,0.00079970935,0.00017911778,0.0035778827,0.0006706518],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67137164,0.01829217,0.012215402,0.008526294,0.0048505845,0.0015241296,0.00045805197,0.0006625807,0.014827029,0.00038143343,0.051910356,0.21498036],"study_design_scores_gemma":[0.56907696,0.31594887,0.04338758,0.0011888478,0.0075328704,0.0017336276,0.0002302696,0.004119779,0.0068336064,0.00059026526,0.049195863,0.00016142312],"about_ca_topic_score_codex":0.00024564873,"about_ca_topic_score_gemma":0.00060466933,"teacher_disagreement_score":0.0056454916,"about_ca_system_score_codex":0.0003749418,"about_ca_system_score_gemma":0.0007242154,"threshold_uncertainty_score":0.029856622},"labels":[],"label_agreement":null},{"id":"W2176696615","doi":"10.1002/ajh.24211","title":"Inhibition of phagocytic recognition of anti‐<scp>D</scp> opsonized Rh <scp>D</scp>+ <scp>RBC</scp> by polymer‐mediated immunocamouflage","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Centre for Blood Research, University of British Columbia; Michael Smith Health Research BC; University of British Columbia; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Flow cytometry; Immune system; Monocyte; Antibody; Grafting; Blood transfusion; PEG ratio; Medicine; Red blood cell; Antigen; Immunology; Chemistry; Pharmacology; Andrology; Polymer","score_opus":0.013857806871574667,"score_gpt":0.24944345302375298,"score_spread":0.2355856461521783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176696615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967332,0.00047828493,0.001513992,0.000045233533,0.000013158977,0.000043528424,0.00007747801,0.000025278141,0.0010698305],"genre_scores_gemma":[0.9954041,0.0005124939,0.0020282462,0.000058335187,0.000008513633,0.000046873865,0.00021260491,0.000008642476,0.0017202533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997749,0.00004949951,0.000021991225,0.000033501863,0.000044970555,0.00007520686],"domain_scores_gemma":[0.9999033,0.00003722345,0.000018606355,0.000011841162,0.00001445655,0.000014631466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024533368,0.00040735287,0.00024914817,0.00014205615,0.00010510805,0.0002497718,0.00026168462,0.00032201596,0.0013934061],"category_scores_gemma":[0.00014877846,0.00012293631,0.00027791594,0.0000987583,0.0001711743,0.00014690722,0.00023989582,0.0005059994,0.00032300386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093593706,0.000038053575,0.000110688525,0.000031258493,0.0000028877569,0.000022001446,0.000009859785,0.000033677676,0.9988116,0.00005304779,0.00002663135,0.000766792],"study_design_scores_gemma":[0.000009635473,0.00042501357,0.001911705,0.0000047737,0.000004603124,0.00007061942,0.000009428222,0.000822742,0.9963496,0.000008635114,0.00038150634,0.0000016523227],"about_ca_topic_score_codex":0.0008327207,"about_ca_topic_score_gemma":0.0007998534,"teacher_disagreement_score":0.0013934061,"about_ca_system_score_codex":0.00027722312,"about_ca_system_score_gemma":0.00023342767,"threshold_uncertainty_score":0.004661441},"labels":[],"label_agreement":null},{"id":"W2179085550","doi":"10.1002/ajh.24239","title":"Reply to H.J adams et al: “Is <scp>FDG‐PET/CT</scp> a sensitive and specific method for the detection of extranodal involvement in diffuse large <scp>B</scp>‐cell lymphoma?”","year":2015,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Bone marrow; Rituximab; Radiology; Nuclear medicine; Internal medicine","score_opus":0.01974240030807576,"score_gpt":0.2907686698551946,"score_spread":0.27102626954711884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179085550","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056505814,0.0032056917,0.00019047383,0.93301994,0.062383387,0.000016502076,0.00012279164,0.000050104052,0.0004461103],"genre_scores_gemma":[0.004649892,0.0025252602,0.0003355968,0.8976221,0.09255044,0.00004101136,0.0000697871,0.00003786039,0.0021680521],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972331,0.0009082052,0.00049168355,0.00047971602,0.0006187099,0.00026854972],"domain_scores_gemma":[0.98638994,0.007040326,0.00093985855,0.00033857275,0.0040006684,0.0012906264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045360522,0.0011362263,0.0020885665,0.0009941292,0.001788306,0.002225167,0.0031150926,0.020597884,0.0034517269],"category_scores_gemma":[0.02643331,0.0009074153,0.0010309303,0.0008842671,0.002409361,0.004389368,0.0011380607,0.030138321,0.0039662276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008729567,0.000027924025,0.0007748637,0.00010351107,0.000023611643,0.00059034344,0.000085987616,0.000041893825,0.00012362652,0.00042645968,0.993193,0.0045214538],"study_design_scores_gemma":[0.00022850155,0.00017815857,0.004992646,0.0006924949,0.0001438513,0.006809482,0.0010603997,0.0010809142,0.00110273,0.004848712,0.978628,0.00023408076],"about_ca_topic_score_codex":0.0030014992,"about_ca_topic_score_gemma":0.0037605353,"teacher_disagreement_score":0.020597884,"about_ca_system_score_codex":0.0020533507,"about_ca_system_score_gemma":0.0024752342,"threshold_uncertainty_score":0.0239892},"labels":[],"label_agreement":null},{"id":"W2191119087","doi":"10.1002/ajh.24258","title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10‐Color flow cytometry diagnosis and HyperCVAD therapy","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Induction chemotherapy; Retrospective cohort study; Acute leukemia; CD34; Gastroenterology; Surgery; Leukemia; Chemotherapy; Oncology; Stem cell","score_opus":0.027336212607212796,"score_gpt":0.3085883594998523,"score_spread":0.2812521468926395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191119087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770653,0.00031957676,0.0007914584,0.000041126863,0.0000042292445,0.000016711552,0.000020572974,0.000010502557,0.0010892564],"genre_scores_gemma":[0.9994259,0.00008687891,0.0003082458,0.000021173351,0.0000052258747,0.000005346436,0.000048398346,0.0000017948962,0.00009704491],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998441,0.00004722703,0.000014293876,0.000026672382,0.00003847308,0.000029234603],"domain_scores_gemma":[0.99976176,0.00010512491,0.00004724683,0.000017675538,0.000030302463,0.000038011138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033442938,0.00012300408,0.00016638936,0.00040411495,0.00018635739,0.00024147717,0.00012097854,0.00017591071,0.00058488455],"category_scores_gemma":[0.0008848664,0.00007952393,0.00007639317,0.00017559734,0.00023135089,0.00016723873,0.00017267246,0.00020420215,0.00017414885],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012002222,0.00014701931,0.86360323,0.000054211792,0.000026489293,0.018665383,0.00026201925,0.0005169875,0.051713604,0.00018708484,0.00034112003,0.063282646],"study_design_scores_gemma":[0.00013236803,0.0019439852,0.80520076,0.00003748046,0.00009629988,0.14710818,0.00036573372,0.004456679,0.036626235,0.00035679093,0.0036566416,0.000018809424],"about_ca_topic_score_codex":0.0005719395,"about_ca_topic_score_gemma":0.00089625164,"teacher_disagreement_score":0.00058488455,"about_ca_system_score_codex":0.00032543027,"about_ca_system_score_gemma":0.00016652285,"threshold_uncertainty_score":0.0023611188},"labels":[],"label_agreement":null},{"id":"W2256816906","doi":"10.1002/ajh.24329","title":"Safety and efficacy of intrathecal rituximab in children with <scp>B</scp> cell lymphoid CD20+ malignancies: An international retrospective study","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Rituximab; CD20; Lymphoma; Adverse effect; Internal medicine; Oncology; Gastroenterology","score_opus":0.004908555378995419,"score_gpt":0.2480252671786096,"score_spread":0.24311671179961417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256816906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998326,0.0011290063,0.00007621404,0.000024951027,0.0000029034475,0.000008120291,0.0000912427,0.0000024500177,0.00033913762],"genre_scores_gemma":[0.99933344,0.0003962201,0.0000555165,0.000028993942,0.000009115844,0.000009439419,0.0001305313,0.0000021872934,0.000034414516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991129,0.00028218716,0.00017727834,0.00014046868,0.0002139099,0.000073247655],"domain_scores_gemma":[0.99663335,0.0007978112,0.0019468955,0.0001685313,0.00021642323,0.00023695975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080418435,0.0001889871,0.00037378707,0.00050976156,0.00020124618,0.00055756647,0.00022593535,0.00032634646,0.0004976656],"category_scores_gemma":[0.0027802135,0.00017238688,0.00043145134,0.0007569019,0.00044136358,0.0003296976,0.00018157039,0.00045554622,0.0001387791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005120678,0.000087454064,0.99226123,0.000045650424,0.00011549331,0.00071914354,0.00010863809,0.00011215068,0.0005386761,0.000023374732,0.00008038763,0.0053958413],"study_design_scores_gemma":[0.00008347656,0.0030249965,0.98577785,0.000043555505,0.00026660555,0.007851465,0.00027080346,0.0003508303,0.00096650404,0.000029502258,0.0013226913,0.000011701303],"about_ca_topic_score_codex":0.0013597116,"about_ca_topic_score_gemma":0.000857828,"teacher_disagreement_score":0.0013597116,"about_ca_system_score_codex":0.00048971054,"about_ca_system_score_gemma":0.00047072387,"threshold_uncertainty_score":0.00425297},"labels":[],"label_agreement":null},{"id":"W2277138589","doi":"10.1002/ajh.24287","title":"<sup>18</sup>FDG‐PET/CT: 21st century approach to leukemic tumors in 124 cases","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Occult; Leukemia; Chemotherapy; Disease; Radiology; Refractory (planetary science); Minimal residual disease; Oncology; Internal medicine; Pathology","score_opus":0.03395286486311565,"score_gpt":0.31540887691118596,"score_spread":0.2814560120480703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277138589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760666,0.00655121,0.0051657334,0.00052257505,0.00006772527,0.00013837236,0.00035719678,0.00015557771,0.010974911],"genre_scores_gemma":[0.9922084,0.002752361,0.003406422,0.00012163933,0.00010872518,0.000026424224,0.00031792777,0.000028401797,0.0010297757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995196,0.00007791558,0.00010973281,0.00007163757,0.00013191995,0.000089240486],"domain_scores_gemma":[0.9991345,0.00021126031,0.00028918326,0.0001326996,0.00011850674,0.00011393942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005508602,0.0005382936,0.00018235565,0.004334133,0.000611275,0.00096198753,0.000854969,0.00083789957,0.001790622],"category_scores_gemma":[0.0023361915,0.0003858967,0.00026577074,0.0019780272,0.0009670343,0.00069250603,0.000657461,0.00038283694,0.0009792346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023394992,0.00018296251,0.76872367,0.00022827125,0.00006747866,0.1417995,0.0008259978,0.00050076755,0.017687555,0.0006771677,0.0014810237,0.06759157],"study_design_scores_gemma":[0.000028421648,0.0002509739,0.32260984,0.00015119642,0.00014974065,0.646781,0.0008715735,0.002465512,0.012939664,0.00092242466,0.012770953,0.000058702062],"about_ca_topic_score_codex":0.0011052828,"about_ca_topic_score_gemma":0.0020802855,"teacher_disagreement_score":0.004334133,"about_ca_system_score_codex":0.00047940967,"about_ca_system_score_gemma":0.00041956492,"threshold_uncertainty_score":0.005990207},"labels":[],"label_agreement":null},{"id":"W2283900472","doi":"10.1002/ajh.24339","title":"Long‐term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review","year":2016,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Incidence (geometry); Population; Internal medicine; Stroke (engine); Neurocognitive; Cumulative incidence; Quality of life (healthcare); Pediatrics; Disease; Transplantation; Psychiatry; Cognition","score_opus":0.027690355300619817,"score_gpt":0.3202582878954277,"score_spread":0.2925679325948079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283900472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031140826,0.9957152,0.00012263913,0.00019170574,0.00006619709,0.00023658933,0.00035345057,0.0000065967856,0.00019353406],"genre_scores_gemma":[0.046495937,0.95116675,0.00060158846,0.0005481693,0.00008896558,0.00062429823,0.00036392114,0.000006149389,0.00010416299],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.993038,0.0023104888,0.002885544,0.00049627316,0.0010686644,0.00020111789],"domain_scores_gemma":[0.9724187,0.018249352,0.0064266045,0.00035806882,0.0022715211,0.00027584363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00702028,0.0011554473,0.0080903545,0.005988048,0.00055876555,0.002506282,0.0016804152,0.001595444,0.0028777486],"category_scores_gemma":[0.035921443,0.00088106364,0.008128418,0.007732011,0.00079001504,0.0019313489,0.0011849354,0.0011314858,0.00018763366],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030613662,0.000019743838,0.0017580634,0.95635056,0.022775982,0.00010732242,0.00019091589,0.00010274712,0.00010642834,0.00011223773,0.0007320369,0.017437868],"study_design_scores_gemma":[0.0005842959,0.00037190205,0.01131826,0.7959049,0.18160608,0.0005337444,0.0003645226,0.00014825774,0.00020491554,0.0002738281,0.008636762,0.000052564967],"about_ca_topic_score_codex":0.008542041,"about_ca_topic_score_gemma":0.020394702,"teacher_disagreement_score":0.008542041,"about_ca_system_score_codex":0.003473147,"about_ca_system_score_gemma":0.007818466,"threshold_uncertainty_score":0.037127256},"labels":[],"label_agreement":null},{"id":"W2286519782","doi":"10.1002/ajh.24285","title":"Pediatric‐inspired therapy compared to allografting for <scp>P</scp>hiladelphia chromosome‐negative adult ALL in first complete remission","year":2015,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Genentech; Health Resources and Services Administration; Medac; Swedish Orphan Biovitrum; Otsuka America; Incyte; Dana-Farber Cancer Institute; Blue Cross and Blue Shield Association; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Chimerix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Takeda Oncology; University of Minnesota; Otsuka America Pharmaceutical; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; Ariad Pharmaceuticals; U.S. Navy; Osiris Therapeutics; Celgene; U.S. Department of Health and Human Services; Health Research; U.S. Public Health Service; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Be The Match Foundation; GlaxoSmithKline","keywords":"Medicine; Hazard ratio; Internal medicine; Cohort; Chemotherapy; Transplantation; Hematopoietic cell; Incidence (geometry); Hematopoietic stem cell transplantation; Gastroenterology; Regimen; Chemotherapy regimen; Leukemia; Oncology; Haematopoiesis; Stem cell; Confidence interval","score_opus":0.06018271158077865,"score_gpt":0.34214405059249414,"score_spread":0.2819613390117155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286519782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797887,0.0013426339,0.000100680394,0.000069122354,0.000022009828,0.00003239187,0.00004476024,0.0000042333168,0.00040525687],"genre_scores_gemma":[0.998546,0.0008601352,0.00014818941,0.00007456031,0.000042296175,0.00003458067,0.00011181689,0.0000019232227,0.00018062939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996915,0.00019575562,0.00001506774,0.000032451448,0.000026028862,0.000039355702],"domain_scores_gemma":[0.99935704,0.00022132492,0.00019477317,0.000044125973,0.000016982658,0.0001656822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007110098,0.00017466387,0.00050907035,0.00012399233,0.00012274162,0.0002711378,0.0001755774,0.0001934388,0.001216001],"category_scores_gemma":[0.0008987405,0.0000609181,0.0003443717,0.00017636098,0.00017780549,0.00019822994,0.00015349871,0.00058888126,0.00010649049],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5156367,0.011751825,0.11746532,0.0005789888,0.0015775809,0.00027966194,0.00042576264,0.005056838,0.01666018,0.0011180601,0.0020146454,0.32743445],"study_design_scores_gemma":[0.034432758,0.61278063,0.3276901,0.00023068438,0.002185103,0.00089049037,0.00021008859,0.0045043263,0.010133502,0.0006716385,0.0062378733,0.00003292385],"about_ca_topic_score_codex":0.0006320459,"about_ca_topic_score_gemma":0.0016403041,"teacher_disagreement_score":0.001216001,"about_ca_system_score_codex":0.00035209238,"about_ca_system_score_gemma":0.00044707055,"threshold_uncertainty_score":0.004067898},"labels":[],"label_agreement":null},{"id":"W2290639160","doi":"10.1002/ajh.24342","title":"Impact of HLA‐Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta‐Analysis","year":2016,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Deutscher Akademischer Austauschdienst","keywords":"Hematopoietic stem cell transplantation; Human leukocyte antigen; Meta-analysis; Transplantation; Stem cell; Medicine; Immunology; Internal medicine; Biology; Genetics; Antigen","score_opus":0.03981211741244985,"score_gpt":0.3509354095221212,"score_spread":0.3111232921096714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290639160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0319955,0.9639826,0.0014880947,0.00043098762,0.00032143135,0.00011420466,0.0009846316,0.00005728415,0.0006252951],"genre_scores_gemma":[0.7097877,0.283096,0.002605434,0.0012320029,0.0005816102,0.00040107378,0.0015456388,0.0000765489,0.00067390956],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99378777,0.0034362974,0.001115305,0.0008978881,0.00047926148,0.00028358283],"domain_scores_gemma":[0.9884644,0.009097644,0.0011686241,0.0005504909,0.00053000666,0.00018883449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01034692,0.0023748577,0.009968777,0.002964683,0.00053075305,0.002581205,0.0015457557,0.0018904174,0.0030174502],"category_scores_gemma":[0.017716024,0.0009716816,0.040961288,0.0041532726,0.00037572236,0.0010978443,0.0009954685,0.0021310952,0.00029931826],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044063334,0.000022297087,0.014093337,0.035491027,0.93767256,0.0001594166,0.00003440049,0.00091070903,0.0002527754,0.000117856565,0.0005272579,0.0063120285],"study_design_scores_gemma":[0.000384833,0.00013914028,0.0061205383,0.0016982534,0.9902828,0.00006787256,0.000015594143,0.00034881555,0.000101201025,0.0001655502,0.0006638676,0.000011608892],"about_ca_topic_score_codex":0.004343914,"about_ca_topic_score_gemma":0.007093107,"teacher_disagreement_score":0.01034692,"about_ca_system_score_codex":0.0011167651,"about_ca_system_score_gemma":0.001008959,"threshold_uncertainty_score":0.0547204},"labels":[],"label_agreement":null},{"id":"W2295624617","doi":"10.1002/ajh.24351","title":"Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Retrospective cohort study; Central nervous system; Clinical Practice; Intensive care medicine; Oncology; Internal medicine; Family medicine","score_opus":0.025557997983065527,"score_gpt":0.3449735239218295,"score_spread":0.319415525938764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295624617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99943024,0.00021715027,0.00004163662,0.000018366833,0.0000021079204,0.000011948596,0.00012225739,0.000002747323,0.00015350462],"genre_scores_gemma":[0.99939644,0.00015898945,0.000074881886,0.00004386761,0.000010596491,0.000020445812,0.00022873221,0.000001852798,0.00006425966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993849,0.00015721477,0.00007786,0.00016765026,0.00011143307,0.000100879275],"domain_scores_gemma":[0.9980149,0.00034865143,0.0009347015,0.00012819358,0.00019577709,0.00037779263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006775583,0.0003255556,0.00046846026,0.00096367084,0.0006707093,0.0007715403,0.00040331754,0.00046325376,0.0013392946],"category_scores_gemma":[0.0018331445,0.0005649964,0.00022412579,0.0019912971,0.00050286634,0.0006809501,0.00068526407,0.0003982852,0.00034271565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045455206,0.000033686436,0.9984029,0.0000108940385,0.00001336313,0.0002732811,0.00016415524,0.000013866731,0.00012333144,0.0000057566153,0.00007067808,0.0008426498],"study_design_scores_gemma":[0.00002460789,0.00039159798,0.9956993,0.000016156037,0.000024064984,0.0023647784,0.000797209,0.00011080994,0.000074103315,0.000013134876,0.00047696207,0.000007452859],"about_ca_topic_score_codex":0.0050797067,"about_ca_topic_score_gemma":0.0049498384,"teacher_disagreement_score":0.0050797067,"about_ca_system_score_codex":0.0005367548,"about_ca_system_score_gemma":0.0005092463,"threshold_uncertainty_score":0.010100305},"labels":[],"label_agreement":null},{"id":"W2296398034","doi":"10.1002/ajh.24360","title":"Long‐term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome‐positive leukemias treated with bosutinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Tyrosine-kinase inhibitor; Nilotinib; Myeloid leukemia; Cardiology; Oncology; Cancer","score_opus":0.00965328692726936,"score_gpt":0.2594641061946532,"score_spread":0.24981081926738385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296398034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954743,0.003424809,0.00023486288,0.00006710644,0.000008406312,0.00003791471,0.00014586808,0.000005516734,0.00060126936],"genre_scores_gemma":[0.99875593,0.0005714145,0.00015870309,0.00010133786,0.000021725255,0.000029144056,0.00023383796,0.0000015981058,0.00012636151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990294,0.0005088661,0.00011498997,0.00009793885,0.00017027283,0.000078422025],"domain_scores_gemma":[0.99738187,0.00086097704,0.0011272886,0.00011650969,0.00021690225,0.00029654914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024839728,0.00021067806,0.00067018415,0.00029136785,0.00022046125,0.00057801127,0.0002004243,0.00030410057,0.00068757916],"category_scores_gemma":[0.0028524299,0.00012996662,0.00069451163,0.00037795884,0.00019649153,0.0003603622,0.00021553063,0.00074121484,0.000103638355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020404002,0.00087594386,0.8993504,0.00029722843,0.0013902594,0.0006307187,0.0001520791,0.00084351766,0.014565939,0.00008064768,0.00035373634,0.06105563],"study_design_scores_gemma":[0.001064715,0.029499797,0.9579828,0.000056387722,0.0011269514,0.002036072,0.00015305233,0.0013350577,0.004647307,0.00011491078,0.001957782,0.000025194784],"about_ca_topic_score_codex":0.00025303283,"about_ca_topic_score_gemma":0.000792046,"teacher_disagreement_score":0.0024839728,"about_ca_system_score_codex":0.0003597111,"about_ca_system_score_gemma":0.00028027483,"threshold_uncertainty_score":0.013136685},"labels":[],"label_agreement":null},{"id":"W2341059062","doi":"10.1002/ajh.24386","title":"In memoriam: Bernard G. Forget","year":2016,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; McGill University; Massachusetts General Hospital","keywords":"Internship; Medical school; Medical laboratory; Medicine; Family medicine; Medical education; Pathology","score_opus":0.0038785220571578294,"score_gpt":0.27859000961649605,"score_spread":0.2747114875593382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341059062","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003025006,0.007760624,0.00036761814,0.2835512,0.7023186,0.00004185476,0.00024394944,0.00017203235,0.0052416218],"genre_scores_gemma":[0.005806057,0.01111994,0.0005353965,0.331377,0.5988757,0.00013895237,0.00038350542,0.0001507573,0.05161267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998423,0.00029541718,0.00016221959,0.0003510229,0.0005920112,0.00017636434],"domain_scores_gemma":[0.9908738,0.001638209,0.00040104808,0.0002443145,0.0048135156,0.0020290236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023973433,0.0019485728,0.0018715318,0.0010990844,0.0020784747,0.004030439,0.0021304039,0.0062068366,0.016908111],"category_scores_gemma":[0.02506518,0.00047137606,0.0012469889,0.00039482713,0.001251132,0.003137837,0.001800284,0.014284882,0.020990457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000103681905,0.0000059718463,0.00005977901,0.000025705238,0.0000035503906,0.000164298,0.00001713681,0.000013771415,0.000015350322,0.0001219122,0.99567163,0.003890442],"study_design_scores_gemma":[0.00002795694,0.000031144085,0.00034020672,0.00020859028,0.000012639369,0.0017315829,0.00011960182,0.0000958028,0.0001260079,0.0008672719,0.9964169,0.000022166309],"about_ca_topic_score_codex":0.0024641529,"about_ca_topic_score_gemma":0.0035218387,"teacher_disagreement_score":0.016908111,"about_ca_system_score_codex":0.0021473384,"about_ca_system_score_gemma":0.0032010055,"threshold_uncertainty_score":0.05656326},"labels":[],"label_agreement":null},{"id":"W2343370722","doi":"10.1002/ajh.24369","title":"Long‐term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Sanofi; Pfizer","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; Enzyme replacement therapy; Surgery; Disease","score_opus":0.009121903291583551,"score_gpt":0.28823567416420665,"score_spread":0.27911377087262307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343370722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662316,0.0024761888,0.00017657065,0.000099383346,0.000015791049,0.000049992774,0.00014083886,0.0000194374,0.0003986448],"genre_scores_gemma":[0.9983845,0.0006160924,0.00021248325,0.00016931565,0.00003117292,0.000048051428,0.00028897144,0.0000030024066,0.00024643342],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999624,0.00015123868,0.00005698499,0.00004864354,0.000047559828,0.00007155171],"domain_scores_gemma":[0.99923,0.00014970875,0.00024693704,0.00006708063,0.000077234225,0.00022912091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008831052,0.00031883162,0.001135528,0.00017318361,0.0003824851,0.00031329523,0.00019474071,0.00044928887,0.00078078144],"category_scores_gemma":[0.0009646308,0.0001259017,0.00095092563,0.00021570925,0.00030116425,0.0003918729,0.00015056424,0.0008314878,0.00023288948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4347048,0.016931545,0.11308321,0.00077123026,0.002455686,0.0013849098,0.0007072885,0.0030923141,0.12597345,0.00015028803,0.0023381412,0.29840723],"study_design_scores_gemma":[0.04054213,0.56634563,0.3581937,0.00009821268,0.002843635,0.0022839282,0.0002390116,0.0018429875,0.022010183,0.0002501461,0.005252622,0.00009801516],"about_ca_topic_score_codex":0.00048076466,"about_ca_topic_score_gemma":0.0009123729,"teacher_disagreement_score":0.001135528,"about_ca_system_score_codex":0.00032038442,"about_ca_system_score_gemma":0.0002742394,"threshold_uncertainty_score":0.004670322},"labels":[],"label_agreement":null},{"id":"W2346165635","doi":"10.1002/ajh.24313","title":"Hepcidin as a new biomarker for detecting autologous blood transfusion","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Hepcidin; Biomarker; Medicine; Blood transfusion; Intensive care medicine; Immunology; Internal medicine; Anemia; Biology","score_opus":0.012878040328913015,"score_gpt":0.28581194794632125,"score_spread":0.2729339076174082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346165635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332691,0.032984268,0.026834233,0.0007452247,0.00056706934,0.00086901966,0.00047005893,0.00031378138,0.0039472985],"genre_scores_gemma":[0.97367126,0.0028663657,0.01956527,0.00038542392,0.0001715405,0.00033850144,0.00031860292,0.000019638059,0.0026634696],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987853,0.0007191404,0.000033290627,0.0001325158,0.00028558352,0.00004401628],"domain_scores_gemma":[0.9994809,0.00019947879,0.00011549208,0.000043977674,0.000092397895,0.00006787811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019930797,0.00054766954,0.00073920866,0.0006989288,0.00020046804,0.00078448164,0.00029310054,0.00061096257,0.0011258471],"category_scores_gemma":[0.0014312126,0.00025099647,0.00021091865,0.00040956805,0.00040611194,0.0003460447,0.00027107965,0.00079868006,0.00024409291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019305438,0.0016231653,0.06890503,0.0008130018,0.0003654087,0.00034544023,0.00019089844,0.0009745876,0.75812536,0.0007088386,0.001403287,0.1472396],"study_design_scores_gemma":[0.0016642906,0.049062423,0.20256136,0.0003002055,0.0016573918,0.0032772291,0.00031720087,0.033847123,0.6830568,0.0017542037,0.022381725,0.000120166784],"about_ca_topic_score_codex":0.0003071176,"about_ca_topic_score_gemma":0.000415765,"teacher_disagreement_score":0.0019930797,"about_ca_system_score_codex":0.00025768782,"about_ca_system_score_gemma":0.00037081743,"threshold_uncertainty_score":0.010540485},"labels":[],"label_agreement":null},{"id":"W2346787971","doi":"10.1002/ajh.24412","title":"Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; St. Michael's Hospital","funders":"American Society of Hematology","keywords":"Relevance (law); Stewardship (theology); Medicine; Leverage (statistics); Harm; MEDLINE; Medical education; Psychology; Political science; Computer science; Law; Social psychology","score_opus":0.4357153574452297,"score_gpt":0.5454252801276466,"score_spread":0.10970992268241686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346787971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4084829,0.050781347,0.1684566,0.19243903,0.011307978,0.041129652,0.010262336,0.0023658518,0.11477428],"genre_scores_gemma":[0.26253572,0.013346118,0.6969445,0.011598797,0.0013106492,0.0060648844,0.0028200564,0.0002512535,0.005128043],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9229617,0.03700696,0.018896142,0.0020907575,0.017329957,0.0017144735],"domain_scores_gemma":[0.643871,0.21440665,0.032439657,0.011321775,0.08890941,0.009051508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10325586,0.00094000436,0.0016315192,0.014982709,0.0032806965,0.0049625253,0.001982835,0.0025189847,0.004788279],"category_scores_gemma":[0.33945242,0.00087107345,0.002248048,0.007139043,0.0010883766,0.0034987573,0.0041251457,0.0033539713,0.0013863635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004658228,0.000624512,0.082955025,0.011485044,0.0008395588,0.0006802431,0.006829752,0.0012170763,0.0030179773,0.006795866,0.14546324,0.7396258],"study_design_scores_gemma":[0.0011126038,0.0017525763,0.14657722,0.04281861,0.0040562064,0.0015741143,0.020132829,0.014638465,0.008050733,0.04975543,0.7086755,0.0008557454],"about_ca_topic_score_codex":0.004321267,"about_ca_topic_score_gemma":0.02238273,"teacher_disagreement_score":0.10325586,"about_ca_system_score_codex":0.0049698274,"about_ca_system_score_gemma":0.029165205,"threshold_uncertainty_score":0.5460757},"labels":[],"label_agreement":null},{"id":"W2406437958","doi":"10.1002/ajh.24399","title":"Enzyme replacement therapy with taliglucerase alfa: 36‐month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Amicus Therapeutics; Emory University; Sanofi; Pfizer","keywords":"Medicine; Enzyme replacement therapy; Adverse effect; Internal medicine; Gastroenterology; Pediatrics; Disease","score_opus":0.007541624364545126,"score_gpt":0.2585930362985003,"score_spread":0.25105141193395514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406437958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989166,0.0006843184,0.000094630625,0.00003129247,0.000006474821,0.00002097044,0.000071257986,0.00001374019,0.00016077344],"genre_scores_gemma":[0.99894744,0.0003030715,0.00018224036,0.00006561811,0.000020449299,0.000023734501,0.0002471176,0.0000026816122,0.0002075625],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99977547,0.00007053887,0.00003024153,0.000040315368,0.000028032371,0.00005539479],"domain_scores_gemma":[0.9993968,0.0000784196,0.00014354357,0.000065815184,0.00004600722,0.00026938377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000698264,0.0004437433,0.0011327977,0.00017883192,0.00025925587,0.00039016918,0.00021418897,0.00042269946,0.0006743268],"category_scores_gemma":[0.0006448298,0.00012632657,0.0006667248,0.00022140521,0.00033530727,0.00036511544,0.00016837317,0.00083417335,0.00023396222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5006326,0.037529297,0.11015431,0.00031762634,0.0012149127,0.0014805396,0.00093255827,0.0023710025,0.14352483,0.00012852225,0.0015342769,0.2001795],"study_design_scores_gemma":[0.036450703,0.6799081,0.25452477,0.000036527585,0.00072760164,0.002439596,0.00020726741,0.0024574678,0.020089917,0.00009841676,0.0030101014,0.000049627703],"about_ca_topic_score_codex":0.0007236945,"about_ca_topic_score_gemma":0.0005374749,"teacher_disagreement_score":0.0011327977,"about_ca_system_score_codex":0.00027894168,"about_ca_system_score_gemma":0.00024744746,"threshold_uncertainty_score":0.0036928654},"labels":[],"label_agreement":null},{"id":"W2408540430","doi":"10.1002/ajh.24429","title":"Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Multicenter study; Medicine; Hodgkin lymphoma; Central nervous system; Lymphoma; Oncology; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.008471791095465113,"score_gpt":0.280387025698044,"score_spread":0.27191523460257894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408540430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753976,0.00047276242,0.00009742606,0.00008447435,0.000003714589,0.0000209114,0.0011884923,0.000004142971,0.0005883144],"genre_scores_gemma":[0.9974395,0.00019670727,0.00010724868,0.000041282685,0.00001200191,0.000028741926,0.0021163106,0.0000025000402,0.000055709916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989385,0.00031100534,0.00018971763,0.00027254413,0.00017333691,0.00011486464],"domain_scores_gemma":[0.99663275,0.0003772669,0.0017684918,0.0002556974,0.00052823575,0.00043761884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020094449,0.00022866142,0.0003729225,0.0013838052,0.00044161058,0.0008335047,0.00041084466,0.00036817454,0.00060231134],"category_scores_gemma":[0.0034212582,0.00015504356,0.0002607703,0.002274591,0.00026461575,0.00066901086,0.000963032,0.00024132,0.00015439194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044425575,0.000013157171,0.99880576,0.0000066164785,0.000024316732,0.000031681262,0.00008808352,0.000016052909,0.00007073081,0.00000898003,0.0001200366,0.00077020796],"study_design_scores_gemma":[0.000010776682,0.000041899737,0.9986808,0.000010770496,0.000026238671,0.00043019885,0.00030564694,0.00007363071,0.00005103369,0.000016116857,0.00034876945,0.0000040238997],"about_ca_topic_score_codex":0.003930528,"about_ca_topic_score_gemma":0.004322227,"teacher_disagreement_score":0.003930528,"about_ca_system_score_codex":0.00046929088,"about_ca_system_score_gemma":0.00052780885,"threshold_uncertainty_score":0.010627151},"labels":[],"label_agreement":null},{"id":"W2466941182","doi":"10.1002/ajh.24479","title":"Deferiprone‐induced agranulocytosis: 20 years of clinical observations","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Neutropenia; Deferiprone; Pediatrics; Leukopenia; Absolute neutrophil count; Internal medicine; Thalassemia; Chemotherapy","score_opus":0.03249723208838206,"score_gpt":0.3199428435003279,"score_spread":0.28744561141194586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466941182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7367074,0.24782898,0.003241832,0.0032942418,0.00029697374,0.00016973272,0.0005991227,0.000119027114,0.0077427016],"genre_scores_gemma":[0.87260485,0.113799535,0.0024976118,0.005990368,0.001589326,0.00009905461,0.0016782682,0.000057351102,0.0016836129],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99741745,0.0005350827,0.0005941645,0.0005868803,0.00059268717,0.00027366882],"domain_scores_gemma":[0.99225426,0.0031755504,0.0015340516,0.00066548755,0.0015591609,0.0008115594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061379117,0.00072031334,0.0011556294,0.0015028886,0.00054896827,0.0018411813,0.0006914585,0.0012739616,0.00058824784],"category_scores_gemma":[0.006638961,0.00036343257,0.0007436405,0.0017529457,0.0014035559,0.0015990882,0.0009438925,0.0014748381,0.00042353923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003297779,0.0022134648,0.3482211,0.0012253519,0.00086182496,0.01174514,0.004484,0.0014385026,0.011375778,0.0026016724,0.0071090735,0.60542643],"study_design_scores_gemma":[0.0005856755,0.01523785,0.673464,0.0029004992,0.0015657692,0.07136043,0.0031069403,0.0040222593,0.0090453,0.004636434,0.21371117,0.00036364535],"about_ca_topic_score_codex":0.001618243,"about_ca_topic_score_gemma":0.0014039048,"teacher_disagreement_score":0.0061379117,"about_ca_system_score_codex":0.0013451191,"about_ca_system_score_gemma":0.001103784,"threshold_uncertainty_score":0.03246075},"labels":[],"label_agreement":null},{"id":"W2507407318","doi":"10.1002/ajh.24545","title":"<scp>I</scp>nvestigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health","keywords":"Dyskeratosis congenita; Biology; Mutation; Telomere; Germline mutation; Germline; Genetics; Germline mosaicism; Phenotype; X-inactivation; Telomerase; Skewed X-inactivation; X chromosome; Cancer research; Gene","score_opus":0.019486905393089594,"score_gpt":0.3107879121040287,"score_spread":0.29130100671093906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507407318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552,0.00041320012,0.00044808688,0.00014859962,0.000015056642,0.000014118154,0.00027428448,0.000042148462,0.0031244985],"genre_scores_gemma":[0.9985253,0.00009945004,0.00028224403,0.000040649084,0.000019951121,0.000005477676,0.00014494824,0.000013776577,0.0008681424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999157,0.000018009407,0.0000106090765,0.000023481707,0.000019531062,0.000012671298],"domain_scores_gemma":[0.9997869,0.00005869718,0.000068589485,0.00001655079,0.000023779536,0.00004552551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019223904,0.0002560245,0.00020205523,0.0006549662,0.00017844357,0.0002325573,0.0000967993,0.00019466682,0.0047614053],"category_scores_gemma":[0.0005126423,0.000065014465,0.000083866384,0.000129791,0.00020605554,0.0001281451,0.00016675594,0.00014999078,0.00035852226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019708015,0.0002872452,0.73373204,0.00007427548,0.000056939913,0.05726697,0.0005786073,0.00016635562,0.15236363,0.0006137986,0.0038518403,0.049037535],"study_design_scores_gemma":[0.000047449164,0.0011024809,0.7403809,0.000036765032,0.000055406916,0.21716097,0.00034640124,0.0009444343,0.03335318,0.00023790127,0.006314434,0.000019657991],"about_ca_topic_score_codex":0.00051238685,"about_ca_topic_score_gemma":0.00042022334,"teacher_disagreement_score":0.0047614053,"about_ca_system_score_codex":0.00010443468,"about_ca_system_score_gemma":0.000056555506,"threshold_uncertainty_score":0.015928447},"labels":[],"label_agreement":null},{"id":"W2516537857","doi":"10.1002/ajh.24536","title":"Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Nilotinib; Dasatinib; Internal medicine; Imatinib; Cumulative incidence; Adverse effect; Nausea; Myeloid leukemia; Gastroenterology; Oncology; Cohort","score_opus":0.014649612863998386,"score_gpt":0.3128337850963781,"score_spread":0.2981841722323797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516537857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880214,0.009053321,0.00042295805,0.0002541455,0.0000642238,0.000107456406,0.00041754855,0.00003635205,0.0016227098],"genre_scores_gemma":[0.99593484,0.0016744948,0.00026240732,0.00026150624,0.00005747171,0.00004806825,0.00089501723,0.0000043163877,0.0008618385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997136,0.00008499213,0.000022938455,0.000031091124,0.000072459516,0.00007499764],"domain_scores_gemma":[0.9996057,0.000091003574,0.00013464343,0.000021414557,0.00003642839,0.00011079376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013931135,0.00027362956,0.00075762713,0.00018825116,0.00023921221,0.00035726395,0.0002784424,0.00021612615,0.00080778525],"category_scores_gemma":[0.0005554331,0.00007950892,0.0004892218,0.0001987917,0.00013852527,0.00032622175,0.0002237052,0.0007457184,0.00027336777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06497496,0.0049354406,0.17804386,0.00101151,0.0016159244,0.0026385735,0.00028967773,0.0017245513,0.06651157,0.00038484362,0.0076194797,0.6702496],"study_design_scores_gemma":[0.016756851,0.23375997,0.6716598,0.00035760461,0.0020780484,0.009774343,0.00019567105,0.0042472817,0.02536048,0.0005213786,0.035210844,0.000077752666],"about_ca_topic_score_codex":0.00040300237,"about_ca_topic_score_gemma":0.0022838567,"teacher_disagreement_score":0.0013931135,"about_ca_system_score_codex":0.00036498078,"about_ca_system_score_gemma":0.00039972167,"threshold_uncertainty_score":0.0073675513},"labels":[],"label_agreement":null},{"id":"W2529791032","doi":"10.1002/ajh.24575","title":"Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Univariate analysis; Confidence interval; Cumulative incidence; Relative risk; Acute lymphocytic leukemia; Young adult; Gastroenterology; Leukemia; Surgery; Transplantation; Lymphoblastic Leukemia; Multivariate analysis","score_opus":0.008773666557131656,"score_gpt":0.2645232949211232,"score_spread":0.25574962836399157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529791032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995784,0.00021740772,0.00003147749,0.000018493847,0.0000019562804,0.000001877574,0.000048625967,0.0000012704327,0.00010057783],"genre_scores_gemma":[0.99965656,0.00014560152,0.00003680832,0.000018316845,0.000007720411,0.0000012919636,0.00009793494,4.5360142e-7,0.000035271274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999162,0.000029038114,0.000010620956,0.000013526302,0.00001464961,0.000016006514],"domain_scores_gemma":[0.9994906,0.00008397231,0.00028835537,0.000025981746,0.000021132822,0.00008994955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030145154,0.0001179039,0.00015703564,0.00021207838,0.00012067369,0.00025312934,0.00008610996,0.00013085162,0.00064696127],"category_scores_gemma":[0.0010381181,0.00007173045,0.00016503381,0.00021945962,0.00012229232,0.00019286567,0.00019918958,0.00021617934,0.00012302672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041257386,0.000045248325,0.9932213,0.000008078692,0.000026466163,0.000100661506,0.00004352589,0.00006593307,0.0007774981,0.000014471381,0.00008170131,0.0052025313],"study_design_scores_gemma":[0.00001776514,0.00042628837,0.9983688,0.00000477431,0.000036599326,0.00045009376,0.0000644455,0.00020316707,0.00014035162,0.000026076907,0.00025964333,0.0000020864118],"about_ca_topic_score_codex":0.00090222736,"about_ca_topic_score_gemma":0.0015914766,"teacher_disagreement_score":0.00090222736,"about_ca_system_score_codex":0.00013039338,"about_ca_system_score_gemma":0.00013906842,"threshold_uncertainty_score":0.0021642447},"labels":[],"label_agreement":null},{"id":"W2568877958","doi":"10.1002/ajh.24639","title":"Sepsis and persisting neutropenia in a drug addict","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre","funders":"","keywords":"Neutropenia; Medicine; Sepsis; Drug; Intensive care medicine; Drug addict; Internal medicine; Pharmacology; Chemotherapy; Addiction; Psychiatry","score_opus":0.005854179095339528,"score_gpt":0.2576043996369472,"score_spread":0.25175022054160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568877958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504096,0.004293044,0.00051834714,0.0031912841,0.00026142795,0.00009404902,0.00016175964,0.000061638515,0.006377515],"genre_scores_gemma":[0.99718887,0.00096051826,0.00019699874,0.00083740073,0.00023330435,0.000009552823,0.000055908415,0.0000042994184,0.00051303447],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99974996,0.000034762943,0.000031319025,0.00006443233,0.000042200583,0.00007735398],"domain_scores_gemma":[0.9995485,0.00007310167,0.00009869013,0.000015778724,0.000035668043,0.00022828604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025189164,0.0008406594,0.0005916198,0.0011615062,0.0018628502,0.0006979556,0.00044869803,0.0018975658,0.0018635793],"category_scores_gemma":[0.001488403,0.00053985155,0.00043028238,0.00063022785,0.00058007543,0.00077435427,0.0007079236,0.0015530585,0.00043755336],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006408907,0.00008185657,0.050638232,0.000028643606,0.000010844641,0.94636,0.00017941189,0.000057381014,0.0007405726,0.000117013056,0.0004172717,0.0013046631],"study_design_scores_gemma":[0.000028148927,0.0003854309,0.07119681,0.00006166488,0.000028779301,0.92544025,0.00043809452,0.0005312475,0.00026053606,0.00030566665,0.0013048912,0.000018473003],"about_ca_topic_score_codex":0.0015579374,"about_ca_topic_score_gemma":0.00237618,"teacher_disagreement_score":0.0018975658,"about_ca_system_score_codex":0.0008523153,"about_ca_system_score_gemma":0.0005189442,"threshold_uncertainty_score":0.006234288},"labels":[],"label_agreement":null},{"id":"W2589788830","doi":"10.1002/ajh.24693","title":"A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene; Sanofi; Eli Lilly and Company; Amgen","keywords":"Medicine; Lenalidomide; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Cyclophosphamide; Lymphoplasmacytic Lymphoma; Dexamethasone; Lymphoma; Waldenstrom macroglobulinemia; Macroglobulinemia; Marginal zone B-cell lymphoma; Surgery; Oncology; Multiple myeloma; Chemotherapy; Immunology; B cell; Marginal zone","score_opus":0.027037348486308777,"score_gpt":0.34947976618728904,"score_spread":0.32244241770098026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589788830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934198,0.0008038466,0.000438597,0.00025290388,0.00010036776,0.003501008,0.00043221455,0.000046593286,0.0010045553],"genre_scores_gemma":[0.988665,0.0009944221,0.0021264583,0.0008136293,0.00017731659,0.004234736,0.0012145259,0.00002134507,0.0017525346],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992151,0.00049822143,0.000035994075,0.00008751864,0.000054437667,0.00010871011],"domain_scores_gemma":[0.99891853,0.00027671282,0.00013129457,0.00008398998,0.000063551815,0.0005258769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029770443,0.0012773746,0.0017849208,0.00042764063,0.00052139995,0.0009725365,0.000992364,0.0011614724,0.0032561307],"category_scores_gemma":[0.0013041812,0.0007310117,0.0009851927,0.00036147426,0.001003729,0.00076538307,0.0003262768,0.0032322404,0.00062890956],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76677006,0.15594807,0.0051530516,0.00043831102,0.0007632821,0.00035523705,0.00031935176,0.0018268395,0.02055246,0.00027606744,0.0019954357,0.045601767],"study_design_scores_gemma":[0.70785135,0.28595278,0.003201841,0.000015125162,0.00013231226,0.000102924,0.000033915978,0.00062280864,0.0010640612,0.00010134493,0.0009078343,0.000013729757],"about_ca_topic_score_codex":0.0009896071,"about_ca_topic_score_gemma":0.002264879,"teacher_disagreement_score":0.0032561307,"about_ca_system_score_codex":0.0008816666,"about_ca_system_score_gemma":0.0017493172,"threshold_uncertainty_score":0.015744269},"labels":[],"label_agreement":null},{"id":"W2594382618","doi":"10.1002/ajh.24717","title":"Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Foundation for the National Institutes of Health","keywords":"Amyloidosis; AL amyloidosis; Immunoglobulin light chain; Monoclonal; Amyloid (mycology); Chemistry; Exosome; Kidney; Laser capture microdissection; Molecular biology; Microvesicles; Medicine; Monoclonal antibody; Pathology; Antibody; Biology; Internal medicine; Biochemistry; Immunology","score_opus":0.006674407985861748,"score_gpt":0.28229529855705904,"score_spread":0.27562089057119726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594382618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912752,0.0037226083,0.0033412168,0.00040510294,0.00006325239,0.00017267627,0.00017923705,0.000079748475,0.0007609098],"genre_scores_gemma":[0.9956813,0.0004475502,0.00301642,0.0002713926,0.00008267643,0.00010117833,0.00015385567,0.000008929377,0.0002366079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989767,0.0005042169,0.000053397875,0.00016176885,0.00023544481,0.00006851377],"domain_scores_gemma":[0.9983663,0.0006389634,0.0003375832,0.00012251161,0.00024015839,0.00029454075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021215514,0.00045530245,0.00085384795,0.00036036497,0.000247748,0.0012505822,0.00034254396,0.0007912665,0.0007378317],"category_scores_gemma":[0.0023882657,0.00019307746,0.00060316414,0.00019916699,0.00026787762,0.00071774103,0.00046449763,0.000878635,0.00016397222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049417842,0.008849541,0.4846944,0.0008967081,0.0012802447,0.001340364,0.0006025914,0.001860204,0.1692125,0.00039803854,0.0017999229,0.27964762],"study_design_scores_gemma":[0.005199999,0.10023684,0.7012178,0.0003445164,0.0030676704,0.006370014,0.0009634684,0.019120399,0.14915662,0.0014574385,0.012663991,0.0002012874],"about_ca_topic_score_codex":0.00011085045,"about_ca_topic_score_gemma":0.00012233127,"teacher_disagreement_score":0.0021215514,"about_ca_system_score_codex":0.00032728183,"about_ca_system_score_gemma":0.00029000294,"threshold_uncertainty_score":0.011219978},"labels":[],"label_agreement":null},{"id":"W2598501803","doi":"10.1002/ajh.24741","title":"Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Glanzmann's thrombasthenia; Thrombasthenia; Platelet; Internal medicine; Surgery; Cardiology; Platelet aggregation","score_opus":0.017927975080819353,"score_gpt":0.32580165929613,"score_spread":0.30787368421531064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598501803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84603363,0.0020016371,0.019147478,0.0008779893,0.00030717885,0.03334077,0.067360744,0.00086179405,0.03006877],"genre_scores_gemma":[0.89716804,0.0010569196,0.020576283,0.00065971847,0.0002829564,0.02097537,0.054717705,0.00024923185,0.004313741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9684549,0.009360117,0.01217019,0.002843515,0.0057796906,0.0013916353],"domain_scores_gemma":[0.9009292,0.014944134,0.040900182,0.012566845,0.028042842,0.0026166937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035694648,0.0007974762,0.0017429007,0.0074090715,0.0010422013,0.0015416186,0.0013341461,0.00067470025,0.003371169],"category_scores_gemma":[0.05149858,0.00054699654,0.001159005,0.006224896,0.0007496329,0.0011433483,0.0024632988,0.0010475616,0.0017609375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035599442,0.00037303963,0.9407836,0.0005219424,0.00032797136,0.0002261381,0.0010293758,0.00056444795,0.0012439921,0.0005792951,0.015485757,0.03530444],"study_design_scores_gemma":[0.00061518856,0.0007020125,0.9675955,0.0002894649,0.0003558897,0.0006143156,0.00059497636,0.0032609971,0.0022736455,0.00037114543,0.023240833,0.00008606874],"about_ca_topic_score_codex":0.0036292921,"about_ca_topic_score_gemma":0.0059168716,"teacher_disagreement_score":0.035694648,"about_ca_system_score_codex":0.0013371832,"about_ca_system_score_gemma":0.0031956802,"threshold_uncertainty_score":0.18877357},"labels":[],"label_agreement":null},{"id":"W2603194473","doi":"10.1002/ajh.24740","title":"Monocytosis in polycythemia vera: Clinical and molecular correlates","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monocytosis; Leukocytosis; Medicine; Chronic myelomonocytic leukemia; Internal medicine; Gastroenterology; Myelofibrosis; Univariate analysis; Myeloid; Neutrophilia; Myelodysplastic syndromes; Bone marrow; Multivariate analysis","score_opus":0.021558517347115398,"score_gpt":0.35488325895712824,"score_spread":0.33332474161001285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603194473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988354,0.0006163104,0.00012461256,0.00004317133,0.0000071377094,0.000005313398,0.00010633661,0.0000032507762,0.00025835793],"genre_scores_gemma":[0.9997793,0.00006957565,0.00004020533,0.000008188923,0.000014416198,0.0000015664676,0.00006324933,3.8905992e-7,0.000023127512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971205,0.000117538206,0.000037387512,0.000040080657,0.000044626046,0.00004826215],"domain_scores_gemma":[0.99864036,0.0004415619,0.0005212956,0.00005589163,0.0001279349,0.00021290287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465871,0.00017991508,0.00018881456,0.00055132585,0.00022939865,0.00035308936,0.0001578781,0.00022151858,0.0011534761],"category_scores_gemma":[0.0017420249,0.00011091197,0.00011861558,0.0005680597,0.00031124428,0.00021689865,0.00024563842,0.0003135686,0.00014342567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014090288,0.000011497027,0.9976059,0.000009010978,0.000012263114,0.00018202949,0.000013632201,0.000034755514,0.0008188202,0.000013231861,0.000051682993,0.0011061254],"study_design_scores_gemma":[0.0000087775425,0.0001229409,0.99694186,0.000007105065,0.000017095428,0.0020775392,0.00008297578,0.00033928888,0.00020293162,0.00006195419,0.00013460066,0.0000028875397],"about_ca_topic_score_codex":0.00068796915,"about_ca_topic_score_gemma":0.0009536149,"teacher_disagreement_score":0.0011534761,"about_ca_system_score_codex":0.00013713099,"about_ca_system_score_gemma":0.00014370108,"threshold_uncertainty_score":0.003858745},"labels":[],"label_agreement":null},{"id":"W2617335676","doi":"10.1002/ajh.24801","title":"Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Enzyme replacement therapy; Glucocerebrosidase; Medicine; Disease; Gaucher's disease; Pediatrics; Internal medicine","score_opus":0.024376949542531626,"score_gpt":0.3534491133295444,"score_spread":0.32907216378701276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617335676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959881,0.0006749975,0.00010354542,0.00007355407,0.000009918054,0.000022152586,0.0017595511,0.0000091879165,0.001358874],"genre_scores_gemma":[0.9969695,0.00018209856,0.000087705026,0.000060419094,0.00000912399,0.000015255185,0.002445976,0.000005356928,0.00022450216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990074,0.00019240746,0.00015062162,0.00027798832,0.00015595203,0.00021553032],"domain_scores_gemma":[0.99742764,0.0002693635,0.0015505446,0.00019219464,0.00031052783,0.00024970513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010870493,0.00015733362,0.00042029427,0.00085885683,0.00033081594,0.0007962988,0.00037682574,0.00031805443,0.0011960577],"category_scores_gemma":[0.0034197485,0.00017877773,0.00048243892,0.0012739932,0.00018529817,0.00051420886,0.0005607207,0.0004977382,0.00032575775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021511191,0.000018826679,0.9971033,0.000010122649,0.000038453956,0.00011669874,0.000082416766,0.000031757918,0.0001513565,0.000032468586,0.0002583168,0.001941148],"study_design_scores_gemma":[0.000007084422,0.00004827953,0.9986738,0.000009819766,0.000024582274,0.0004713854,0.00009495074,0.00006200131,0.00006051828,0.000015914433,0.00052755466,0.000004138672],"about_ca_topic_score_codex":0.007506406,"about_ca_topic_score_gemma":0.008866442,"teacher_disagreement_score":0.007506406,"about_ca_system_score_codex":0.0005745222,"about_ca_system_score_gemma":0.00060685084,"threshold_uncertainty_score":0.01492542},"labels":[],"label_agreement":null},{"id":"W2724756454","doi":"10.1002/ajh.24832","title":"Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Medicine; Mucocutaneous zone; Telangiectasia; ACVRL1; Endoglin; Anemia; Gastrointestinal bleeding; Gastroenterology; Internal medicine; Genetic disorder; Dermatology; Pathology; Disease","score_opus":0.007948102240533907,"score_gpt":0.25543178065029437,"score_spread":0.24748367840976046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724756454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969332,0.0014128431,0.00008248912,0.00012592647,0.000013162057,0.000009306952,0.00048498606,0.000012030991,0.00092602405],"genre_scores_gemma":[0.99905497,0.00029940577,0.00009129627,0.000023752997,0.00002167606,0.0000058709193,0.00037081848,0.000002973731,0.00012920742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996395,0.00007391546,0.00006313864,0.00006735453,0.00008675894,0.00006924061],"domain_scores_gemma":[0.99844307,0.00027874904,0.00061675604,0.00005017858,0.00022384533,0.0003873817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060878025,0.00028350658,0.000314393,0.0014039744,0.00038155718,0.00060060964,0.00044803577,0.00050994847,0.002421182],"category_scores_gemma":[0.002677603,0.00027806172,0.0003278758,0.0013877327,0.00027043506,0.00046869676,0.0004152649,0.0007075482,0.0003750045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032618467,0.000015878199,0.9990976,0.000004349987,0.000012990664,0.000076439625,0.000016712811,0.000020124133,0.00004728732,0.000008735379,0.000090016016,0.0005772453],"study_design_scores_gemma":[0.0000030277597,0.000053610267,0.9986904,0.000011587744,0.000023949211,0.0007077598,0.00009670687,0.00023720984,0.000026992127,0.000036697387,0.00010802918,0.0000040914206],"about_ca_topic_score_codex":0.0062671998,"about_ca_topic_score_gemma":0.0047171623,"teacher_disagreement_score":0.0062671998,"about_ca_system_score_codex":0.0002835082,"about_ca_system_score_gemma":0.00031462387,"threshold_uncertainty_score":0.012461424},"labels":[],"label_agreement":null},{"id":"W2734059981","doi":"10.1002/ajh.24842","title":"ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Predictive power; Medicine; Internal medicine","score_opus":0.041434262351583755,"score_gpt":0.34633243900680855,"score_spread":0.3048981766552248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734059981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94031274,0.0027576624,0.02092623,0.00082025846,0.00033581865,0.0012055655,0.012304781,0.0009201027,0.02041686],"genre_scores_gemma":[0.9719676,0.000498708,0.01451235,0.0002456327,0.00020647906,0.0006346897,0.009618693,0.00009378124,0.0022221159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983789,0.00046330507,0.00023229962,0.00023547563,0.0005520245,0.00013807735],"domain_scores_gemma":[0.99133694,0.002998874,0.0027429867,0.00043391495,0.002053369,0.00043398363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046386924,0.0009387732,0.0009109683,0.004337416,0.000309093,0.0013716585,0.00092008954,0.0006059336,0.0033888973],"category_scores_gemma":[0.013869093,0.0001362456,0.0013899144,0.0018017243,0.00046476937,0.0006225808,0.0010488894,0.0008940247,0.0008348281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018498824,0.0002453157,0.86938274,0.00029694414,0.0007470349,0.00013263026,0.00019388199,0.005095905,0.002077589,0.00069779746,0.010647521,0.10863275],"study_design_scores_gemma":[0.0006014213,0.0012876656,0.95985824,0.00022208111,0.0006964537,0.001411192,0.00011960261,0.02116796,0.0013213704,0.0011720059,0.012040775,0.00010127008],"about_ca_topic_score_codex":0.005351367,"about_ca_topic_score_gemma":0.0044853664,"teacher_disagreement_score":0.005351367,"about_ca_system_score_codex":0.00074679224,"about_ca_system_score_gemma":0.0016696373,"threshold_uncertainty_score":0.02453202},"labels":[],"label_agreement":null},{"id":"W2738096170","doi":"10.1002/ajh.24871","title":"Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non‐transfused cohorts","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Renal function; Albuminuria; Creatinine; Urology; Internal medicine; Kidney disease; Glomerular hyperfiltration; Kidney; Diabetic nephropathy","score_opus":0.013791860485723355,"score_gpt":0.2634233961170121,"score_spread":0.24963153563128873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738096170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762887,0.00020208176,0.00006246217,0.00002345794,0.0000027840858,0.000015004593,0.0018275328,0.0000036910976,0.000234143],"genre_scores_gemma":[0.9953302,0.00019013832,0.00011532033,0.000036677866,0.00001039922,0.000044850418,0.0040746094,0.0000050452295,0.00019273843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995447,0.00010109526,0.00007073071,0.0001098212,0.000116017094,0.000057558416],"domain_scores_gemma":[0.99866164,0.00013753325,0.0006583018,0.00015234276,0.0001458112,0.0002442821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009636892,0.00028506343,0.0005787878,0.00077112933,0.00027186467,0.00044577816,0.0003132707,0.0002935743,0.0010503703],"category_scores_gemma":[0.0017164799,0.00020473928,0.0004312096,0.001324868,0.00021144138,0.00053876924,0.00042276495,0.0005393606,0.00012684814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015802466,0.00007521866,0.9951277,0.00003118722,0.00019936467,0.00006878403,0.00011372942,0.00008944218,0.0006046985,0.00004142821,0.00045701183,0.0016112244],"study_design_scores_gemma":[0.000065740016,0.0002892514,0.9991021,0.0000043536925,0.000044339868,0.00010390076,0.000044928292,0.00009798046,0.00006992158,0.000010612886,0.00016386167,0.0000031187815],"about_ca_topic_score_codex":0.0072795195,"about_ca_topic_score_gemma":0.007975479,"teacher_disagreement_score":0.0072795195,"about_ca_system_score_codex":0.00040560297,"about_ca_system_score_gemma":0.00028013723,"threshold_uncertainty_score":0.014474273},"labels":[],"label_agreement":null},{"id":"W2739756331","doi":"10.1002/ajh.24877","title":"Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trial","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi Genzyme","keywords":"Medicine; Disease; Phase (matter); Pediatrics; Internal medicine; Physics","score_opus":0.03070885738041767,"score_gpt":0.36448212080545594,"score_spread":0.33377326342503827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739756331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922382,0.004009696,0.00017946097,0.00039587964,0.00015098156,0.00040213435,0.00095801055,0.00004054582,0.0016251765],"genre_scores_gemma":[0.99263716,0.001398258,0.00029690165,0.00080595026,0.00030763086,0.0007517682,0.002340165,0.000012547359,0.0014497319],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994299,0.00024451362,0.000053911946,0.00008630029,0.000063604,0.00012167727],"domain_scores_gemma":[0.99825937,0.0002665449,0.0006298419,0.0001264807,0.00012971679,0.00058804493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017106419,0.0009531861,0.0020296723,0.00025897077,0.0006114018,0.0010059442,0.00037801234,0.0014572435,0.0027010415],"category_scores_gemma":[0.0018718354,0.00024885428,0.0018195811,0.00033002874,0.00053868524,0.0010455477,0.00044423173,0.0024279973,0.0005829453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9054175,0.0111432085,0.021585621,0.0008168456,0.002560993,0.00027888946,0.00029885626,0.0009258537,0.0029461689,0.00021588472,0.003669867,0.05014034],"study_design_scores_gemma":[0.4841002,0.38229775,0.12110681,0.0002926371,0.0033321362,0.00056882366,0.0002562051,0.0012791955,0.0013451497,0.0008904329,0.004432179,0.00009858666],"about_ca_topic_score_codex":0.0006305273,"about_ca_topic_score_gemma":0.0012734934,"teacher_disagreement_score":0.0027010415,"about_ca_system_score_codex":0.00039926448,"about_ca_system_score_gemma":0.00047150056,"threshold_uncertainty_score":0.009046853},"labels":[],"label_agreement":null},{"id":"W2759976150","doi":"10.1002/ajh.24914","title":"Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia","year":2017,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pharmacokinetics; Medicine; Adverse effect; Dosing; Proteinuria; Internal medicine; Creatinine; Thalassemia; Pharmacology; Gastroenterology; Kidney","score_opus":0.007580817443427474,"score_gpt":0.2851408014773208,"score_spread":0.2775599840338933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759976150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998784,0.00041520098,0.00035399123,0.00006227768,0.0000074197087,0.000054761207,0.000056434623,0.00003604397,0.00022990908],"genre_scores_gemma":[0.99866545,0.00028876428,0.0004020014,0.00009170308,0.00001988085,0.00005740674,0.00015788231,0.000010801642,0.00030611194],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997485,0.00014344981,0.000012479923,0.00002975232,0.00004223974,0.00002361093],"domain_scores_gemma":[0.9996469,0.00009344927,0.00010111331,0.000040803865,0.000030354746,0.000087425295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006797836,0.0003817813,0.0006029322,0.00014806545,0.00016634684,0.0004332301,0.00026849026,0.00046740758,0.0008021011],"category_scores_gemma":[0.0006169713,0.00024803256,0.0003428385,0.00013600806,0.0003514971,0.00035715138,0.000118370626,0.0013540159,0.00022204894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17512387,0.025514036,0.013426854,0.0005594893,0.00057807023,0.0005489871,0.00063732825,0.0059589166,0.50948673,0.00028862263,0.0020500703,0.26582712],"study_design_scores_gemma":[0.046887897,0.8128743,0.057222035,0.00005123771,0.00046168148,0.0016859031,0.0002007936,0.011956137,0.06304601,0.0002661984,0.005298263,0.000049552433],"about_ca_topic_score_codex":0.00033295708,"about_ca_topic_score_gemma":0.0003271224,"teacher_disagreement_score":0.0008021011,"about_ca_system_score_codex":0.00020485293,"about_ca_system_score_gemma":0.0003893993,"threshold_uncertainty_score":0.0035951138},"labels":[],"label_agreement":null},{"id":"W2769980455","doi":"10.1002/ajh.24980","title":"Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia","year":2017,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Jewish General Hospital; Queen's University; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Randomized controlled trial; Cytarabine; Clinical trial; Oncology; Myeloid leukemia; Internal medicine; Intensive care medicine","score_opus":0.03236221611949127,"score_gpt":0.3474311390534881,"score_spread":0.31506892293399685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769980455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8622875,0.01917248,0.0067812027,0.020492619,0.0037280312,0.02870494,0.023742015,0.0011407426,0.033950463],"genre_scores_gemma":[0.8250274,0.008370563,0.025699785,0.029871983,0.0030424318,0.054980956,0.021691343,0.0002792077,0.031036384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99859375,0.0009103629,0.00003530515,0.00018101723,0.0001411292,0.0001383211],"domain_scores_gemma":[0.998558,0.00037534907,0.00026956073,0.0001201487,0.00008734921,0.00058954733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039298483,0.002493042,0.0021827498,0.0005536107,0.0005587533,0.0012969725,0.0013173969,0.0022384205,0.010200924],"category_scores_gemma":[0.003340061,0.00036107542,0.0021312889,0.00044550098,0.001009839,0.0019528526,0.00166195,0.0050438177,0.002014623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7912924,0.010852875,0.0033632999,0.0018638808,0.0017700148,0.0003865203,0.00025128276,0.0017750121,0.0075073894,0.0036831566,0.041161012,0.1360931],"study_design_scores_gemma":[0.8849256,0.090946086,0.0036115183,0.00023707346,0.0005710531,0.0002827268,0.00005655157,0.0012814456,0.0011332416,0.0021611964,0.014738397,0.000055138495],"about_ca_topic_score_codex":0.00057295547,"about_ca_topic_score_gemma":0.0017273262,"teacher_disagreement_score":0.010200924,"about_ca_system_score_codex":0.00093807135,"about_ca_system_score_gemma":0.0022622128,"threshold_uncertainty_score":0.034125447},"labels":[],"label_agreement":null},{"id":"W2783219391","doi":"10.1002/ajh.25034","title":"Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; Wellcome Trust; Wellcome","keywords":"Baseline (sea); Medicine; Multicenter study; Demography; Geography; Internal medicine; Political science; Randomized controlled trial","score_opus":0.0076588171572207495,"score_gpt":0.27428832989895274,"score_spread":0.26662951274173197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783219391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966624,0.0003377651,0.00011895971,0.00024695307,0.000009346765,0.0004274717,0.001045192,0.0000057521834,0.0011462101],"genre_scores_gemma":[0.9968707,0.00018139675,0.0002492584,0.00036973826,0.000020425807,0.0010205052,0.0009822872,0.0000073564893,0.000298344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809426,0.0009416987,0.00014410214,0.00024015272,0.00022256166,0.0003572302],"domain_scores_gemma":[0.99809843,0.00031391298,0.0007091525,0.00012353275,0.00022073735,0.0005342947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003323273,0.00052853784,0.0007869832,0.0005217638,0.0012672921,0.0012128326,0.00047718268,0.0007186592,0.002281064],"category_scores_gemma":[0.006036657,0.0003244569,0.00057564006,0.000951649,0.0005478661,0.0010922229,0.0011426819,0.00083541183,0.00040898006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01032775,0.0029380326,0.96176314,0.00021857528,0.00054521754,0.00061696547,0.0040840534,0.00023164577,0.0014796937,0.00033118462,0.0032546092,0.014209056],"study_design_scores_gemma":[0.0015730408,0.0045576566,0.9846934,0.0001709572,0.00036842702,0.0006194175,0.0034782793,0.00038234555,0.00022119728,0.00023586379,0.0036529521,0.00004645319],"about_ca_topic_score_codex":0.004034516,"about_ca_topic_score_gemma":0.00569904,"teacher_disagreement_score":0.004034516,"about_ca_system_score_codex":0.00045350942,"about_ca_system_score_gemma":0.0008645864,"threshold_uncertainty_score":0.017575324},"labels":[],"label_agreement":null},{"id":"W2793035957","doi":"10.1002/ajh.25059","title":"Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rivaroxaban; Venous thromboembolism; Warfarin; Internal medicine; Cancer; Low molecular weight heparin; Major bleeding; Heparin; Surgery; Thrombosis; Atrial fibrillation","score_opus":0.009411923762697514,"score_gpt":0.29101764082430387,"score_spread":0.28160571706160636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793035957","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97060704,0.024121972,0.00025146065,0.0007583558,0.000087309345,0.000077281016,0.0016604271,0.000008782264,0.0024272557],"genre_scores_gemma":[0.99547535,0.0029184748,0.00013292617,0.00019782891,0.00012006623,0.000027687143,0.0009914589,0.0000024674762,0.00013374825],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99561393,0.001523021,0.00082006253,0.00048195705,0.0013376847,0.00022333987],"domain_scores_gemma":[0.9847734,0.0045160176,0.008012042,0.0005568237,0.0014175413,0.00072419987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00497536,0.00014065893,0.00078385585,0.0008402922,0.00033414605,0.0012251905,0.000326181,0.0005119777,0.0009467992],"category_scores_gemma":[0.021479063,0.00013843336,0.0016777624,0.0016518648,0.00025767085,0.0007875466,0.00039924943,0.0008052982,0.00015036884],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005675842,0.00021998321,0.95314956,0.00042925746,0.0026520456,0.00008230448,0.00009460368,0.00032092707,0.00018472245,0.00017313543,0.0008197067,0.036197897],"study_design_scores_gemma":[0.00033185017,0.0024115162,0.992465,0.0001738471,0.0013901045,0.0003442291,0.00011203537,0.00073381356,0.00017424049,0.00022210417,0.0016240403,0.000017251616],"about_ca_topic_score_codex":0.0016663847,"about_ca_topic_score_gemma":0.0023590715,"teacher_disagreement_score":0.00497536,"about_ca_system_score_codex":0.0008097644,"about_ca_system_score_gemma":0.00071591884,"threshold_uncertainty_score":0.02631253},"labels":[],"label_agreement":null},{"id":"W2799641062","doi":"10.1002/ajh.25134","title":"Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Museums Association","keywords":"Placebo; Lenalidomide; Medicine; Clinical endpoint; Internal medicine; Multiple myeloma; Ixazomib; Quality of life (healthcare); Hazard ratio; Dexamethasone; Surgery; Gastroenterology; Randomized controlled trial; Confidence interval; Carfilzomib; Pathology","score_opus":0.06886877488201884,"score_gpt":0.3831735620730968,"score_spread":0.3143047871910779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799641062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819693,0.0079340935,0.00041728848,0.00070722075,0.00016314641,0.0018495384,0.004664949,0.00004428746,0.0022501422],"genre_scores_gemma":[0.9846193,0.0033402934,0.0009554065,0.0008592617,0.00021473473,0.002447321,0.005143887,0.000017353921,0.002402462],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99938905,0.00037890312,0.00002260751,0.0000556337,0.00008110706,0.00007259034],"domain_scores_gemma":[0.9992995,0.00017771269,0.00017088246,0.00002972138,0.00005881035,0.00026330136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019163797,0.00096822536,0.0015054847,0.00031031275,0.00031767227,0.00056235364,0.00045684408,0.0007697531,0.0030960965],"category_scores_gemma":[0.0009112057,0.00037200237,0.001527527,0.00039424287,0.00042420832,0.00025380455,0.00031145473,0.0019159392,0.0002451352],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92335296,0.00809883,0.009261569,0.0015089832,0.0039528008,0.00007615325,0.00015075282,0.0011945985,0.010538435,0.00012886655,0.0036183144,0.038117677],"study_design_scores_gemma":[0.73372376,0.16814442,0.08722184,0.00012627314,0.0032802124,0.00014078837,0.00005968892,0.001125023,0.0022368643,0.00013759418,0.003758876,0.00004466143],"about_ca_topic_score_codex":0.001363737,"about_ca_topic_score_gemma":0.0038281425,"teacher_disagreement_score":0.0030960965,"about_ca_system_score_codex":0.000568742,"about_ca_system_score_gemma":0.0006929434,"threshold_uncertainty_score":0.010357499},"labels":[],"label_agreement":null},{"id":"W2799711263","doi":"10.1002/ajh.25125","title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Placebo; Syk; Adverse effect; Internal medicine; Immune thrombocytopenia; Splenectomy; Nausea; Gastroenterology; Clinical endpoint; Randomized controlled trial; Platelet; Spleen; Tyrosine kinase; Receptor","score_opus":0.027664849115529702,"score_gpt":0.3570882363265265,"score_spread":0.3294233872109968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799711263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74458504,0.2229123,0.0031519427,0.007052941,0.0018987268,0.007713612,0.0051961546,0.00041751837,0.0070718094],"genre_scores_gemma":[0.91711605,0.06176981,0.0034610669,0.00477783,0.0010744117,0.006014742,0.0036543743,0.000059960254,0.0020717955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985447,0.00067173596,0.00022790437,0.00022300277,0.00020044016,0.00013223798],"domain_scores_gemma":[0.99825984,0.00057197636,0.00057112414,0.0000921248,0.00023306363,0.00027200775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046714414,0.001290254,0.0030869597,0.00036220485,0.0003536076,0.0012333256,0.00074874546,0.002088807,0.0034001719],"category_scores_gemma":[0.004185226,0.000372807,0.003334144,0.000644612,0.00062726036,0.0011159033,0.00026136494,0.001823565,0.00045010613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80427456,0.0036520972,0.002563769,0.010260304,0.011450329,0.0001626851,0.0001886367,0.00074076164,0.007707248,0.00037197588,0.006923025,0.15170456],"study_design_scores_gemma":[0.95523673,0.027333355,0.0065288874,0.00038834923,0.0036543391,0.00019608912,0.000042025455,0.00036866212,0.0007007373,0.00029974393,0.0052120807,0.00003897818],"about_ca_topic_score_codex":0.00064019643,"about_ca_topic_score_gemma":0.0018668718,"teacher_disagreement_score":0.0046714414,"about_ca_system_score_codex":0.0009148852,"about_ca_system_score_gemma":0.0010271197,"threshold_uncertainty_score":0.024705231},"labels":[],"label_agreement":null},{"id":"W2799775749","doi":"10.1002/ajh.25110","title":"Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rituximab; Immune thrombocytopenia; Observational study; Pediatrics; Splenectomy; Internal medicine; Lymphoma","score_opus":0.007807345850754926,"score_gpt":0.30327939581495145,"score_spread":0.2954720499641965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799775749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881455,0.0032918206,0.0015012475,0.0038535981,0.000061806844,0.00005689179,0.00026520537,0.000014796735,0.0028090628],"genre_scores_gemma":[0.9969426,0.00090114435,0.0014228115,0.00037371632,0.000041845884,0.000021352289,0.00014127472,0.000004914845,0.00015028121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994538,0.004229471,0.00024931197,0.00023969356,0.00035488608,0.0003886761],"domain_scores_gemma":[0.9749921,0.018800825,0.0043062293,0.00024006091,0.00035466475,0.0013060645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043234234,0.0002712071,0.0005473003,0.0006144854,0.0006626573,0.0013718505,0.0003594487,0.0007731027,0.0025733698],"category_scores_gemma":[0.026474658,0.00029582452,0.00083003595,0.0008479737,0.0005290905,0.0005731996,0.0005401302,0.0012119331,0.00024302398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012528982,0.00033819946,0.9226928,0.00019563829,0.00046689226,0.0008719531,0.0016835771,0.0042603947,0.00014212601,0.0010667047,0.004687241,0.062341463],"study_design_scores_gemma":[0.0008167667,0.0013273936,0.93575424,0.00080619205,0.0005150652,0.0048216977,0.005690697,0.03300805,0.00078032474,0.0058861235,0.01045592,0.0001375051],"about_ca_topic_score_codex":0.006413762,"about_ca_topic_score_gemma":0.008094645,"teacher_disagreement_score":0.006413762,"about_ca_system_score_codex":0.001448061,"about_ca_system_score_gemma":0.0018252765,"threshold_uncertainty_score":0.0228647},"labels":[],"label_agreement":null},{"id":"W2799971934","doi":"10.1002/ajh.25123","title":"Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CXCL13; Medicine; Chemokine; Immunology; Cytokine; Pathogenesis; Germinal center; Hypergammaglobulinemia; Antibody; Inflammation; Chemokine receptor; B cell","score_opus":0.010089957079526878,"score_gpt":0.2780532486777299,"score_spread":0.26796329159820304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799971934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842536,0.00080851157,0.00022493552,0.00004711129,0.00000745642,0.000009039158,0.000154984,0.000014528101,0.0003080588],"genre_scores_gemma":[0.99880636,0.000196678,0.00047542911,0.000067521534,0.0000144684545,0.000007064891,0.000279125,0.0000031451902,0.00015009893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982554,0.00002494322,0.000017708828,0.00003924359,0.000054335822,0.00003821351],"domain_scores_gemma":[0.9998486,0.000023468849,0.000051207226,0.000009584937,0.000029444955,0.000037567042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023759676,0.00030023884,0.00034139055,0.00092601636,0.00042501706,0.00046886833,0.00014143104,0.0004494341,0.0006692408],"category_scores_gemma":[0.00031442926,0.00016514448,0.00021873537,0.0006238088,0.0002738005,0.00019718558,0.00028439157,0.00033078346,0.0001628137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022618952,0.00015368445,0.2710284,0.0002243176,0.00016286648,0.0036780227,0.0005827591,0.00036355256,0.7023236,0.00011212655,0.0007207608,0.018388089],"study_design_scores_gemma":[0.000028922668,0.0004059063,0.9708086,0.000018177408,0.000047902467,0.0057848734,0.00028281318,0.0009165109,0.02022758,0.00010433049,0.0013619562,0.0000124772905],"about_ca_topic_score_codex":0.00080086815,"about_ca_topic_score_gemma":0.0010770238,"teacher_disagreement_score":0.00092601636,"about_ca_system_score_codex":0.00028360038,"about_ca_system_score_gemma":0.00014283457,"threshold_uncertainty_score":0.00223881},"labels":[],"label_agreement":null},{"id":"W2885564727","doi":"10.1002/ajh.25245","title":"A common functional <i>PIEZO1</i> deletion allele associates with red blood cell density in sickle cell disease patients","year":2018,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Genentech; Johns Hopkins University; National Institutes of Health; Alnylam Pharmaceuticals; Novo Nordisk; Doris Duke Charitable Foundation","keywords":"PIEZO1; Allele; Sickle cell anemia; Medicine; Internal medicine; Immunology; Biology; Genetics; Disease; Gene; Mechanosensitive channels","score_opus":0.006793025150322906,"score_gpt":0.20960515029112964,"score_spread":0.20281212514080674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885564727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923253,0.00009629035,0.00020603862,0.0000298204,0.000004051988,0.0000144184705,0.00017177174,0.00000830189,0.0002368362],"genre_scores_gemma":[0.9993093,0.000063745036,0.0002748589,0.000037134236,0.000013386082,0.000012651047,0.00019233789,0.0000054115726,0.00009123664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999589,0.00007399466,0.000055034852,0.00015757295,0.00007876668,0.000045581703],"domain_scores_gemma":[0.999044,0.00022638263,0.00037418777,0.00006320197,0.000103739185,0.0001884278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041688338,0.00055773254,0.000431279,0.0010944929,0.00087195623,0.0004715597,0.00039703553,0.00052097294,0.0023140095],"category_scores_gemma":[0.0014300402,0.00019625,0.000301986,0.0007556933,0.0004448826,0.00023181413,0.00051146897,0.0004277287,0.00018618937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006729176,0.000118297125,0.97430134,0.00003472709,0.00011113516,0.0045473273,0.00044425478,0.00015229701,0.013909223,0.00019503507,0.00046479754,0.0050486005],"study_design_scores_gemma":[0.000039519487,0.00026356592,0.9852545,0.000022317376,0.000086120905,0.011443449,0.00016582882,0.00042286288,0.0016363002,0.000152613,0.00049456896,0.000018331568],"about_ca_topic_score_codex":0.0021174175,"about_ca_topic_score_gemma":0.0015010793,"teacher_disagreement_score":0.0023140095,"about_ca_system_score_codex":0.00021235379,"about_ca_system_score_gemma":0.0002491009,"threshold_uncertainty_score":0.0077410936},"labels":[],"label_agreement":null},{"id":"W2888496958","doi":"10.1002/ajh.25259","title":"Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Cilag; Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Obinutuzumab; Chemoimmunotherapy; Medicine; Ofatumumab; Fludarabine; Chronic lymphocytic leukemia; Internal medicine; Rituximab; Bendamustine; Oncology; Cyclophosphamide; Alemtuzumab; Neutropenia; Venetoclax; Leukemia; Chemotherapy; Lymphoma; Transplantation","score_opus":0.0710266598013649,"score_gpt":0.43057955698391287,"score_spread":0.35955289718254796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888496958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96609646,0.02767503,0.0007207988,0.00034619498,0.00057026895,0.0026019332,0.0005477029,0.0000412849,0.0014002911],"genre_scores_gemma":[0.9855532,0.007895237,0.00093346334,0.00072570186,0.00042443426,0.0026002019,0.00091845635,0.000018064955,0.00093117025],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99683595,0.0020231958,0.00043617544,0.0003037869,0.00018932861,0.00021145822],"domain_scores_gemma":[0.9965718,0.0014006699,0.0010420476,0.00027730555,0.00030079106,0.00040742502],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0065341806,0.001101439,0.002647131,0.00063203205,0.00029992472,0.001568849,0.00073916046,0.0016595434,0.0028718493],"category_scores_gemma":[0.0042125126,0.000528463,0.0047124433,0.000654298,0.0007762641,0.0013745793,0.0005006407,0.0021095853,0.0004769428],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96170694,0.0051312307,0.0012734011,0.0016262082,0.007848851,0.000038139053,0.00009881853,0.00033898614,0.0028639706,0.000093720955,0.00024964215,0.018730102],"study_design_scores_gemma":[0.67605275,0.30087516,0.009376569,0.0003074888,0.00891498,0.00009760368,0.00010403124,0.0005343609,0.00126977,0.00024844712,0.002168306,0.000050479906],"about_ca_topic_score_codex":0.00036050755,"about_ca_topic_score_gemma":0.0009544257,"teacher_disagreement_score":0.9973529,"about_ca_system_score_codex":0.00082259055,"about_ca_system_score_gemma":0.00067445496,"threshold_uncertainty_score":0.03455645},"labels":[],"label_agreement":null},{"id":"W2890915995","doi":"10.1002/ajh.25284","title":"The “American (cancer) patients first” plan to reduce drug prices—A critical assessment","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer drugs; Prescription drug; Reimbursement; Drug prices; Health care; Medical prescription; Competition (biology); Actuarial science; Patient Protection and Affordable Care Act; Business; Health insurance; Medicine; Drug; Finance; Public economics; Economics; Economic growth; Pharmacology","score_opus":0.018034998622509898,"score_gpt":0.30256395135945496,"score_spread":0.28452895273694506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890915995","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010664049,0.025294023,0.00047069605,0.9589924,0.0059988224,0.000029000665,0.00006674355,0.000073251394,0.00800867],"genre_scores_gemma":[0.04983993,0.07828483,0.0038939742,0.8348293,0.026946822,0.00019265716,0.00027325028,0.00015181961,0.0055874116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98615706,0.004623563,0.0008163728,0.0008658295,0.0063198814,0.0012173145],"domain_scores_gemma":[0.9496854,0.015752634,0.0023798647,0.0014651144,0.011784482,0.018932607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019858032,0.0011316,0.0013836372,0.0016480373,0.0055407505,0.011894033,0.004526431,0.0154676605,0.021733806],"category_scores_gemma":[0.055460647,0.0007611089,0.0014738357,0.0015640738,0.005650767,0.014292403,0.0050463835,0.025581524,0.0039497134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013818986,0.0002293591,0.0011009878,0.00056609925,0.00008097649,0.00020373646,0.0003221841,0.00019984426,0.00013812319,0.027210651,0.79989,0.16991983],"study_design_scores_gemma":[0.00020260837,0.00051413255,0.0037054983,0.0042414605,0.00010981431,0.00056321174,0.0018160614,0.00067554286,0.0002961793,0.03726874,0.95050526,0.000101390535],"about_ca_topic_score_codex":0.0070567587,"about_ca_topic_score_gemma":0.014752367,"teacher_disagreement_score":0.021733806,"about_ca_system_score_codex":0.008186965,"about_ca_system_score_gemma":0.03356034,"threshold_uncertainty_score":0.10502058},"labels":[],"label_agreement":null},{"id":"W2892305705","doi":"10.1002/ajh.25273","title":"A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Dosing; Adverse effect; Myocardial infarction; Placebo; Internal medicine; Acute coronary syndrome; Platelet; Pharmacology; Anesthesia","score_opus":0.005830681435395879,"score_gpt":0.2717543100705577,"score_spread":0.26592362863516184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892305705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992994,0.0016941421,0.00045449153,0.0003212652,0.000092315575,0.001940025,0.0014751388,0.00008184082,0.0009467202],"genre_scores_gemma":[0.98357564,0.0032195116,0.0021697483,0.0015344343,0.00023141826,0.0036281438,0.0030206908,0.000055473894,0.0025648645],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993123,0.00030758794,0.0000344691,0.00009801499,0.00009684501,0.00015088903],"domain_scores_gemma":[0.9990606,0.00013666363,0.00019517905,0.0000828187,0.000083597784,0.0004411053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018634072,0.0016858901,0.002427706,0.00044191023,0.00039501503,0.000836905,0.00072990666,0.0013078201,0.0035249186],"category_scores_gemma":[0.0009822886,0.000656078,0.0020789772,0.0004610487,0.00076463656,0.00064828305,0.0003687009,0.0032396629,0.00080736546],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71779394,0.12955306,0.03133232,0.001003289,0.0039627072,0.0014722338,0.0006653221,0.0028254583,0.044403568,0.00051108573,0.006868838,0.05960813],"study_design_scores_gemma":[0.48198298,0.46747094,0.039538346,0.00004994085,0.00090668286,0.0008923626,0.00011778366,0.00093950925,0.003142445,0.00017834397,0.0047219107,0.00005879668],"about_ca_topic_score_codex":0.0019734774,"about_ca_topic_score_gemma":0.0026297711,"teacher_disagreement_score":0.0035249186,"about_ca_system_score_codex":0.0009612157,"about_ca_system_score_gemma":0.0019765387,"threshold_uncertainty_score":0.011792064},"labels":[],"label_agreement":null},{"id":"W2892405030","doi":"10.1002/ajh.25296","title":"Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Portola Pharmaceuticals","keywords":"Medicine; Quartile; Internal medicine; Albumin; Odds ratio; Hypoalbuminemia; Gastroenterology; Venous thromboembolism; Surgery; Confidence interval; Thrombosis","score_opus":0.011655674733558533,"score_gpt":0.2711215888406412,"score_spread":0.25946591410708264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892405030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163556,0.0052887145,0.0003859562,0.00034085207,0.00008210392,0.000088900975,0.0012997611,0.000016445812,0.00086162216],"genre_scores_gemma":[0.99576557,0.0011909651,0.0003280657,0.00020518145,0.00015316477,0.00011033855,0.001914988,0.00001378078,0.0003180477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788433,0.0013286152,0.00019470067,0.0002689289,0.00020391966,0.000119470045],"domain_scores_gemma":[0.9934441,0.0032355965,0.0016007139,0.0007765357,0.00032125603,0.0006217913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00453198,0.00076789624,0.0019790404,0.00028098546,0.00020825944,0.0015662146,0.0006595257,0.0006653902,0.0017944331],"category_scores_gemma":[0.0085326405,0.00032080192,0.0028428813,0.0005736336,0.00036022547,0.0006397768,0.0007394729,0.0016529418,0.00020278653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42842242,0.0007728531,0.50146675,0.0023079468,0.03415126,0.00045502462,0.00022394779,0.0027171732,0.0020884743,0.0006388293,0.0038896776,0.022865674],"study_design_scores_gemma":[0.076725125,0.014891787,0.8493384,0.0005127595,0.04129769,0.00072614255,0.00023496021,0.010152662,0.0007005912,0.0022642445,0.0030088604,0.00014683227],"about_ca_topic_score_codex":0.001023389,"about_ca_topic_score_gemma":0.0011349721,"teacher_disagreement_score":0.00453198,"about_ca_system_score_codex":0.00031440976,"about_ca_system_score_gemma":0.0004634868,"threshold_uncertainty_score":0.023967683},"labels":[],"label_agreement":null},{"id":"W2895436157","doi":"10.1002/ajh.25305","title":"Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Point of care; Newborn screening; Point-of-care testing; Sickle cell trait; Disease; Sickle cell anemia; Pediatrics; Anemia; Dipstick; Internal medicine; Immunology; Pathology","score_opus":0.012646056030886187,"score_gpt":0.28882393077649976,"score_spread":0.27617787474561356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895436157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777967,0.00042634815,0.0005032799,0.000110097186,0.000008784282,0.0001777603,0.00041823124,0.000020903388,0.0005550284],"genre_scores_gemma":[0.9975758,0.00020958605,0.0015766083,0.0000650025,0.000010349483,0.00008556772,0.00038293714,0.0000036138733,0.0000905391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985933,0.000701113,0.00011214899,0.00024810468,0.00023202666,0.00011336312],"domain_scores_gemma":[0.997614,0.00037967318,0.00075632293,0.000116442156,0.0007574814,0.00037607495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022209582,0.0004950565,0.00049638026,0.00096030615,0.0004766467,0.000614829,0.0005201237,0.00040067543,0.0006933705],"category_scores_gemma":[0.004216671,0.00034581008,0.0003035829,0.0008009364,0.00026161625,0.0003700136,0.00087304355,0.0004153633,0.00016882847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037831883,0.00018052412,0.98859197,0.000062148574,0.00007122685,0.00025114184,0.00034878717,0.00013025365,0.001413433,0.000025046149,0.000532233,0.008014925],"study_design_scores_gemma":[0.00007319151,0.0010361201,0.9952786,0.000055953293,0.000055964018,0.00089000247,0.00040470922,0.001225184,0.00047473022,0.00002123634,0.00047099002,0.000013280038],"about_ca_topic_score_codex":0.0074928687,"about_ca_topic_score_gemma":0.0081044175,"teacher_disagreement_score":0.0074928687,"about_ca_system_score_codex":0.00084151817,"about_ca_system_score_gemma":0.00072591763,"threshold_uncertainty_score":0.014898539},"labels":[],"label_agreement":null},{"id":"W2900157951","doi":"10.1002/ajh.25343","title":"Development of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO<sup>©</sup>)","year":2018,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Celgene; Sanofi","keywords":"Medicine; Quality of life (healthcare); Thalassemia; Physical therapy; Internal medicine; Nursing","score_opus":0.006970634728578485,"score_gpt":0.24483701213062634,"score_spread":0.23786637740204786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900157951","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760473,0.00046656525,0.005896304,0.000719043,0.0001223915,0.004727212,0.0059669684,0.00008438063,0.0059698257],"genre_scores_gemma":[0.95970154,0.0003213366,0.026218168,0.0003050579,0.00003152998,0.007471931,0.004845465,0.000014741307,0.0010901839],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971073,0.001472326,0.0006524415,0.0001553197,0.00048145774,0.00013116903],"domain_scores_gemma":[0.99261206,0.0027725897,0.002265579,0.00020668915,0.0016936286,0.00044946186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046976944,0.00036403714,0.00047577315,0.0009982564,0.00030284864,0.00064099656,0.0004740445,0.00036919804,0.0020545158],"category_scores_gemma":[0.011273804,0.00019250372,0.001272244,0.00070147647,0.00014591528,0.00069480686,0.0008030434,0.000774843,0.0003276886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018966992,0.0022305122,0.8060846,0.0010404693,0.00049756066,0.0002589373,0.0022681626,0.0017978904,0.0028322442,0.00085098,0.010601112,0.16964081],"study_design_scores_gemma":[0.00044330835,0.0026186816,0.9794263,0.00019638454,0.000152958,0.00038566443,0.0015989211,0.0046710037,0.0014390894,0.00035468017,0.008653634,0.000059499882],"about_ca_topic_score_codex":0.0008163969,"about_ca_topic_score_gemma":0.0019462792,"teacher_disagreement_score":0.0046976944,"about_ca_system_score_codex":0.000633136,"about_ca_system_score_gemma":0.00085465866,"threshold_uncertainty_score":0.02484411},"labels":[],"label_agreement":null},{"id":"W2900357627","doi":"10.1002/ajh.25342","title":"Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors","year":2018,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Nilotinib; Dasatinib; Discontinuation; Medicine; Imatinib; Bosutinib; Clinical trial; Tyrosine-kinase inhibitor; Tyrosine kinase; Myeloid leukemia; Oncology; Intensive care medicine; Imatinib mesylate; Internal medicine; Cancer","score_opus":0.027303292112272524,"score_gpt":0.3110332930561482,"score_spread":0.2837300009438757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900357627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010833376,0.9983736,0.000058307956,0.00016764873,0.00012615063,0.000006256387,0.00002732344,0.0000048816046,0.0011273903],"genre_scores_gemma":[0.0006763697,0.9985393,0.00010596378,0.000144584,0.00007929466,0.000007919879,0.00004084379,0.0000011996705,0.0004043889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973565,0.00004796225,0.00004937499,0.000039359133,0.00010934313,0.000018395465],"domain_scores_gemma":[0.9997328,0.0001278331,0.000054336793,0.000009055501,0.000058306545,0.000017696482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047086613,0.00060437346,0.0012255271,0.0019392392,0.00026740963,0.0007303436,0.0006704266,0.0006911587,0.004572104],"category_scores_gemma":[0.0008951131,0.00018667038,0.00067308114,0.0016990207,0.00028881014,0.0009040858,0.00048618147,0.0012939076,0.0016560694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007249404,0.000052789248,0.0001523344,0.034024138,0.00012911818,0.00011842913,0.000052724743,0.00020800745,0.0010007598,0.0027966022,0.03385495,0.9275377],"study_design_scores_gemma":[0.000025761126,0.000076886885,0.0008722211,0.008165524,0.0001695372,0.0013158519,0.000044792792,0.000048855873,0.00031065184,0.0011313206,0.9878265,0.000012027751],"about_ca_topic_score_codex":0.0008337513,"about_ca_topic_score_gemma":0.0017787116,"teacher_disagreement_score":0.004572104,"about_ca_system_score_codex":0.00044281813,"about_ca_system_score_gemma":0.00096679945,"threshold_uncertainty_score":0.015295148},"labels":[],"label_agreement":null},{"id":"W2913633350","doi":"10.1002/ajh.25425","title":"How we diagnose and manage altered oxygen affinity hemoglobin variants","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University; University of Toronto","funders":"","keywords":"P50; Hemoglobin; Oxygen–haemoglobin dissociation curve; Oxygen; Pathophysiology; Hemoglobin variants; Globin; Medicine; Chemistry; Gene; Computational biology; Biology; Internal medicine; Biochemistry","score_opus":0.027600631122274254,"score_gpt":0.3042322498232529,"score_spread":0.2766316187009787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913633350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041789992,0.98851764,0.00094188,0.0054478473,0.0013820934,0.000013480572,0.00003560859,0.00003962051,0.0032039362],"genre_scores_gemma":[0.0030226924,0.9896818,0.0015246553,0.0027734595,0.0018886161,0.000016325113,0.00008464145,0.000007970928,0.0009998862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969757,0.000068983165,0.00006521068,0.00005371251,0.000088905676,0.000025706913],"domain_scores_gemma":[0.9994715,0.00021762798,0.00008115096,0.000016651533,0.00016349417,0.000049705326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047583051,0.0007408522,0.00089508796,0.0023193725,0.00038052537,0.0012618912,0.0008249792,0.0015252343,0.0022738508],"category_scores_gemma":[0.001958996,0.0002078502,0.00042588316,0.0010187761,0.0004753683,0.0023791306,0.0005635864,0.0026122339,0.002141226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039804712,0.00006675781,0.0011175296,0.007881177,0.000079984864,0.0025425104,0.00017930863,0.00032812625,0.0009927074,0.0034862484,0.0921762,0.8911096],"study_design_scores_gemma":[0.00002218219,0.000069256406,0.0029899844,0.014545161,0.000184399,0.043325786,0.00043119115,0.00025373514,0.00067583955,0.0084825605,0.9289682,0.000051621293],"about_ca_topic_score_codex":0.0014471773,"about_ca_topic_score_gemma":0.0017627741,"teacher_disagreement_score":0.0023193725,"about_ca_system_score_codex":0.00055951835,"about_ca_system_score_gemma":0.001081758,"threshold_uncertainty_score":0.0076068044},"labels":[],"label_agreement":null},{"id":"W2916734627","doi":"10.1002/ajh.25444","title":"Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; Hamilton Health Sciences","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Nausea; Immune thrombocytopenia; Placebo; Gastroenterology; Randomized controlled trial; Rituximab; Platelet","score_opus":0.022707622681206886,"score_gpt":0.37527865384977466,"score_spread":0.35257103116856775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916734627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808621,0.0096148085,0.0009434526,0.0011193433,0.00015987418,0.0024013363,0.001111995,0.0001364812,0.0036505582],"genre_scores_gemma":[0.9895347,0.0027134314,0.0013622043,0.0010911928,0.00011527948,0.002257401,0.0015251717,0.00001437708,0.0013863433],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947435,0.00027987084,0.000054206153,0.000052243468,0.00005081083,0.00008859479],"domain_scores_gemma":[0.99955434,0.00009515807,0.0001326593,0.00003565414,0.000051370855,0.00013091213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001952062,0.0005520286,0.0011963317,0.00014678217,0.00036461683,0.0006248194,0.00039648844,0.00079031545,0.0020930076],"category_scores_gemma":[0.0012242746,0.00018497335,0.0011365213,0.0002417133,0.0002969166,0.0005939691,0.00025328604,0.0014725204,0.00039762154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7011614,0.00697911,0.013071934,0.0019592626,0.0022050408,0.00046447577,0.0003228739,0.0012147913,0.018944615,0.0006676075,0.010247974,0.242761],"study_design_scores_gemma":[0.75969434,0.16232328,0.0501321,0.00022002406,0.0010904343,0.0014622738,0.00009685256,0.0016624475,0.005013862,0.00069575146,0.017556395,0.00005230781],"about_ca_topic_score_codex":0.000403687,"about_ca_topic_score_gemma":0.0014325879,"teacher_disagreement_score":0.0020930076,"about_ca_system_score_codex":0.00044727558,"about_ca_system_score_gemma":0.0008438114,"threshold_uncertainty_score":0.010323644},"labels":[],"label_agreement":null},{"id":"W2926453305","doi":"10.1002/ajh.25484","title":"Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Myeloid leukemia; Oncology; Internal medicine; Leukemia; Overall survival","score_opus":0.04014980143188264,"score_gpt":0.36836509498511977,"score_spread":0.32821529355323714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926453305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006232852,0.9995565,0.00001854296,0.00009685537,0.00004613985,0.0000017586863,0.000008345932,0.0000016868372,0.00020779087],"genre_scores_gemma":[0.0004982446,0.9992053,0.00003934463,0.000085790816,0.000046549318,0.0000031066827,0.000016940628,5.1538126e-7,0.00010422651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980587,0.00004742679,0.000035846355,0.000029545181,0.00006486468,0.000016522275],"domain_scores_gemma":[0.99968255,0.00016924857,0.000059185797,0.000006653032,0.00006356622,0.000018810939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061339734,0.00059996115,0.0012632079,0.0014882173,0.00016192655,0.00069636607,0.0008635918,0.0007171814,0.002861308],"category_scores_gemma":[0.0011212325,0.00014664102,0.0006359654,0.0014519638,0.0002776437,0.00078784535,0.0005085567,0.0010945899,0.0008139291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012519275,0.00003329464,0.00015362303,0.026999718,0.00015870706,0.000053916414,0.00003127378,0.00023566888,0.0003486865,0.0016788308,0.019127024,0.9510541],"study_design_scores_gemma":[0.00009464668,0.00026901127,0.0028998104,0.032057136,0.00082308345,0.0013657273,0.0001089036,0.00016036106,0.00040880838,0.0033281294,0.95845336,0.000031101375],"about_ca_topic_score_codex":0.0007954915,"about_ca_topic_score_gemma":0.0014018414,"teacher_disagreement_score":0.002861308,"about_ca_system_score_codex":0.00053181825,"about_ca_system_score_gemma":0.00080160605,"threshold_uncertainty_score":0.009572089},"labels":[],"label_agreement":null},{"id":"W2930335684","doi":"10.1002/ajh.25471","title":"Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso‐occlusive pain","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Maternal and Child Health Bureau; National Center for Complementary and Integrative Health; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Bolus (digestion); Emergency department; Sickle cell anemia; Anemia; Anesthesia; Vaso-occlusive crisis; Saline; Hemoglobin; Internal medicine; Disease","score_opus":0.002380926632563807,"score_gpt":0.19961123653444918,"score_spread":0.19723030990188536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930335684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964833,0.00017509637,0.00002228913,0.000016468048,0.0000021364747,0.000001959287,0.00004735185,0.0000010211683,0.000085277476],"genre_scores_gemma":[0.9997092,0.00013077717,0.00003970656,0.000012203282,0.0000033576182,0.0000023233579,0.000079231904,7.4021403e-7,0.000022560382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991806,0.00019267514,0.00014309405,0.00012609496,0.00023201572,0.00012554589],"domain_scores_gemma":[0.99661785,0.00077582547,0.002067073,0.00009086638,0.00018091976,0.00026739735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000555697,0.00016810783,0.00027418762,0.00043989703,0.00022227348,0.0005070809,0.0001944355,0.00026350323,0.00091470906],"category_scores_gemma":[0.004129663,0.00019717355,0.000308371,0.00058253313,0.00028367477,0.0003371607,0.00032242574,0.00054599775,0.00011898136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027375638,0.000014189161,0.99911207,0.0000048082065,0.000010435656,0.000063594016,0.000050405793,0.000012288576,0.000077840225,0.0000032362643,0.000022382586,0.00060143584],"study_design_scores_gemma":[0.0000015208851,0.000070446215,0.9992939,0.0000045697516,0.000006175902,0.00036836803,0.00012448634,0.000050586037,0.00003526766,0.0000030180688,0.00004038817,0.0000012176298],"about_ca_topic_score_codex":0.002435458,"about_ca_topic_score_gemma":0.003209853,"teacher_disagreement_score":0.002435458,"about_ca_system_score_codex":0.00027287405,"about_ca_system_score_gemma":0.00028607133,"threshold_uncertainty_score":0.0048425198},"labels":[],"label_agreement":null},{"id":"W2934060647","doi":"10.1002/ajh.25479","title":"Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Romiplostim; Medicine; Rituximab; Immune thrombocytopenia; Eltrombopag; Thrombopoietin; Internal medicine; Platelet; Observational study; Quality of life (healthcare); Splenectomy; Randomized controlled trial; Pediatrics","score_opus":0.004745746361677056,"score_gpt":0.24962198573607897,"score_spread":0.24487623937440192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934060647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234826,0.015034004,0.00013989596,0.00047383213,0.000049564587,0.000036656205,0.0007936705,0.000018034189,0.0011060078],"genre_scores_gemma":[0.9952035,0.0029818795,0.0003323177,0.0001839652,0.000039293896,0.000061908126,0.0010593383,0.0000045195416,0.00013334677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995061,0.00018159798,0.000050263683,0.00006384039,0.00011416936,0.000084031366],"domain_scores_gemma":[0.99851626,0.00033891655,0.000675924,0.000038098704,0.00008397033,0.000346964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074493355,0.00026809226,0.0007848802,0.00032666366,0.00016772021,0.00038387688,0.00016390656,0.00033626173,0.0008684335],"category_scores_gemma":[0.0021228136,0.00007827888,0.0012616364,0.00052077236,0.00015361702,0.0003381277,0.0002905315,0.0008409322,0.000099900404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007918602,0.0013950128,0.8713787,0.0008818658,0.0017052281,0.00041953288,0.00024340213,0.0007479121,0.0008207172,0.00019757039,0.0040779957,0.11021346],"study_design_scores_gemma":[0.0011415036,0.0071000294,0.9862066,0.00030089027,0.0008169317,0.0011827261,0.00017098493,0.0005028082,0.00053602725,0.00006884521,0.0019538715,0.000018717292],"about_ca_topic_score_codex":0.001793861,"about_ca_topic_score_gemma":0.0026164153,"teacher_disagreement_score":0.001793861,"about_ca_system_score_codex":0.0006330419,"about_ca_system_score_gemma":0.0004897072,"threshold_uncertainty_score":0.0045930743},"labels":[],"label_agreement":null},{"id":"W2934397726","doi":"10.1002/ajh.25475","title":"Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; Spark Therapeutics; Shionogi; Ochsner Health; Asahi Kasei Pharma Corporation; Bristol-Myers Squibb Canada; Thomas Jefferson University; Shire; CSL Behring; University of Washington; Johns Hopkins University; Henry Ford Health System; Alexion Pharmaceuticals; LEO Pharma Research Foundation; Pfizer; Heart and Stroke Foundation of Canada; Bayer; Kaiser Permanente; Novo Nordisk; Servier Canada","keywords":"Rivaroxaban; Dabigatran; Idarucizumab; Apixaban; Medicine; Intensive care medicine; Stewardship (theology); Warfarin; Atrial fibrillation; Internal medicine; Political science","score_opus":0.09804816687785856,"score_gpt":0.39920515714931276,"score_spread":0.3011569902714542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934397726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103243634,0.9789821,0.00035733354,0.013674365,0.0016484815,0.000048194965,0.00017652944,0.000025779247,0.0049840636],"genre_scores_gemma":[0.0004910096,0.99218714,0.001201591,0.0038887763,0.0005129614,0.000042546155,0.00021207731,0.0000060724756,0.0014577494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981281,0.00044482504,0.00040374213,0.0001170895,0.0008215033,0.000084796906],"domain_scores_gemma":[0.9957489,0.0016718336,0.0006422814,0.00006445821,0.0016682675,0.00020427811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030259052,0.0009827389,0.0012070455,0.0039822226,0.00042241684,0.0015509983,0.0013581081,0.0032223202,0.0056285276],"category_scores_gemma":[0.0080023315,0.00035777962,0.0012770382,0.0036569906,0.0006114851,0.0021215908,0.0008947162,0.0032659105,0.0030499683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035894478,0.000075249285,0.00021808431,0.016977588,0.00006257548,0.00014225503,0.0001640897,0.00016911821,0.00026253384,0.005789805,0.3876604,0.58844244],"study_design_scores_gemma":[0.0000235656,0.000030425506,0.00043772717,0.021183833,0.00006825309,0.00039167714,0.000049510767,0.000036135316,0.00006297641,0.0012515764,0.9764524,0.000011929738],"about_ca_topic_score_codex":0.008494105,"about_ca_topic_score_gemma":0.015425717,"teacher_disagreement_score":0.008494105,"about_ca_system_score_codex":0.0018416151,"about_ca_system_score_gemma":0.007887196,"threshold_uncertainty_score":0.018829286},"labels":[],"label_agreement":null},{"id":"W2963795579","doi":"10.1002/ajh.25590","title":"Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Measles; Medicine; Immunity; Hematopoietic stem cell transplantation; Immunology; Vaccination; Transplantation; Measles vaccine; Immune system; Internal medicine","score_opus":0.013638942982270164,"score_gpt":0.2522506622606989,"score_spread":0.23861171927842875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963795579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968606,0.0014257364,0.0002183667,0.000038140075,0.000016321635,0.00008670857,0.00025350193,0.000011741703,0.0010888694],"genre_scores_gemma":[0.99825317,0.00044630462,0.00016328586,0.00009261228,0.000046214223,0.00004024047,0.00072660024,0.000003798367,0.00022782],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994609,0.00009233597,0.00009211222,0.00008504847,0.00013280995,0.00013674812],"domain_scores_gemma":[0.9989378,0.00020084978,0.000559346,0.00005731265,0.00008287868,0.00016179292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006535548,0.00024376893,0.0007657431,0.00060156465,0.0003671861,0.00051854266,0.00030367234,0.00030523105,0.0010247085],"category_scores_gemma":[0.0016463209,0.00013048704,0.00037433888,0.00070739316,0.0003196409,0.00041318237,0.00047956067,0.0005922867,0.00021062243],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023773522,0.00022551742,0.9775869,0.0001333716,0.000081861195,0.004615026,0.00020456254,0.00017661878,0.0024362458,0.000056168396,0.0002475148,0.011858828],"study_design_scores_gemma":[0.000030769537,0.0015576183,0.9904287,0.000043147716,0.00006550373,0.0055474113,0.00018520429,0.00022819133,0.0009871441,0.00005936077,0.00085693155,0.000010061938],"about_ca_topic_score_codex":0.0010911978,"about_ca_topic_score_gemma":0.0015227485,"teacher_disagreement_score":0.0010911978,"about_ca_system_score_codex":0.0005029716,"about_ca_system_score_gemma":0.00050680933,"threshold_uncertainty_score":0.003649354},"labels":[],"label_agreement":null},{"id":"W2964265037","doi":"10.1002/ajh.25581","title":"IgA‐mediated autoimmune hemolytic anemia","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Coombs test; Haptoglobin; Internal medicine; Immunology; Cold Agglutinin; Hemolytic anemia; Spherocytosis; Hemolysis; Hereditary spherocytosis; Anemia; Gastroenterology; Antibody; Spleen; Splenectomy","score_opus":0.024920370886816527,"score_gpt":0.32345504839614014,"score_spread":0.2985346775093236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964265037","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92155236,0.014308497,0.0030907665,0.0030047751,0.0004768853,0.00029005465,0.0008541757,0.00048686733,0.055935685],"genre_scores_gemma":[0.99073374,0.002755847,0.0005673491,0.001103154,0.0003912721,0.000027528027,0.00019728547,0.000020987785,0.0042028264],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983287,0.000027865042,0.000013713712,0.000045770612,0.000024414996,0.00005529916],"domain_scores_gemma":[0.99979967,0.00004849482,0.000036974667,0.000020018007,0.000027792885,0.00006717664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016535136,0.0009296431,0.0005664091,0.00065716216,0.0006672865,0.00033475854,0.00037417372,0.0008192378,0.0030895642],"category_scores_gemma":[0.00064401573,0.00026414666,0.00032584099,0.00045827683,0.00030572963,0.00045457194,0.00032642987,0.0010276962,0.0009513788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025886498,0.00033823238,0.06538773,0.00015622735,0.00003716285,0.9052515,0.00027710228,0.00016505996,0.008414326,0.0006765077,0.003918475,0.015118865],"study_design_scores_gemma":[0.00005827348,0.0007072754,0.06352938,0.000088043555,0.000056295714,0.9246698,0.00014441584,0.00066236604,0.0013899913,0.00037016108,0.0083071785,0.000016837332],"about_ca_topic_score_codex":0.0011374706,"about_ca_topic_score_gemma":0.00093717215,"teacher_disagreement_score":0.0030895642,"about_ca_system_score_codex":0.00036579728,"about_ca_system_score_gemma":0.00018164728,"threshold_uncertainty_score":0.010335684},"labels":[],"label_agreement":null},{"id":"W2966833955","doi":"10.1002/ajh.25601","title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Isochromosome; Myeloid; Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.008288603416969935,"score_gpt":0.24722726755154503,"score_spread":0.2389386641345751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966833955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830741,0.007114892,0.0022763927,0.00015641337,0.00004049333,0.00007097576,0.00071800826,0.00014179287,0.0064068506],"genre_scores_gemma":[0.99594057,0.0017087861,0.000687682,0.00005135293,0.00007291849,0.000014351932,0.00063622155,0.000013770196,0.000874433],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997491,0.000031205767,0.000029446517,0.00007998106,0.000055036006,0.000055129876],"domain_scores_gemma":[0.9992342,0.00012933774,0.00044020545,0.00004732686,0.000056974506,0.00009192671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014291823,0.000886648,0.00035926505,0.0015297811,0.00029468475,0.0003764997,0.0004791262,0.00060898246,0.0038748276],"category_scores_gemma":[0.0008333725,0.00023172353,0.000180181,0.0012109806,0.0005495952,0.0001988099,0.0004127009,0.00036501262,0.000765243],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015549151,0.00023119057,0.67194897,0.0006756617,0.00016511184,0.18357562,0.00042529593,0.0005885456,0.08193626,0.0019471997,0.00288196,0.05406939],"study_design_scores_gemma":[0.000049488553,0.00026604012,0.46676084,0.00009367752,0.00013927513,0.5102494,0.00020987321,0.0005040463,0.01191027,0.001060626,0.008725795,0.000030659176],"about_ca_topic_score_codex":0.00096580095,"about_ca_topic_score_gemma":0.0006702691,"teacher_disagreement_score":0.0038748276,"about_ca_system_score_codex":0.0001763825,"about_ca_system_score_gemma":0.00021753613,"threshold_uncertainty_score":0.012962639},"labels":[],"label_agreement":null},{"id":"W2972627544","doi":"10.1002/ajh.25637","title":"Rifaximin for sickle cell disease","year":2019,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health","keywords":"Rifaximin; Medicine; Disease; Internal medicine; Intensive care medicine; Biology; Antibiotics; Genetics","score_opus":0.007621559220972164,"score_gpt":0.2486370862614922,"score_spread":0.24101552704052004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972627544","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.098162845,0.7690161,0.007513228,0.021953348,0.010620682,0.0007047313,0.0010857794,0.00089884823,0.09004456],"genre_scores_gemma":[0.7347338,0.15864642,0.010541279,0.03153088,0.009798075,0.0005190227,0.002291801,0.0001331704,0.051805463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998723,0.00004391785,0.000013373433,0.000019968016,0.00002261907,0.0000277389],"domain_scores_gemma":[0.9998499,0.000038172595,0.000040167237,0.0000097882685,0.000017601284,0.000044351902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021085754,0.00038459848,0.0003391642,0.0002468819,0.0002848336,0.0001981143,0.00022154393,0.00047411118,0.010948636],"category_scores_gemma":[0.00056712487,0.000055561683,0.00030482016,0.00016971359,0.00016488894,0.0002173087,0.0002591538,0.00059129455,0.0048993737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031458423,0.0004423305,0.006186248,0.0029405367,0.0001422055,0.030851565,0.00017475951,0.0002248738,0.028555678,0.0020287486,0.13855158,0.78675556],"study_design_scores_gemma":[0.0014793994,0.005521081,0.0254701,0.0013238619,0.00019921918,0.0814103,0.00010952433,0.00048734355,0.010593279,0.0019912964,0.8713525,0.000062090156],"about_ca_topic_score_codex":0.00021248704,"about_ca_topic_score_gemma":0.00027325677,"teacher_disagreement_score":0.010948636,"about_ca_system_score_codex":0.00022671455,"about_ca_system_score_gemma":0.00030864484,"threshold_uncertainty_score":0.036626816},"labels":[],"label_agreement":null},{"id":"W2981294727","doi":"10.1002/ajh.25660","title":"Serotonin‐release assay‐negative heparin‐induced thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Heparin-induced thrombocytopenia; Medicine; Platelet factor 4; Internal medicine; Immunoassay; Heparin; Platelet; Antibody; Gastroenterology; Platelet activation; Cohort; Immunology","score_opus":0.018391238843773628,"score_gpt":0.2994848147493245,"score_spread":0.28109357590555084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981294727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734086,0.00022812335,0.00033750574,0.000019207724,0.000008151986,0.000047190402,0.00014425837,0.000013781905,0.0018609406],"genre_scores_gemma":[0.99909616,0.000069254274,0.00020488704,0.000046853664,0.000011021801,0.000011376909,0.00019636918,0.0000029210576,0.00036113325],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99958223,0.000057218946,0.00004683955,0.00009790123,0.00012446454,0.000091290975],"domain_scores_gemma":[0.9992052,0.00017456601,0.00015187007,0.00010668279,0.0001608966,0.00020079974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003247834,0.00040733578,0.0004357122,0.0005876034,0.00045477477,0.0003961282,0.00033177107,0.00034359502,0.0019605695],"category_scores_gemma":[0.0016428219,0.00020864047,0.00019720083,0.00036289697,0.0005263311,0.00027462404,0.00024062519,0.00028067568,0.0005512252],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062670204,0.0001974432,0.9734456,0.000046464556,0.00005310226,0.007386295,0.000395016,0.00009094301,0.011664074,0.0001437696,0.0003664388,0.005584118],"study_design_scores_gemma":[0.00009411368,0.0019121815,0.9524716,0.000016838001,0.00007847342,0.037918616,0.00021308106,0.0007012523,0.004480249,0.00008803781,0.0020089627,0.000016635184],"about_ca_topic_score_codex":0.002280222,"about_ca_topic_score_gemma":0.0021237442,"teacher_disagreement_score":0.002280222,"about_ca_system_score_codex":0.00018379281,"about_ca_system_score_gemma":0.00032452124,"threshold_uncertainty_score":0.006558776},"labels":[],"label_agreement":null},{"id":"W2990454217","doi":"10.1002/ajh.25688","title":"Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Leukocytosis; Monocytosis; Medicine; Myeloproliferative neoplasm; Hepatosplenomegaly; Disease; Chronic myelomonocytic leukemia; Immunology; Bone marrow; Bioinformatics; Cancer research; Oncology; Myelodysplastic syndromes; Internal medicine; Myelofibrosis; Biology","score_opus":0.018840278390420205,"score_gpt":0.3197540739869434,"score_spread":0.3009137955965232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990454217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012244965,0.99662775,0.00012756571,0.0010159131,0.0007748605,0.000005792847,0.00006466688,0.0000173729,0.0012436176],"genre_scores_gemma":[0.0006431051,0.9965463,0.00025884877,0.0007831538,0.00087943336,0.000006967241,0.00016565228,0.0000033646102,0.00071306183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997613,0.00004929773,0.000043768392,0.000033261942,0.000089373905,0.000022979968],"domain_scores_gemma":[0.99928457,0.0002743893,0.00009580064,0.000014502284,0.00026661332,0.00006418479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005917148,0.0007279384,0.0011399302,0.0024066886,0.0002205826,0.0008546799,0.00077033136,0.00077136705,0.005749227],"category_scores_gemma":[0.0014644559,0.00020620039,0.0005075311,0.0021038244,0.0002704281,0.0011384875,0.0005959024,0.0017025191,0.002647247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075428936,0.000036560166,0.00028005187,0.0085879825,0.00007234082,0.00014621417,0.000034455228,0.00020991125,0.0005175651,0.0013735563,0.104093954,0.8845719],"study_design_scores_gemma":[0.000018363615,0.000063697764,0.00079534523,0.0061282236,0.00014791133,0.001385359,0.000034151162,0.000078694284,0.00010826111,0.0009287817,0.99029773,0.0000134702095],"about_ca_topic_score_codex":0.001376829,"about_ca_topic_score_gemma":0.0028314379,"teacher_disagreement_score":0.005749227,"about_ca_system_score_codex":0.0007297933,"about_ca_system_score_gemma":0.001169889,"threshold_uncertainty_score":0.019233048},"labels":[],"label_agreement":null},{"id":"W2992753565","doi":"10.1002/ajh.25699","title":"Characterizing the effect of exposure to microgravity on anemia: more space is worse","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Spaceflight effects on biology","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anemia; Space (punctuation); Internal medicine; Computer science","score_opus":0.004368688696197927,"score_gpt":0.27463480894738546,"score_spread":0.2702661202511875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992753565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993709,0.00023629997,0.00013478842,0.000011340494,0.0000022766892,0.000005341535,0.000051739284,0.000001414416,0.00018602736],"genre_scores_gemma":[0.99945265,0.00011280051,0.00018412815,0.000018443949,0.000006841739,0.0000067205438,0.00008632745,8.881052e-7,0.00013130653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998179,0.00007260758,0.000014411145,0.00003379017,0.000036352307,0.000024959165],"domain_scores_gemma":[0.9994653,0.00015098238,0.00020670744,0.000051802188,0.000047560257,0.000077654535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004040612,0.00021909794,0.00019080461,0.0003126909,0.00016490294,0.0002834466,0.00012129712,0.00020054166,0.00071541854],"category_scores_gemma":[0.0007491351,0.00006550129,0.00026983395,0.0002552436,0.00025109245,0.00017264365,0.0002315409,0.00024346488,0.00006680138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018275975,0.00023424324,0.9367948,0.00009976503,0.00020302611,0.000108020984,0.0004630511,0.00028676385,0.04075144,0.000048811053,0.000095327916,0.019087024],"study_design_scores_gemma":[0.0000018977953,0.0009379953,0.9977437,0.00000275516,0.000016236983,0.00005837808,0.00007887172,0.000049527727,0.0010112452,0.000009787118,0.000087629865,0.0000019491213],"about_ca_topic_score_codex":0.0014702919,"about_ca_topic_score_gemma":0.0024030062,"teacher_disagreement_score":0.0014702919,"about_ca_system_score_codex":0.00015584736,"about_ca_system_score_gemma":0.00013331193,"threshold_uncertainty_score":0.002923429},"labels":[],"label_agreement":null},{"id":"W2993637233","doi":"10.1002/ajh.25701","title":"The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease","year":2019,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Allergan; Sanofi Genzyme; Sanofi; Pfizer; Amgen","keywords":"Biosimilar; Medicine; European union; Comparability; Orphan drug; Business; International trade; Bioinformatics","score_opus":0.047903286074954005,"score_gpt":0.3767017784107156,"score_spread":0.32879849233576164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993637233","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001439627,0.35947144,0.003352786,0.61677945,0.011659981,0.00003253154,0.00010976568,0.00017199734,0.006982473],"genre_scores_gemma":[0.040519584,0.566833,0.011172599,0.33107153,0.044719588,0.000113734066,0.00025107368,0.00021149965,0.00510735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9812307,0.00803681,0.0018365072,0.0014242026,0.006512685,0.00095914636],"domain_scores_gemma":[0.9185031,0.05533077,0.003025375,0.0027761224,0.012259263,0.008105374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05026233,0.00085352705,0.0019315124,0.0026315164,0.001930825,0.0100259585,0.0027791958,0.015612802,0.013069972],"category_scores_gemma":[0.079918966,0.0006583337,0.00142641,0.002274351,0.010711474,0.01948281,0.005357952,0.023495685,0.004059754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005296702,0.0002717169,0.00066994026,0.0025918537,0.00008963248,0.0009821185,0.0011097776,0.0008735493,0.0009070448,0.18340418,0.3275466,0.48102394],"study_design_scores_gemma":[0.00017408944,0.00039148537,0.00055064005,0.0040948493,0.00003344459,0.0012565594,0.00076047226,0.0003445055,0.0004633923,0.14836153,0.843502,0.00006705066],"about_ca_topic_score_codex":0.002012874,"about_ca_topic_score_gemma":0.0029299704,"teacher_disagreement_score":0.05026233,"about_ca_system_score_codex":0.00512688,"about_ca_system_score_gemma":0.008567544,"threshold_uncertainty_score":0.2658158},"labels":[],"label_agreement":null},{"id":"W2997593504","doi":"10.1002/ajh.25711","title":"Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Clinical endpoint; Neutropenia; Pneumonitis; Common Terminology Criteria for Adverse Events; Gastroenterology; Surgery; Diarrhea; Clinical trial; Chemotherapy; Lung","score_opus":0.00603779465155581,"score_gpt":0.24111143628222584,"score_spread":0.23507364163067002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997593504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728731,0.016149433,0.0011258407,0.00045438606,0.000075902084,0.00051043875,0.003402855,0.00010551496,0.005302523],"genre_scores_gemma":[0.9876502,0.002079515,0.00051369413,0.001000434,0.00014420523,0.0003400402,0.007114801,0.000025721354,0.0011313107],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99881184,0.00032268304,0.00013755879,0.0001556226,0.00036610974,0.0002062595],"domain_scores_gemma":[0.99631244,0.000719678,0.0014791809,0.00035420395,0.00059045,0.000544097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051655252,0.0004252811,0.0015213991,0.0005952788,0.0006262667,0.0012437406,0.00040524258,0.0007584268,0.0010759444],"category_scores_gemma":[0.0030540032,0.00023952444,0.001434844,0.0007606235,0.0002949698,0.0010166058,0.00041502685,0.001857539,0.00040274335],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09691467,0.004954872,0.56071955,0.001262852,0.0054666586,0.0014835118,0.00061322976,0.003949163,0.019222174,0.00040782648,0.011698016,0.29330748],"study_design_scores_gemma":[0.012977094,0.062728636,0.89492154,0.00026972842,0.0039504506,0.0020134272,0.00015228281,0.0028751076,0.004658465,0.0005563226,0.014787992,0.0001090632],"about_ca_topic_score_codex":0.000739506,"about_ca_topic_score_gemma":0.0014696677,"teacher_disagreement_score":0.0051655252,"about_ca_system_score_codex":0.0010312402,"about_ca_system_score_gemma":0.0007766588,"threshold_uncertainty_score":0.027318299},"labels":[],"label_agreement":null},{"id":"W3005954983","doi":"10.1002/ajh.25754","title":"Fixing the MRI R2‐iron calibration in liver","year":2020,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Calibration; Medicine; Radiology; Nuclear medicine; Mathematics; Statistics","score_opus":0.008765878781771229,"score_gpt":0.23791694013416528,"score_spread":0.22915106135239405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005954983","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4253007,0.14792466,0.33307385,0.00579268,0.0020538294,0.004506126,0.027497027,0.0039422354,0.049908843],"genre_scores_gemma":[0.8577431,0.0072697746,0.11887825,0.0024672823,0.00030940856,0.0037803927,0.005509033,0.0015603604,0.0024824277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.948359,0.029193493,0.008721977,0.0064272895,0.0067094457,0.0005888384],"domain_scores_gemma":[0.8659214,0.08878747,0.021682257,0.0142502915,0.009021248,0.00033740688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06726729,0.0012873025,0.0016149908,0.0047971723,0.0008318396,0.0022868598,0.0024461707,0.0020087613,0.011383824],"category_scores_gemma":[0.19451588,0.0010063334,0.0029196995,0.008261489,0.0011720279,0.0015545409,0.0022654373,0.0008622315,0.002871273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00889706,0.00044075635,0.25701407,0.03598022,0.016243374,0.0031611852,0.0038064518,0.011329815,0.021972742,0.0142744025,0.04956521,0.5773147],"study_design_scores_gemma":[0.002030763,0.004283543,0.3756635,0.015929986,0.021665363,0.010732785,0.0017520067,0.024397654,0.096332915,0.030268282,0.41610065,0.0008426021],"about_ca_topic_score_codex":0.0026255136,"about_ca_topic_score_gemma":0.0036914973,"teacher_disagreement_score":0.06726729,"about_ca_system_score_codex":0.0011993223,"about_ca_system_score_gemma":0.0015343094,"threshold_uncertainty_score":0.3557477},"labels":[],"label_agreement":null},{"id":"W3006298960","doi":"10.1002/ajh.25753","title":"Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Missense mutation; Pyruvate kinase deficiency; Compound heterozygosity; Genotype; Genetics; Hemolytic anemia; Medicine; Internal medicine; Biology; Allele; Mutation; Gene; Pyruvate kinase","score_opus":0.014172899727697764,"score_gpt":0.2619822443655167,"score_spread":0.24780934463781895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006298960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996308,0.00006976743,0.00008691354,0.000010163098,0.000001826482,0.0000026452672,0.000032159547,0.0000028963443,0.00016287729],"genre_scores_gemma":[0.99980336,0.000022044998,0.00004654836,0.0000067460874,0.0000038813555,0.0000024244375,0.00006918351,0.0000019865965,0.000043735436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945027,0.00012661106,0.00008366924,0.00013701805,0.00011109423,0.00009144377],"domain_scores_gemma":[0.9990138,0.0004163426,0.00029601008,0.00008909016,0.000060854996,0.00012389036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003602813,0.0002709094,0.00039656498,0.0009835974,0.00027862936,0.00039218384,0.00022143772,0.0003458432,0.0016220154],"category_scores_gemma":[0.002117338,0.00019462952,0.00022242674,0.00043289797,0.00034852303,0.0001988194,0.00036255273,0.00024958779,0.0003252358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027582835,0.000029634577,0.98321044,0.000011602113,0.000040914754,0.0026352615,0.00016909938,0.00011874141,0.009508866,0.0000817797,0.00007541454,0.0038424202],"study_design_scores_gemma":[0.000018148268,0.00023284522,0.9824027,0.0000052526752,0.000035485613,0.015445799,0.00014499568,0.0003313955,0.0009928661,0.00012750897,0.00025395458,0.00000906375],"about_ca_topic_score_codex":0.00033439556,"about_ca_topic_score_gemma":0.00029470553,"teacher_disagreement_score":0.0016220154,"about_ca_system_score_codex":0.000108075736,"about_ca_system_score_gemma":0.00009086545,"threshold_uncertainty_score":0.005426228},"labels":[],"label_agreement":null},{"id":"W3007085808","doi":"10.1002/ajh.25766","title":"Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Ibrutinib; IGHV@; Rituximab; Oncology; Gastroenterology; Surgery; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.07603734731203367,"score_gpt":0.4028478104530401,"score_spread":0.3268104631410064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007085808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788205,0.018387653,0.00033100578,0.00038213862,0.00006429332,0.00040357112,0.0007647315,0.000020404092,0.00082570687],"genre_scores_gemma":[0.9913788,0.0047342936,0.0006412219,0.00056376855,0.00022383437,0.00045503452,0.0016664554,0.000010093937,0.00032635857],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9970686,0.0022146038,0.00017815802,0.00020671896,0.00018767774,0.0001442216],"domain_scores_gemma":[0.99604034,0.0013358878,0.001302392,0.0003118177,0.00029787014,0.0007116176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009707335,0.0006003764,0.0017364589,0.0004324958,0.00031385722,0.0014703086,0.00053187454,0.00079288846,0.0007754486],"category_scores_gemma":[0.004233585,0.0002865496,0.001613724,0.0007715005,0.0004998861,0.00084670685,0.00030448468,0.0011100274,0.00016176683],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6883104,0.0053190175,0.14476372,0.0013734681,0.008134308,0.00021971129,0.0003503661,0.0014295285,0.0063279234,0.00019633769,0.0024445145,0.14113069],"study_design_scores_gemma":[0.33005336,0.205528,0.43370393,0.0005959258,0.012127488,0.00063074776,0.00021471441,0.0026406145,0.0023212282,0.00029420998,0.011802019,0.00008775993],"about_ca_topic_score_codex":0.00054342067,"about_ca_topic_score_gemma":0.001368358,"teacher_disagreement_score":0.009707335,"about_ca_system_score_codex":0.00073871046,"about_ca_system_score_gemma":0.000818509,"threshold_uncertainty_score":0.051337898},"labels":[],"label_agreement":null},{"id":"W3008307159","doi":"10.1002/ajh.25768","title":"Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep‐vein thrombosis and progressive limb ischemic necrosis following vascular surgery","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University","funders":"","keywords":"Medicine; Surgery; Gangrene; Thrombosis; Revascularization; Aspirin; Deep vein; Anesthesia; Myocardial infarction; Internal medicine","score_opus":0.01279358704368465,"score_gpt":0.2622809764237684,"score_spread":0.24948738938008375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008307159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737583,0.0066906977,0.002435034,0.0044872933,0.0003949415,0.00029609274,0.00012984387,0.00010823327,0.011699582],"genre_scores_gemma":[0.9968611,0.0010343243,0.00035188376,0.0008639639,0.00029340756,0.000015758076,0.000048183578,0.0000054382367,0.0005258401],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996884,0.000055582903,0.000036182766,0.0000501362,0.00006267366,0.00010697743],"domain_scores_gemma":[0.999448,0.00009891463,0.00012002343,0.000023664938,0.000042339063,0.00026717954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002901819,0.0006687412,0.00070055824,0.0010740447,0.0010113693,0.0007791808,0.00047683052,0.0014257962,0.0009189389],"category_scores_gemma":[0.0019697093,0.0003290871,0.00046030132,0.00063465873,0.00055215386,0.0008188082,0.00040705496,0.0019579085,0.00023867436],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011911493,0.00012192824,0.0438084,0.000063023355,0.000027976956,0.94977945,0.00022533746,0.00012453849,0.001023542,0.00018144365,0.00072205695,0.0038032157],"study_design_scores_gemma":[0.00004304616,0.0006211266,0.06396821,0.00012298794,0.000034069173,0.931767,0.00036598952,0.0008241997,0.00046704672,0.00034915705,0.0014187377,0.000018551249],"about_ca_topic_score_codex":0.0013241834,"about_ca_topic_score_gemma":0.0037256181,"teacher_disagreement_score":0.0014257962,"about_ca_system_score_codex":0.0007591864,"about_ca_system_score_gemma":0.0008022457,"threshold_uncertainty_score":0.0055083036},"labels":[],"label_agreement":null},{"id":"W3009946828","doi":"10.1002/ajh.25776","title":"Safety and efficacy of self‐administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Argenx; Sanofi Genzyme; Zafgen; Daiichi Sankyo Europe; Agios Pharmaceuticals; Celgene; Shionogi; Sanofi; Alnylam Pharmaceuticals; Pfizer; Amgen","keywords":"Romiplostim; Medicine; Adverse effect; Immune thrombocytopenia; Clinical trial; Internal medicine; Randomized controlled trial; Self-administration; Platelet; Pediatrics; Thrombopoietin","score_opus":0.041102499621267656,"score_gpt":0.3620563649409327,"score_spread":0.320953865319665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009946828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.936126,0.04300299,0.0025568495,0.00041358772,0.000053008614,0.0026970273,0.013246911,0.0001457586,0.0017579206],"genre_scores_gemma":[0.97922933,0.0050831735,0.0038689082,0.00042530498,0.00006174266,0.0014225983,0.009650268,0.00002606922,0.00023255704],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98289067,0.009818534,0.0032152296,0.0016903882,0.0019469047,0.00043830473],"domain_scores_gemma":[0.9656733,0.015717156,0.012717781,0.0025554346,0.0024248268,0.00091142155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018724184,0.0006451556,0.0035666125,0.0020642634,0.0002937801,0.0028272483,0.0007396156,0.0008316589,0.0011807521],"category_scores_gemma":[0.020892097,0.00046482697,0.0047728843,0.003710888,0.00043446978,0.0011805518,0.0008810259,0.0007082205,0.00014220862],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20012277,0.0027817274,0.46811947,0.009464397,0.16625988,0.00027888952,0.0003985414,0.0042074374,0.0053337524,0.0004060153,0.0030269101,0.13960025],"study_design_scores_gemma":[0.07399014,0.042452402,0.6904553,0.0017358348,0.1666606,0.0009643168,0.0003871022,0.008172598,0.004087678,0.0005128349,0.010398524,0.00018266936],"about_ca_topic_score_codex":0.001011992,"about_ca_topic_score_gemma":0.0024359908,"teacher_disagreement_score":0.018724184,"about_ca_system_score_codex":0.0010801912,"about_ca_system_score_gemma":0.0019645344,"threshold_uncertainty_score":0.09902418},"labels":[],"label_agreement":null},{"id":"W3011341107","doi":"10.1002/ajh.25783","title":"Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: <scp>CALGB</scp>/Alliance 50403","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Bortezomib; Etoposide; Progression-free survival; Surgery; Transplantation; Cytarabine; Clinical endpoint; Autologous stem-cell transplantation; Oncology; Gastroenterology; Multiple myeloma; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.013162266208827433,"score_gpt":0.2597290467004244,"score_spread":0.24656678049159697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011341107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770397,0.0007995717,0.00012392952,0.00020225836,0.00004180011,0.00022185534,0.00015542006,0.000023450333,0.0007277774],"genre_scores_gemma":[0.9981823,0.00034519713,0.00028827164,0.00023816671,0.000049204522,0.00020923962,0.0002819324,0.0000036105778,0.00040213086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997185,0.00014127036,0.000019932946,0.000033724427,0.000029251205,0.000057367506],"domain_scores_gemma":[0.99969244,0.000056010518,0.00006651161,0.000022393495,0.00001045903,0.00015213744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094790116,0.0003713272,0.0006781006,0.00020817546,0.0002509845,0.00034247703,0.0003914228,0.00036824125,0.0017961663],"category_scores_gemma":[0.00048991735,0.00019012268,0.0004087213,0.00018954546,0.00045853772,0.0002561212,0.00021342492,0.0010320344,0.0002363018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72757244,0.0178926,0.017410018,0.0004222916,0.000823124,0.0001999768,0.00016252155,0.002705236,0.049469475,0.00039680972,0.0044164606,0.17852914],"study_design_scores_gemma":[0.4071543,0.50516254,0.06324631,0.000111739006,0.00093005924,0.0005274114,0.0000784461,0.0044427025,0.012722746,0.00042633878,0.005171684,0.000025743364],"about_ca_topic_score_codex":0.002068349,"about_ca_topic_score_gemma":0.006024384,"teacher_disagreement_score":0.002068349,"about_ca_system_score_codex":0.001000634,"about_ca_system_score_gemma":0.0008841383,"threshold_uncertainty_score":0.007260084},"labels":[],"label_agreement":null},{"id":"W3021624220","doi":"10.1002/ajh.25851","title":"Management of <scp>CLL</scp> patients early in the <scp>COVID</scp>‐19 pandemic: An international survey of <scp>CLL</scp> experts","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; National Institutes of Health; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Discontinuation; Pandemic; Immunosenescence; Immunology; Chronic lymphocytic leukemia; Intensive care medicine; Internal medicine; Disease; Coronavirus disease 2019 (COVID-19); Leukemia; Immune system","score_opus":0.05015140238158752,"score_gpt":0.3411833603282778,"score_spread":0.29103195794669023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021624220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4399888,0.20823985,0.0019445166,0.2842539,0.002356483,0.00036943064,0.0017407503,0.00021574771,0.06089047],"genre_scores_gemma":[0.7882582,0.13812222,0.0037850982,0.06162582,0.0031077317,0.00018122475,0.0014130559,0.00007148829,0.0034351947],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993318,0.00021574469,0.00010602664,0.000047971138,0.00017580429,0.00012260844],"domain_scores_gemma":[0.99785537,0.00038817574,0.0005264863,0.000035878038,0.0004785016,0.00071549433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011573568,0.00012109014,0.00025055485,0.00042662045,0.0005805981,0.00074143667,0.0004130987,0.00074076,0.0026673514],"category_scores_gemma":[0.0059336503,0.00008756793,0.00025589563,0.00051729317,0.00034641175,0.000941455,0.00077669293,0.0012426896,0.0004942189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005098512,0.00022803409,0.278156,0.0013286368,0.000106000414,0.0032451828,0.0045351945,0.00043410913,0.0016330937,0.0014192265,0.27701822,0.43138644],"study_design_scores_gemma":[0.00021938563,0.0012861624,0.39076835,0.010992516,0.00023866082,0.02268145,0.02683807,0.0014625026,0.0010282021,0.004928574,0.539397,0.00015916779],"about_ca_topic_score_codex":0.0032262744,"about_ca_topic_score_gemma":0.0053797252,"teacher_disagreement_score":0.0032262744,"about_ca_system_score_codex":0.0007244601,"about_ca_system_score_gemma":0.0015743213,"threshold_uncertainty_score":0.008923113},"labels":[],"label_agreement":null},{"id":"W3034069616","doi":"10.1002/ajh.25901","title":"Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia","year":2020,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Heparin; Immunoassay; Platelet factor 4; Medicine; Heparin-induced thrombocytopenia; Platelet; Antibody; Platelet activation; Immunology; Internal medicine; Gastroenterology","score_opus":0.1485544085621829,"score_gpt":0.3655095292608665,"score_spread":0.21695512069868358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034069616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13627481,0.71755517,0.057415903,0.0380395,0.00508012,0.001832859,0.00670899,0.00047578872,0.03661688],"genre_scores_gemma":[0.85871357,0.06361959,0.03766351,0.031030942,0.0042082355,0.0011473247,0.0021988356,0.00014056404,0.0012773956],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.8998606,0.04500551,0.022953365,0.007682644,0.023399515,0.0010983296],"domain_scores_gemma":[0.7174075,0.22443067,0.02122993,0.0060150702,0.029922182,0.0009947277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069751814,0.0011582325,0.0026146688,0.004237197,0.00061875297,0.0036921462,0.0037538407,0.0020405555,0.0024121546],"category_scores_gemma":[0.2467334,0.0007911096,0.001877295,0.0027525693,0.0016207194,0.0028589664,0.0011060601,0.0018604136,0.000981515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002651011,0.00025581033,0.5221142,0.021427162,0.0047166315,0.0024550122,0.0022942775,0.0030443815,0.0025516115,0.0062553454,0.03942422,0.39281023],"study_design_scores_gemma":[0.0010494239,0.004980328,0.4688249,0.07953898,0.014206995,0.040968508,0.0042414875,0.043229427,0.014870618,0.027505891,0.29995415,0.0006293359],"about_ca_topic_score_codex":0.010536013,"about_ca_topic_score_gemma":0.010367135,"teacher_disagreement_score":0.069751814,"about_ca_system_score_codex":0.0017657292,"about_ca_system_score_gemma":0.002615716,"threshold_uncertainty_score":0.36888725},"labels":[],"label_agreement":null},{"id":"W3039763738","doi":"10.1002/ajh.25926","title":"Characterization of the severe phenotype of pyruvate kinase deficiency","year":2020,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Phenotype; Pyruvate kinase; Medicine; Genetics; Biology; Internal medicine; Gene; Glycolysis; Metabolism","score_opus":0.012940307487476729,"score_gpt":0.23895412364590066,"score_spread":0.22601381615842392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039763738","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354008,0.008419658,0.004084756,0.030508772,0.011921503,0.00016216558,0.0009992899,0.00011963042,0.008383415],"genre_scores_gemma":[0.9744648,0.0018768318,0.0016264373,0.0069309035,0.012832168,0.000032640102,0.00040647245,0.00003246241,0.0017973154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995834,0.00010206065,0.00008477158,0.00008030513,0.00007363137,0.00007581156],"domain_scores_gemma":[0.9976803,0.0010196038,0.00030435284,0.000110744455,0.0004016282,0.00048330982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000629329,0.00041112007,0.00041992043,0.0006320953,0.00023082056,0.00063232094,0.00066508783,0.00092702854,0.0019756614],"category_scores_gemma":[0.0036432028,0.00016425717,0.00017568776,0.0003870001,0.00036329264,0.00051257294,0.00031094026,0.0010297289,0.000642892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022547625,0.0006524542,0.53031695,0.0007730755,0.00017436942,0.2510969,0.0009050287,0.0004146223,0.021912143,0.0013514112,0.09619421,0.09395405],"study_design_scores_gemma":[0.00021828795,0.0011766632,0.3377434,0.00030305324,0.00012504573,0.57246405,0.00076997525,0.0045372755,0.005580064,0.0010476053,0.07593831,0.00009630328],"about_ca_topic_score_codex":0.00033652873,"about_ca_topic_score_gemma":0.0004041236,"teacher_disagreement_score":0.0019756614,"about_ca_system_score_codex":0.00019168755,"about_ca_system_score_gemma":0.00017322738,"threshold_uncertainty_score":0.0066092014},"labels":[],"label_agreement":null},{"id":"W3084307312","doi":"10.1002/ajh.25992","title":"Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Histopathology; Medicine; Pathology; Clinical endpoint; Internal medicine; Lymph node; Plasma cell; Disease; Etiology; Pathogenesis; Clinical trial; Bone marrow","score_opus":0.051173255153865796,"score_gpt":0.330022158712673,"score_spread":0.2788489035588072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084307312","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071370184,0.8741707,0.006590844,0.024553152,0.0027079766,0.00079757086,0.0022437864,0.00017614629,0.017389547],"genre_scores_gemma":[0.67423856,0.2600038,0.03232014,0.022820344,0.0055122077,0.0005236939,0.003066856,0.00012729464,0.0013870599],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9898745,0.0053875535,0.001801681,0.0006780255,0.0020395173,0.00021877496],"domain_scores_gemma":[0.92922866,0.042020544,0.01073784,0.0034061172,0.013399828,0.0012069964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02166603,0.00046883748,0.002465404,0.002115486,0.00050691486,0.002406864,0.0019363206,0.0012032436,0.0022723554],"category_scores_gemma":[0.059065014,0.0003382323,0.002137952,0.0020580492,0.0008498123,0.0017089613,0.00060222985,0.0015163183,0.0010091542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022092983,0.0003791498,0.07558724,0.01553202,0.0028371485,0.0000569591,0.0001735228,0.00093843247,0.0007424961,0.0010062263,0.013461303,0.8870763],"study_design_scores_gemma":[0.007156807,0.013370043,0.3812635,0.117472544,0.031682897,0.0019999542,0.0018833863,0.009717635,0.004872314,0.010891149,0.41929582,0.00039393603],"about_ca_topic_score_codex":0.0021854735,"about_ca_topic_score_gemma":0.007374494,"teacher_disagreement_score":0.02166603,"about_ca_system_score_codex":0.0011222006,"about_ca_system_score_gemma":0.0027362353,"threshold_uncertainty_score":0.1145823},"labels":[],"label_agreement":null},{"id":"W3093977038","doi":"10.1002/ajh.26036","title":"Immune thrombocytopenia (<scp>ITP</scp>) <scp>World Impact Survey</scp> (<scp>I‐WISh</scp>): Impact of <scp>ITP</scp> on health‐related quality of life","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Chugai Pharmaceutical; Novartis Pharma; Grifols; Swedish Orphan Biovitrum; Novo Nordisk; Momenta Pharmaceuticals; Gilead Sciences; Pfizer; Novartis Pharmaceuticals Corporation; Amgen; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Work productivity; Productivity; Disease; Immune system; Internal medicine; Pediatrics; Immunology; Platelet; Nursing","score_opus":0.04085826417815964,"score_gpt":0.3482589772983303,"score_spread":0.30740071312017064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093977038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519527,0.0022895816,0.00032511828,0.00096271234,0.000058603364,0.0005304079,0.03177144,0.000075918855,0.012033619],"genre_scores_gemma":[0.97336584,0.0013643437,0.00051792496,0.00082882575,0.000058118712,0.0002899027,0.022168227,0.000008269181,0.0013984687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903536,0.00023364632,0.00022038541,0.00005410845,0.00032485602,0.00013158245],"domain_scores_gemma":[0.9968491,0.00040956013,0.0015637898,0.00009632443,0.00055904745,0.000522317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001122808,0.00023654301,0.00029856272,0.001218633,0.00024724938,0.0005029958,0.00021116293,0.00033951033,0.002234542],"category_scores_gemma":[0.0029476827,0.000110804365,0.0005526082,0.0018177546,0.00016712412,0.00041543218,0.0005956648,0.0005359884,0.00035969223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015151435,0.00011548731,0.98234046,0.00012477288,0.00013660378,0.00007710506,0.00010381361,0.00010627183,0.00013480488,0.000059019978,0.0061544264,0.010495643],"study_design_scores_gemma":[0.00001700753,0.00014235747,0.9976253,0.0000384273,0.000025553221,0.00017026572,0.000079295096,0.00006279515,0.000056229233,0.0000169202,0.0017614816,0.0000042702777],"about_ca_topic_score_codex":0.007336667,"about_ca_topic_score_gemma":0.012644389,"teacher_disagreement_score":0.007336667,"about_ca_system_score_codex":0.00050105056,"about_ca_system_score_gemma":0.00035091347,"threshold_uncertainty_score":0.014587939},"labels":[],"label_agreement":null},{"id":"W3094089270","doi":"10.1002/ajh.26034","title":"Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Lille","keywords":"Splenectomy; Medicine; Myelofibrosis; Hazard ratio; Transplantation; Incidence (geometry); Surgery; Hematopoietic cell; Internal medicine; Hematopoietic stem cell transplantation; Confidence interval; Bone marrow; Haematopoiesis; Spleen; Stem cell","score_opus":0.014417830692706574,"score_gpt":0.2808319163925815,"score_spread":0.2664140856998749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094089270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982305,0.00070922676,0.00012872042,0.0001162361,0.0000043503505,0.000008019823,0.00045322036,0.0000056258054,0.00034415178],"genre_scores_gemma":[0.9986921,0.00037592274,0.00007819007,0.00006675843,0.000013619597,0.0000074625245,0.0006957858,0.0000021137748,0.0000680887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914765,0.00030460028,0.00006595842,0.00022908783,0.00009711482,0.00015554257],"domain_scores_gemma":[0.9970925,0.0005220884,0.0014077458,0.0003010536,0.00034271408,0.0003339811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016257146,0.00040824426,0.00042316993,0.00089133484,0.0005017261,0.0007267147,0.0004567735,0.00062026473,0.001482304],"category_scores_gemma":[0.0023046995,0.0003855132,0.00095590815,0.0012446127,0.0003467959,0.0004967275,0.00041890526,0.0005485587,0.00016979726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000664303,0.000022705643,0.99843806,0.000008671704,0.00006477212,0.00007823865,0.0000705584,0.000051600957,0.00005375459,0.000018012348,0.00014387132,0.00098332],"study_design_scores_gemma":[0.000012040241,0.00006716173,0.99883074,0.000014422986,0.000054420103,0.0002535262,0.00015195063,0.00021743371,0.000018771998,0.000014139272,0.00035962684,0.0000057900093],"about_ca_topic_score_codex":0.083061874,"about_ca_topic_score_gemma":0.07893665,"teacher_disagreement_score":0.083061874,"about_ca_system_score_codex":0.0016592424,"about_ca_system_score_gemma":0.001474751,"threshold_uncertainty_score":0.16515678},"labels":[],"label_agreement":null},{"id":"W3094480710","doi":"10.1002/ajh.26033","title":"Fresh <i>vs.</i> frozen allogeneic peripheral blood stem cell grafts: A successful timely option","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cryopreservation; Medicine; Transplantation; Surgery; Fresh frozen plasma; Cord blood; Graft-versus-host disease; Internal medicine; Platelet; Biology","score_opus":0.011772557782038307,"score_gpt":0.24336316391779336,"score_spread":0.23159060613575505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094480710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789796,0.014751343,0.0030495147,0.00040235303,0.00015400656,0.00006809888,0.00022247483,0.000038254915,0.0023342539],"genre_scores_gemma":[0.99514717,0.0029430308,0.0012612144,0.00010959308,0.00011231234,0.000013941345,0.00015789652,0.000006886732,0.00024788856],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997714,0.00008472027,0.00001919083,0.00004099478,0.00005533501,0.000028435032],"domain_scores_gemma":[0.9994735,0.00022177224,0.0001527625,0.000052915388,0.000033354987,0.00006571367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013168775,0.00021837653,0.0003543014,0.00023036698,0.00011636644,0.00057883887,0.00025370342,0.00016690754,0.0016627453],"category_scores_gemma":[0.0010623221,0.00007274285,0.00040996433,0.00018516854,0.00025892907,0.00042834377,0.00024384169,0.00041236664,0.00017772819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034840442,0.00083069125,0.1921301,0.0008400617,0.0008115609,0.000864477,0.00024826944,0.0030941255,0.030666623,0.0014647403,0.0024823546,0.7317265],"study_design_scores_gemma":[0.0042887977,0.093351915,0.74872196,0.001410458,0.004373266,0.013046476,0.0009948699,0.011967953,0.09388733,0.0073108873,0.020455949,0.00019016392],"about_ca_topic_score_codex":0.00033251516,"about_ca_topic_score_gemma":0.0008271387,"teacher_disagreement_score":0.0016627453,"about_ca_system_score_codex":0.00028427583,"about_ca_system_score_gemma":0.0003401528,"threshold_uncertainty_score":0.0069643855},"labels":[],"label_agreement":null},{"id":"W3103365133","doi":"10.1002/ajh.26045","title":"Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Disease; Pediatrics; Internal medicine; Platelet","score_opus":0.01685971017784169,"score_gpt":0.2921030030863628,"score_spread":0.27524329290852106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103365133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876886,0.000499422,0.00023488904,0.00047705387,0.000018837316,0.00027839365,0.0068962155,0.000027331393,0.003879192],"genre_scores_gemma":[0.9949464,0.00030295757,0.0004232552,0.0003181199,0.000018323568,0.00018837128,0.0033662,0.000004564665,0.0004318718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982237,0.00067750626,0.00034010556,0.00010095723,0.0004109097,0.00024684906],"domain_scores_gemma":[0.99450064,0.0008478545,0.0028132256,0.000193535,0.0006434589,0.0010011641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002651648,0.0002752361,0.0003774887,0.00097367825,0.0003600605,0.0006483251,0.00042132463,0.00046990594,0.0015891638],"category_scores_gemma":[0.0054034316,0.00024349809,0.0007532595,0.0015614994,0.00033152444,0.0007484137,0.0013676943,0.0008616159,0.0002833874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014980916,0.00014486724,0.9923422,0.00006991293,0.0000930913,0.000038282462,0.00052574446,0.0001533125,0.00010422868,0.0000398448,0.00142788,0.004910955],"study_design_scores_gemma":[0.00001887707,0.00023151832,0.9978442,0.000027363461,0.000020769769,0.00007520028,0.00056374044,0.00012559733,0.000050384966,0.000018723918,0.0010170188,0.000006584094],"about_ca_topic_score_codex":0.008171113,"about_ca_topic_score_gemma":0.009621709,"teacher_disagreement_score":0.008171113,"about_ca_system_score_codex":0.00062486203,"about_ca_system_score_gemma":0.00042399167,"threshold_uncertainty_score":0.016247094},"labels":[],"label_agreement":null},{"id":"W3112349182","doi":"10.1002/ajh.26078","title":"On the trail of blood doping—<scp>microRNA</scp> fingerprints to monitor autologous blood transfusions in vivo","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Israel Science Foundation; World Anti-Doping Agency","keywords":"Medicine; Whole blood; Blood transfusion; Autologous blood; microRNA; Blood sampling; Blood volume; Internal medicine; Surgery; Gene; Biology","score_opus":0.008007889183901915,"score_gpt":0.23867889120692143,"score_spread":0.23067100202301952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112349182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481517,0.003923111,0.04174693,0.00023165766,0.00018033726,0.00012047229,0.0010825779,0.00034521153,0.0042178747],"genre_scores_gemma":[0.9753857,0.001609625,0.01924291,0.0003740101,0.00006745829,0.00014574466,0.0006265465,0.00007247441,0.0024754403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994979,0.00012184825,0.000024530584,0.00016663737,0.00015378931,0.00003519277],"domain_scores_gemma":[0.99949384,0.00013459267,0.00016875457,0.000048063273,0.00010852629,0.000046225174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005479026,0.00030884793,0.00036336848,0.00041774762,0.00021912009,0.00054662966,0.00019375187,0.00034747165,0.0010799026],"category_scores_gemma":[0.0009025391,0.00016763885,0.00028772015,0.00049468834,0.00033075194,0.0002695498,0.00022046527,0.00048219197,0.00057230215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016955661,0.0002803778,0.08750266,0.00041506073,0.000181663,0.00030436553,0.00038493722,0.001740137,0.7924532,0.000790393,0.0010922912,0.1131593],"study_design_scores_gemma":[0.000027366625,0.0030049826,0.34043765,0.000086637,0.00031602342,0.0017070208,0.00032647265,0.020192312,0.6230247,0.0013045401,0.009488067,0.000084291685],"about_ca_topic_score_codex":0.00042541328,"about_ca_topic_score_gemma":0.0009660154,"teacher_disagreement_score":0.0010799026,"about_ca_system_score_codex":0.00016726936,"about_ca_system_score_gemma":0.00026894835,"threshold_uncertainty_score":0.0036126971},"labels":[],"label_agreement":null},{"id":"W3112794144","doi":"10.1002/ajh.26075","title":"Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative: <scp>HIT</scp> or not <scp>HIT</scp>?","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Heparin-induced thrombocytopenia; Medicine; Immunoassay; Platelet factor 4; Heparin; Antibody; Platelet; Immunology; Serology; Monoclonal antibody; Internal medicine","score_opus":0.03117714273087011,"score_gpt":0.2936135034304565,"score_spread":0.26243636069958637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112794144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98574567,0.0042334874,0.0024151122,0.00040069333,0.00009880193,0.0001027259,0.0005425793,0.00007923876,0.0063816486],"genre_scores_gemma":[0.99645644,0.0009659431,0.0011389882,0.00035575888,0.00005231871,0.000014750204,0.00039088083,0.000014167611,0.0006107517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999539,0.0000740213,0.00009254437,0.00009524259,0.00009540522,0.00010368304],"domain_scores_gemma":[0.99929535,0.00022521568,0.00015838878,0.000049998864,0.00015559226,0.00011535761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005103973,0.00051037926,0.00041697142,0.0012239511,0.00030292748,0.00047631763,0.00045577402,0.0007342527,0.00159004],"category_scores_gemma":[0.00155621,0.0001540559,0.00028790344,0.0007108245,0.00062835595,0.0004099763,0.0002997429,0.00046213416,0.00047669734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070929574,0.00015869191,0.6813777,0.00034905184,0.00008631625,0.26200902,0.0008338852,0.00018842994,0.029263172,0.00043602343,0.0027646618,0.021823768],"study_design_scores_gemma":[0.000038622347,0.0006206194,0.33824468,0.0001204037,0.00018824745,0.6301672,0.00097245874,0.0013612823,0.018811772,0.00035288828,0.009080405,0.00004140745],"about_ca_topic_score_codex":0.0015730237,"about_ca_topic_score_gemma":0.0012982881,"teacher_disagreement_score":0.00159004,"about_ca_system_score_codex":0.00030728453,"about_ca_system_score_gemma":0.00027734842,"threshold_uncertainty_score":0.0053192377},"labels":[],"label_agreement":null},{"id":"W3127681212","doi":"10.1002/ajh.26114","title":"Young platelet millionaires with essential thrombocythemia","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Medicine; Thrombocytosis; Context (archaeology); Incidence (geometry); Aspirin; Internal medicine; Thrombosis; Young adult; Platelet","score_opus":0.006870433168835954,"score_gpt":0.2670210640124645,"score_spread":0.26015063084362855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127681212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934348,0.001087221,0.00027350642,0.000056256435,0.000020556517,0.00012577944,0.0014311133,0.000019764146,0.0035509027],"genre_scores_gemma":[0.99658257,0.0005213215,0.00038790767,0.00017430435,0.00005583575,0.00008013318,0.0013338048,0.0000048923202,0.00085930474],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99981815,0.00003085684,0.0000343935,0.000042522217,0.000037797327,0.000036270176],"domain_scores_gemma":[0.9995436,0.000069782305,0.00021936951,0.000028507475,0.000037102054,0.000101689824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022377924,0.00018545568,0.0003312123,0.00062320323,0.00046478884,0.0003659565,0.00016740226,0.00018278127,0.0038326604],"category_scores_gemma":[0.0007251153,0.000117955635,0.00013073426,0.0007827906,0.00015607936,0.00025814274,0.00031374893,0.00023943631,0.00052525656],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024019857,0.000078780875,0.98725116,0.00005964339,0.000019880057,0.003999475,0.00019006924,0.000038576112,0.00073676876,0.0001385809,0.0009470187,0.0062998505],"study_design_scores_gemma":[0.000024414296,0.00048339742,0.9768506,0.000050311675,0.000030506611,0.016686516,0.00024801714,0.00015853821,0.00021318172,0.00011761677,0.005129188,0.000007702981],"about_ca_topic_score_codex":0.0010802153,"about_ca_topic_score_gemma":0.0023640245,"teacher_disagreement_score":0.0038326604,"about_ca_system_score_codex":0.00015968154,"about_ca_system_score_gemma":0.00023850509,"threshold_uncertainty_score":0.012821555},"labels":[],"label_agreement":null},{"id":"W3131061582","doi":"10.1002/ajh.26136","title":"A <scp>Phase I</scp> dose‐escalation study of <scp>DCLL9718S</scp>, an antibody‐drug conjugate targeting <scp>C</scp>‐type lectin‐like molecule‐1 (<scp>CLL</scp>‐1) in patients with acute myeloid leukemia","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"National Center for Advancing Translational Sciences; Genentech","keywords":"Antibody-drug conjugate; Cancer research; Myeloid leukemia; Antibody; Myeloid; Chemistry; Monoclonal antibody; Molecular biology; Immunology; Medicine; Biology","score_opus":0.007897356507361076,"score_gpt":0.2654896933773154,"score_spread":0.25759233686995436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131061582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97878623,0.0033356636,0.0017910671,0.0009741578,0.00026370076,0.006019723,0.0030096807,0.0003291582,0.0054906625],"genre_scores_gemma":[0.9713965,0.003826971,0.0037364617,0.0018039157,0.00014552323,0.004375596,0.005249409,0.00010051339,0.009365104],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966264,0.000095729556,0.000011954749,0.000078464254,0.00007718901,0.000073976335],"domain_scores_gemma":[0.9995414,0.00006418464,0.00009044375,0.00004411459,0.00003784348,0.00022205143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008253189,0.001669723,0.0014525626,0.0006292438,0.00045080303,0.001131525,0.00091945817,0.0012959365,0.003939999],"category_scores_gemma":[0.00051363057,0.00068531337,0.0010621237,0.0006171062,0.00088308833,0.0006167675,0.00030403014,0.0039077476,0.0010274912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31373975,0.16484302,0.004492113,0.001860296,0.0022098864,0.00066462567,0.000621883,0.010503397,0.25985968,0.0015783391,0.024098799,0.21552828],"study_design_scores_gemma":[0.33709732,0.5997872,0.011203801,0.000103149876,0.00061609637,0.00071153766,0.000094899864,0.003606606,0.028783334,0.00065675535,0.017257558,0.000081797254],"about_ca_topic_score_codex":0.0015955155,"about_ca_topic_score_gemma":0.004066739,"teacher_disagreement_score":0.003939999,"about_ca_system_score_codex":0.0013657542,"about_ca_system_score_gemma":0.0019273859,"threshold_uncertainty_score":0.013180554},"labels":[],"label_agreement":null},{"id":"W3131177835","doi":"10.1002/ajh.26131","title":"Upgrading the evidence for the use of ambroxol in Gaucher disease and <scp>GBA</scp> related Parkinson: Investigator initiated registry based on real life data","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Cambridge","keywords":"Medicine; Glucocerebrosidase; Adverse effect; Internal medicine; Ambroxol; Disease; Clinical trial; Pediatrics; Anesthesia","score_opus":0.2050609579674024,"score_gpt":0.38075330447263694,"score_spread":0.17569234650523455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131177835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86391735,0.0514827,0.0058143153,0.0035587242,0.0002866285,0.0039415797,0.050742764,0.0003179946,0.019937957],"genre_scores_gemma":[0.9439622,0.010444703,0.008228242,0.0017882128,0.00028467533,0.0018435257,0.032497127,0.000117776144,0.00083354063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9544218,0.022353446,0.013487129,0.0024277226,0.0065640276,0.0007458115],"domain_scores_gemma":[0.77197665,0.06825666,0.1013019,0.024895182,0.031005168,0.002564349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03445324,0.0003286325,0.0013803061,0.002370856,0.00046542217,0.0020481143,0.0014543675,0.0010006684,0.0029223382],"category_scores_gemma":[0.07301066,0.00035590926,0.0020774077,0.004238529,0.0005578856,0.0012988527,0.0009648073,0.0010946481,0.0010032143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020106295,0.0006634495,0.8089203,0.0070152273,0.0052647158,0.00036868258,0.0008233221,0.00062899926,0.0019212458,0.000809003,0.0126779135,0.14080079],"study_design_scores_gemma":[0.0037537424,0.0069028293,0.9045593,0.0057812557,0.007136314,0.0020349466,0.00067957526,0.0012117581,0.004833023,0.00048531403,0.06250359,0.000118367585],"about_ca_topic_score_codex":0.0010437717,"about_ca_topic_score_gemma":0.0017481953,"teacher_disagreement_score":0.03445324,"about_ca_system_score_codex":0.00090215605,"about_ca_system_score_gemma":0.0024629002,"threshold_uncertainty_score":0.18220836},"labels":[],"label_agreement":null},{"id":"W3133701599","doi":"10.1002/ajh.26147","title":"Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the <scp>MCRN</scp>‐003/<scp>MYX</scp>.1 single arm phase <scp>II</scp> trial","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; University of Ottawa; Western University; Saint John Regional Hospital; Hôtel-Dieu de Québec; Hotel Dieu Hospital; Princess Margaret Cancer Centre; Micropharma (Canada); University of Alberta; University of New Brunswick; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Amgen Canada; Amgen","keywords":"Carfilzomib; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Regimen; Clinical endpoint; Internal medicine; Cyclophosphamide; Adverse effect; Gastroenterology; Phases of clinical research; Metastatic breast cancer; Thalidomide; Progression-free survival; Refractory (planetary science); Oncology; Neutropenia; Toxicity; Chemotherapy; Clinical trial; Cancer; Breast cancer","score_opus":0.04164704233889885,"score_gpt":0.3148523281370852,"score_spread":0.27320528579818637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133701599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849759,0.01082215,0.00026530607,0.00092695997,0.0001640095,0.00047746193,0.00065123,0.000061867,0.0016551313],"genre_scores_gemma":[0.99106055,0.004251206,0.0006426813,0.00066014857,0.0001788387,0.0003285149,0.0010845496,0.000015856329,0.0017775581],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997409,0.00012799994,0.000013009434,0.000032120635,0.000033595174,0.000052393432],"domain_scores_gemma":[0.99964774,0.00006505972,0.00006757544,0.00002091163,0.000017584434,0.00018108686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012343228,0.00064422784,0.0013495653,0.00024643436,0.00024753975,0.0006859505,0.0003881812,0.0005690177,0.0015910994],"category_scores_gemma":[0.00052100647,0.00020501511,0.0007837516,0.00031278038,0.00037377462,0.00033572232,0.00018171224,0.0016876943,0.00022382574],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7447882,0.008328636,0.00608092,0.0012845426,0.0024123471,0.00023578116,0.00023385932,0.002901851,0.022762809,0.00029214186,0.007188383,0.20349053],"study_design_scores_gemma":[0.7636078,0.1870796,0.034430694,0.00017557509,0.0018160049,0.000404022,0.000096361095,0.0020276704,0.003249729,0.0003438011,0.006730276,0.00003847064],"about_ca_topic_score_codex":0.0018584454,"about_ca_topic_score_gemma":0.007949933,"teacher_disagreement_score":0.0018584454,"about_ca_system_score_codex":0.000784368,"about_ca_system_score_gemma":0.00072880945,"threshold_uncertainty_score":0.0065277815},"labels":[],"label_agreement":null},{"id":"W3137319952","doi":"10.1002/ajh.26172","title":"Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Tolerability; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Carfilzomib; Oncology; Internal medicine; Adverse effect","score_opus":0.023214654556878978,"score_gpt":0.32930533429055875,"score_spread":0.30609067973367976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137319952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963767,0.003231553,0.00003035243,0.000066182096,0.00001677087,0.000008631471,0.000049226703,0.0000020474383,0.00021855834],"genre_scores_gemma":[0.99928445,0.00041474894,0.0000330006,0.000069230875,0.000022646791,0.0000067484466,0.000076663826,0.0000010752117,0.00009135225],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999479,0.00027456103,0.000051578798,0.000052431133,0.0000716771,0.00007066592],"domain_scores_gemma":[0.9982097,0.0006069602,0.00066212134,0.000119965305,0.000056612935,0.00034465402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024087776,0.00024531895,0.0005998016,0.0001733523,0.00013596566,0.0004240062,0.00017975939,0.00021765626,0.0006076394],"category_scores_gemma":[0.0019985721,0.00010750098,0.0011663545,0.00016073055,0.00021382027,0.00032779798,0.00029734435,0.00047758676,0.000059129154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36756825,0.002027314,0.48089537,0.00043459565,0.006769498,0.00018378515,0.00020312543,0.001933453,0.0076061008,0.00016835016,0.0008681971,0.13134192],"study_design_scores_gemma":[0.010094984,0.072924845,0.9087948,0.00009649467,0.002936056,0.0003388194,0.00009407993,0.0015335055,0.0016306094,0.0002072341,0.0013178835,0.000030662708],"about_ca_topic_score_codex":0.0007352354,"about_ca_topic_score_gemma":0.0016939008,"teacher_disagreement_score":0.0024087776,"about_ca_system_score_codex":0.00025457644,"about_ca_system_score_gemma":0.0002738219,"threshold_uncertainty_score":0.012738943},"labels":[],"label_agreement":null},{"id":"W3138379858","doi":"10.1002/ajh.26159","title":"Risk of infection in <scp>MPN</scp> patients in the era of <scp>C</scp>ovid‐<scp>19</scp>: A prospective multicenter study of <scp>257</scp> patients from the <scp>CML‐MPN Q</scp>uebec <scp>R</scp>esearch <scp>G</scp>roup","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université du Québec; Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Ruxolitinib; Internal medicine; Population; Cohort; Essential thrombocythemia; Prospective cohort study; Myelofibrosis; Polycythemia vera; Concordance; Immunology","score_opus":0.01385321085323726,"score_gpt":0.27859430188749085,"score_spread":0.2647410910342536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138379858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847597,0.0007364099,0.00004601347,0.00006037038,0.000007813048,0.000012197576,0.0003584026,0.000002216221,0.00030054006],"genre_scores_gemma":[0.9989767,0.00031722014,0.00005740854,0.00005337196,0.000028457338,0.00001020729,0.00046002862,0.0000025434135,0.000094041716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994165,0.00016026209,0.000055432283,0.00014515953,0.00010995152,0.00011272212],"domain_scores_gemma":[0.998716,0.0001541531,0.0005830807,0.000099897676,0.00008820851,0.00035860713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063207815,0.00035206383,0.0004354228,0.00059138983,0.0006495648,0.00093242,0.00037355997,0.0008126194,0.0014153395],"category_scores_gemma":[0.0017550897,0.00036155505,0.00047259062,0.00095405465,0.00035180702,0.0005524663,0.00060059474,0.0008870735,0.0002810093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023851471,0.000030968808,0.9984641,0.000009429977,0.00004127015,0.00009342054,0.00005465644,0.000014111658,0.00008357601,0.000011187485,0.00013410748,0.00082466967],"study_design_scores_gemma":[0.000022413353,0.00026097088,0.99809533,0.000014689437,0.000049519298,0.0007372702,0.0002452769,0.00015348039,0.000050105693,0.00003606263,0.00032535708,0.000009436603],"about_ca_topic_score_codex":0.004809933,"about_ca_topic_score_gemma":0.0050620106,"teacher_disagreement_score":0.004809933,"about_ca_system_score_codex":0.00042278023,"about_ca_system_score_gemma":0.0005399918,"threshold_uncertainty_score":0.009563923},"labels":[],"label_agreement":null},{"id":"W3151335737","doi":"10.1002/ajh.26181","title":"Ineffectiveness of high‐dose methotrexate for prevention of <scp>CNS</scp> relapse in diffuse large <scp>B</scp>‐cell lymphoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services; University of Calgary; Alberta Advanced Education; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Methotrexate; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Primary central nervous system lymphoma; Central nervous system; Gastroenterology; Antifolate; Chemotherapy; Oncology; Antimetabolite","score_opus":0.011175951484408767,"score_gpt":0.2873974435163136,"score_spread":0.2762214920319048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151335737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981793,0.0012783243,0.000034504505,0.000050460796,0.0000039457627,0.000010478335,0.0000338388,0.0000043936634,0.00040486423],"genre_scores_gemma":[0.9995894,0.00025120034,0.00004456915,0.000021078611,0.000006426603,0.0000016085379,0.000040846367,7.472482e-7,0.000044108798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967206,0.00010601259,0.00003375368,0.000032340864,0.00011035808,0.000045504523],"domain_scores_gemma":[0.9987423,0.0002610987,0.0005882907,0.00006181932,0.00014548279,0.00020107647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468216,0.00012099724,0.0002641852,0.00027976494,0.00019131979,0.0003684888,0.00030443125,0.00018570552,0.00032528385],"category_scores_gemma":[0.001899852,0.0000831355,0.00019506128,0.0004049844,0.00026491794,0.00016825617,0.0001307299,0.00028082772,0.0000628672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013885077,0.00018177832,0.96807927,0.00006330516,0.00007559033,0.00031478135,0.00010161311,0.00020783766,0.0020835751,0.000015179016,0.00017226732,0.027316371],"study_design_scores_gemma":[0.000041169504,0.0010594979,0.99735886,0.000016431695,0.00005761517,0.00047867236,0.00005495995,0.00021286625,0.00041084763,0.000008171592,0.0002979861,0.0000030065335],"about_ca_topic_score_codex":0.030169984,"about_ca_topic_score_gemma":0.08306206,"teacher_disagreement_score":0.030169984,"about_ca_system_score_codex":0.0014702982,"about_ca_system_score_gemma":0.0015036982,"threshold_uncertainty_score":0.059988797},"labels":[],"label_agreement":null},{"id":"W3154787439","doi":"10.1002/ajh.26193","title":"Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from <scp>CYP‐C</scp>","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; Hospital for Sick Children; SickKids Foundation; University of Toronto; McMaster University; McMaster Children's Hospital; Izaak Walton Killam Health Centre; Nova Scotia Cancer Centre; Nova Scotia Health Authority; Hôpital de l'Enfant-Jésus","funders":"Pediatric Oncology Group of Ontario; Government of Canada; Public Health Agency; Australian Government; Public Health Agency of Canada","keywords":"Medicine; Interquartile range; Internal medicine; Pulmonary embolism; Proportional hazards model; Retrospective cohort study; Cohort; Thrombosis; Population; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Gastroenterology; Surgery; Leukemia","score_opus":0.010659307495026027,"score_gpt":0.2711803409569189,"score_spread":0.26052103346189287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154787439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970372,0.0018176226,0.000092264854,0.00011810988,0.000008590845,0.0000059612407,0.0005633302,0.000004142831,0.0003529161],"genre_scores_gemma":[0.9977964,0.0014873666,0.00007919532,0.000052801362,0.000028072267,0.000004972636,0.00045829013,0.0000030239476,0.00008978732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996183,0.00009002299,0.000041922838,0.00008926981,0.00010325589,0.000057171044],"domain_scores_gemma":[0.9982451,0.0004602642,0.0008673634,0.00009939151,0.00018387167,0.00014397061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000526834,0.00017609885,0.0002432187,0.0006209769,0.00022297692,0.00058892247,0.00016146294,0.00025155756,0.0010317051],"category_scores_gemma":[0.0023968061,0.00015796979,0.00045408192,0.0012624093,0.00032633933,0.00020252125,0.00024092848,0.0004169287,0.000096488635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004437302,0.0000043563036,0.9981,0.000017631424,0.00004490922,0.000118792086,0.00005300787,0.000021171352,0.00006749096,0.00001553554,0.00014146624,0.0013712046],"study_design_scores_gemma":[0.0000060844145,0.000040762963,0.99815446,0.000013334182,0.00006143975,0.00087979675,0.00008365493,0.00006928342,0.00006584203,0.000012768383,0.00060934125,0.0000031826028],"about_ca_topic_score_codex":0.017091284,"about_ca_topic_score_gemma":0.013948934,"teacher_disagreement_score":0.017091284,"about_ca_system_score_codex":0.0005272281,"about_ca_system_score_gemma":0.00056100666,"threshold_uncertainty_score":0.03398359},"labels":[],"label_agreement":null},{"id":"W3156234252","doi":"10.1002/ajh.26186","title":"Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Myelofibrosis; Decitabine; Medicine; Azacitidine; Internal medicine; Myeloproliferative neoplasm; Venetoclax; Essential thrombocythemia; Neuroblastoma RAS viral oncogene homolog; Gastroenterology; KRAS; Myeloid; Leukemia; Polycythemia vera; Oncology; Bone marrow; Chronic lymphocytic leukemia; Biology; Cancer","score_opus":0.020234828184528552,"score_gpt":0.3300823838677404,"score_spread":0.3098475556832119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156234252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998955,0.00052000425,0.000079904494,0.000013233641,0.0000035104335,0.000011471125,0.000027549311,0.0000031081684,0.00038630687],"genre_scores_gemma":[0.99959797,0.00016408753,0.000065686516,0.000010619663,0.000010488185,0.0000054516695,0.00006131293,0.0000013441902,0.00008309471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997595,0.000052726486,0.000031161864,0.00006976863,0.00003314741,0.000053749045],"domain_scores_gemma":[0.9995511,0.00009467214,0.00016765417,0.000053533036,0.000023645405,0.00010937164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026581786,0.00026311586,0.00026279344,0.00041192406,0.00047207263,0.00030437266,0.00027651543,0.0003253344,0.00081528595],"category_scores_gemma":[0.00093439,0.00019547944,0.00020269008,0.0003582706,0.00035779685,0.00020261259,0.00031609437,0.00028146888,0.0001790913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006968787,0.00021534474,0.922733,0.000057285586,0.000070301925,0.056744915,0.00046774338,0.00017005207,0.00514515,0.000113955975,0.00027829356,0.013307179],"study_design_scores_gemma":[0.00015101543,0.0022284712,0.69116515,0.00003490183,0.00012047018,0.2989044,0.0006124358,0.0006257398,0.0034323165,0.000094029994,0.0026105337,0.000020512563],"about_ca_topic_score_codex":0.0008083489,"about_ca_topic_score_gemma":0.0010428911,"teacher_disagreement_score":0.00081528595,"about_ca_system_score_codex":0.00026716932,"about_ca_system_score_gemma":0.00022800744,"threshold_uncertainty_score":0.0027273297},"labels":[],"label_agreement":null},{"id":"W3159913046","doi":"10.1002/ajh.26212","title":"Diagnostic value of D‐dimers for limb deep vein thrombosis in children: A prospective study","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of Toronto","keywords":"Medicine; Receiver operating characteristic; Post-thrombotic syndrome; Confidence interval; Odds ratio; Prospective cohort study; D-dimer; Deep vein; Percentile; Area under the curve; Logistic regression; Thrombosis; Internal medicine; Surgery","score_opus":0.00847039046746402,"score_gpt":0.29376159854236444,"score_spread":0.28529120807490044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159913046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896324,0.00045788582,0.000107974935,0.000040943833,0.0000073563265,0.00000967971,0.0002164155,0.0000025290096,0.00019401191],"genre_scores_gemma":[0.9992575,0.00023752025,0.00019128072,0.000023397468,0.000015463189,0.000010528178,0.00022575205,0.0000017155597,0.000036802256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987613,0.0004124747,0.00018408365,0.00026337546,0.0002407881,0.00013804121],"domain_scores_gemma":[0.9952865,0.0014399962,0.0020050497,0.00023880004,0.00047067364,0.0005589611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016996323,0.00044503363,0.0004850622,0.0012510415,0.00036803944,0.0008036795,0.00041795036,0.00063778,0.00091295945],"category_scores_gemma":[0.007191411,0.00035989375,0.00054543023,0.0012268568,0.000486023,0.0007820354,0.00046359462,0.0008402098,0.00029154707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003715655,0.00001287882,0.9994779,0.000005032939,0.000012070871,0.000057852285,0.00002273996,0.000009924883,0.00003280033,0.0000060636044,0.000022129541,0.0003034812],"study_design_scores_gemma":[0.000010300589,0.00023691221,0.99784744,0.00001487573,0.000041423307,0.0011908168,0.00020522233,0.00017184456,0.00006896965,0.000020510894,0.00018639218,0.0000053094486],"about_ca_topic_score_codex":0.0017922062,"about_ca_topic_score_gemma":0.0016995901,"teacher_disagreement_score":0.0017922062,"about_ca_system_score_codex":0.0003051132,"about_ca_system_score_gemma":0.00056628196,"threshold_uncertainty_score":0.008988619},"labels":[],"label_agreement":null},{"id":"W3165381538","doi":"10.1002/ajh.26261","title":"Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Gastroenterology; Population; Oncology","score_opus":0.017818009130890246,"score_gpt":0.31031762290113085,"score_spread":0.2924996137702406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165381538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408925,0.005022452,0.000060522223,0.00024057816,0.000056028646,0.00004987941,0.00015076276,0.00000691778,0.00032358637],"genre_scores_gemma":[0.99718755,0.0013042933,0.000099682984,0.0003069278,0.00009462688,0.00005966403,0.00038629142,0.000002415633,0.00055857503],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99938107,0.00038584814,0.00003450291,0.000068622605,0.00005169833,0.00007818404],"domain_scores_gemma":[0.9992472,0.00017341448,0.00025265175,0.000032727025,0.000020113544,0.00027393302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017268725,0.0005436427,0.0010170329,0.0002763673,0.00014965535,0.0005724148,0.0004169569,0.0006972858,0.0013986649],"category_scores_gemma":[0.00082767213,0.0002156412,0.0016222595,0.00025898387,0.00039051115,0.00049744884,0.00039428403,0.0010409976,0.00020211247],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.873298,0.004071947,0.06417808,0.00025573676,0.0037922445,0.000087835186,0.00010140281,0.0013275271,0.004290321,0.00012793786,0.0008885193,0.04758048],"study_design_scores_gemma":[0.32675725,0.32154655,0.3333151,0.00021462915,0.0055453638,0.00033734474,0.0002348798,0.0044103935,0.0026844435,0.0007580545,0.0041246777,0.00007130454],"about_ca_topic_score_codex":0.0014211783,"about_ca_topic_score_gemma":0.004046703,"teacher_disagreement_score":0.0017268725,"about_ca_system_score_codex":0.00068763027,"about_ca_system_score_gemma":0.0004942771,"threshold_uncertainty_score":0.009132624},"labels":[],"label_agreement":null},{"id":"W3170705440","doi":"10.1002/ajh.26268","title":"Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Hemostasis and Thrombosis Research Society; Cancer Prevention and Research Institute of Texas; American Society of Hematology; National Hemophilia Foundation","keywords":"Medicine; Internal medicine; Thrombosis; Anticoagulant; Retrospective cohort study; Surgery; Transplantation; Hematology; Hematopoietic stem cell transplantation; Logistic regression; Warfarin","score_opus":0.017241189200122308,"score_gpt":0.31534603708270537,"score_spread":0.29810484788258307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170705440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997658,0.0016789796,0.00007871017,0.00009146514,0.000008136145,0.0000033608137,0.00005817189,0.0000027717422,0.00042046647],"genre_scores_gemma":[0.9996735,0.00015210712,0.000023566912,0.000019820553,0.0000126845725,0.0000010580375,0.000051203824,8.8512013e-7,0.00006529312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983759,0.0005767214,0.00023546773,0.00018670515,0.0004026164,0.0002226198],"domain_scores_gemma":[0.99402976,0.0016003301,0.0030926096,0.00022082763,0.0003109284,0.0007455336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013222382,0.00014291616,0.00028694654,0.00035636066,0.00017906654,0.00088605133,0.00022882303,0.0003474902,0.0010856914],"category_scores_gemma":[0.0076009184,0.00008052743,0.0007732014,0.00056875206,0.00024290911,0.00032556988,0.000331606,0.00068224245,0.00010873701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006131308,0.000059679038,0.9916659,0.000016633674,0.00021075369,0.00009838237,0.000026868376,0.00010015845,0.00016867822,0.000034903187,0.00006938647,0.006935594],"study_design_scores_gemma":[0.00001757294,0.0004437332,0.99802196,0.000015536087,0.00018326152,0.00047119884,0.000038835125,0.00043405432,0.00012969435,0.00006005433,0.0001795677,0.0000046780506],"about_ca_topic_score_codex":0.0014703611,"about_ca_topic_score_gemma":0.0019572154,"teacher_disagreement_score":0.0014703611,"about_ca_system_score_codex":0.00035879956,"about_ca_system_score_gemma":0.00042844916,"threshold_uncertainty_score":0.0069927573},"labels":[],"label_agreement":null},{"id":"W3173172916","doi":"10.1002/ajh.26274","title":"Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (<scp>FILO</scp>)","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Chronic lymphocytic leukemia; Leukemia cutis; Merkel cell carcinoma; IGHV@; Leukemia; Medicine; Pathology; Carcinoma; Immunology","score_opus":0.02323319188451987,"score_gpt":0.32291421686711275,"score_spread":0.29968102498259286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173172916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998936,0.00047941168,0.00004671116,0.00003029904,0.0000022792387,0.000013273354,0.00018661439,0.0000027967978,0.000302726],"genre_scores_gemma":[0.99936897,0.00012282988,0.000046759757,0.000042809355,0.000016329408,0.000011431509,0.0003142113,0.0000013065611,0.000075366486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994293,0.0001234608,0.00005715969,0.00016195748,0.00008888598,0.00013924761],"domain_scores_gemma":[0.9988738,0.0001617869,0.0003957756,0.00006606686,0.00015089748,0.0003516687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006812259,0.00045700566,0.00040362522,0.0022257788,0.0008362823,0.00091699976,0.00030334367,0.000617188,0.0012474557],"category_scores_gemma":[0.0014433545,0.00023019397,0.00033427443,0.0012641515,0.0005361994,0.0004957001,0.0004597908,0.00029970545,0.0003259354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009593855,0.00003409753,0.9975006,0.0000066178222,0.000018931478,0.00035162544,0.00011495215,0.000018811887,0.0005066237,0.000014658006,0.00007866653,0.0012583345],"study_design_scores_gemma":[0.000012307621,0.00016607765,0.99658245,0.000008560917,0.000016468663,0.0024176093,0.00020237676,0.000047777652,0.00006531746,0.00001379427,0.0004620167,0.000005329111],"about_ca_topic_score_codex":0.009418153,"about_ca_topic_score_gemma":0.0065017804,"teacher_disagreement_score":0.009418153,"about_ca_system_score_codex":0.0009319285,"about_ca_system_score_gemma":0.0005472195,"threshold_uncertainty_score":0.018726707},"labels":[],"label_agreement":null},{"id":"W3174342652","doi":"10.1002/ajh.26276","title":"Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Sanofi Genzyme; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Concomitant; Internal medicine; Gastroenterology; Clinical endpoint; Enzyme replacement therapy; Disease; Clinical trial; Pathological; Pathology","score_opus":0.06823739378827903,"score_gpt":0.4201139288326081,"score_spread":0.3518765350443291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174342652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98823184,0.0025636985,0.00042461362,0.0004227965,0.00012662249,0.0009066236,0.0037812805,0.000076083736,0.0034663025],"genre_scores_gemma":[0.98627454,0.0005628303,0.00042296931,0.0007789927,0.00015213186,0.0012055689,0.008183585,0.00001858301,0.00240069],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989065,0.00039976434,0.00009621846,0.00011938481,0.0001837615,0.00029441275],"domain_scores_gemma":[0.9969959,0.0004571445,0.00094156165,0.0002170962,0.00044786962,0.0009404955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004407468,0.0010912773,0.0022513983,0.00034400666,0.000727671,0.0011612788,0.00066679413,0.001669878,0.0031518945],"category_scores_gemma":[0.002517987,0.00028157787,0.0025564034,0.00039619242,0.00069195457,0.0011639744,0.00054610724,0.0028212254,0.00078794523],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8303769,0.021299254,0.053831335,0.00078803184,0.0035330376,0.00046566903,0.00031264627,0.0034367011,0.01141644,0.00024488012,0.011767726,0.062527396],"study_design_scores_gemma":[0.17075023,0.548436,0.2620552,0.00015626644,0.0035929165,0.0008323134,0.00024634713,0.0021755705,0.0048829215,0.0005620993,0.0061621536,0.00014799878],"about_ca_topic_score_codex":0.0013207494,"about_ca_topic_score_gemma":0.0016342603,"teacher_disagreement_score":0.004407468,"about_ca_system_score_codex":0.00088605727,"about_ca_system_score_gemma":0.00097540615,"threshold_uncertainty_score":0.023309171},"labels":[],"label_agreement":null},{"id":"W3176714232","doi":"10.1002/ajh.26282","title":"Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; University of Alberta","funders":"Karyopharm Therapeutics","keywords":"Medicine; Bortezomib; Multiple myeloma; Internal medicine; Dexamethasone; Family medicine; Library science; Gerontology","score_opus":0.011060448868156745,"score_gpt":0.24692227025848532,"score_spread":0.23586182139032857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176714232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159884,0.0045606033,0.00004344957,0.00037364237,0.000041259063,0.000051043564,0.0003369415,0.000010421196,0.0029837873],"genre_scores_gemma":[0.99653876,0.001858905,0.0000710353,0.00039798638,0.000079805846,0.00003165065,0.000419286,0.0000018303697,0.0006008043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997087,0.000055161043,0.000046150442,0.00003893869,0.00008622095,0.000064902684],"domain_scores_gemma":[0.99940765,0.000074585514,0.0002302291,0.000009456962,0.00005524297,0.00022285583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037416533,0.00029898516,0.0005985042,0.0007539249,0.0006074437,0.0006320354,0.00029226646,0.00046545677,0.0020782917],"category_scores_gemma":[0.0014642696,0.00018008827,0.00056633,0.00094015076,0.0002713954,0.0006949757,0.00040640318,0.0006362264,0.0002280733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016085862,0.0006788706,0.97364604,0.00016966423,0.000263709,0.00404359,0.0003890214,0.00023068636,0.0005377673,0.00004310633,0.0012156699,0.017173281],"study_design_scores_gemma":[0.000102105,0.0010576306,0.9946695,0.00006397396,0.00008966365,0.0028693546,0.00030665594,0.00017540381,0.000035445668,0.00003873429,0.0005801016,0.000011566211],"about_ca_topic_score_codex":0.0049285963,"about_ca_topic_score_gemma":0.006934496,"teacher_disagreement_score":0.0049285963,"about_ca_system_score_codex":0.0007136781,"about_ca_system_score_gemma":0.0004500313,"threshold_uncertainty_score":0.009799778},"labels":[],"label_agreement":null},{"id":"W3191391516","doi":"10.1002/ajh.26310","title":"Diagnostic work‐up for severe aplastic anemia in children: Consensus of the <scp>North American Pediatric Aplastic Anemia Consortium</scp>","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Aplastic anemia; Hematologist; Bone marrow failure; Anemia; Pediatrics; Bone marrow; Myelodysplastic syndromes; Intensive care medicine; Internal medicine; Haematopoiesis; Disease; Stem cell","score_opus":0.00793597049063087,"score_gpt":0.24326854051857652,"score_spread":0.23533257002794566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191391516","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22956246,0.15705325,0.12588216,0.29869398,0.010045773,0.0031168212,0.003231107,0.0013002587,0.17111409],"genre_scores_gemma":[0.63303256,0.10365238,0.2221992,0.021893261,0.0043758187,0.0009788808,0.004453517,0.00023908059,0.009175342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685174,0.0010082169,0.00082423043,0.00021280468,0.0008332093,0.00026976923],"domain_scores_gemma":[0.99173427,0.0017433184,0.0004999485,0.00020093948,0.004874348,0.0009471937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009055183,0.00050954515,0.0006438909,0.0033944903,0.0009971661,0.0011286234,0.001770228,0.0011732214,0.0012641323],"category_scores_gemma":[0.010581177,0.00027837444,0.0010460812,0.0011832836,0.0008869007,0.00094604975,0.0014576653,0.0031297007,0.00069601904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023180195,0.0002587803,0.19988856,0.0018369716,0.0002547017,0.012622266,0.0036606286,0.0029190239,0.008366203,0.0064995405,0.19890435,0.56455725],"study_design_scores_gemma":[0.00021649827,0.00042734246,0.3047265,0.01898121,0.00060910813,0.07046251,0.017066212,0.00964952,0.011811168,0.0139342435,0.5518372,0.00027834502],"about_ca_topic_score_codex":0.00940404,"about_ca_topic_score_gemma":0.01771936,"teacher_disagreement_score":0.00940404,"about_ca_system_score_codex":0.001629952,"about_ca_system_score_gemma":0.0064806044,"threshold_uncertainty_score":0.047888935},"labels":[],"label_agreement":null},{"id":"W3195845985","doi":"10.1002/ajh.26323","title":"The International Hemoglobinopathy Research Network (<scp>INHERENT</scp>): An international initiative to study the role of genetic modifiers in hemoglobinopathies","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"H2020 Marie Skłodowska-Curie Actions; European Regional Development Fund; Consumers, Health and Food Executive Agency; National Heart, Lung, and Blood Institute; Research and Innovation Foundation; European Commission","keywords":"Hemoglobinopathy; Medicine; Thalassemia; Hemolytic anemia; Internal medicine","score_opus":0.029790262350011795,"score_gpt":0.32182424314323804,"score_spread":0.29203398079322623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195845985","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12978975,0.1959291,0.049529813,0.14408043,0.021069935,0.00733505,0.307759,0.0041057835,0.14040107],"genre_scores_gemma":[0.25740892,0.121012636,0.1393247,0.043485835,0.015460535,0.014441533,0.36016417,0.0016388693,0.047062848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511355,0.0023058932,0.00025599956,0.0006884504,0.0012059449,0.0004301742],"domain_scores_gemma":[0.980699,0.003691571,0.0035179055,0.0009856941,0.0043509803,0.006754823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012368625,0.0018254226,0.0020051273,0.0034965486,0.00095455296,0.0029683302,0.002695152,0.002138017,0.0088431835],"category_scores_gemma":[0.009093523,0.00034861354,0.0010371315,0.0055396943,0.0008714114,0.0013931122,0.003941494,0.0025736548,0.002625892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004525875,0.00077650964,0.14780904,0.00193007,0.0015812375,0.0007142529,0.0002856915,0.0013111695,0.0037407319,0.018088132,0.41710076,0.40213647],"study_design_scores_gemma":[0.0029049548,0.0016588041,0.43526995,0.0031144964,0.001296097,0.0015191037,0.00032382747,0.0033292559,0.0023125182,0.0110899415,0.5370473,0.00013373472],"about_ca_topic_score_codex":0.009107262,"about_ca_topic_score_gemma":0.0075581423,"teacher_disagreement_score":0.012368625,"about_ca_system_score_codex":0.0023925502,"about_ca_system_score_gemma":0.011292231,"threshold_uncertainty_score":0.06541228},"labels":[],"label_agreement":null},{"id":"W3201926699","doi":"10.1002/ajh.26368","title":"Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency; Partnership for Clean Competition","keywords":"Erythropoietin; Reticulocyte; Erythropoiesis; Medicine; Biomarker; Hemoglobin; Internal medicine; Transferrin receptor; Endocrinology; Pharmacology; Immunology; Transferrin; Anemia; Chemistry; Biochemistry","score_opus":0.011658667282752288,"score_gpt":0.2895959310689638,"score_spread":0.27793726378621153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201926699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96592337,0.0029085495,0.029741246,0.00014450624,0.000041107323,0.00006468804,0.000312428,0.00018886263,0.0006752114],"genre_scores_gemma":[0.947108,0.0015012685,0.048926305,0.00028603803,0.000043519554,0.00008978777,0.00030687667,0.000040046274,0.0016982716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996648,0.000119160795,0.000015842143,0.00009333907,0.00007637645,0.000030525083],"domain_scores_gemma":[0.99971455,0.00008004872,0.00008844005,0.000022632803,0.00006512596,0.000029295003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047091194,0.0002753025,0.00027656605,0.00047296938,0.000089033456,0.00024192192,0.00019820764,0.000358726,0.00052712],"category_scores_gemma":[0.00053097116,0.00018696109,0.00017918543,0.00017527232,0.00013994705,0.00013840907,0.00015549187,0.00039938037,0.0003173983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017148523,0.000026409,0.0029888183,0.000037237794,0.000010523535,0.00002574383,0.000033001397,0.00005493049,0.99167174,0.000016118285,0.00007497275,0.0048889094],"study_design_scores_gemma":[0.00003175106,0.001331988,0.084088854,0.00001661752,0.0000711109,0.0010703907,0.00007614454,0.005603231,0.9059472,0.00007651849,0.0016616047,0.000024659696],"about_ca_topic_score_codex":0.00043981613,"about_ca_topic_score_gemma":0.0007936444,"teacher_disagreement_score":0.00052712,"about_ca_system_score_codex":0.00014021728,"about_ca_system_score_gemma":0.000117203315,"threshold_uncertainty_score":0.0024904013},"labels":[],"label_agreement":null},{"id":"W3205845588","doi":"10.1002/ajh.26377","title":"A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Medicine; Population; Internal medicine; Oncology; Relative survival; Myeloproliferative neoplasm; Myeloid leukemia; Immunology; Epidemiology; Bone marrow; Cancer registry","score_opus":0.049623567506686936,"score_gpt":0.34078069779412856,"score_spread":0.2911571302874416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205845588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761873,0.00047480335,0.00009551999,0.00004815246,0.000010987098,0.00001650819,0.0013967049,0.0000059081776,0.0003326261],"genre_scores_gemma":[0.99813783,0.00021593127,0.00005481677,0.000036443897,0.000017292212,0.000016114933,0.0014573922,0.0000023964956,0.00006178846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990458,0.00019013851,0.00016331048,0.0002791363,0.0001984177,0.00012323607],"domain_scores_gemma":[0.9976803,0.0002560812,0.0011569385,0.0002204623,0.0003157031,0.00037052372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013598391,0.0004026558,0.0004492118,0.0023189038,0.00052295404,0.00092749274,0.0007691614,0.00075479114,0.0009502573],"category_scores_gemma":[0.0025793016,0.0004308856,0.00072657445,0.0027207783,0.00051415566,0.0011277072,0.0010053464,0.00072543044,0.00021864612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003593159,0.000025586989,0.9993,0.000007728566,0.00008960297,0.000023240831,0.000036576,0.000029004063,0.000033717126,0.000011195848,0.00007274513,0.00033460048],"study_design_scores_gemma":[0.0000050826907,0.000053135424,0.99939644,0.0000064251844,0.000034955636,0.0001021736,0.00014849239,0.00010804834,0.000014421854,0.000011786141,0.00011582855,0.000003316555],"about_ca_topic_score_codex":0.016109312,"about_ca_topic_score_gemma":0.02227924,"teacher_disagreement_score":0.016109312,"about_ca_system_score_codex":0.00093274354,"about_ca_system_score_gemma":0.0006371478,"threshold_uncertainty_score":0.03203112},"labels":[],"label_agreement":null},{"id":"W3210624555","doi":"10.1002/ajh.26400","title":"Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase <scp>IB</scp>/<scp>II</scp> study","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Internal medicine; Obinutuzumab; Tolerability; Rituximab; Oncology; Bendamustine; Antibody-drug conjugate; Lymphoma; Phases of clinical research; Follicular lymphoma; Refractory (planetary science); Gastroenterology; Chemotherapy; Immunology; Adverse effect; Monoclonal antibody; Antibody; Biology","score_opus":0.01415377187334877,"score_gpt":0.29010160797930074,"score_spread":0.27594783610595197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210624555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986264,0.007859578,0.00071573677,0.00031583264,0.00016070867,0.0012531102,0.0013327672,0.00006842559,0.0020298718],"genre_scores_gemma":[0.991557,0.0034468037,0.0005609371,0.000651433,0.0001865248,0.00059165666,0.0015710904,0.000027896247,0.0014066298],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994808,0.00021818862,0.000038038816,0.00009166905,0.00009366329,0.00007775045],"domain_scores_gemma":[0.9988973,0.00021501326,0.00027262204,0.000121552024,0.00011415054,0.00037931273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018463361,0.00090609805,0.0017487253,0.0003081544,0.00030725903,0.0015530881,0.00076549506,0.0010394447,0.0022198798],"category_scores_gemma":[0.0012080651,0.0004255926,0.0012742504,0.00041261635,0.0006987266,0.00087206333,0.00018834542,0.0019126167,0.00061884255],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7170617,0.042804405,0.009854493,0.0014800141,0.0026845238,0.0004212532,0.0003919983,0.0025772278,0.04425538,0.00042562376,0.0046743373,0.173369],"study_design_scores_gemma":[0.41979462,0.529845,0.027369171,0.00014586521,0.001805065,0.0008233035,0.00010143624,0.0022217082,0.007818925,0.0005116468,0.009506529,0.00005677904],"about_ca_topic_score_codex":0.0007202276,"about_ca_topic_score_gemma":0.0010539371,"teacher_disagreement_score":0.0022198798,"about_ca_system_score_codex":0.001142295,"about_ca_system_score_gemma":0.0011784453,"threshold_uncertainty_score":0.0097644925},"labels":[],"label_agreement":null},{"id":"W4200605356","doi":"10.1002/ajh.26434","title":"Efficacy and tolerability of <scp>once‐weekly</scp> selinexor, bortezomib, and dexamethasone in comparison with standard <scp>twice‐weekly</scp> bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the <scp>BOSTON</scp> study","year":2021,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Karyopharm Therapeutics","keywords":"Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Internal medicine; Population; Pharmacology; Nephrotoxicity; Renal function; Tolerability; Oncology; Kidney; Adverse effect","score_opus":0.01931272400488909,"score_gpt":0.29232031986818535,"score_spread":0.27300759586329626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200605356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987069,0.009505021,0.00014632993,0.00015810785,0.00005583362,0.00025502217,0.002068689,0.000018635761,0.0007232664],"genre_scores_gemma":[0.99347186,0.0020289922,0.0001721168,0.00020163928,0.00012485324,0.00024337863,0.0031734735,0.000015819613,0.0005679765],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99919385,0.00025597317,0.0001278193,0.00018375162,0.00012865738,0.000109930486],"domain_scores_gemma":[0.9986798,0.00026511188,0.00046281336,0.00014487696,0.000102011865,0.00034538138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001917636,0.0010142926,0.0030376143,0.0005389721,0.00029451202,0.0010495101,0.0005650042,0.00087857636,0.0025166627],"category_scores_gemma":[0.0013999422,0.00043722894,0.0068136244,0.0008192499,0.00042897492,0.0009255215,0.0004128656,0.0014776714,0.00044816092],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8025128,0.0029720622,0.11403159,0.0014242103,0.026263114,0.00023759711,0.00020868426,0.0019424772,0.007603575,0.0001001257,0.0022071763,0.040496506],"study_design_scores_gemma":[0.19141342,0.16424887,0.59343255,0.00030999997,0.037768863,0.00081252184,0.00036507857,0.0029117388,0.002760749,0.00072752073,0.0050115464,0.000237093],"about_ca_topic_score_codex":0.0010368412,"about_ca_topic_score_gemma":0.0027969542,"teacher_disagreement_score":0.0030376143,"about_ca_system_score_codex":0.0009198266,"about_ca_system_score_gemma":0.00064918294,"threshold_uncertainty_score":0.010141492},"labels":[],"label_agreement":null},{"id":"W4205503064","doi":"10.1002/ajh.26465","title":"Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas","keywords":"Disease; Malignancy; Hematologic malignancy; Myeloid; Allele; Hematologic disease; Hematology; Genetic association; Haematopoiesis","score_opus":0.03151317610258437,"score_gpt":0.3728961058598902,"score_spread":0.34138292975730583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205503064","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070759333,0.99011165,0.0007054268,0.00023433937,0.00010915819,0.0002878067,0.0011586515,0.00003311632,0.00028395953],"genre_scores_gemma":[0.21506101,0.77711725,0.0028119788,0.0009486239,0.00027656415,0.0014353729,0.0019059636,0.000049339975,0.00039385326],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9925655,0.0031893095,0.0022584887,0.000884404,0.00080501946,0.00029721906],"domain_scores_gemma":[0.97966206,0.015179126,0.0028243985,0.0006786871,0.0014040953,0.00025155206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011052978,0.0023884191,0.016122317,0.0066721006,0.0007126654,0.0030626957,0.0022612724,0.0018546344,0.0037423293],"category_scores_gemma":[0.025773691,0.0013717173,0.031458754,0.009535276,0.0006317577,0.0014043254,0.0014609646,0.0014746415,0.00033659628],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011793791,0.000024485742,0.008376149,0.3801742,0.5995952,0.00015143442,0.00008230489,0.0005768502,0.00021542082,0.00012801074,0.0008509811,0.008645676],"study_design_scores_gemma":[0.0002815084,0.00011838667,0.005256832,0.022731623,0.9695042,0.00010288379,0.00004106767,0.00020348138,0.000090489644,0.00016569096,0.0014816241,0.000022146383],"about_ca_topic_score_codex":0.006850166,"about_ca_topic_score_gemma":0.015390483,"teacher_disagreement_score":0.016122317,"about_ca_system_score_codex":0.0021022114,"about_ca_system_score_gemma":0.0032239244,"threshold_uncertainty_score":0.058454454},"labels":[],"label_agreement":null},{"id":"W4210289504","doi":"10.1002/ajh.26481","title":"Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Leukocytosis; Ruxolitinib; Monocytosis; Chronic myelomonocytic leukemia; Immunology; Oncology; Disease; Myelodysplastic syndromes; Cancer research; Bioinformatics; Myelofibrosis; Bone marrow; Internal medicine; Biology","score_opus":0.00728513728808696,"score_gpt":0.24919690401785277,"score_spread":0.2419117667297658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210289504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086297886,0.9570074,0.0014389772,0.022263026,0.008094167,0.000039142527,0.0007454868,0.00023200814,0.009316853],"genre_scores_gemma":[0.0050977706,0.95332,0.0028197824,0.013418213,0.017590582,0.000065157,0.0025066633,0.000057564386,0.005124284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993765,0.00016400925,0.000104939485,0.00006444451,0.00022602755,0.000064185675],"domain_scores_gemma":[0.99735415,0.0008057239,0.00029344938,0.00005232351,0.0012055123,0.00028892714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013044557,0.00090126944,0.0013443519,0.0024346795,0.0003153981,0.0012996143,0.00093799713,0.0013380679,0.007559455],"category_scores_gemma":[0.004935509,0.00026454538,0.00068667385,0.0018413503,0.00035479842,0.0019250362,0.000922795,0.0027485525,0.0037969635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009544336,0.000030830146,0.0010567505,0.0019097378,0.000062200364,0.00017817332,0.000033686716,0.00023779007,0.00028421122,0.0011084435,0.32450223,0.6705004],"study_design_scores_gemma":[0.00003574611,0.00007740026,0.0018783143,0.0060448116,0.00015867196,0.0016831587,0.000046910638,0.00018024957,0.00010470148,0.0013536734,0.98841375,0.000022627308],"about_ca_topic_score_codex":0.0028167136,"about_ca_topic_score_gemma":0.0065113665,"teacher_disagreement_score":0.007559455,"about_ca_system_score_codex":0.0013446792,"about_ca_system_score_gemma":0.0017019218,"threshold_uncertainty_score":0.02528888},"labels":[],"label_agreement":null},{"id":"W4210974090","doi":"10.1002/ajh.26493","title":"Immunogenicity of a 5‐dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"St. Antonius Ziekenhuis; ZonMw","keywords":"Medicine; Pneumococcal polysaccharide vaccine; Pneumococcal conjugate vaccine; Immunogenicity; Vaccination; Hematopoietic stem cell transplantation; Immunology; Pneumococcal vaccine; Transplantation; Serotype; Vaccination schedule; Pneumococcal infections; Internal medicine; Streptococcus pneumoniae; Antibody; Immunization; Pneumococcal disease; Antibiotics","score_opus":0.010245731203748954,"score_gpt":0.26769308146892973,"score_spread":0.2574473502651808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210974090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996599,0.00010902394,0.00011239926,0.000008533252,0.0000065256095,0.000011872708,0.000015685713,0.0000027687802,0.00007326707],"genre_scores_gemma":[0.99965227,0.000060710303,0.00011546519,0.000018507619,0.000009566619,0.000012913241,0.000084291765,7.984588e-7,0.00004551304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997061,0.00008420776,0.000030561736,0.0000346477,0.00008728392,0.000057342946],"domain_scores_gemma":[0.9994978,0.000076831864,0.0002434139,0.00004279193,0.000032648808,0.0001064995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008296291,0.00017525227,0.00031044916,0.00012977986,0.00010179035,0.00023092578,0.00016862365,0.00018583483,0.00040919887],"category_scores_gemma":[0.0011150812,0.000071882605,0.00028308632,0.00012528972,0.0001146971,0.00018301026,0.00013205268,0.0003289742,0.000104727675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04586618,0.008358435,0.5505515,0.00027660595,0.00060906087,0.0007462601,0.00033615655,0.008050211,0.22887513,0.00019505687,0.00078318483,0.15535226],"study_design_scores_gemma":[0.00084233476,0.18272571,0.7707796,0.00005158213,0.0002711139,0.0010361649,0.00017081843,0.0039460333,0.03886944,0.00009049511,0.0011964218,0.000020260897],"about_ca_topic_score_codex":0.0003100927,"about_ca_topic_score_gemma":0.00037054834,"teacher_disagreement_score":0.0008296291,"about_ca_system_score_codex":0.00021714882,"about_ca_system_score_gemma":0.0002669379,"threshold_uncertainty_score":0.004387498},"labels":[],"label_agreement":null},{"id":"W4211256599","doi":"10.1002/ajh.26492","title":"A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institutes of Health; Department for International Development; National Institute for Health and Care Research; Medical Research Council Canada; University College London; Wellcome Trust","keywords":"Medicine; Anemia; Sickle cell anemia; Pediatrics; Malaria; Blood transfusion; Algorithm; Internal medicine; Disease; Immunology","score_opus":0.003990007576450975,"score_gpt":0.21823796224987302,"score_spread":0.21424795467342203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211256599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6923014,0.004019642,0.27234852,0.0069357143,0.0005514298,0.0034556305,0.008501195,0.0026815278,0.009204922],"genre_scores_gemma":[0.7720659,0.00076604215,0.2175131,0.0007922999,0.00019414266,0.0015049923,0.0058191167,0.00006108999,0.0012833424],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998317,0.00063567085,0.00027688663,0.00028991635,0.00030168213,0.00017876872],"domain_scores_gemma":[0.99461234,0.0030248782,0.00069478905,0.00012630461,0.0012078196,0.0003338698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034590007,0.0011081869,0.0014330865,0.0035059717,0.0006986194,0.0015882635,0.0017476394,0.0010137033,0.0029178886],"category_scores_gemma":[0.017688371,0.00040003675,0.0010518167,0.0014121049,0.00029303096,0.00082396413,0.0012517166,0.0015435743,0.00074819726],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001756675,0.0006799148,0.7240756,0.00031883942,0.000462529,0.00080407155,0.00039802794,0.035136357,0.0016034233,0.0016059316,0.018785119,0.2143735],"study_design_scores_gemma":[0.00079145253,0.00089504744,0.1363407,0.00051082135,0.00068991474,0.0023834438,0.0007003006,0.838628,0.003256292,0.007444211,0.008215677,0.00014412761],"about_ca_topic_score_codex":0.006319572,"about_ca_topic_score_gemma":0.0052128336,"teacher_disagreement_score":0.006319572,"about_ca_system_score_codex":0.00080885366,"about_ca_system_score_gemma":0.0015671067,"threshold_uncertainty_score":0.018293202},"labels":[],"label_agreement":null},{"id":"W4212859128","doi":"10.1002/ajh.26500","title":"Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Internal medicine; Hazard ratio; Refractory (planetary science); Oncology; Gastroenterology; Transplantation; Lymphoma; Classical Hodgkin lymphoma; Salvage therapy; Confidence interval; Chemotherapy; Hodgkin lymphoma","score_opus":0.011533827656359238,"score_gpt":0.2596016456974174,"score_spread":0.24806781804105815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212859128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995839,0.00014661658,0.00008630578,0.000014854085,0.0000018876818,0.0000021281787,0.00003078137,0.000002756969,0.00013066317],"genre_scores_gemma":[0.99983335,0.000019514504,0.00003959018,0.0000041718076,0.000004399937,0.0000014368721,0.00006182057,5.624555e-7,0.000035091452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984777,0.00005505477,0.000013141313,0.0000241057,0.000030138508,0.000029721892],"domain_scores_gemma":[0.9994566,0.00018603657,0.00016925727,0.000025441223,0.00003612077,0.00012651531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004076827,0.00024007935,0.0002091009,0.00042901476,0.00011424542,0.00032270036,0.00017361117,0.00022635538,0.0010837307],"category_scores_gemma":[0.0009655627,0.00008180746,0.0002571263,0.00026733673,0.00018556691,0.00021700683,0.0003032809,0.00027672193,0.0001284213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003595688,0.000016113003,0.9960891,0.0000042561664,0.00002356389,0.00009107213,0.00001453074,0.00019663534,0.00054567587,0.000019841573,0.000051525534,0.0025882043],"study_design_scores_gemma":[0.000020911868,0.00031420964,0.9955492,0.0000050941653,0.00005494851,0.00076958863,0.00005182247,0.002501557,0.00043806285,0.00010603296,0.00018341096,0.0000052713276],"about_ca_topic_score_codex":0.0005448163,"about_ca_topic_score_gemma":0.00076697406,"teacher_disagreement_score":0.0010837307,"about_ca_system_score_codex":0.0001785767,"about_ca_system_score_gemma":0.00014319007,"threshold_uncertainty_score":0.0036254525},"labels":[],"label_agreement":null},{"id":"W4213100173","doi":"10.1002/ajh.21294","title":"2nd Mayo/NASCOLA Coagulation Testing Quality Conference","year":2008,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; University of Waterloo; McMaster University","funders":"","keywords":"Citation; Quality (philosophy); Information retrieval; Computer science; Library science; Medicine; Philosophy; Epistemology","score_opus":0.07455863133513141,"score_gpt":0.30334295183456406,"score_spread":0.22878432049943265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213100173","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021345552,0.1050526,0.0810362,0.25761256,0.06418761,0.0060583963,0.018091146,0.010331999,0.43628386],"genre_scores_gemma":[0.16278557,0.08941129,0.16938446,0.071903355,0.04012184,0.007140259,0.07380114,0.0053017894,0.38015038],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9789883,0.004627214,0.0028732968,0.0016147259,0.010954824,0.00094174227],"domain_scores_gemma":[0.9457006,0.0039596907,0.0028551156,0.0039035897,0.040055748,0.0035251786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03161624,0.0016740542,0.001394599,0.006287226,0.001527341,0.008978362,0.0034917337,0.0038592936,0.040705565],"category_scores_gemma":[0.03473955,0.0006243507,0.0017292531,0.0023963945,0.0012961649,0.0020740407,0.0036474352,0.0043102857,0.023725286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044624956,0.0002684315,0.008436445,0.00062866765,0.00012748373,0.00069080835,0.00011078693,0.00047913936,0.0020689536,0.002701112,0.6505107,0.33353117],"study_design_scores_gemma":[0.000081963364,0.00018760367,0.015722347,0.001873213,0.000079051126,0.0015509753,0.00012279717,0.0010539793,0.0012516715,0.0020188894,0.9760098,0.000047756905],"about_ca_topic_score_codex":0.010032785,"about_ca_topic_score_gemma":0.013050029,"teacher_disagreement_score":0.040705565,"about_ca_system_score_codex":0.0050849607,"about_ca_system_score_gemma":0.010050381,"threshold_uncertainty_score":0.16720468},"labels":[],"label_agreement":null},{"id":"W4213242181","doi":"10.1002/ajh.26505","title":"Myeloid neoplasm with <scp>PDGFRB</scp> rearrangement, presenting as systemic mastocytosis‐chronic eosinophilic leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Surrey Memorial Hospital; Royal Columbian Hospital","funders":"","keywords":"Medicine; Pathology; Systemic mastocytosis; Bone marrow; Neutrophilia; Eosinophilia; Myelofibrosis; Extramedullary hematopoiesis; Eosinophilic; Leukemia; Immunology; Haematopoiesis; Biology","score_opus":0.007780135260848282,"score_gpt":0.2418526578116358,"score_spread":0.23407252255078753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213242181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97083616,0.0038229816,0.0019358625,0.0015596283,0.00017645041,0.0002688593,0.0010821357,0.00020741388,0.020110467],"genre_scores_gemma":[0.99560475,0.0011818875,0.00060906046,0.0003310353,0.00017999484,0.000023762319,0.00034635665,0.00001858152,0.0017046144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99984276,0.000011170182,0.000013266336,0.000044662407,0.000022142032,0.000066014756],"domain_scores_gemma":[0.99978393,0.00004220934,0.000041170973,0.000017257384,0.000014148124,0.00010126045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013267745,0.0010469317,0.00048129336,0.0009317899,0.00077843823,0.0005556674,0.00036923026,0.0014091777,0.0030730402],"category_scores_gemma":[0.0005294414,0.00043050354,0.00023631759,0.0007692479,0.00038680315,0.0005764205,0.00043326893,0.0006583658,0.0014253876],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017122264,0.000078927806,0.01824356,0.00007625508,0.000010768317,0.9686794,0.000101641475,0.00014787253,0.007220873,0.00030262786,0.0010774812,0.003889352],"study_design_scores_gemma":[0.000053267027,0.00022579332,0.04142802,0.000024567937,0.000020195703,0.95409095,0.00010210375,0.0004594402,0.00080749806,0.00023649851,0.0025411479,0.000010505447],"about_ca_topic_score_codex":0.00087611104,"about_ca_topic_score_gemma":0.0015998145,"teacher_disagreement_score":0.0030730402,"about_ca_system_score_codex":0.00041531696,"about_ca_system_score_gemma":0.00032298506,"threshold_uncertainty_score":0.010280311},"labels":[],"label_agreement":null},{"id":"W4213365409","doi":"10.1002/ajh.26508","title":"Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Autoimmune hemolytic anemia; Adverse effect; Anemia; Internal medicine; Clinical endpoint; Gastroenterology; Haptoglobin; Syk; Clinical trial; Tyrosine kinase","score_opus":0.03779419354714667,"score_gpt":0.3875418852873847,"score_spread":0.349747691740238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213365409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96734357,0.015504893,0.0016358634,0.0018027048,0.0004966005,0.0038324299,0.004270442,0.000326865,0.004786663],"genre_scores_gemma":[0.97634375,0.007574445,0.0020358413,0.0025536146,0.0003461267,0.0031066108,0.0043401923,0.000051651154,0.0036477381],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995838,0.00015030074,0.000032549357,0.0000793179,0.00007062145,0.000083438565],"domain_scores_gemma":[0.99958056,0.00006902924,0.00009956824,0.00003283534,0.00006331001,0.00015469524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001256399,0.0013207474,0.0023026601,0.0002493918,0.00030971362,0.0010729403,0.00068293366,0.0013280382,0.0044402992],"category_scores_gemma":[0.0009876216,0.00035794202,0.001318884,0.00034512303,0.0005061284,0.0012055793,0.00022732734,0.0019073561,0.0009444404],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5624681,0.046384126,0.008256591,0.00733845,0.0072878166,0.0012683787,0.0004991252,0.005851152,0.05301236,0.0012671079,0.039174236,0.26719257],"study_design_scores_gemma":[0.75559515,0.20511863,0.011254898,0.00016972361,0.0010172282,0.0017027986,0.00010703138,0.0031255183,0.004346903,0.000681202,0.016805515,0.00007542235],"about_ca_topic_score_codex":0.00040141732,"about_ca_topic_score_gemma":0.0014653939,"teacher_disagreement_score":0.0044402992,"about_ca_system_score_codex":0.0006980285,"about_ca_system_score_gemma":0.0011079299,"threshold_uncertainty_score":0.014854312},"labels":[],"label_agreement":null},{"id":"W4220684932","doi":"10.1002/ajh.26534","title":"A t(6;14;9)(p22;q22;q34) <scp>three‐way</scp> translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chromosomal translocation; Myeloid leukemia; Medicine; Myeloid; Biology; Cancer research; Gene; Genetics","score_opus":0.01851038053093702,"score_gpt":0.2822152237193325,"score_spread":0.2637048431883955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220684932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98368615,0.0005582636,0.0045638713,0.0013920608,0.00019497686,0.00013915417,0.00084010954,0.0001853708,0.008440051],"genre_scores_gemma":[0.99635065,0.00012964889,0.0021320938,0.00014081699,0.00009039006,0.000016722057,0.00021314343,0.000027415792,0.0008990947],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99977976,0.000022542576,0.000021999303,0.000074320196,0.000046552366,0.000054753054],"domain_scores_gemma":[0.9994466,0.0001834057,0.00011464458,0.00003837264,0.00004552642,0.00017153315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014793464,0.00069478736,0.00039921654,0.0009317079,0.0005130999,0.0008238044,0.00084118714,0.0020307358,0.003396204],"category_scores_gemma":[0.001158924,0.0003581738,0.00040527948,0.00081243867,0.00080662454,0.0005166565,0.0006298297,0.0011875989,0.0008213166],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000525356,0.00008712178,0.014828539,0.00006338493,0.00002228065,0.88377213,0.00033619945,0.000756951,0.087108016,0.0033756325,0.0014936889,0.0076305815],"study_design_scores_gemma":[0.00013299029,0.00051937025,0.049116705,0.000016223998,0.00007080278,0.92184645,0.00033778246,0.0028265275,0.015100864,0.0027074795,0.0072868364,0.000038023623],"about_ca_topic_score_codex":0.0012183284,"about_ca_topic_score_gemma":0.0010697335,"teacher_disagreement_score":0.003396204,"about_ca_system_score_codex":0.00047164146,"about_ca_system_score_gemma":0.00036196946,"threshold_uncertainty_score":0.01136148},"labels":[],"label_agreement":null},{"id":"W4220971510","doi":"10.1002/ajh.26536","title":"Health‐related quality of life in patients with <scp>light chain</scp> amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the <scp>ANDROMEDA</scp> study","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Alberta Health Services","funders":"Janssen Research and Development","keywords":"Medicine; Andromeda; Daratumumab; Internal medicine; Bortezomib; Population; Amyloidosis; Cyclophosphamide; Oncology; Multiple myeloma; Chemotherapy","score_opus":0.008644266222533767,"score_gpt":0.24692164534710165,"score_spread":0.23827737912456787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220971510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984871,0.0008904723,0.00008157188,0.00006018383,0.000011386501,0.0000513186,0.00015152595,0.0000038832754,0.00026247735],"genre_scores_gemma":[0.99905795,0.00021065908,0.00018448671,0.00010128579,0.000021534079,0.00005344522,0.0002723096,0.0000010398835,0.000097316726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994198,0.00034320418,0.000048541067,0.0000565728,0.000078926656,0.000053117663],"domain_scores_gemma":[0.9991596,0.00021260198,0.00032128007,0.000051295454,0.00005183719,0.00020344126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018196808,0.00033537266,0.0007632683,0.00018283827,0.00018553066,0.00050836,0.00022140543,0.0003382852,0.00044969443],"category_scores_gemma":[0.0010758532,0.0001470332,0.0011515658,0.0003079359,0.00023232416,0.000298532,0.0002504204,0.0007132055,0.000099891826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17605093,0.009920288,0.66193974,0.000592988,0.005124621,0.00019724904,0.00039189612,0.0036388163,0.01243875,0.00013247236,0.0016105133,0.12796171],"study_design_scores_gemma":[0.026452595,0.07664203,0.88868105,0.0000612331,0.0014464849,0.00034572184,0.00009914065,0.0026945279,0.0018279495,0.00018771779,0.0015278101,0.000033671895],"about_ca_topic_score_codex":0.000474431,"about_ca_topic_score_gemma":0.000873012,"teacher_disagreement_score":0.0018196808,"about_ca_system_score_codex":0.0002919373,"about_ca_system_score_gemma":0.00039320844,"threshold_uncertainty_score":0.0096235275},"labels":[],"label_agreement":null},{"id":"W4230800436","doi":"10.1002/ajh.25128","title":"Issue Information – Table of Contents","year":2018,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Table (database); Citation; Information retrieval; Computer science; Table of contents; World Wide Web; Library science; Database","score_opus":0.012158247047930275,"score_gpt":0.29746320147343985,"score_spread":0.28530495442550957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230800436","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019548555,0.00077739207,0.00048789126,0.002173476,0.009078326,0.00036084265,0.025404587,0.0017619878,0.95975995],"genre_scores_gemma":[0.0011522894,0.00097077026,0.00038065336,0.0015167274,0.0029396273,0.0001264122,0.01716583,0.00081376533,0.97493386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994598,0.000055560384,0.00004606601,0.00009427851,0.00026841727,0.00007583782],"domain_scores_gemma":[0.9961467,0.00051159534,0.00020877109,0.00031672328,0.0017310249,0.0010851814],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006448501,0.0012862575,0.0012994107,0.002616256,0.0012265221,0.0064497003,0.0014796462,0.0015658857,0.9326373],"category_scores_gemma":[0.0057178577,0.0005827495,0.0006296707,0.0031277328,0.00043301086,0.0038319938,0.0013645522,0.0021718103,0.90951806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014384781,0.000022380269,0.000054051507,0.00010349627,0.0000011879242,0.000010384294,0.000004493444,0.00003182868,0.000065184766,0.0004826369,0.9782259,0.020983951],"study_design_scores_gemma":[0.000019060735,0.000016352857,0.000333065,0.00013073412,0.0000013708803,0.000031240845,0.000014447871,0.00004472454,0.000061575236,0.0005020389,0.99884087,0.000004534455],"about_ca_topic_score_codex":0.0028747155,"about_ca_topic_score_gemma":0.0038351566,"teacher_disagreement_score":0.067362726,"about_ca_system_score_codex":0.0011630999,"about_ca_system_score_gemma":0.0018714275,"threshold_uncertainty_score":0.09608477},"labels":[],"label_agreement":null},{"id":"W4231993637","doi":"10.1002/ajh.21469","title":"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment","year":2009,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Garcia; Medicine; Chapel; Art; Humanities; Library science; Art history; Computer science","score_opus":0.07805500487584956,"score_gpt":0.3916754681790257,"score_spread":0.31362046330317617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231993637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094484945,0.9662217,0.000083234256,0.027293859,0.0051321415,0.0000074380628,0.000053858497,0.000011852033,0.0011014111],"genre_scores_gemma":[0.0020054171,0.93981224,0.00035696308,0.045307647,0.011358173,0.000033576183,0.00008983696,0.0000059640374,0.0010301543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979672,0.00047784948,0.00046759433,0.00019298644,0.0008054841,0.00008892352],"domain_scores_gemma":[0.9929929,0.004279993,0.0010132607,0.00016978619,0.0013948828,0.00014915472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044098324,0.000680976,0.002914662,0.0011238855,0.00035818064,0.0011079278,0.0019625737,0.004720656,0.002313567],"category_scores_gemma":[0.01085284,0.00031517236,0.0015810339,0.0021387353,0.0009848389,0.001669456,0.00046718994,0.0054271286,0.001540567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027845244,0.00003684091,0.00054025353,0.019253755,0.00037025035,0.00026704298,0.00007869557,0.00014918108,0.00040423896,0.002596487,0.5680038,0.4080211],"study_design_scores_gemma":[0.00053433207,0.00028147604,0.004727976,0.03319049,0.0013564228,0.0030327167,0.00011590652,0.00016888506,0.00041719485,0.0032380982,0.9528795,0.000057065525],"about_ca_topic_score_codex":0.003629904,"about_ca_topic_score_gemma":0.006447824,"teacher_disagreement_score":0.004720656,"about_ca_system_score_codex":0.0009584794,"about_ca_system_score_gemma":0.0026538253,"threshold_uncertainty_score":0.023321688},"labels":[],"label_agreement":null},{"id":"W4233703217","doi":"10.1002/ajh.23701","title":"The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review","year":2014,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; National database; Mutation; Database; Pediatrics; Genetics; Biology; Computer science; Gene","score_opus":0.07830894096168113,"score_gpt":0.431359321562862,"score_spread":0.3530503806011809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233703217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033700842,0.98617166,0.00012799927,0.0018424223,0.00049606356,0.00013279932,0.007910347,0.00004243781,0.002939179],"genre_scores_gemma":[0.0016162334,0.9920664,0.00045030014,0.0008439015,0.00013387152,0.000083503706,0.003935606,0.000008205835,0.00086202024],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99874336,0.00010812735,0.0002472455,0.000078898505,0.0007312942,0.00009113089],"domain_scores_gemma":[0.9940428,0.0011551465,0.00092384126,0.00010632592,0.003503057,0.0002687888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019115402,0.0009847282,0.0036361525,0.011365079,0.000685202,0.0012898779,0.0024567307,0.0009431029,0.013252215],"category_scores_gemma":[0.007624301,0.00038837106,0.001674377,0.018186264,0.0005385456,0.00095790246,0.000883032,0.0009264863,0.0020651123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019009356,0.000027223323,0.00085344183,0.13812438,0.0007971425,0.000115743096,0.000065280765,0.00014946907,0.00026314845,0.0011173442,0.39029807,0.46799874],"study_design_scores_gemma":[0.00011808442,0.00004937607,0.007598137,0.09178774,0.0028892779,0.0004819655,0.00009477796,0.00008422591,0.00024508437,0.00043248496,0.89616144,0.000057404],"about_ca_topic_score_codex":0.16422999,"about_ca_topic_score_gemma":0.32869008,"teacher_disagreement_score":0.83577,"about_ca_system_score_codex":0.0052138427,"about_ca_system_score_gemma":0.027684547,"threshold_uncertainty_score":0.3265481},"labels":[],"label_agreement":null},{"id":"W4236133913","doi":"10.1002/ajh.22083","title":"Fourth Congress of the International BioIron Society (IBIS) Biennial World Meeting (BioIron 2011) May 22 – 26, 2011 Sheraton Vancouver Wall Centre Hotel Vancouver, BC, Canada","year":2011,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibis; Citation; Library science; Political science; Media studies; Law; Sociology; Computer science","score_opus":0.006774097912266287,"score_gpt":0.20366736705121546,"score_spread":0.19689326913894917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236133913","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016258184,0.038699314,0.006463804,0.104152694,0.17108653,0.0008140061,0.0056594717,0.0012419192,0.65562403],"genre_scores_gemma":[0.010483045,0.005570565,0.0014145991,0.0022648592,0.00448443,0.00010836921,0.0019339002,0.00017394581,0.97356623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993173,0.0000968586,0.000019565372,0.0001018986,0.00026967595,0.00019469818],"domain_scores_gemma":[0.9985544,0.00004469671,0.000045977824,0.000028905133,0.0005994066,0.0007266795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021412116,0.0010458042,0.00069754734,0.0007825042,0.002031336,0.004414122,0.00085538055,0.0020570308,0.15058787],"category_scores_gemma":[0.0008170284,0.00025829734,0.0005482673,0.0006264449,0.0005494402,0.0007437755,0.0018030514,0.0024445795,0.06529914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015674505,0.00008621254,0.00069717475,0.00007887457,0.000008205744,0.000054747,0.000033228673,0.000077183126,0.0005840229,0.000500919,0.9665031,0.03121956],"study_design_scores_gemma":[0.000013554931,0.00004795308,0.002569729,0.000041599706,0.000005826179,0.000042401738,0.00013300688,0.000097897624,0.00020183339,0.00013983499,0.9966983,0.0000079909905],"about_ca_topic_score_codex":0.019503484,"about_ca_topic_score_gemma":0.09999264,"teacher_disagreement_score":0.9804965,"about_ca_system_score_codex":0.0025345047,"about_ca_system_score_gemma":0.003732064,"threshold_uncertainty_score":0.50376666},"labels":[],"label_agreement":null},{"id":"W4238367063","doi":"10.1002/ajh.22074","title":"Erratum to: Unexpectedly low pulse oximetry measurements associated with variant hemoglobins: A systematic review","year":2011,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hemoglobin; Pulse oximetry; Hemoglobin variants; Asymptomatic; Medicine; Hypoxemia; Hemoglobinopathy; Hemoglobin A2; Gastroenterology; Internal medicine; Anesthesia; Hemolytic anemia","score_opus":0.02117126790640444,"score_gpt":0.28036718651291537,"score_spread":0.2591959186065109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238367063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014492723,0.9659988,0.0002832191,0.009557583,0.01933308,0.00026142027,0.0023254473,0.000052370935,0.00073877646],"genre_scores_gemma":[0.0186975,0.945872,0.00089119346,0.01920038,0.011196513,0.0005161432,0.001996134,0.00006859656,0.001561535],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947519,0.00097555283,0.0025458466,0.0005001866,0.0010451563,0.00018129125],"domain_scores_gemma":[0.9588004,0.023280544,0.009933103,0.0005868957,0.0068608476,0.00053819607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005794453,0.0014120511,0.0038882592,0.010770394,0.00051308377,0.0016267457,0.0015480135,0.0021562562,0.011755065],"category_scores_gemma":[0.04520637,0.0010195883,0.0024373888,0.010986523,0.0008828099,0.003102912,0.001529551,0.0012690193,0.0012482407],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004252409,0.000034724046,0.003325003,0.69330883,0.0030700092,0.0013028425,0.00032505183,0.00011205661,0.00026770413,0.00046920852,0.21875554,0.07860367],"study_design_scores_gemma":[0.00065550924,0.0002883417,0.019467996,0.71104366,0.02269291,0.0061071087,0.0008626727,0.00019578394,0.0004681027,0.00067417807,0.23739214,0.00015154295],"about_ca_topic_score_codex":0.0054763285,"about_ca_topic_score_gemma":0.010846822,"teacher_disagreement_score":0.011755065,"about_ca_system_score_codex":0.001865814,"about_ca_system_score_gemma":0.00564516,"threshold_uncertainty_score":0.03932464},"labels":[],"label_agreement":null},{"id":"W4240889406","doi":"10.1002/(sici)1096-8652(200005)64:1<82::aid-ajh20>3.3.co;2-u","title":"Decreased expression of p33ING1 mRNA in lymphoid malignancies","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.007835042333373116,"score_gpt":0.26017268592153003,"score_spread":0.2523376435881569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240889406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751925,0.00074568327,0.000440171,0.000043453052,0.000008972963,0.000005319277,0.0001418802,0.00002157344,0.0010737398],"genre_scores_gemma":[0.99811554,0.00024286319,0.00034004552,0.000022543481,0.000011944537,0.000009325697,0.00025389902,0.000006243899,0.0009976866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992085,0.000010642735,0.0000059307754,0.000014653381,0.000018772675,0.000029166447],"domain_scores_gemma":[0.99986935,0.000034669752,0.000028246155,0.000010730125,0.000022534665,0.000034513316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010548669,0.00011065095,0.00011938801,0.00045827925,0.00021374587,0.00026837486,0.000090081056,0.00017837314,0.0023514961],"category_scores_gemma":[0.00027125236,0.000106446634,0.000071956194,0.0002162688,0.00018981313,0.00015553027,0.000109402026,0.00030554435,0.00027923036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006631421,0.000038649927,0.015504044,0.000045192162,0.000008496394,0.0004929511,0.00007069469,0.00005502317,0.9767422,0.00012576372,0.00018106816,0.00607287],"study_design_scores_gemma":[0.000055833367,0.00085452263,0.46699306,0.000016182634,0.00008755578,0.00784641,0.0005346869,0.001280291,0.51521885,0.00023530533,0.006868057,0.000009163232],"about_ca_topic_score_codex":0.0005240131,"about_ca_topic_score_gemma":0.00041982616,"teacher_disagreement_score":0.0023514961,"about_ca_system_score_codex":0.0002038452,"about_ca_system_score_gemma":0.00013345157,"threshold_uncertainty_score":0.007866502},"labels":[],"label_agreement":null},{"id":"W4245969999","doi":"10.1002/ajh.25052","title":"ISSUE INFORMATION – TABLE OF CONTENTS","year":2018,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Table (database); Citation; Information retrieval; Computer science; Table of contents; World Wide Web; Database","score_opus":0.01643390759841842,"score_gpt":0.2487697075030919,"score_spread":0.23233579990467348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245969999","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017325477,0.0007807518,0.00046455718,0.001966426,0.009541385,0.0003083247,0.037790343,0.0019227569,0.9470521],"genre_scores_gemma":[0.0011198074,0.0008921967,0.00033520613,0.001226022,0.0027843814,0.00012927674,0.020323314,0.0010255972,0.97216415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926573,0.0000743211,0.000062101506,0.0001399694,0.0003608425,0.00009714158],"domain_scores_gemma":[0.99539906,0.00061637466,0.00024566372,0.00041239295,0.0022033746,0.00112311],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00071322755,0.0014303753,0.0015646659,0.0029833282,0.001398928,0.007738199,0.0016486682,0.0016231516,0.9303699],"category_scores_gemma":[0.006782379,0.0005984791,0.0006563801,0.0041524563,0.00048014548,0.0041834395,0.0015107645,0.002275391,0.9172901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011343891,0.000015747104,0.00004842181,0.00009976623,0.0000011594483,0.000007760231,0.000004740767,0.00002947504,0.000048035552,0.0005107332,0.9833218,0.01590111],"study_design_scores_gemma":[0.000014661908,0.000012921898,0.00036510805,0.00014173014,0.0000013205813,0.000020842013,0.0000159804,0.00004168524,0.00005658087,0.0005254782,0.9987991,0.0000047267936],"about_ca_topic_score_codex":0.0041740425,"about_ca_topic_score_gemma":0.0048907567,"teacher_disagreement_score":0.06963009,"about_ca_system_score_codex":0.0014591452,"about_ca_system_score_gemma":0.0022388946,"threshold_uncertainty_score":0.09931886},"labels":[],"label_agreement":null},{"id":"W4247033018","doi":"10.1002/ajh.24349","title":"Issue Information – Masthead","year":2016,"lang":"en","type":"paratext","venue":"American Journal of Hematology","topic":"Corporate Taxation and Avoidance","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; World Wide Web; Computer science","score_opus":0.008828484369616923,"score_gpt":0.23533607091181277,"score_spread":0.22650758654219585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247033018","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022040433,0.0003888717,0.00029965758,0.0021995583,0.009118898,0.0002750607,0.007242811,0.0012811369,0.97897357],"genre_scores_gemma":[0.0007421942,0.00022048572,0.00009549122,0.0009517574,0.0014739687,0.000049664268,0.002383293,0.00032805468,0.9937551],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991247,0.000087853216,0.00006150586,0.00013991042,0.00046230562,0.0001238048],"domain_scores_gemma":[0.99624324,0.0005778294,0.0002002761,0.00042071636,0.0015329315,0.001025022],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010198642,0.0011220648,0.0011457845,0.0018456965,0.0014251304,0.006496362,0.0015832334,0.003099635,0.9149323],"category_scores_gemma":[0.00534479,0.00067605515,0.0007260318,0.0021557505,0.0006043493,0.004081343,0.0017616986,0.0025474497,0.89341056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020309857,0.000016490412,0.000042394055,0.00006329576,8.1058874e-7,0.000012250438,0.000005593153,0.000020427573,0.00008802157,0.0006872578,0.9825325,0.016510602],"study_design_scores_gemma":[0.000016997812,0.000018124316,0.0002797076,0.00006764639,8.45425e-7,0.000020414345,0.000014347089,0.00004157692,0.00007086272,0.00042349918,0.99904186,0.000004032251],"about_ca_topic_score_codex":0.002280107,"about_ca_topic_score_gemma":0.004071605,"teacher_disagreement_score":0.08506769,"about_ca_system_score_codex":0.0010630742,"about_ca_system_score_gemma":0.0018070603,"threshold_uncertainty_score":0.121338725},"labels":[],"label_agreement":null},{"id":"W4252684203","doi":"10.1002/1096-8652(200007)64:3<206::aid-ajh12>3.3.co;2-r","title":"β‐thalassemia intermedia caused by compound heterozygosity for Hb Malay (β codon 19 AAC→AGC; Asn→Ser) and codons 41/42 (‐CTTT) β0‐thalassemia mutation","year":2000,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"University of Hong Kong","keywords":"Thalassemia; Intermedia; Compound heterozygosity; Loss of heterozygosity; Hemoglobinopathy; Mutation; Genetics; Malay; Medicine; Hemolytic anemia; Biology; Internal medicine; Allele; Gene","score_opus":0.006762114833858221,"score_gpt":0.26577169687254637,"score_spread":0.2590095820386881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252684203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608517,0.0005713997,0.0006234821,0.00016548375,0.000026205065,0.000033002856,0.000041482985,0.00003262026,0.0024211286],"genre_scores_gemma":[0.9985316,0.00035749917,0.00042629914,0.000087072185,0.00008756576,0.000008080398,0.000044185035,0.0000064552564,0.00045114144],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99983454,0.000019080135,0.000019370107,0.000040822113,0.000025262683,0.00006087485],"domain_scores_gemma":[0.9994935,0.000121790086,0.00017412282,0.000041503037,0.000014394864,0.00015467408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015917275,0.001175752,0.0003432041,0.0007476421,0.0010503078,0.00041600288,0.00035583446,0.00077481003,0.002713701],"category_scores_gemma":[0.0009770758,0.00057350675,0.00029639844,0.0005077629,0.0007886987,0.0004609204,0.0006844576,0.00094826746,0.0006601885],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001965829,0.00009031915,0.07750652,0.000048366444,0.000023009154,0.9071972,0.00049746933,0.00006413926,0.0073131523,0.00023428656,0.0005175964,0.0063113812],"study_design_scores_gemma":[0.000023592449,0.00012456562,0.018702714,0.000006854266,0.000026523983,0.97881114,0.00009734517,0.000114974544,0.0013394482,0.00013469887,0.00060948223,0.00000859434],"about_ca_topic_score_codex":0.0009075903,"about_ca_topic_score_gemma":0.0010280502,"teacher_disagreement_score":0.002713701,"about_ca_system_score_codex":0.00021985105,"about_ca_system_score_gemma":0.00022157436,"threshold_uncertainty_score":0.009078264},"labels":[],"label_agreement":null},{"id":"W4280569962","doi":"10.1002/ajh.26587","title":"Optical genome mapping for structural variation analysis in hematologic malignancies","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Karyotype; Chromosomal translocation; Biology; Copy-number variation; Comparative genomic hybridization; Computational biology; Microarray; Myeloid leukemia; Structural variation; Cytogenetics; DNA microarray; Genome; Breakpoint; Genetics; Chromosome; Cancer research; Gene","score_opus":0.019104876557572377,"score_gpt":0.3051088845966437,"score_spread":0.28600400803907133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280569962","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028738428,0.9537013,0.028709192,0.0022468625,0.0015089585,0.000121134435,0.00043638228,0.00043647946,0.009965877],"genre_scores_gemma":[0.031492516,0.88170755,0.07489208,0.002165346,0.0015614766,0.00027861362,0.0011261211,0.00016522683,0.006611062],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985733,0.0004387767,0.000108761466,0.0002255381,0.0005861232,0.000067381],"domain_scores_gemma":[0.99849415,0.0007714608,0.0002395073,0.00008164468,0.00035968877,0.000053499483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023002776,0.0005899199,0.0007629836,0.004062176,0.00029891502,0.0013354657,0.0008336739,0.00094439223,0.003107541],"category_scores_gemma":[0.0031680593,0.0003433923,0.00071053393,0.0027199904,0.0006863487,0.00097614847,0.0007689173,0.0015294753,0.002023994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007535877,0.00003641347,0.0030021968,0.0066468376,0.00017677127,0.0006036255,0.00011954852,0.0003836171,0.03149061,0.008098572,0.028733088,0.9206334],"study_design_scores_gemma":[0.000023618913,0.00018943837,0.010206656,0.0020132454,0.00025813418,0.00628762,0.0001424104,0.00085468247,0.026779216,0.0055759912,0.94760364,0.000065262815],"about_ca_topic_score_codex":0.0013538483,"about_ca_topic_score_gemma":0.0018991666,"teacher_disagreement_score":0.004062176,"about_ca_system_score_codex":0.0008849225,"about_ca_system_score_gemma":0.0008842102,"threshold_uncertainty_score":0.012165189},"labels":[],"label_agreement":null},{"id":"W4280590103","doi":"10.1002/ajh.26599","title":"Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Hematopoietic stem cell transplantation; Medicine; Stem cell; Transplantation; Immunology; Haematopoiesis; Disease; Red blood cell; Hematopoietic stem cell; Flow cytometry; Biology; Internal medicine","score_opus":0.018938787312093516,"score_gpt":0.36853629157915807,"score_spread":0.34959750426706454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280590103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009892883,0.99926275,0.00011627432,0.00013002126,0.0000832568,0.0000038770304,0.000014057384,0.0000047610897,0.00028603847],"genre_scores_gemma":[0.00046377393,0.9990386,0.00021094832,0.00008230242,0.00006714087,0.000005950992,0.000022476595,0.0000012940358,0.00010751932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996081,0.00006879554,0.00008760317,0.00007023555,0.0001450007,0.000020320937],"domain_scores_gemma":[0.9989374,0.0006556609,0.0001309729,0.000020499392,0.00021645511,0.000038946964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013134961,0.0008082661,0.0016829481,0.002725575,0.00022442601,0.0010334487,0.0010282217,0.0009536203,0.0019783312],"category_scores_gemma":[0.0016410976,0.0003021882,0.0007528404,0.0024032623,0.0005310797,0.001486461,0.0005405523,0.0011977142,0.0009767918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074004376,0.000061626924,0.00033153463,0.025199808,0.00010040809,0.00011465356,0.00006412466,0.00026972833,0.001242309,0.0014472553,0.010787205,0.9603073],"study_design_scores_gemma":[0.000031910185,0.00033527092,0.0036393902,0.016008781,0.0005917655,0.0025010456,0.00015867206,0.000281256,0.0014811105,0.0024048008,0.97249943,0.00006647636],"about_ca_topic_score_codex":0.0011803078,"about_ca_topic_score_gemma":0.0013738287,"teacher_disagreement_score":0.002725575,"about_ca_system_score_codex":0.0004748373,"about_ca_system_score_gemma":0.001267358,"threshold_uncertainty_score":0.006946504},"labels":[],"label_agreement":null},{"id":"W4281285399","doi":"10.1002/ajh.26618","title":"Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia","year":2022,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Myeloid leukemia; Population; Cancer registry; Cancer; Internal medicine; Oncology; Incidence (geometry); Leukemia; Tyrosine-kinase inhibitor; Clinical trial","score_opus":0.02980958234156228,"score_gpt":0.2920588869648335,"score_spread":0.26224930462327123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281285399","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057755064,0.24373688,0.021353796,0.5922341,0.03337796,0.00034339313,0.0012757368,0.0011766421,0.0487465],"genre_scores_gemma":[0.26805985,0.08674718,0.047786564,0.52891797,0.04900875,0.0005630648,0.0007278536,0.00058198255,0.017606912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925061,0.0035348649,0.0014741694,0.00055872084,0.0017434469,0.00018260548],"domain_scores_gemma":[0.97472906,0.016414734,0.0025030745,0.0015489487,0.003773652,0.0010305577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010894689,0.00035487927,0.0014314014,0.00093126856,0.0009736272,0.0023516426,0.0014439196,0.004748838,0.004406123],"category_scores_gemma":[0.03778963,0.00025978958,0.0012212662,0.0009470671,0.0014951939,0.002644978,0.00061742245,0.00942158,0.004257477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019177194,0.00035228013,0.025651662,0.004891002,0.00051754894,0.015969617,0.003294088,0.00043645667,0.0065598628,0.0083671,0.4786343,0.45340833],"study_design_scores_gemma":[0.00023222022,0.000640213,0.013359236,0.0042191003,0.00036270608,0.027387997,0.0016905824,0.00059104274,0.004538966,0.011345668,0.93551797,0.00011428651],"about_ca_topic_score_codex":0.0014418791,"about_ca_topic_score_gemma":0.003334049,"teacher_disagreement_score":0.010894689,"about_ca_system_score_codex":0.0006946331,"about_ca_system_score_gemma":0.0015383644,"threshold_uncertainty_score":0.057617307},"labels":[],"label_agreement":null},{"id":"W4281616742","doi":"10.1002/ajh.26623","title":"Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Cancer Prevention and Research Institute of Texas","keywords":"Medicine; Pacific islanders; Comorbidity; Internal medicine; Cancer; Pulmonary embolism; Incidence (geometry); Deep vein; Retrospective cohort study; Cohort; Thrombosis; Population; Environmental health","score_opus":0.01096841307301755,"score_gpt":0.2681943746078794,"score_spread":0.2572259615348619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281616742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900097,0.00018395143,0.000052315772,0.00006319382,0.0000027499113,0.000006085871,0.00046197182,0.000001813745,0.00022692798],"genre_scores_gemma":[0.9993837,0.00007248128,0.000027578642,0.000030570765,0.0000051462816,0.000006760442,0.00043744355,7.248598e-7,0.00003566179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993735,0.00015851767,0.00009484182,0.00012263861,0.00011363285,0.00013689416],"domain_scores_gemma":[0.9985146,0.00025034632,0.00069963315,0.00011048636,0.00014401168,0.00028090586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006379122,0.0001590283,0.00029374394,0.001169683,0.0004558585,0.0006290774,0.0003552616,0.00029899884,0.00079209026],"category_scores_gemma":[0.003598797,0.00023477628,0.0003918789,0.0014508174,0.00029800987,0.00046283004,0.0008004767,0.00043515782,0.00007857085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024342402,0.000009835559,0.9993254,0.00000273147,0.000025115953,0.000020912283,0.00005663007,0.000023432778,0.000019582572,0.000013008219,0.0000565994,0.00042241215],"study_design_scores_gemma":[0.00000300129,0.000025852869,0.9993674,0.0000044351914,0.000011848278,0.00010353631,0.00020364278,0.00016418553,0.000014145345,0.000033116215,0.000066234614,0.000002719042],"about_ca_topic_score_codex":0.022566939,"about_ca_topic_score_gemma":0.02536636,"teacher_disagreement_score":0.022566939,"about_ca_system_score_codex":0.00047471828,"about_ca_system_score_gemma":0.00041555063,"threshold_uncertainty_score":0.04487115},"labels":[],"label_agreement":null},{"id":"W4281909242","doi":"10.1002/ajh.26624","title":"Circulating rhabdoid tumor cells in the peripheral blood of a neonate","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Peripheral blood; Medicine; Pathology; Peripheral; Immunology; Internal medicine","score_opus":0.005448422926695108,"score_gpt":0.2362852525992625,"score_spread":0.23083682967256738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281909242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777956,0.0011762136,0.0024286292,0.001385652,0.00019755482,0.000056451194,0.00114032,0.00012146046,0.0057142144],"genre_scores_gemma":[0.99151844,0.0009289573,0.002257066,0.00060906645,0.00006932443,0.000024896723,0.0004430123,0.00002595143,0.004123235],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998161,0.000016103972,0.00001903618,0.00008512699,0.000032030912,0.000031598862],"domain_scores_gemma":[0.99961805,0.00017241928,0.000048209087,0.000037866168,0.000028637673,0.00009476321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016637969,0.00021544186,0.00039331062,0.0007141896,0.00050594413,0.00038310201,0.00030375054,0.0009802623,0.0019729459],"category_scores_gemma":[0.0010234826,0.00016052392,0.00017072198,0.0002746523,0.0004029046,0.00026854762,0.000403212,0.00080090057,0.0005997405],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038201336,0.00010288812,0.04101055,0.00008024597,0.000025190433,0.9049849,0.0012344639,0.00020045362,0.034043126,0.00089076697,0.0027149634,0.014330373],"study_design_scores_gemma":[0.000018453056,0.00086118927,0.12185411,0.000099163735,0.000051862706,0.8513158,0.000989148,0.0009184774,0.01654506,0.00074076495,0.006565161,0.000040877785],"about_ca_topic_score_codex":0.001905528,"about_ca_topic_score_gemma":0.001810903,"teacher_disagreement_score":0.0019729459,"about_ca_system_score_codex":0.00035573813,"about_ca_system_score_gemma":0.00017641396,"threshold_uncertainty_score":0.0066001415},"labels":[],"label_agreement":null},{"id":"W4283458238","doi":"10.1002/ajh.26644","title":"Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Akebia Therapeutics","keywords":"Darbepoetin alfa; Transferrin saturation; Anemia; Hepcidin; Erythropoietin; Medicine; Erythropoiesis; Internal medicine; Mean corpuscular volume; Kidney disease; Ferritin; Endocrinology; Hemoglobin; Serum iron; Mean corpuscular hemoglobin; Gastroenterology; Iron deficiency","score_opus":0.002878125387538174,"score_gpt":0.21766477630844827,"score_spread":0.2147866509209101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283458238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396354,0.0051473523,0.000063906555,0.00019891394,0.00003275331,0.00004514692,0.00006124104,0.000011264901,0.00047594376],"genre_scores_gemma":[0.99853015,0.00090326305,0.00015158523,0.00014683447,0.000026403259,0.000025202191,0.00007962235,0.0000010591704,0.00013598838],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979526,0.000110191,0.000020296673,0.000021859043,0.000025132773,0.000027273405],"domain_scores_gemma":[0.99954647,0.00013202468,0.00012098456,0.000019427769,0.000033068525,0.00014803137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005238064,0.00021087684,0.00067288487,0.00017662351,0.00017896175,0.00032208412,0.00015693267,0.00027579506,0.0006198883],"category_scores_gemma":[0.0010577479,0.00012880664,0.0005041146,0.00020600877,0.0001874527,0.00018219992,0.00018432809,0.00071794394,0.000067001645],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5394289,0.015251219,0.09523468,0.0012707855,0.0025216842,0.0005808622,0.00037757488,0.0015199371,0.0328209,0.000323944,0.0026181699,0.30805138],"study_design_scores_gemma":[0.18087906,0.4110749,0.3816785,0.0002467408,0.0022589688,0.001587706,0.0002896428,0.0039580064,0.008790083,0.0004026776,0.008776234,0.0000574279],"about_ca_topic_score_codex":0.0007877331,"about_ca_topic_score_gemma":0.002263916,"teacher_disagreement_score":0.0007877331,"about_ca_system_score_codex":0.0003422502,"about_ca_system_score_gemma":0.00047665447,"threshold_uncertainty_score":0.0027701855},"labels":[],"label_agreement":null},{"id":"W4283703366","doi":"10.1002/ajh.26645","title":"Real‐life incidence of thrombotic events in leukemia patients treated with ponatinib","year":2022,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ponatinib; Medicine; Incidence (geometry); Leukemia; Internal medicine; Oncology; Myeloid leukemia; Dasatinib","score_opus":0.011279186742634548,"score_gpt":0.2667247574138395,"score_spread":0.25544557067120494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97814345,0.011640052,0.0014629277,0.0007483734,0.00010229934,0.00017314879,0.003934438,0.000046335805,0.0037490807],"genre_scores_gemma":[0.99393964,0.002272031,0.00048916973,0.00026929635,0.00022150361,0.00006378367,0.0025223056,0.000010276849,0.00021208894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747556,0.0005966411,0.00061546924,0.0005016939,0.0005945469,0.00021601985],"domain_scores_gemma":[0.99528176,0.0007100266,0.00288043,0.00021028155,0.00037171823,0.0005458212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010989336,0.00024665674,0.00084269495,0.00078501675,0.00032727994,0.0011071154,0.0004131591,0.0007080805,0.0019892324],"category_scores_gemma":[0.0062973453,0.00022322642,0.00088823016,0.001381637,0.00031934178,0.00094768306,0.0006104064,0.0012144152,0.0004235394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013664699,0.000096985656,0.9819865,0.0002692392,0.00036107053,0.00073423615,0.00011623548,0.00029581593,0.00022546915,0.00028776872,0.0008837068,0.013376446],"study_design_scores_gemma":[0.00015525808,0.0011849389,0.98091954,0.00017732839,0.00031178902,0.007674455,0.0004009365,0.0019945146,0.0004514622,0.0007444574,0.0059139263,0.00007126153],"about_ca_topic_score_codex":0.00090394705,"about_ca_topic_score_gemma":0.0009336265,"teacher_disagreement_score":0.0019892324,"about_ca_system_score_codex":0.0007138998,"about_ca_system_score_gemma":0.0005531705,"threshold_uncertainty_score":0.00665468},"labels":[],"label_agreement":null},{"id":"W4284895899","doi":"10.1002/ajh.26654","title":"Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Disease; Transplantation; Hematopoietic stem cell transplantation; Ruxolitinib; Stem cell; Oncology; Immunology; Internal medicine; Bone marrow; Biology","score_opus":0.028133156894663783,"score_gpt":0.32871746541423763,"score_spread":0.30058430851957385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284895899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010639066,0.99912864,0.00008652494,0.00022251204,0.00010878315,0.0000056086205,0.000013831492,0.000004826042,0.0003228254],"genre_scores_gemma":[0.0008236855,0.99846244,0.00022171403,0.00020966893,0.00008695805,0.000009740459,0.00002967392,0.0000011726215,0.00015500469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982905,0.000046110417,0.000038122318,0.000022437665,0.000049840706,0.0000144457745],"domain_scores_gemma":[0.9996817,0.00019268924,0.000044502973,0.0000066854896,0.000059306945,0.0000151733475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007208377,0.00056030764,0.001201442,0.0015859636,0.00016704686,0.0007041838,0.00084245653,0.0008850367,0.0032739989],"category_scores_gemma":[0.001195064,0.00015964943,0.0008019735,0.0008101198,0.00022184411,0.000835378,0.00044515755,0.0013186892,0.0007541562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000919019,0.000070446025,0.00013710147,0.03114195,0.000207793,0.00010660745,0.000041532094,0.00033776782,0.00063323235,0.0025004097,0.015598474,0.94913286],"study_design_scores_gemma":[0.00011480736,0.0002618745,0.0017514792,0.031643786,0.0007872492,0.0017559489,0.00010014526,0.00024331296,0.0006265801,0.0037011723,0.9589818,0.000031826625],"about_ca_topic_score_codex":0.00059322285,"about_ca_topic_score_gemma":0.0013190529,"teacher_disagreement_score":0.0032739989,"about_ca_system_score_codex":0.0003965487,"about_ca_system_score_gemma":0.00074611825,"threshold_uncertainty_score":0.010952592},"labels":[],"label_agreement":null},{"id":"W4290841268","doi":"10.1002/ajh.26686","title":"Ponatinib after failure of <scp>second‐generation</scp> tyrosine kinase inhibitor in resistant <scp>chronic‐phase</scp> chronic myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Ponatinib; Myeloid leukemia; Medicine; Tyrosine kinase; Dasatinib; Cancer research; Internal medicine; Receptor; Imatinib","score_opus":0.009934436151821244,"score_gpt":0.2624419304253864,"score_spread":0.2525074942735651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290841268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979645,0.00044789043,0.00015191603,0.00009815783,0.000012674075,0.000058773356,0.00029935918,0.000017630528,0.00094911584],"genre_scores_gemma":[0.99910444,0.00011940197,0.000084239146,0.00006061006,0.0000067720694,0.000018151988,0.00039068435,0.0000026182108,0.00021300954],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998323,0.000032689248,0.00001825442,0.00003344489,0.0000425668,0.0000407426],"domain_scores_gemma":[0.999723,0.000054858134,0.000073034775,0.000024793891,0.000022190558,0.000102048034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003709932,0.00015736632,0.0005576329,0.00012232625,0.00020822669,0.0003384221,0.00015215906,0.00022147087,0.0007752532],"category_scores_gemma":[0.00045294472,0.000050957184,0.00037730092,0.00020206854,0.00019760153,0.00022747109,0.00015756045,0.0005669759,0.00017815066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13438264,0.0062355725,0.28809744,0.0007697475,0.001390628,0.008724958,0.0006641544,0.0057040895,0.17092091,0.00083900796,0.016710179,0.36556068],"study_design_scores_gemma":[0.019260785,0.15194726,0.71728677,0.00008081847,0.00065454567,0.01756967,0.00026320384,0.011229864,0.057822544,0.0007163429,0.023098243,0.00006992282],"about_ca_topic_score_codex":0.0012224859,"about_ca_topic_score_gemma":0.002474601,"teacher_disagreement_score":0.0012224859,"about_ca_system_score_codex":0.0006346548,"about_ca_system_score_gemma":0.00045466836,"threshold_uncertainty_score":0.004604757},"labels":[],"label_agreement":null},{"id":"W4294990810","doi":"10.1002/ajh.26721","title":"Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"","keywords":"Pulse oximetry; Carboxyhemoglobin; Medicine; Hypoxemia; Oxygen saturation; Hemoglobin; Phlebotomy; Intensive care medicine; Internal medicine; Cardiology; Anesthesia; Oxygen; Chemistry","score_opus":0.013570490142779794,"score_gpt":0.22994376044178208,"score_spread":0.21637327029900227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294990810","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25275373,0.27102226,0.053329404,0.3647972,0.0049546543,0.0001733168,0.0007830902,0.00038574103,0.051800627],"genre_scores_gemma":[0.84904337,0.09343182,0.018909793,0.03105221,0.0047724103,0.00012039093,0.00020861429,0.00006675628,0.0023946376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986185,0.000560673,0.00021760944,0.00013121509,0.00036463133,0.000107330605],"domain_scores_gemma":[0.99569535,0.002241028,0.00082253665,0.00018027441,0.00076323486,0.0002975379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033932503,0.00034422663,0.00058484136,0.0011196332,0.00061096286,0.0017164716,0.000873173,0.0013444364,0.0009732627],"category_scores_gemma":[0.010958771,0.00020482909,0.00024357981,0.00076161354,0.0018151798,0.003259517,0.0011389408,0.002696329,0.0003476584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014407386,0.00020615125,0.46639916,0.0009579256,0.00013776367,0.003548025,0.006039862,0.0007965527,0.0037183836,0.03315698,0.027994603,0.45690048],"study_design_scores_gemma":[0.000024884295,0.00042161753,0.6318588,0.00722433,0.00027030008,0.026599716,0.014294138,0.006786047,0.0042340155,0.12005702,0.18805128,0.00017779943],"about_ca_topic_score_codex":0.005064516,"about_ca_topic_score_gemma":0.0055563767,"teacher_disagreement_score":0.005064516,"about_ca_system_score_codex":0.000785334,"about_ca_system_score_gemma":0.0010077611,"threshold_uncertainty_score":0.017945409},"labels":[],"label_agreement":null},{"id":"W4296276644","doi":"10.1002/ajh.26726","title":"Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma","year":2022,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society; Wellcome Trust; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Stem cell; Lymphoma; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Medicine; Oncology; Autologous stem-cell transplantation; Immunology; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.02238040149386456,"score_gpt":0.33572820172904616,"score_spread":0.3133478002351816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296276644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819905,0.00095598114,0.00016202676,0.000061512554,0.000004547386,0.0000046830414,0.00003533174,0.0000053598014,0.0005714773],"genre_scores_gemma":[0.9997255,0.00011435179,0.000052856547,0.000021912974,0.000010457162,0.0000013267684,0.00004254874,0.0000011765709,0.000029840407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996716,0.00011269123,0.000031517673,0.000049682905,0.000070789894,0.00006380744],"domain_scores_gemma":[0.9985826,0.00054357393,0.0005306262,0.00009315395,0.00009334711,0.00015666564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065690133,0.00013068366,0.00022399824,0.00036233367,0.00027618845,0.0005130077,0.00015781893,0.00027102744,0.00084119634],"category_scores_gemma":[0.002282005,0.00009020174,0.00011768746,0.0003679256,0.00036614423,0.00028783758,0.00031818362,0.00038695877,0.000115269664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044464145,0.000025469019,0.98440534,0.000025517713,0.000023027076,0.0016472476,0.00006077238,0.00019573649,0.0020144826,0.000075477394,0.00015082852,0.010931427],"study_design_scores_gemma":[0.000019714573,0.00027324122,0.9857862,0.00002363559,0.000067482724,0.010353906,0.00019293648,0.0010997112,0.0010372595,0.0004096639,0.00072787673,0.000008222961],"about_ca_topic_score_codex":0.00028639965,"about_ca_topic_score_gemma":0.00060402567,"teacher_disagreement_score":0.00084119634,"about_ca_system_score_codex":0.00019666528,"about_ca_system_score_gemma":0.00024314591,"threshold_uncertainty_score":0.0034740567},"labels":[],"label_agreement":null},{"id":"W4306411219","doi":"10.1002/ajh.26767","title":"Utilization of <scp>real‐world</scp> data in assessing treatment effectiveness for diffuse large <scp>B‐cell</scp> lymphoma","year":2022,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"MorphoSys; Verastem Oncology; Teva Pharmaceutical Industries; Genentech; Celgene; Adaptive Biotechnologies; Gilead Sciences; TG Therapeutics; Pfizer; Bristol-Myers Squibb","keywords":"Observational study; Medicine; Covariate; Clinical trial; Randomized controlled trial; Oncology; Propensity score matching; Diffuse large B-cell lymphoma; Sample size determination; Comparative effectiveness research; Clinical study design; Internal medicine; Lymphoma; Computer science; Statistics; Machine learning; Pathology; Alternative medicine","score_opus":0.08210967973667803,"score_gpt":0.396500964877894,"score_spread":0.31439128514121595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306411219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018827287,0.99868804,0.00019317871,0.00021822024,0.00006874408,0.000053885033,0.0000866367,0.0000047281073,0.0004982278],"genre_scores_gemma":[0.004265845,0.9940912,0.00094074354,0.0003520596,0.00007016771,0.00010334535,0.000088352725,0.0000036508309,0.00008457024],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9936645,0.0033311339,0.0011902539,0.0004131299,0.0012863418,0.00011477171],"domain_scores_gemma":[0.9630441,0.03127825,0.0028682728,0.0006486276,0.001957918,0.00020289533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014046163,0.0009370043,0.005293972,0.0061394796,0.00024111668,0.0023940383,0.0011939262,0.0015351686,0.0035955566],"category_scores_gemma":[0.02682579,0.00046659028,0.004265066,0.005647339,0.00064459356,0.0018308347,0.0007516429,0.0020932388,0.0004885205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035720202,0.00006268359,0.0005827286,0.26501042,0.005831556,0.000054410917,0.00007823248,0.0006289494,0.0005228594,0.0028935478,0.005332296,0.718645],"study_design_scores_gemma":[0.0009336168,0.0013886759,0.014021719,0.42466158,0.045564342,0.001179288,0.00040536714,0.0013065148,0.0013769574,0.007278508,0.5017544,0.00012897741],"about_ca_topic_score_codex":0.002352868,"about_ca_topic_score_gemma":0.00544875,"teacher_disagreement_score":0.014046163,"about_ca_system_score_codex":0.0017852605,"about_ca_system_score_gemma":0.0041744625,"threshold_uncertainty_score":0.07428408},"labels":[],"label_agreement":null},{"id":"W4313453663","doi":"10.1002/ajh.26809","title":"Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Microsemi (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Venetoclax; Medicine; Lymphoma; Brentuximab vedotin; Obinutuzumab; Follicular lymphoma; Rituximab; Oncology; Internal medicine; Antibody-drug conjugate; Cancer research; Antibody; Immunology; Chronic lymphocytic leukemia; Leukemia; Monoclonal antibody; CD30","score_opus":0.02619885197197588,"score_gpt":0.33404745906188976,"score_spread":0.3078486070899139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955414,0.0025373956,0.00046923652,0.00011190331,0.00002895483,0.00017669855,0.00013445504,0.00005688626,0.00094305264],"genre_scores_gemma":[0.99627054,0.0016204951,0.0005637456,0.000068644025,0.000027084312,0.00010118339,0.00044626748,0.000010375188,0.00089170504],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998186,0.00006177222,0.000008362846,0.000020876285,0.00003141062,0.000058900412],"domain_scores_gemma":[0.9998684,0.000023490451,0.000030051706,0.000017950153,0.000011275657,0.00004884852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000526316,0.00040433748,0.00071257266,0.0002489848,0.00017337246,0.0006031828,0.0004435722,0.0003554969,0.0010008862],"category_scores_gemma":[0.00023114495,0.00016199266,0.00033506157,0.00023143737,0.00031328085,0.00037047453,0.00015275842,0.0013729106,0.00017093877],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027453804,0.021848315,0.002669235,0.00055586535,0.00042882582,0.00019154177,0.00031133022,0.0032088272,0.8203669,0.00071064633,0.0025638456,0.119690835],"study_design_scores_gemma":[0.044801388,0.41029024,0.027403241,0.00011079152,0.00088403816,0.001668967,0.00024089516,0.008750401,0.48575854,0.00041607095,0.019616405,0.00005899174],"about_ca_topic_score_codex":0.0011204942,"about_ca_topic_score_gemma":0.0028886427,"teacher_disagreement_score":0.0011204942,"about_ca_system_score_codex":0.0005004794,"about_ca_system_score_gemma":0.00049358525,"threshold_uncertainty_score":0.0036312938},"labels":[],"label_agreement":null},{"id":"W4313453780","doi":"10.1002/ajh.26830","title":"Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Pyruvate kinase deficiency; Medicine; Bone mineral; Thalassemia; Osteoporosis; Osteopenia; Internal medicine; Pyruvate kinase; Hemolytic anemia; Endocrinology; Iron deficiency; Bone density; Bone disease; Anemia; Glycolysis","score_opus":0.010876141273883252,"score_gpt":0.24196212256145427,"score_spread":0.23108598128757102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453780","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0324789,0.07814251,0.0031091566,0.49247828,0.38381708,0.00012614042,0.0009150611,0.0004366397,0.008496217],"genre_scores_gemma":[0.18631588,0.037250336,0.0014232225,0.12330385,0.64356726,0.00006813649,0.00038873116,0.00014359069,0.007538941],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998643,0.00032038102,0.0002800731,0.0002414648,0.00036128817,0.00015378326],"domain_scores_gemma":[0.9936545,0.0034572915,0.0006562598,0.0001459043,0.0013931217,0.0006930169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001599727,0.0011401756,0.0017574547,0.0015862565,0.00070352445,0.0015497118,0.002418316,0.006786422,0.004017867],"category_scores_gemma":[0.013160142,0.0007671571,0.00059285684,0.0010141728,0.0011176948,0.0015407116,0.0005800865,0.0058452645,0.0015580804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011784914,0.0001899548,0.020582207,0.0021409858,0.00047791944,0.100602366,0.00035434708,0.00045019915,0.0014750044,0.0012415831,0.81048006,0.060826823],"study_design_scores_gemma":[0.00085569685,0.0007466383,0.046126656,0.0040496234,0.0009645741,0.41631773,0.0008819507,0.006120568,0.002948429,0.005109166,0.5155501,0.00032897844],"about_ca_topic_score_codex":0.0011139665,"about_ca_topic_score_gemma":0.0016675855,"teacher_disagreement_score":0.006786422,"about_ca_system_score_codex":0.0008111359,"about_ca_system_score_gemma":0.0006558854,"threshold_uncertainty_score":0.013441086},"labels":[],"label_agreement":null},{"id":"W4313645529","doi":"10.1002/ajh.26837","title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Complementary and Integrative Health; Maternal and Child Health Bureau; National Heart, Lung, and Blood Institute; School of Medicine, Emory University; National Center for Advancing Translational Sciences; Health Resources and Services Administration; University at Buffalo; Doris Duke Charitable Foundation; Scheme for Promotion of Academic and Research Collaboration; Seattle Children's Research Institute; National Institutes of Health; U.S. Department of Health and Human Services; Cincinnati Children's Hospital Medical Center; Emory University; Nationwide Children's Hospital","keywords":"Medicine; Emergency department; Interquartile range; Vaso-occlusive crisis; Fentanyl; Acute chest syndrome; Odds ratio; Emergency medicine; Pediatric emergency medicine; Sickle cell anemia; Pediatrics; Anesthesia; Internal medicine; Disease","score_opus":0.004811454954734607,"score_gpt":0.24153338180287254,"score_spread":0.23672192684813792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313645529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862075,0.00094096607,0.000036065343,0.00014141269,0.0000041817602,0.000009255176,0.00011361832,0.000001242264,0.00013262178],"genre_scores_gemma":[0.9988539,0.0006690601,0.00016791825,0.00007252636,0.00002948208,0.000010194615,0.0001619107,0.0000013054458,0.0000335209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891627,0.0005189551,0.00010824079,0.00014637005,0.00016080773,0.00014936789],"domain_scores_gemma":[0.99662894,0.0008452376,0.0017177234,0.00010387155,0.00031730297,0.00038684256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014923497,0.00028581862,0.00042551127,0.00064817467,0.00034850655,0.0007331207,0.00031924224,0.00046088762,0.0009973105],"category_scores_gemma":[0.004150654,0.00023678874,0.00056833966,0.0010620342,0.00030424527,0.00059619296,0.00049211783,0.00053175114,0.00010537771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071517024,0.00004656276,0.9984945,0.000015400861,0.000057451623,0.00012018564,0.00006784955,0.000014771425,0.00006564793,0.000009880851,0.00005768644,0.0009784657],"study_design_scores_gemma":[0.000026265163,0.00032472503,0.99769187,0.000026803587,0.00007335877,0.0008510173,0.00062580593,0.00012104221,0.000056138517,0.000009410846,0.00018917574,0.0000043157424],"about_ca_topic_score_codex":0.0047174734,"about_ca_topic_score_gemma":0.005736719,"teacher_disagreement_score":0.0047174734,"about_ca_system_score_codex":0.00044970514,"about_ca_system_score_gemma":0.00055189495,"threshold_uncertainty_score":0.009380043},"labels":[],"label_agreement":null},{"id":"W4313649378","doi":"10.1002/ajh.26838","title":"A young woman with persistent sore throat, <scp>Epstein–Barr</scp> virus, lymphadenopathy, and aberrant <scp>CD4</scp> + <scp>CD7</scp>‐ T‐cells","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Sore throat; Medicine; Immunology; Virus; Viremia; Hematopoietic stem cell transplantation; Population; Lymphocytosis; Transplantation; Internal medicine","score_opus":0.0097441918260875,"score_gpt":0.24099911838518745,"score_spread":0.23125492655909996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313649378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97323567,0.0025982058,0.0011673175,0.005187897,0.00036731415,0.00013008868,0.0003255899,0.00009516302,0.016892778],"genre_scores_gemma":[0.99472165,0.0010258174,0.00040327368,0.0011870108,0.00017023303,0.000014370611,0.00007672505,0.000010479488,0.0023902876],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998222,0.000021267513,0.000018270854,0.00004404634,0.000028656417,0.00006572131],"domain_scores_gemma":[0.99960333,0.000110665605,0.0000477133,0.000020364489,0.00003263647,0.00018534328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015395664,0.0007253036,0.00043692,0.0010975228,0.0016425522,0.00064270844,0.00034399438,0.0018617867,0.0029303005],"category_scores_gemma":[0.0013003078,0.00061152736,0.0004257705,0.00073295797,0.00059500034,0.0009814996,0.00051827804,0.0017233824,0.0006709753],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010103064,0.0001258221,0.03641574,0.000031758063,0.0000110659,0.9569624,0.0004067289,0.000046233763,0.0019178793,0.00021497057,0.000844048,0.0029224064],"study_design_scores_gemma":[0.000015947122,0.00022266665,0.024096193,0.000030776428,0.000019121333,0.9725018,0.0004618105,0.00018150952,0.0004422762,0.00021429353,0.0018004507,0.000013250975],"about_ca_topic_score_codex":0.0033185836,"about_ca_topic_score_gemma":0.006534571,"teacher_disagreement_score":0.0033185836,"about_ca_system_score_codex":0.00049461244,"about_ca_system_score_gemma":0.0006454176,"threshold_uncertainty_score":0.009802878},"labels":[],"label_agreement":null},{"id":"W4317867940","doi":"10.1002/ajh.26861","title":"Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with <i>BCR‐ABL</i> negative myeloproliferative neoplasms","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University Health Network; Kingston Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Esophagogastroduodenoscopy; Medicine; Myeloproliferative Disorders; Portal hypertension; Internal medicine; Myelofibrosis; Gastroenterology; Endoscopy; Bone marrow; Cirrhosis","score_opus":0.013368725638416056,"score_gpt":0.25538521505860007,"score_spread":0.242016489420184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317867940","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066954255,0.07642204,0.0022920135,0.6733119,0.17285798,0.00016586318,0.00091274,0.00032783017,0.006755397],"genre_scores_gemma":[0.28934923,0.037545767,0.0020049587,0.1870213,0.47873494,0.00010747616,0.00039902088,0.00012413943,0.0047131325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857974,0.00047240936,0.0003303725,0.00019616868,0.00027404883,0.00014734142],"domain_scores_gemma":[0.98863775,0.0053544827,0.0011925536,0.0002279254,0.0031680556,0.0014192513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001916057,0.0008393703,0.001254116,0.0015655757,0.00069625815,0.0013627328,0.0014722989,0.005535225,0.0027436165],"category_scores_gemma":[0.017801803,0.0005568744,0.000526159,0.00077856955,0.00068833807,0.0017727755,0.00041820126,0.005502363,0.001157177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018673257,0.0003136734,0.08693195,0.0026886207,0.0005502281,0.04773115,0.0005268501,0.0003355474,0.0016768469,0.00077741564,0.7695286,0.08707166],"study_design_scores_gemma":[0.001626237,0.0018478386,0.19758065,0.011385693,0.002209185,0.28316793,0.002675611,0.011895226,0.004871089,0.005312711,0.47684696,0.00058088294],"about_ca_topic_score_codex":0.0012676332,"about_ca_topic_score_gemma":0.0019380104,"teacher_disagreement_score":0.005535225,"about_ca_system_score_codex":0.00079327275,"about_ca_system_score_gemma":0.0005910032,"threshold_uncertainty_score":0.010133147},"labels":[],"label_agreement":null},{"id":"W4321374903","doi":"10.1002/ajh.26881","title":"Impact of sex on outcomes in patients with hairy cell leukemia. An <scp>HCL</scp> patient data registry analysis","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Hairy Cell Leukemia Foundation","keywords":"Medicine; Leukemia; Internal medicine; Oncology","score_opus":0.021657586152965563,"score_gpt":0.3240060220795596,"score_spread":0.302348435926594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321374903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97052974,0.0021714754,0.00024716966,0.00055226404,0.000053764314,0.000052993004,0.023529077,0.000022128388,0.0028414375],"genre_scores_gemma":[0.98791957,0.00051150064,0.00015702282,0.00021001376,0.00004181271,0.000063882755,0.010741257,0.000018575736,0.00033640277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983077,0.00038525072,0.00031555837,0.00036421916,0.00036499163,0.00026215904],"domain_scores_gemma":[0.99502414,0.00085846114,0.002660303,0.00033694485,0.00052158453,0.00059851824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002027286,0.00015706861,0.00050936424,0.0011510141,0.00043477656,0.00097098947,0.00039454966,0.00032880018,0.0037295707],"category_scores_gemma":[0.006032598,0.00013658563,0.0011345828,0.0019235215,0.00017152002,0.0008196321,0.00087775296,0.0007463354,0.00050499884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028073767,0.000017354227,0.99607795,0.000038335547,0.00015475282,0.000076375276,0.00004094965,0.00005002197,0.000032685104,0.000053036823,0.00081400026,0.002363727],"study_design_scores_gemma":[0.000034253095,0.00020481047,0.9952932,0.000065966226,0.00021095063,0.00078346394,0.0003541654,0.00036612042,0.00006717844,0.00011749471,0.0024885826,0.000013815474],"about_ca_topic_score_codex":0.0044798064,"about_ca_topic_score_gemma":0.007538217,"teacher_disagreement_score":0.0044798064,"about_ca_system_score_codex":0.0005167646,"about_ca_system_score_gemma":0.0008251251,"threshold_uncertainty_score":0.012476683},"labels":[],"label_agreement":null},{"id":"W4321600787","doi":"10.1002/ajh.26890","title":"Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Internal medicine; Oncology; Second line; Surgery; First line; Bone marrow","score_opus":0.04967768675891962,"score_gpt":0.37728214272357113,"score_spread":0.3276044559646515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321600787","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987816,0.00045290546,0.0000764745,0.000056980643,0.000014037838,0.000028832907,0.00018806654,0.000001668061,0.00039933313],"genre_scores_gemma":[0.99899465,0.0001383665,0.00006966812,0.00007648615,0.000041674954,0.000034198794,0.00053837924,0.0000019504726,0.000104594714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988691,0.0003544163,0.00015199705,0.00018126033,0.000166721,0.00027656957],"domain_scores_gemma":[0.9949126,0.0014303591,0.0021383525,0.00017176452,0.00034902804,0.0009977273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002070081,0.00027159316,0.00073279557,0.0010719514,0.00036694447,0.0007911646,0.00050942303,0.00055118103,0.0016190499],"category_scores_gemma":[0.0051682116,0.00013827636,0.0011312832,0.000688182,0.0005209451,0.00097329984,0.0010193115,0.0010203681,0.00033092004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010707277,0.000730743,0.97606796,0.000091769536,0.00043324166,0.00033295195,0.0002771829,0.0002841347,0.00042439144,0.00016365462,0.00041888672,0.010067875],"study_design_scores_gemma":[0.00027999814,0.0073269573,0.98949605,0.000057340963,0.00017233677,0.00056701765,0.00049257104,0.00064020377,0.00019627831,0.0002904407,0.00045894782,0.000021802753],"about_ca_topic_score_codex":0.0009360531,"about_ca_topic_score_gemma":0.0016675156,"teacher_disagreement_score":0.002070081,"about_ca_system_score_codex":0.0009324832,"about_ca_system_score_gemma":0.000545638,"threshold_uncertainty_score":0.010947764},"labels":[],"label_agreement":null},{"id":"W4323353705","doi":"10.1002/ajh.26900","title":"Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Assistance publique-Hôpitaux de Paris; Ministère des Affaires Sociales et de la Santé; GlaxoSmithKline; Amgen","keywords":"Medicine; Immune thrombocytopenia; Cohort; Multivariate analysis; Pediatrics; Internal medicine; Immunology; Antibody","score_opus":0.00878671072839698,"score_gpt":0.285020243960318,"score_spread":0.276233533231921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323353705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993698,0.00017745844,0.000037222788,0.000010295694,0.0000016946706,0.0000024984013,0.00029160845,0.0000013354053,0.00010819549],"genre_scores_gemma":[0.9993284,0.00008753957,0.000041478175,0.000008171208,0.0000049965356,0.0000058149126,0.00048175725,0.0000012941605,0.00004057809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951625,0.00012918893,0.000058051806,0.00010962722,0.00007523131,0.00011171259],"domain_scores_gemma":[0.99861264,0.00040771972,0.0006262225,0.000087592074,0.00010362568,0.00016228817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005816089,0.00027021833,0.0004713089,0.00062880316,0.00027000508,0.0005715796,0.00021110555,0.00033075793,0.0010655923],"category_scores_gemma":[0.0019568354,0.0002043689,0.0005171726,0.00083258783,0.00015075272,0.00026039986,0.00036177988,0.00032160268,0.00011304212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006999851,0.000005668963,0.9993051,0.0000022136849,0.00001750208,0.000060425584,0.000013754124,0.000037034948,0.000034100984,0.0000042176353,0.000020836253,0.00042907835],"study_design_scores_gemma":[0.0000063012885,0.00009946819,0.99896765,0.0000051929815,0.000028052173,0.0004303799,0.00005617654,0.00023040707,0.000038488917,0.000008832076,0.00012683531,0.0000022130068],"about_ca_topic_score_codex":0.006257635,"about_ca_topic_score_gemma":0.005912453,"teacher_disagreement_score":0.006257635,"about_ca_system_score_codex":0.0003961299,"about_ca_system_score_gemma":0.0003453849,"threshold_uncertainty_score":0.01244241},"labels":[],"label_agreement":null},{"id":"W4360983730","doi":"10.1002/ajh.26920","title":"<i>JAK2</i> unmutated erythrocytosis: 2023 Update on diagnosis and management","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.015402661478499939,"score_gpt":0.29491209372074717,"score_spread":0.2795094322422472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360983730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012485676,0.9714305,0.001858431,0.00883182,0.0030250356,0.000038560134,0.00059354317,0.0002271864,0.012746434],"genre_scores_gemma":[0.0070219943,0.96698314,0.0033014219,0.007300048,0.0072446405,0.00005848939,0.0024759509,0.000059681228,0.0055546532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968386,0.000056020883,0.00007204792,0.00004215021,0.000108004715,0.000037909278],"domain_scores_gemma":[0.99863714,0.0004901215,0.00018337902,0.00002338292,0.0005117951,0.00015418105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006665108,0.00083608995,0.0011075669,0.0033021274,0.00035064915,0.0010880273,0.0011441681,0.0012638242,0.008148468],"category_scores_gemma":[0.0025946246,0.0002774521,0.0007635116,0.0017807804,0.00039184093,0.001808356,0.000775619,0.002513072,0.0044860714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009731428,0.000041451083,0.001452557,0.0030286766,0.00006461475,0.0012306113,0.00006062699,0.0004416495,0.0008096186,0.0011952824,0.22803526,0.7635425],"study_design_scores_gemma":[0.00003703136,0.00009153812,0.0032103774,0.0098327985,0.00021281483,0.016851986,0.00010209847,0.0004205929,0.00033177403,0.0017672658,0.9671019,0.000039744238],"about_ca_topic_score_codex":0.0025998177,"about_ca_topic_score_gemma":0.005520671,"teacher_disagreement_score":0.008148468,"about_ca_system_score_codex":0.0010676485,"about_ca_system_score_gemma":0.0010159299,"threshold_uncertainty_score":0.02725929},"labels":[],"label_agreement":null},{"id":"W4366352141","doi":"10.1002/ajh.26933","title":"Sodium‐glucose co‐transporter‐2 inhibitor use and <i>JAK2</i> unmutated erythrocytosis in 100 consecutive cases","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Erythropoietin; Canagliflozin; Internal medicine; Hematocrit; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.024676470683525832,"score_gpt":0.28041496752649064,"score_spread":0.2557384968429648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366352141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940701,0.0025760925,0.00027702283,0.00019173227,0.00003306147,0.000048867507,0.00028448887,0.000029365545,0.0024892145],"genre_scores_gemma":[0.99830914,0.0008354324,0.00013678645,0.00008432587,0.000054868335,0.000017820106,0.00030696607,0.00000841491,0.0002462612],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9993794,0.00007340778,0.00009898238,0.00015739934,0.00016746159,0.0001232107],"domain_scores_gemma":[0.9993137,0.000101314516,0.00027609937,0.000051342326,0.00006085701,0.00019661566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003627583,0.0004308184,0.00046073983,0.0017674943,0.00076444243,0.0007160297,0.00073115417,0.0009381639,0.0023847816],"category_scores_gemma":[0.0010798897,0.00069321494,0.0005836775,0.0016037478,0.0006373148,0.0009924037,0.0007355756,0.001015019,0.0005590514],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015191613,0.00008246118,0.96652055,0.00003225247,0.00005247989,0.028154239,0.00018495324,0.00014278933,0.0004831157,0.00008753028,0.0005918493,0.0035157893],"study_design_scores_gemma":[0.00002608562,0.00019254106,0.87409365,0.00006174922,0.00008631145,0.122330636,0.0005988483,0.0009060225,0.00024043958,0.00017591001,0.0012547377,0.000033035212],"about_ca_topic_score_codex":0.0039317696,"about_ca_topic_score_gemma":0.004337406,"teacher_disagreement_score":0.0039317696,"about_ca_system_score_codex":0.00061310333,"about_ca_system_score_gemma":0.00037826758,"threshold_uncertainty_score":0.007977903},"labels":[],"label_agreement":null},{"id":"W4368356099","doi":"10.1002/ajh.26932","title":"Stereochemistry and functions of the new cysteinyl‐resolvin, <scp>4S</scp>,<scp>5R‐RCTR1</scp>, in efferocytosis and erythrophagocytosis of human senescent erythrocytes","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Efferocytosis; Phagocytosis; Lipid signaling; Phagocyte; Inflammation; Macrophage; Chemistry; Docosahexaenoic acid; Apoptosis; Mediator; Biochemistry; Phosphatidylserine; Cell biology; Biology; In vitro; Immunology; Fatty acid; Receptor; Polyunsaturated fatty acid; Phospholipid; Membrane","score_opus":0.014947140477903128,"score_gpt":0.2877475472222326,"score_spread":0.2728004067443295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368356099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501896,0.001374864,0.0022521797,0.00004168158,0.000008765259,0.000010457578,0.00015291512,0.000015417583,0.0011248592],"genre_scores_gemma":[0.9970175,0.00047968136,0.0012148167,0.000017524126,0.0000047742546,0.000007842499,0.00015572069,0.000005630357,0.0010964979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993134,0.00002007159,0.000005602484,0.000016829337,0.000014334359,0.000011875863],"domain_scores_gemma":[0.99993885,0.0000075807516,0.000022845848,0.000008277044,0.000011455135,0.000010924176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013879538,0.00020433169,0.00007136924,0.00013743101,0.00008201593,0.00015646782,0.00014151858,0.00017123127,0.00067947886],"category_scores_gemma":[0.00014757241,0.000068419475,0.00014282286,0.00007996178,0.00015820767,0.00015422817,0.00010167753,0.0002082803,0.00021668119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110705136,0.000003860037,0.00021046004,0.000010907321,0.0000022916029,0.000033910626,0.000017643933,0.000051337305,0.9983882,0.00013890874,0.000007692048,0.0010242165],"study_design_scores_gemma":[0.000004254976,0.000093126866,0.0020815681,0.0000013225081,0.0000046817995,0.00010471704,0.000017433293,0.00019572058,0.9966865,0.000041833297,0.0007664353,0.0000024299188],"about_ca_topic_score_codex":0.00037182882,"about_ca_topic_score_gemma":0.000342864,"teacher_disagreement_score":0.00067947886,"about_ca_system_score_codex":0.00019697512,"about_ca_system_score_gemma":0.00015835316,"threshold_uncertainty_score":0.0022731423},"labels":[],"label_agreement":null},{"id":"W4375955263","doi":"10.1002/ajh.26950","title":"Recurrent severe thrombocytopenia in critical illness complicated by hemolysis","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; Hamilton General Hospital; Hamilton Regional Laboratory Medicine Program; Trillium Health Centre","funders":"","keywords":"Medicine; Disseminated intravascular coagulation; Sepsis; Internal medicine; Platelet; Gastroenterology; Acute kidney injury; Intensive care unit; Anesthesia","score_opus":0.03492234752198582,"score_gpt":0.3655232383113049,"score_spread":0.3306008907893191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788408,0.007145378,0.0016390831,0.0035746042,0.00037688485,0.00016339398,0.00021526784,0.00015108043,0.007893456],"genre_scores_gemma":[0.9970415,0.00097090635,0.00028753222,0.00082043407,0.00047194894,0.000012586108,0.00009901487,0.000008638221,0.00028733787],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995441,0.00009351169,0.00006599164,0.000085990556,0.000082156126,0.0001282774],"domain_scores_gemma":[0.9991942,0.00020866342,0.00022293469,0.000051896117,0.0000660653,0.0002561652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323604,0.0012117317,0.0008877208,0.0013820792,0.0011663807,0.0008629761,0.00088121893,0.002512332,0.0011240655],"category_scores_gemma":[0.0026280568,0.0005592643,0.00060242787,0.0010524186,0.00058565295,0.00080903247,0.0005801318,0.0019844472,0.00039785964],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011002149,0.00006630321,0.074583925,0.000049916252,0.000029314826,0.92008156,0.00021610956,0.0000875558,0.0008339283,0.00011927762,0.0010735295,0.002748602],"study_design_scores_gemma":[0.00003095202,0.00024982166,0.06720249,0.00005544717,0.00004765326,0.9300208,0.00024379569,0.0006947395,0.0002835068,0.0002199962,0.00092912046,0.000021697073],"about_ca_topic_score_codex":0.0016106716,"about_ca_topic_score_gemma":0.0020918555,"teacher_disagreement_score":0.002512332,"about_ca_system_score_codex":0.0006122785,"about_ca_system_score_gemma":0.000413456,"threshold_uncertainty_score":0.004442394},"labels":[],"label_agreement":null},{"id":"W4377093091","doi":"10.1002/ajh.26935","title":"Comprehensive profiling of clinical <scp>JAK</scp> inhibitors in myeloproliferative neoplasms","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; MPN Research Foundation; National Institutes of Health; Alvin J. Siteman Cancer Center; Institute of Clinical and Translational Sciences; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Ruxolitinib; Myeloproliferative neoplasm; Cancer research; Janus kinase; STAT3; stat; Myelofibrosis; Biology; Medicine; Pharmacology; Cytokine; Signal transduction; Immunology; Bone marrow; Genetics","score_opus":0.04216840408838109,"score_gpt":0.3690324555668604,"score_spread":0.3268640514784793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377093091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749908,0.0075095,0.0035676158,0.00030061684,0.000025221158,0.00013471342,0.008930117,0.00018172398,0.004359677],"genre_scores_gemma":[0.97439474,0.0048522037,0.0057009864,0.00030323208,0.000035283127,0.00013910861,0.012098496,0.000044999702,0.0024309666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997712,0.000021272166,0.000017973127,0.000047499154,0.0001028515,0.00003916952],"domain_scores_gemma":[0.9998356,0.000032141386,0.000053136017,0.000010875485,0.000041785883,0.000026352844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023181345,0.00022223088,0.00033626685,0.0008842596,0.00020076493,0.0005547257,0.000113752765,0.00020675537,0.00086471735],"category_scores_gemma":[0.00028412326,0.00007601,0.0001743384,0.0007802073,0.00013744674,0.00014588247,0.00015231046,0.00029609964,0.00033226894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007178346,0.000121554076,0.041416377,0.00030511912,0.000099774865,0.00035696864,0.00006883733,0.0014533274,0.8975908,0.00027886115,0.0015997797,0.05599081],"study_design_scores_gemma":[0.000060796043,0.0015517642,0.34665307,0.00008147592,0.00036492432,0.004103428,0.0002703044,0.0056137405,0.5936252,0.0005978221,0.047046043,0.000031474767],"about_ca_topic_score_codex":0.000456441,"about_ca_topic_score_gemma":0.0013242093,"teacher_disagreement_score":0.0008842596,"about_ca_system_score_codex":0.00024868894,"about_ca_system_score_gemma":0.00040241753,"threshold_uncertainty_score":0.0028927326},"labels":[],"label_agreement":null},{"id":"W4378172560","doi":"10.1002/ajh.26958","title":"Carbon monoxide as a clinical marker of hemolysis","year":2023,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Child Health and Human Development","keywords":"Hemolysis; Carboxyhemoglobin; Carbon monoxide; Heme; Medicine; Hematology; Internal medicine; Chemistry; Gastroenterology; Biochemistry; Catalysis","score_opus":0.03504164081012351,"score_gpt":0.381328292745936,"score_spread":0.3462866519358125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000676935,0.99863714,0.00016383259,0.0003098796,0.00026042567,0.000002901548,0.00001583277,0.000006461624,0.00053590076],"genre_scores_gemma":[0.0010454193,0.99752,0.00023459374,0.0002919583,0.00040304483,0.000009521102,0.00004871994,0.0000026304513,0.00044409218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995117,0.000104768784,0.00008775484,0.00009141025,0.00017196807,0.000032342738],"domain_scores_gemma":[0.9988533,0.0006254745,0.00011050815,0.000034388177,0.00031287075,0.000063418716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013123207,0.0012231009,0.002156374,0.0036512776,0.0002453917,0.0012466676,0.0011628972,0.0014795752,0.0023229371],"category_scores_gemma":[0.0019745652,0.00034057623,0.0007717461,0.0022920368,0.00078330445,0.0012348231,0.0006964901,0.0028253468,0.0024238338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012000814,0.00007774807,0.000760542,0.009889084,0.00019389243,0.00027310196,0.00004453223,0.00029424197,0.0011316123,0.003977301,0.03842579,0.94481224],"study_design_scores_gemma":[0.000024268287,0.000105649626,0.0021662305,0.004211913,0.00024926726,0.0026863753,0.000058850164,0.00018484918,0.0009266456,0.003250866,0.98609656,0.000038463702],"about_ca_topic_score_codex":0.0010389804,"about_ca_topic_score_gemma":0.0010543007,"teacher_disagreement_score":0.0036512776,"about_ca_system_score_codex":0.00083476095,"about_ca_system_score_gemma":0.0009762518,"threshold_uncertainty_score":0.007771015},"labels":[],"label_agreement":null},{"id":"W4381158392","doi":"10.1002/ajh.26990","title":"A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (<scp>CARAMEL</scp>)","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Carfilzomib; Medicine; Melphalan; Multiple myeloma; Autologous stem-cell transplantation; Clinical endpoint; Internal medicine; Transplantation; Urology; Cohort; Oncology; Adverse effect; Surgery; Lenalidomide; Clinical trial","score_opus":0.028734602147727665,"score_gpt":0.3382647170175598,"score_spread":0.3095301148698321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381158392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956802,0.00064657856,0.0004990269,0.00025222305,0.000074033946,0.0017901614,0.00038085232,0.00005767793,0.0006192426],"genre_scores_gemma":[0.985981,0.001030662,0.0037853573,0.00091545697,0.00016984147,0.003954169,0.002173864,0.00002228071,0.0019675079],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997118,0.00014161716,0.00001045283,0.000040190884,0.00003500757,0.000060809416],"domain_scores_gemma":[0.99969864,0.00003664706,0.000066033186,0.000025967754,0.000023842174,0.0001489545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011768697,0.0011232262,0.0009313999,0.00041773607,0.00037647437,0.0005510739,0.00065291644,0.00095362397,0.0018729351],"category_scores_gemma":[0.00040309076,0.00048489068,0.0007138994,0.00025179223,0.0005014192,0.0004227923,0.00030251622,0.0023583432,0.0003272712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3694225,0.18754187,0.010104795,0.00066710473,0.00091007224,0.00048085715,0.00042610118,0.0047791293,0.2628679,0.00069105945,0.008449173,0.15365946],"study_design_scores_gemma":[0.31366143,0.64108545,0.016373614,0.0000368908,0.00030837225,0.000428514,0.000048687878,0.0018992169,0.02018302,0.00021941075,0.0057286113,0.000026809057],"about_ca_topic_score_codex":0.0007151813,"about_ca_topic_score_gemma":0.0020795846,"teacher_disagreement_score":0.0018729351,"about_ca_system_score_codex":0.0006777698,"about_ca_system_score_gemma":0.0011717667,"threshold_uncertainty_score":0.0062655807},"labels":[],"label_agreement":null},{"id":"W4381470212","doi":"10.1002/ajh.26994","title":"Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Bruyère; University of Ottawa","funders":"Servier; University of Ottawa; LEO Pharma; Ottawa Hospital Research Institute; Pfizer","keywords":"Medicine; Venous thromboembolism; Kidney disease; Arthroplasty; Anticoagulant; Hip arthroplasty; Surgery; Internal medicine; Thrombosis","score_opus":0.010248397083041342,"score_gpt":0.26176314311540816,"score_spread":0.25151474603236684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381470212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990922,0.00023391936,0.000029545301,0.000039884355,0.00000463953,0.0000064994274,0.0003324972,0.0000016181654,0.00025919717],"genre_scores_gemma":[0.9993387,0.00013354351,0.00003626056,0.000028300037,0.000008610569,0.0000036260856,0.00030344937,6.4265134e-7,0.00014686298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961984,0.000047164503,0.000035482186,0.000089326066,0.00010386056,0.000104162114],"domain_scores_gemma":[0.9991812,0.000070454254,0.0004063006,0.0000648215,0.00010353537,0.00017371932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035380232,0.00021047588,0.00030208044,0.0005099343,0.0005560825,0.00060786906,0.00042109957,0.00042488746,0.0008831296],"category_scores_gemma":[0.0015392115,0.00034016347,0.0005825709,0.0009207275,0.00028375888,0.00028273487,0.00037985065,0.0005519934,0.000109355715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045873905,0.000016289065,0.9994074,0.00000429304,0.000031951746,0.000022143096,0.000021465365,0.000014029671,0.000041295076,0.0000062487493,0.000051980554,0.0003370549],"study_design_scores_gemma":[0.000007860592,0.000030891435,0.9996159,0.0000048240418,0.000022356275,0.000074361895,0.000051894553,0.0001059369,0.000009605708,0.0000076069055,0.00006676031,0.000002091917],"about_ca_topic_score_codex":0.24757417,"about_ca_topic_score_gemma":0.3082806,"teacher_disagreement_score":0.24757417,"about_ca_system_score_codex":0.0012390339,"about_ca_system_score_gemma":0.0016166245,"threshold_uncertainty_score":0.49226624},"labels":[],"label_agreement":null},{"id":"W4382011805","doi":"10.1002/ajh.27007","title":"Classification of accelerated phase chronic myeloid leukemia in the era of the <scp>BCR</scp>::<scp>ABL1</scp> tyrosine kinase inhibitors: A work in progress","year":2023,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Ascentage Pharma; British Mycological Society; Novartis","keywords":"Myeloid leukemia; Tyrosine kinase; Cancer research; Medicine; Internal medicine; Receptor","score_opus":0.017855564900483584,"score_gpt":0.30960908258422964,"score_spread":0.2917535176837461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382011805","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015728294,0.010099003,0.00024921627,0.032545254,0.95604235,0.00003202566,0.00006830746,0.000048693044,0.00075794075],"genre_scores_gemma":[0.001080561,0.01056744,0.00027586843,0.014779811,0.9704696,0.000025611573,0.000079786245,0.000020863843,0.0027005603],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810565,0.000429936,0.00041395854,0.00019520274,0.0007137565,0.00014149917],"domain_scores_gemma":[0.98324376,0.0056126504,0.00081395335,0.0003391356,0.008228293,0.0017622998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006220523,0.0024595007,0.0031157725,0.0030143831,0.0014352874,0.003492822,0.0026748665,0.006795233,0.0035131506],"category_scores_gemma":[0.015491287,0.00091563247,0.0022168811,0.0011830167,0.001526446,0.0029327828,0.00076731906,0.014513847,0.0032870625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010820452,0.000021058082,0.00017711057,0.00036992395,0.000044289678,0.0002572752,0.000015876672,0.000049981685,0.000109527406,0.00031957647,0.9828721,0.015655015],"study_design_scores_gemma":[0.00035770476,0.00012440106,0.002396004,0.0016141803,0.00046828834,0.0029277736,0.00015476382,0.00086203223,0.00040938056,0.0024131825,0.9882091,0.00006311738],"about_ca_topic_score_codex":0.0019018773,"about_ca_topic_score_gemma":0.004629395,"teacher_disagreement_score":0.006795233,"about_ca_system_score_codex":0.0021880546,"about_ca_system_score_gemma":0.002010677,"threshold_uncertainty_score":0.03289765},"labels":[],"label_agreement":null},{"id":"W4385667521","doi":"10.1002/ajh.27052","title":"Re‐assessing the effect of fetal hemoglobin on stroke in the Cooperative Study of Sickle Cell Disease","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Fetal hemoglobin; Medicine; Stroke (engine); Disease; Fetus; Hemoglobin; Cell; Internal medicine; Pregnancy; Intensive care medicine; Pediatrics; Biology; Genetics","score_opus":0.009550435321044886,"score_gpt":0.2921621345025671,"score_spread":0.28261169918152224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385667521","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477708,0.02811741,0.0026677654,0.0055348044,0.0010447497,0.0003350024,0.0082273055,0.000040809624,0.00626141],"genre_scores_gemma":[0.9842017,0.0035707,0.0019125672,0.0013580603,0.000793327,0.00029836208,0.006170423,0.000029806559,0.0016651158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9834809,0.01033803,0.0015480242,0.0018396851,0.0020077792,0.00078563916],"domain_scores_gemma":[0.9699431,0.013785097,0.0038071454,0.0052125324,0.005382773,0.0018694875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020085016,0.0008876362,0.0012190342,0.0018963667,0.0012920881,0.0015226362,0.0015862687,0.0019902892,0.0014581617],"category_scores_gemma":[0.037625916,0.00031602298,0.0016998549,0.0033071705,0.00063779665,0.0011214227,0.000996238,0.0021605121,0.00029037838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027581803,0.000108883025,0.977111,0.0001498793,0.0025588002,0.0002579367,0.00024316633,0.00019472647,0.00029419284,0.00042829185,0.0037780837,0.012116832],"study_design_scores_gemma":[0.0006653224,0.0010062795,0.9832276,0.00015369245,0.003568447,0.0004079441,0.0003108806,0.000922991,0.00030643347,0.0006961755,0.008689365,0.000044918084],"about_ca_topic_score_codex":0.04125467,"about_ca_topic_score_gemma":0.052121066,"teacher_disagreement_score":0.04125467,"about_ca_system_score_codex":0.000952493,"about_ca_system_score_gemma":0.0019567516,"threshold_uncertainty_score":0.10622102},"labels":[],"label_agreement":null},{"id":"W4386303249","doi":"10.1002/ajh.27073","title":"Risk of progression in chronic <scp>phase‐chronic</scp> myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the <scp>TFR‐PRO</scp> study","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Università degli Studi di Milano-Bicocca","keywords":"Discontinuation; Medicine; Cohort; Internal medicine; Myeloid leukemia; Prospective cohort study; Cohort study; Oncology","score_opus":0.016880785678153112,"score_gpt":0.32471810413039887,"score_spread":0.30783731845224577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386303249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825245,0.00080510596,0.00020478235,0.000035129215,0.000007115484,0.000030604617,0.00046936187,0.0000041880467,0.00019121356],"genre_scores_gemma":[0.99865663,0.00017241105,0.000108719105,0.000038753973,0.000019158684,0.00002762552,0.0008220406,0.0000037824825,0.00015083591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978042,0.0013051478,0.00018207278,0.00032617943,0.00023912985,0.00014322657],"domain_scores_gemma":[0.9938387,0.002534827,0.0020570094,0.0007857169,0.00029854948,0.00048518786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00581402,0.00039173095,0.00080689706,0.00040035075,0.00023018979,0.00090332935,0.0004814044,0.00068796356,0.0008616253],"category_scores_gemma":[0.004830015,0.0002724324,0.0027307475,0.0006021704,0.00022302136,0.00042232065,0.00053499494,0.0009939986,0.000104677856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050391767,0.00016168164,0.93231946,0.00021045192,0.003766891,0.00021543526,0.00012542677,0.0006767903,0.0011414036,0.00009439049,0.00044883223,0.010447467],"study_design_scores_gemma":[0.002433785,0.0063734283,0.9835774,0.00004436468,0.0028388887,0.0005397058,0.00010444176,0.002293643,0.00041608117,0.00014689792,0.0012097722,0.000021498252],"about_ca_topic_score_codex":0.0010046135,"about_ca_topic_score_gemma":0.0013169422,"teacher_disagreement_score":0.00581402,"about_ca_system_score_codex":0.00029137393,"about_ca_system_score_gemma":0.00041610992,"threshold_uncertainty_score":0.03074783},"labels":[],"label_agreement":null},{"id":"W4386415343","doi":"10.1002/ajh.27079","title":"A globally applicable “triple <scp>A</scp>” risk model for essential thrombocythemia based on <scp>A</scp>ge, <scp>A</scp>bsolute neutrophil count, and <scp>A</scp>bsolute lymphocyte count","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Firenze; Ministero della Salute","keywords":"Medicine; Myelofibrosis; Internal medicine; Essential thrombocythemia; Absolute neutrophil count; Gastroenterology; Akaike information criterion; International Prognostic Scoring System; Lymphocyte; Neutropenia; Myelodysplastic syndromes; Bone marrow; Platelet; Chemotherapy","score_opus":0.014006456477845966,"score_gpt":0.27438056488019474,"score_spread":0.26037410840234876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386415343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94088376,0.001269413,0.04720828,0.0023790298,0.00027405005,0.00032802342,0.005389359,0.0003729915,0.001895208],"genre_scores_gemma":[0.9872348,0.00013290091,0.0077781193,0.00014777032,0.00009419935,0.00019941926,0.0026054035,0.000048236914,0.0017592404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981059,0.0012967843,0.000079172,0.0002915617,0.00008894437,0.00013757068],"domain_scores_gemma":[0.9979461,0.0012355318,0.00023430861,0.00013333581,0.000229056,0.00022165792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005771588,0.0011621857,0.0009337363,0.0010979333,0.00032616482,0.0009364697,0.0015356503,0.00060611265,0.005505957],"category_scores_gemma":[0.0041648913,0.00036796855,0.0032674088,0.0005892936,0.00023968183,0.00032674902,0.0010792321,0.0014092964,0.00054299954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004100572,0.0005080769,0.8543919,0.00025396812,0.011179511,0.00062525534,0.00018517411,0.08174914,0.0009786858,0.002377287,0.010414887,0.03323557],"study_design_scores_gemma":[0.00093146367,0.0016057898,0.21371481,0.00015130427,0.0056664804,0.000801998,0.0004272174,0.76748836,0.00039464977,0.0049077454,0.0038410386,0.00006922624],"about_ca_topic_score_codex":0.013090299,"about_ca_topic_score_gemma":0.008819759,"teacher_disagreement_score":0.013090299,"about_ca_system_score_codex":0.0006946318,"about_ca_system_score_gemma":0.0015839036,"threshold_uncertainty_score":0.030523479},"labels":[],"label_agreement":null},{"id":"W4386466734","doi":"10.1002/ajh.27088","title":"A novel missense variant in <scp><i>ATP11C</i></scp> is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Tokyo Women's Medical University","keywords":"Flippase; Phosphatidylserine; Red blood cell; Cell biology; Biology; Echinocyte; Biochemistry; Chemistry; Phospholipid; Membrane","score_opus":0.012570485368829022,"score_gpt":0.24239866990177783,"score_spread":0.22982818453294881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386466734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136955,0.0007113538,0.004060974,0.00039889902,0.00018114375,0.00008157411,0.001319146,0.00022342642,0.0016539416],"genre_scores_gemma":[0.9964503,0.0001607541,0.0013665057,0.00019662018,0.00009902054,0.000020445585,0.00050334184,0.000039084043,0.0011638256],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975187,0.000031001833,0.000041386164,0.000086896056,0.000058839047,0.000029999643],"domain_scores_gemma":[0.999509,0.00014622064,0.00017689356,0.00002187228,0.000033581357,0.000112439106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013366132,0.0012995135,0.00046764375,0.00058122043,0.0003734674,0.0002723267,0.0004097813,0.0013918199,0.0023287516],"category_scores_gemma":[0.0004982936,0.00016994125,0.00050531444,0.00051183254,0.00065704784,0.0001425124,0.0003451428,0.0005819913,0.00068277126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001011156,0.00016736193,0.018729089,0.00024954745,0.00023801562,0.46236664,0.00040174753,0.0006324587,0.50045764,0.000892926,0.001979097,0.012874218],"study_design_scores_gemma":[0.0001979451,0.0007845218,0.13342945,0.000093667484,0.00037070454,0.71807915,0.00023307177,0.0042464877,0.13041441,0.00071143877,0.011324669,0.00011448527],"about_ca_topic_score_codex":0.001709731,"about_ca_topic_score_gemma":0.0013087023,"teacher_disagreement_score":0.0023287516,"about_ca_system_score_codex":0.00026982158,"about_ca_system_score_gemma":0.00018127043,"threshold_uncertainty_score":0.0077904463},"labels":[],"label_agreement":null},{"id":"W4386817435","doi":"10.1002/ajh.27098","title":"Bone marrow fibrosis is associated with non‐response to <scp>CD19 CAR T</scp>‐cell therapy in <scp>B</scp>‐acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"CURE Childhood Cancer Association","keywords":"Stromal cell; Bone marrow; Medicine; CD19; Fibrosis; T cell; Cancer research; B cell; Myelofibrosis; Cell therapy; Immunology; Pathology; Cell; Flow cytometry; Biology; Immune system; Antibody","score_opus":0.012103395241732408,"score_gpt":0.2796308972548362,"score_spread":0.26752750201310377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386817435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993892,0.00022368466,0.000098278826,0.00001102086,9.0432206e-7,0.0000053130398,0.00014381048,0.0000072686607,0.00012045037],"genre_scores_gemma":[0.9992306,0.00011981151,0.00013563481,0.000017205068,0.0000032529033,0.000011106204,0.00029333105,0.0000026884625,0.00018637379],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999895,0.000026012965,0.00000986631,0.000024728086,0.000022546808,0.000021839136],"domain_scores_gemma":[0.99971586,0.000054321466,0.00015300528,0.00001428914,0.000017910757,0.000044586057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015630142,0.00012691517,0.00020407779,0.00032961398,0.00011621607,0.00021958353,0.00006261942,0.00014818467,0.0009042571],"category_scores_gemma":[0.00024154581,0.00009090359,0.00013129757,0.00024435416,0.00017519595,0.000071654504,0.00011798365,0.00022843065,0.00016411157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035843113,0.00011329419,0.3489747,0.00010880568,0.00006828928,0.0008396758,0.00016898292,0.00026048583,0.633908,0.00005100091,0.000243218,0.011679278],"study_design_scores_gemma":[0.000011511312,0.00031282203,0.9837847,0.0000047315143,0.00003654148,0.0011737591,0.000063559404,0.0002716207,0.014006447,0.000031260774,0.00030021233,0.0000027961312],"about_ca_topic_score_codex":0.00034894206,"about_ca_topic_score_gemma":0.0006380766,"teacher_disagreement_score":0.0009042571,"about_ca_system_score_codex":0.00011395536,"about_ca_system_score_gemma":0.00009171229,"threshold_uncertainty_score":0.003025055},"labels":[],"label_agreement":null},{"id":"W4387563093","doi":"10.1002/ajh.27123","title":"Severe autoimmune heparin‐induced thrombocytopenia postcardiac surgery: Implications for subsequent cardiac surgery","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Cardiology; Partial thromboplastin time; Internal medicine; Atrial fibrillation; Mitral valve replacement; Myocardial infarction; Cardiac surgery; Surgery; Heart failure; Mitral valve; Platelet","score_opus":0.05798426349889981,"score_gpt":0.330738227842445,"score_spread":0.2727539643435452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022543,0.022633987,0.0026427268,0.038152825,0.0012642703,0.0002656887,0.00032145606,0.00014429646,0.032320585],"genre_scores_gemma":[0.988976,0.004499057,0.00067359465,0.0028170466,0.0018353481,0.000023656123,0.000120478755,0.000008593186,0.0010462365],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996314,0.000081980776,0.0000511878,0.000061627674,0.000077426055,0.000096219264],"domain_scores_gemma":[0.9989636,0.00032076976,0.00027815858,0.000041687807,0.00009812349,0.00029761373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000408341,0.000705764,0.0004534575,0.0009404684,0.0011648113,0.0010725954,0.0007827131,0.0026330096,0.0034392069],"category_scores_gemma":[0.002590536,0.00028095357,0.00047761752,0.00065858226,0.0006766268,0.0012111783,0.00039698728,0.0027318697,0.0004463494],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011885277,0.00020611458,0.20763524,0.00010455682,0.000041165516,0.77851963,0.0003122668,0.00016509574,0.0005285528,0.0006256379,0.0032226325,0.008520307],"study_design_scores_gemma":[0.000030101943,0.0002699784,0.10884014,0.0003848469,0.00005622565,0.8841356,0.0012451772,0.0008220283,0.00020085259,0.0014163567,0.002568433,0.000030212408],"about_ca_topic_score_codex":0.0023039521,"about_ca_topic_score_gemma":0.0031810484,"teacher_disagreement_score":0.0034392069,"about_ca_system_score_codex":0.0006342321,"about_ca_system_score_gemma":0.0008864623,"threshold_uncertainty_score":0.011505306},"labels":[],"label_agreement":null},{"id":"W4387799247","doi":"10.1002/ajh.27134","title":"Lung function decline in children with sickle cell disease treated with hydroxyurea","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lung function; Disease; Sickle cell anemia; Intensive care medicine; Pediatrics; Lung; Internal medicine","score_opus":0.0037829985380958345,"score_gpt":0.21570553633115866,"score_spread":0.21192253779306283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387799247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684227,0.0015740123,0.000042696476,0.00020133614,0.000016935805,0.000016300024,0.00017222408,0.000009642353,0.0011245194],"genre_scores_gemma":[0.9991437,0.0004002648,0.000039311566,0.00009417898,0.000023859955,0.0000072935572,0.00018940894,0.0000017857682,0.0001002901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996648,0.000053794105,0.000033246557,0.000059800732,0.000096310425,0.000092055474],"domain_scores_gemma":[0.9987822,0.00025292125,0.00044747302,0.00002963449,0.00012875901,0.00035904325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002973469,0.00023115551,0.0006426947,0.000697808,0.00055768125,0.0004892171,0.00033422632,0.00059581693,0.0011203218],"category_scores_gemma":[0.0024431963,0.0001435362,0.00046357207,0.00072140124,0.00037348396,0.00056139234,0.0003001507,0.0012221845,0.00015769483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009122445,0.0000782157,0.9953838,0.000016731054,0.000015696116,0.0022168916,0.00014627968,0.000030554933,0.00017413752,0.000018105651,0.00011897491,0.0017092999],"study_design_scores_gemma":[0.000011302044,0.0004286123,0.9912579,0.000022031381,0.000027933962,0.007430985,0.0003117892,0.00007106875,0.00008934086,0.00001966761,0.00032467916,0.000004620795],"about_ca_topic_score_codex":0.00574322,"about_ca_topic_score_gemma":0.0053075035,"teacher_disagreement_score":0.00574322,"about_ca_system_score_codex":0.00074885925,"about_ca_system_score_gemma":0.00048315083,"threshold_uncertainty_score":0.011419535},"labels":[],"label_agreement":null},{"id":"W4389242311","doi":"10.1002/ajh.27167","title":"Dosage of high‐dose methotrexate as <scp>CNS</scp> prophylaxis in <scp>DLBCL: A</scp> detailed analysis of toxicity and impact on <scp>CNS</scp> relapse","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Centre Léon Bérard; Cambridge University Hospitals; BeiGene; Aalborg Universitet; Gilead Sciences; Atara Biotherapeutics; Assistance publique-Hôpitaux de Paris; University Hospital Southampton NHS Foundation Trust; Aalborg Universitetshospital; Incyte; Brown University; University of Cambridge; University Hospitals Bristol NHS Foundation Trust; Celgene","keywords":"Methotrexate; Medicine; Retrospective cohort study; Internal medicine; Oncology; Lymphoma; Toxicity; Antifolate; Antimetabolite","score_opus":0.013641142485164737,"score_gpt":0.2928576976669626,"score_spread":0.2792165551817979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242311","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889563,0.009555519,0.00062166224,0.000065607135,0.000010249791,0.000039157916,0.0003815317,0.000008626539,0.00036140112],"genre_scores_gemma":[0.99744934,0.0016651396,0.00019271384,0.00008011946,0.00004130554,0.000016576974,0.00043552706,0.000007779732,0.00011142098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981298,0.0009342748,0.00027390185,0.00019206744,0.000363272,0.00010667972],"domain_scores_gemma":[0.9962697,0.0014029281,0.0013989134,0.0004762369,0.00019334805,0.0002588112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023474947,0.00025234956,0.00076018,0.00038915157,0.00012983457,0.0006878639,0.00033705644,0.0003522337,0.00081524823],"category_scores_gemma":[0.0039046064,0.00017735508,0.0018545222,0.001241231,0.0002715546,0.0003914577,0.00024830064,0.000479374,0.0001520278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0727243,0.00076853856,0.7202563,0.0012101582,0.009364078,0.00076729717,0.00018407039,0.0047011436,0.0061586807,0.00024519683,0.0008332813,0.18278685],"study_design_scores_gemma":[0.0019886207,0.027008038,0.95274603,0.00017097284,0.00677829,0.0020257602,0.0000848937,0.002074596,0.0030780672,0.00021110514,0.0037979076,0.000035813937],"about_ca_topic_score_codex":0.0007632501,"about_ca_topic_score_gemma":0.0010512352,"teacher_disagreement_score":0.0023474947,"about_ca_system_score_codex":0.00065965514,"about_ca_system_score_gemma":0.0004879097,"threshold_uncertainty_score":0.012414932},"labels":[],"label_agreement":null},{"id":"W4390053864","doi":"10.1002/ajh.27181","title":"Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies","year":2023,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Osteoporosis Canada; McMaster University; Princess Margaret Cancer Centre; McMaster University Medical Centre; Kingston Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Australian and New Zealand Society of Blood Transfusion; NHS Blood and Transplant","keywords":"Medicine; Myelodysplastic syndromes; Randomized controlled trial; Life expectancy; Blood transfusion; Chronic myelomonocytic leukemia; Transfusion therapy; Intensive care medicine; Pediatrics; Internal medicine; Population","score_opus":0.02184465338928655,"score_gpt":0.2907618449598854,"score_spread":0.26891719157059885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390053864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6474907,0.28804561,0.008101904,0.0035807034,0.0028950267,0.039338853,0.005110206,0.00037621462,0.0050608655],"genre_scores_gemma":[0.90854365,0.05077587,0.009773983,0.0031548983,0.0009701755,0.02405777,0.0017944997,0.000054363998,0.0008747529],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.97947305,0.013935137,0.003621754,0.0010915545,0.0012584077,0.0006200137],"domain_scores_gemma":[0.9743886,0.014756824,0.006962345,0.0014825074,0.0015728817,0.00083674485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016765065,0.0015830706,0.007315721,0.0009419714,0.0004255285,0.0024936672,0.0009013677,0.0027249178,0.004512146],"category_scores_gemma":[0.036219474,0.000885715,0.00892169,0.0018696098,0.0012173883,0.0017312915,0.0009197731,0.0020436915,0.0004023759],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83548534,0.0050715837,0.0031781774,0.04544106,0.04880308,0.00015661524,0.00021399968,0.00049843185,0.0016431506,0.00030816157,0.0011633113,0.058037117],"study_design_scores_gemma":[0.8703902,0.049144212,0.008735525,0.004206281,0.06301244,0.00009455233,0.00011362401,0.00036926175,0.00046258277,0.0005659705,0.002809159,0.00009615247],"about_ca_topic_score_codex":0.0012621905,"about_ca_topic_score_gemma":0.0024626825,"teacher_disagreement_score":0.016765065,"about_ca_system_score_codex":0.0014986928,"about_ca_system_score_gemma":0.002747984,"threshold_uncertainty_score":0.08866322},"labels":[],"label_agreement":null},{"id":"W4390492268","doi":"10.1002/ajh.27175","title":"A framework for the clinical implementation of optical genome mapping in hematologic malignancies","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Radboud Universitair Medisch Centrum; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Scope (computer science); Computer science; Medicine; Medical physics","score_opus":0.05847066041567659,"score_gpt":0.402547554615472,"score_spread":0.34407689419979537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390492268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077929595,0.9759325,0.0030669635,0.014442436,0.0023286648,0.000062008956,0.000037703307,0.00005929487,0.0039925966],"genre_scores_gemma":[0.0022256922,0.97194654,0.011534402,0.010184987,0.002130805,0.00020721748,0.00012423251,0.00001956954,0.0016266509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965837,0.0014856324,0.00051688787,0.00032975178,0.00089662237,0.00018741087],"domain_scores_gemma":[0.9956012,0.002351312,0.0003077369,0.00017059133,0.001282943,0.00028621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012159655,0.0013504114,0.00153375,0.00423595,0.0007355269,0.0031450582,0.003213014,0.005717132,0.00290396],"category_scores_gemma":[0.009378603,0.00047952277,0.0012133792,0.0022410813,0.0028591852,0.004744094,0.0027822198,0.0075758933,0.0021593578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005298768,0.00011950084,0.0001957192,0.012785385,0.000055228626,0.00043138932,0.00026575328,0.00097235286,0.0007170898,0.09316606,0.09860085,0.79263765],"study_design_scores_gemma":[0.000015206869,0.000062275714,0.00026212205,0.009068412,0.000036040117,0.00053913984,0.00009055189,0.00017076204,0.0001136267,0.013810873,0.97580904,0.000022090484],"about_ca_topic_score_codex":0.002999358,"about_ca_topic_score_gemma":0.002791812,"teacher_disagreement_score":0.012159655,"about_ca_system_score_codex":0.003922475,"about_ca_system_score_gemma":0.009592127,"threshold_uncertainty_score":0.06430721},"labels":[],"label_agreement":null},{"id":"W4390507753","doi":"10.1002/ajh.27171","title":"Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from <scp>CYP‐C</scp>","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; McMaster University; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Izaak Walton Killam Health Centre; Nova Scotia Cancer Centre; Hospital for Sick Children; Stollery Children's Hospital; Nova Scotia Health Authority","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Induction chemotherapy; Acute lymphocytic leukemia; Cohort; Population; Retrospective cohort study; Univariate analysis; Oncology; Logistic regression; Chemotherapy; Pediatrics; Multivariate analysis; Leukemia; Lymphoblastic Leukemia; Confidence interval","score_opus":0.0186039726505061,"score_gpt":0.3538590728196733,"score_spread":0.3352551001691672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390507753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991773,0.00021781657,0.000034436616,0.000037900874,0.0000021057394,0.000005671812,0.00024565868,0.0000014693535,0.0002775595],"genre_scores_gemma":[0.99929845,0.00029379776,0.000038047332,0.00001967778,0.0000068795775,0.000003186299,0.00025113273,0.0000010393197,0.00008763309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997793,0.0000384594,0.000018058368,0.000036560476,0.00007983312,0.00004775571],"domain_scores_gemma":[0.9993297,0.0001274367,0.00026555173,0.000035229226,0.00015192335,0.000090194975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028153733,0.00014007522,0.00015042591,0.00036441145,0.0003151784,0.00042666314,0.00018926228,0.00016026087,0.00051460083],"category_scores_gemma":[0.0012744415,0.00012140486,0.0002163183,0.0009105166,0.0001675356,0.00010505945,0.00014287462,0.00027788762,0.00006699174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026323823,0.000010389032,0.99832314,0.0000052241626,0.000011086121,0.00021150649,0.00008330401,0.000016619353,0.000083146304,0.000006740251,0.00012445141,0.0010979903],"study_design_scores_gemma":[0.0000027191759,0.000027830822,0.9988631,0.0000033809724,0.000015822614,0.00057530386,0.00011805656,0.00006925978,0.000049623508,0.000002788365,0.0002707361,0.000001496201],"about_ca_topic_score_codex":0.16881156,"about_ca_topic_score_gemma":0.1290074,"teacher_disagreement_score":0.16881156,"about_ca_system_score_codex":0.0010508237,"about_ca_system_score_gemma":0.0013518977,"threshold_uncertainty_score":0.33565795},"labels":[],"label_agreement":null},{"id":"W4391395206","doi":"10.1002/ajh.27222","title":"Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and <scp>meta‐analysis</scp>","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; Ottawa Public Health; University of Ottawa","funders":"","keywords":"Medicine; Thrombophilia; Odds ratio; Internal medicine; Factor V Leiden; Meta-analysis; Methylenetetrahydrofolate reductase; Oncology; Venous thrombosis; Cancer; Prothrombin G20210A; Confidence interval; Thrombosis; Allele; Genetics; Gene; Biology","score_opus":0.019731462516299154,"score_gpt":0.3148006937872948,"score_spread":0.29506923127099566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391395206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00424279,0.9938419,0.0002849106,0.00023292277,0.00016003526,0.0003161291,0.0006326952,0.000020321011,0.00026822035],"genre_scores_gemma":[0.12863992,0.8659035,0.0016016272,0.0010374814,0.0002932139,0.0012419946,0.0008677994,0.000027267546,0.00038725813],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.992766,0.0032133923,0.0021588174,0.0006332212,0.00095664343,0.0002719783],"domain_scores_gemma":[0.98444355,0.011349963,0.0024505937,0.00035855133,0.0012095385,0.00018772624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010213999,0.002016933,0.014583044,0.0060514985,0.0005574591,0.0030704194,0.0014926078,0.0019171241,0.0034596566],"category_scores_gemma":[0.028935485,0.0012615744,0.031116625,0.0073605874,0.00055820186,0.0013576761,0.001216877,0.0012770188,0.00028245116],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097071985,0.00001576422,0.0040300386,0.5720452,0.4114919,0.00015653354,0.00008342104,0.00035210946,0.00022520889,0.000121192286,0.0010145314,0.009493415],"study_design_scores_gemma":[0.0005045958,0.00015195971,0.0048829694,0.06287156,0.9282958,0.00016691689,0.0000533355,0.0001824414,0.000113070724,0.0001818201,0.0025706855,0.000024809746],"about_ca_topic_score_codex":0.0094579,"about_ca_topic_score_gemma":0.020550426,"teacher_disagreement_score":0.014583044,"about_ca_system_score_codex":0.0025898966,"about_ca_system_score_gemma":0.004139838,"threshold_uncertainty_score":0.054017425},"labels":[],"label_agreement":null},{"id":"W4391401303","doi":"10.1002/ajh.27223","title":"Iron‐triggered signaling via <scp>ETS1</scp> and the p38/<scp>JNK MAPK</scp> pathway regulates <i>Bmp6</i> expression","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Trace Elements in Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Narodowym Centrum Nauki; Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN; Narodowe Centrum Nauki; Institute of Genetics; Amgen","keywords":"p38 mitogen-activated protein kinases; MAPK/ERK pathway; Signal transduction; Cell biology; Biology","score_opus":0.00855457474667531,"score_gpt":0.26385296963110405,"score_spread":0.25529839488442874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391401303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923341,0.0010976382,0.0037766828,0.00013852432,0.000022693865,0.000029593863,0.0010574028,0.0000859203,0.001457358],"genre_scores_gemma":[0.98918635,0.0009558718,0.0029246227,0.00009235277,0.000016176566,0.000078678044,0.0015466068,0.000026781623,0.0051726126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989974,0.000009945959,0.000007052809,0.000021781396,0.000027571945,0.00003391051],"domain_scores_gemma":[0.9999354,0.00000717967,0.000019929153,0.000004644287,0.000009163604,0.000023674085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010165601,0.0003587515,0.00018485663,0.00021787033,0.00015908261,0.00018763902,0.00015783565,0.00018473982,0.0012285081],"category_scores_gemma":[0.00005710971,0.00014075874,0.0003313178,0.0000996726,0.00021309916,0.00021500599,0.00021017967,0.00051850063,0.00037369388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007449024,0.0000105837,0.00022014894,0.000024334466,0.0000022521622,0.000029433448,0.000009434151,0.000032470794,0.9990338,0.00006726482,0.000023421584,0.00047250293],"study_design_scores_gemma":[0.000012305282,0.000084210114,0.01503364,0.000005896531,0.00001022611,0.00016224605,0.00004210476,0.00090634834,0.98215586,0.00006142921,0.0015216242,0.000004195915],"about_ca_topic_score_codex":0.00069683837,"about_ca_topic_score_gemma":0.0011448468,"teacher_disagreement_score":0.0012285081,"about_ca_system_score_codex":0.00028773,"about_ca_system_score_gemma":0.00018094336,"threshold_uncertainty_score":0.0041098},"labels":[],"label_agreement":null},{"id":"W4391691583","doi":"10.1002/ajh.27244","title":"Reducing transfusion utilization for children with sickle cell anemia in sub‐Saharan Africa with hydroxyurea: Analysis from the phase <scp>I</scp>/<scp>II REACH</scp> trial","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Fogarty International Center; National Heart, Lung, and Blood Institute; Doris Duke Charitable Foundation; Wellcome Trust; Bristol-Myers Squibb; American Society of Hematology; National Institutes of Health; Cincinnati Children's Hospital Medical Center","keywords":"Medicine; Blood transfusion; Incidence (geometry); Anemia; Sickle cell anemia; Dosing; Pediatrics; Rate ratio; Confidence interval; Clinical trial; Internal medicine; Disease","score_opus":0.010454792346352378,"score_gpt":0.25785140205692586,"score_spread":0.24739660971057348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391691583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985811,0.010037531,0.00025109015,0.0005983163,0.000062782536,0.00040320796,0.0023516482,0.000016162947,0.0004681619],"genre_scores_gemma":[0.9911499,0.0047709607,0.0006060808,0.00046959476,0.0000830682,0.00073246803,0.0019405908,0.0000102538115,0.00023699112],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99710065,0.002126674,0.00017999283,0.00018538984,0.00018741924,0.00021990428],"domain_scores_gemma":[0.99587566,0.001882523,0.0014652562,0.00019177923,0.0001881987,0.0003966428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048204144,0.0007757465,0.0015312473,0.00035825183,0.00025171734,0.0008610914,0.00055943144,0.00067705,0.0015196769],"category_scores_gemma":[0.007518747,0.00040137177,0.0044735377,0.0009562287,0.00039120196,0.0006074981,0.00055062684,0.0015349523,0.00012992499],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53772944,0.0031740982,0.2960955,0.008187025,0.04210743,0.00032439746,0.0007689233,0.0036284586,0.0017466192,0.00046986176,0.00691501,0.098853245],"study_design_scores_gemma":[0.28085425,0.07506681,0.5787177,0.0018660311,0.048809074,0.0007327473,0.00069829,0.0037606552,0.001185022,0.00073552504,0.0074571692,0.000116702766],"about_ca_topic_score_codex":0.0030255974,"about_ca_topic_score_gemma":0.0050947377,"teacher_disagreement_score":0.0048204144,"about_ca_system_score_codex":0.0006844971,"about_ca_system_score_gemma":0.0012258529,"threshold_uncertainty_score":0.025493145},"labels":[],"label_agreement":null},{"id":"W4391722392","doi":"10.1002/ajh.27243","title":"Donor germ‐line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Navy; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Norges Idrettshøgskole; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; BeiGene; HistoGenetics; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Actinium Pharmaceuticals; CareDx; Incyte; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Myelodysplastic syndromes; Stem cell; Medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Germline; Hematopoietic cell; Haematopoiesis; Internal medicine; Biology; Genetics; Bone marrow; Gene","score_opus":0.009485209127532675,"score_gpt":0.25296472988582397,"score_spread":0.2434795207582913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391722392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132556,0.00041226106,0.00009523777,0.0043070763,0.0001703004,0.0000049038395,0.0008031689,0.000012863134,0.0028686523],"genre_scores_gemma":[0.9974523,0.00012231928,0.00006074047,0.0010153791,0.0002078377,0.000005122409,0.0003116133,0.0000029372577,0.0008216865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998654,0.00003849695,0.000011874299,0.000032061707,0.00002102957,0.000031116433],"domain_scores_gemma":[0.99931526,0.00027543126,0.00014661325,0.000039985658,0.000064402295,0.00015818195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018781175,0.00016600364,0.00028881646,0.00024928196,0.00033648222,0.00027625824,0.0001929672,0.00082257687,0.002894366],"category_scores_gemma":[0.001328736,0.000099750185,0.0001871141,0.0004818506,0.00018114223,0.00014827654,0.0001244879,0.0005637747,0.00036234903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010706886,0.000046855508,0.97564805,0.00001948458,0.00006885442,0.004557017,0.00012059137,0.00029803588,0.0015559155,0.00019593877,0.009104808,0.007313763],"study_design_scores_gemma":[0.00012943184,0.00026764302,0.97458535,0.00003229658,0.00010255182,0.01671086,0.0003007493,0.0017973594,0.0004893696,0.0010560066,0.0045060725,0.000022350992],"about_ca_topic_score_codex":0.0016932084,"about_ca_topic_score_gemma":0.0023238158,"teacher_disagreement_score":0.002894366,"about_ca_system_score_codex":0.00022200533,"about_ca_system_score_gemma":0.00018238313,"threshold_uncertainty_score":0.009682655},"labels":[],"label_agreement":null},{"id":"W4391738483","doi":"10.1002/ajh.27246","title":"Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AbbVie Canada; Genentech; Genentech Foundation","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Placebo; Myeloid leukemia; Oncology; Neutropenia; Febrile neutropenia; Hazard ratio; Clinical endpoint; Leukemia; Chemotherapy; Gastroenterology; Clinical trial; Confidence interval; Chronic lymphocytic leukemia; Pathology","score_opus":0.011525101525683406,"score_gpt":0.2991369166163655,"score_spread":0.28761181509068207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391738483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362516,0.0023108104,0.0003464016,0.00019135789,0.00003946533,0.00025953265,0.0017639706,0.000017729191,0.0014455145],"genre_scores_gemma":[0.99407864,0.0007186707,0.00035779487,0.00038961484,0.00007038948,0.0002943372,0.0032561473,0.000006881378,0.0008274828],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989317,0.0005033598,0.000075577234,0.00021868061,0.00012645694,0.00014416351],"domain_scores_gemma":[0.99685425,0.0007223177,0.0010357633,0.0004635351,0.00019728526,0.00072691287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041243816,0.000274973,0.0011223198,0.0002495176,0.000708782,0.00086091016,0.00036417425,0.0009168163,0.0017370823],"category_scores_gemma":[0.0033183552,0.00032186892,0.0012062852,0.00040942596,0.00037264993,0.00072927674,0.0005283781,0.0021774336,0.00039123066],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5860465,0.008458826,0.20449531,0.00065698987,0.0037204265,0.00036511314,0.00043705615,0.0019746642,0.01228665,0.0004707347,0.0057589887,0.17532866],"study_design_scores_gemma":[0.06112862,0.1950918,0.7170617,0.00026147565,0.004702385,0.0006979393,0.00020503809,0.0026557506,0.005195284,0.0006589807,0.012236001,0.000105041574],"about_ca_topic_score_codex":0.0010534151,"about_ca_topic_score_gemma":0.0022922112,"teacher_disagreement_score":0.0041243816,"about_ca_system_score_codex":0.00077352196,"about_ca_system_score_gemma":0.0007188558,"threshold_uncertainty_score":0.021812081},"labels":[],"label_agreement":null},{"id":"W4392354102","doi":"10.1002/ajh.27273","title":"Assessing hypercoagulability and <scp>VTE</scp> risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Queen's University","funders":"","keywords":"Medicine; Thromboelastography; Internal medicine; Cancer; Thrombosis; Chemotherapy; Framingham Risk Score; Risk assessment; Oncology; Surgery; Gastroenterology; Coagulation; Disease","score_opus":0.013957983649479488,"score_gpt":0.2918712535595464,"score_spread":0.27791326991006693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392354102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884605,0.00046674005,0.000085911335,0.00002684545,0.0000034533593,0.000016080523,0.00006965404,0.0000029901928,0.0004823861],"genre_scores_gemma":[0.99952924,0.00014827155,0.00011635403,0.000013307988,0.0000064341816,0.00000834779,0.000069349946,5.225296e-7,0.00010803848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997737,0.000065685155,0.000035996993,0.000034913348,0.000050949122,0.00003889179],"domain_scores_gemma":[0.9994522,0.000101199534,0.00025986438,0.000022636857,0.00006484124,0.00009937797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035911627,0.00021837506,0.00027752513,0.00083022343,0.00019234246,0.0003299507,0.00012328778,0.0002480238,0.00073358585],"category_scores_gemma":[0.0018437664,0.00013583827,0.000218751,0.0006332473,0.00014943375,0.00022927312,0.00029239105,0.00022434277,0.00019627846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012945189,0.000014417052,0.9977307,0.0000064024716,0.000013663049,0.000048088154,0.000041845986,0.00001633191,0.00019118947,0.0000042753663,0.000026929127,0.0017767033],"study_design_scores_gemma":[0.0000070210194,0.00029032142,0.9985304,0.0000055566793,0.000023181245,0.0006313331,0.000086346634,0.00013584402,0.000108830354,0.000014963825,0.00016387666,0.0000022951074],"about_ca_topic_score_codex":0.0012679694,"about_ca_topic_score_gemma":0.001412859,"teacher_disagreement_score":0.0012679694,"about_ca_system_score_codex":0.00015516425,"about_ca_system_score_gemma":0.00012623878,"threshold_uncertainty_score":0.0025211573},"labels":[],"label_agreement":null},{"id":"W4393015884","doi":"10.1002/ajh.27283","title":"Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor <scp>ECOG</scp> performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; bluebird bio; Pharmacyclics; Daiichi Sankyo Europe; Takeda Oncology; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Sanofi; TG Therapeutics; Medac; Ipsen; Jazz Pharmaceuticals; Boston Scientific Corporation; StemCyte; U.S. Navy; Legend Biotech; HistoGenetics; Omeros Corporation; Vertex Pharmaceuticals; Leukemia and Lymphoma Society; U.S. Department of Defense; Celgene; CSL Behring; Bristol-Myers Squibb; Amgen; National Heart, Lung, and Blood Institute; Ascentage Pharma; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Mallinckrodt Pharmaceuticals; Society for Immunotherapy of Cancer; Astellas Pharma US; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Hazard ratio; Refractory (planetary science); Propensity score matching; Lymphoma; Regimen; Salvage therapy; Gastroenterology; Surgery; Oncology; Chemotherapy; Confidence interval; Rituximab","score_opus":0.010061085264894416,"score_gpt":0.2739395781119439,"score_spread":0.2638784928470495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393015884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983767,0.0012098256,0.00003503976,0.000052707117,0.000015039459,0.000011638751,0.0000445333,0.0000027271913,0.0002516658],"genre_scores_gemma":[0.99943846,0.00024619812,0.000038417882,0.000056993544,0.00003201606,0.000008350042,0.000086693035,6.056439e-7,0.00009226506],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99972135,0.00015326813,0.000021024935,0.000041398085,0.0000227445,0.000040187893],"domain_scores_gemma":[0.9994313,0.00016980576,0.00020332338,0.000026938447,0.000013550709,0.0001549809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077444763,0.00016250274,0.00046734075,0.00019390044,0.000101167454,0.0003210773,0.00014261137,0.00022273045,0.0008779308],"category_scores_gemma":[0.0011335582,0.000093854214,0.00052885123,0.00017781007,0.00015904075,0.00028012122,0.00021682028,0.00037122742,0.00007997994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42698866,0.0043175444,0.40732953,0.00043865212,0.0025597909,0.00038099347,0.00014938983,0.0021395453,0.009910084,0.00022849995,0.0010404895,0.14451672],"study_design_scores_gemma":[0.029089885,0.13471445,0.8225567,0.00008068407,0.002714337,0.0006774701,0.00018275931,0.0044984235,0.0022657744,0.00025571455,0.0029305671,0.00003326238],"about_ca_topic_score_codex":0.000449275,"about_ca_topic_score_gemma":0.0014352738,"teacher_disagreement_score":0.0008779308,"about_ca_system_score_codex":0.00032058454,"about_ca_system_score_gemma":0.00023597355,"threshold_uncertainty_score":0.0040956736},"labels":[],"label_agreement":null},{"id":"W4393233690","doi":"10.1002/ajh.27298","title":"Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"Novartis","keywords":"Medicine; Immune thrombocytopenia; Genitourinary system; Clinical trial; Surgery; Internal medicine; Pediatrics; Platelet","score_opus":0.009841349555028312,"score_gpt":0.29615227452975906,"score_spread":0.28631092497473076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393233690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968869,0.0001368166,0.0015705231,0.000026024,0.000014279858,0.0001140271,0.00020047795,0.000011708254,0.0010392247],"genre_scores_gemma":[0.9984773,0.000044233308,0.00095508696,0.000023938894,0.000013939603,0.00010123262,0.00023746905,0.0000074538216,0.00013935809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9622542,0.022260534,0.0044265226,0.0029036931,0.0070189843,0.0011360642],"domain_scores_gemma":[0.9119345,0.045744717,0.014930819,0.008100801,0.017685058,0.0016041697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031194236,0.00036940153,0.0007552321,0.0021798355,0.00071408076,0.0011216529,0.0009107864,0.0005366279,0.0008505175],"category_scores_gemma":[0.07127999,0.00042465056,0.000875738,0.00154293,0.0011469797,0.0015352059,0.002334595,0.00059317786,0.00037953415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005564709,0.00012102465,0.9864944,0.00006886354,0.00022977157,0.000068494395,0.0037979353,0.00015447276,0.00044019418,0.000074487645,0.00015759894,0.007836159],"study_design_scores_gemma":[0.00009249789,0.0012770742,0.9890792,0.00004971775,0.00013947385,0.0004783608,0.0036407532,0.0027506743,0.0013074965,0.00015153826,0.0009782391,0.00005490687],"about_ca_topic_score_codex":0.0023825874,"about_ca_topic_score_gemma":0.0025589557,"teacher_disagreement_score":0.031194236,"about_ca_system_score_codex":0.00097091775,"about_ca_system_score_gemma":0.00067696936,"threshold_uncertainty_score":0.1649729},"labels":[],"label_agreement":null},{"id":"W4393259335","doi":"10.1002/ajh.27307","title":"The presence of additional cytogenetic abnormalities (<scp>ACAs</scp>) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Syndax Pharmaceuticals; Celgene","keywords":"Philadelphia chromosome; Myeloid leukemia; Affect (linguistics); Medicine; Complete remission; Chromosome; Internal medicine; Oncology; Genetics; Chromosomal translocation; Biology; Gene; Psychology; Chemotherapy","score_opus":0.02149606550150339,"score_gpt":0.2822251817310658,"score_spread":0.2607291162295624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393259335","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660519,0.026820501,0.0010587508,0.00084751163,0.000103623046,0.00007408628,0.00021725179,0.000035729838,0.0047906083],"genre_scores_gemma":[0.99537414,0.0030613542,0.00034601302,0.00022501458,0.000052066767,0.000018744913,0.00022458198,0.000004810466,0.00069324643],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997079,0.000059305275,0.000019657402,0.000034283574,0.00014209659,0.00003679196],"domain_scores_gemma":[0.999496,0.00017582731,0.00014594957,0.00004116096,0.00007741299,0.000063630716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005867637,0.0001465419,0.00023284285,0.00025389434,0.00015372281,0.00039774546,0.0002291833,0.00029570382,0.0013900058],"category_scores_gemma":[0.0014842475,0.000071507464,0.00013338414,0.0003034067,0.00023891225,0.00021608536,0.00016833257,0.00043874767,0.00030428966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051859086,0.0008444415,0.28347713,0.0006830919,0.00016399843,0.0011790512,0.00020893561,0.0010724537,0.117510825,0.0010337605,0.0068513886,0.58178914],"study_design_scores_gemma":[0.00060035323,0.015927494,0.7746869,0.00023067275,0.0004526005,0.0160816,0.0003480941,0.0026231746,0.10722695,0.0017240981,0.080047816,0.00005027338],"about_ca_topic_score_codex":0.0006956354,"about_ca_topic_score_gemma":0.0014442208,"teacher_disagreement_score":0.0013900058,"about_ca_system_score_codex":0.0003807365,"about_ca_system_score_gemma":0.00029282094,"threshold_uncertainty_score":0.0046500564},"labels":[],"label_agreement":null},{"id":"W4394614492","doi":"10.1002/ajh.27309","title":"Feminist issues in clinic care, research, and healthcare professionals in thrombosis and hemostasis","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Corporation; Officer; Citation; Medicine; Library science; Management; Law; Political science; Computer science","score_opus":0.07008537270898255,"score_gpt":0.49014362377936327,"score_spread":0.42005825107038075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394614492","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023490759,0.015543822,0.0006441088,0.965208,0.0030340434,0.000018561403,0.000030610634,0.000015187622,0.013156679],"genre_scores_gemma":[0.17891712,0.027711373,0.0024374945,0.76338,0.01844298,0.00024056312,0.00005679876,0.0001585395,0.008655199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9099699,0.06798272,0.0025213885,0.004002403,0.009271836,0.006251641],"domain_scores_gemma":[0.86518294,0.09119269,0.0070046894,0.0035202568,0.007837802,0.025261594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07524426,0.0005317164,0.00089375256,0.0019515165,0.018494133,0.016422909,0.0033182995,0.015217213,0.025543863],"category_scores_gemma":[0.09748652,0.0010291684,0.00064580893,0.0018462851,0.040254336,0.014984299,0.016893527,0.01883761,0.002740138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000150906,0.00019341339,0.008985433,0.00091908954,0.000058226848,0.0021744675,0.084606625,0.00020587552,0.00030122526,0.28249705,0.49302766,0.12688015],"study_design_scores_gemma":[0.000074733136,0.00014135474,0.003391618,0.0036792585,0.000019518166,0.0021781086,0.06293386,0.00014532437,0.00013884032,0.1373305,0.789874,0.00009288404],"about_ca_topic_score_codex":0.013400835,"about_ca_topic_score_gemma":0.027304744,"teacher_disagreement_score":0.07524426,"about_ca_system_score_codex":0.018008761,"about_ca_system_score_gemma":0.027209314,"threshold_uncertainty_score":0.39793444},"labels":[],"label_agreement":null},{"id":"W4394873978","doi":"10.1002/ajh.27311","title":"Novel germline <scp><i>JAK2</i><sup>R715T</sup></scp> mutation causing <scp>PV</scp>‐like erythrocytosis in 3 generations. Amelioration by Ropeg‐Interferon","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Walloon excellence in life sciences and biotechnology; Agentura Pro Zdravotnický Výzkum České Republiky; Fonds De La Recherche Scientifique - FNRS; NextGenerationEU; Grantová Agentura České Republiky; Ludwig Institute for Cancer Research; MPN Research Foundation","keywords":"Biology; Germline mutation; Polycythemia vera; Germline; Mutation; Janus kinase 2; Somatic cell; Myelopoiesis; Molecular biology; Exon; Haematopoiesis; Cancer research; Erythropoietin; Ruxolitinib; Genetics; Myelofibrosis; Immunology; Gene; Stem cell; Bone marrow","score_opus":0.014020668776503457,"score_gpt":0.28183050315371994,"score_spread":0.2678098343772165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960906,0.0002204198,0.0012542857,0.00027481542,0.000043455006,0.00004111617,0.0002269106,0.000075602286,0.0017727248],"genre_scores_gemma":[0.99818665,0.00007050412,0.00047877504,0.000111186055,0.00003346846,0.000010461817,0.000116859075,0.00001934353,0.00097279483],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99986446,0.000019545972,0.000013421612,0.000039722876,0.000033019853,0.000029798879],"domain_scores_gemma":[0.9997634,0.000076459124,0.00004468711,0.000012328832,0.000020241152,0.00008286495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011177506,0.0005939651,0.00023705438,0.00047018687,0.00048136493,0.00025134347,0.00024587227,0.0009945291,0.0013406344],"category_scores_gemma":[0.0003687603,0.00015640772,0.00038820872,0.00019610184,0.00031837632,0.00010152416,0.00018267744,0.0007302872,0.00027566598],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034781478,0.00025930742,0.020180833,0.0000717143,0.000056468292,0.78136265,0.0004952741,0.00056357286,0.18631203,0.0007101544,0.00095644465,0.008683769],"study_design_scores_gemma":[0.00010276328,0.0009056767,0.0727341,0.000033770622,0.0000920624,0.8766028,0.00014829854,0.002771541,0.042137444,0.0005242854,0.0039078263,0.00003931916],"about_ca_topic_score_codex":0.0011733483,"about_ca_topic_score_gemma":0.0012648797,"teacher_disagreement_score":0.0013406344,"about_ca_system_score_codex":0.00030858335,"about_ca_system_score_gemma":0.00016651284,"threshold_uncertainty_score":0.0044848323},"labels":[],"label_agreement":null},{"id":"W4395005490","doi":"10.1002/ajh.27321","title":"Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Leukocytosis; Neutrophilia; Monocytosis; Myeloid; Basophilia; Medicine; Chronic myelomonocytic leukemia; Immunology; Myeloproliferative neoplasm; Myeloid leukemia; Bone marrow; Leukemia; Pathology; Myelodysplastic syndromes; Myelofibrosis","score_opus":0.019823295514765547,"score_gpt":0.33458905212729784,"score_spread":0.3147657566125323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395005490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001000699,0.9776388,0.0016279757,0.012077517,0.0020049647,0.000024909641,0.00033681167,0.000104834704,0.005183532],"genre_scores_gemma":[0.0074389335,0.96996045,0.004160809,0.00668046,0.007274685,0.000055600405,0.0014112495,0.000033355805,0.0029844032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999281,0.00020111643,0.0001266808,0.000077984245,0.0002587899,0.00005460432],"domain_scores_gemma":[0.99639016,0.0012677576,0.0003495292,0.00007289028,0.0016220465,0.00029753463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019332975,0.000781203,0.0014539764,0.0032550013,0.00029071936,0.0012377553,0.0010756447,0.0012822364,0.004356947],"category_scores_gemma":[0.0053526564,0.00032190545,0.00079541525,0.0019564182,0.00042148147,0.0016887706,0.0008819456,0.0025259098,0.0021887803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009055027,0.000045873938,0.0029104326,0.001982947,0.00010484448,0.00036106416,0.00006473472,0.0003500844,0.00039425364,0.002112679,0.14137444,0.8502081],"study_design_scores_gemma":[0.00005484076,0.00011111848,0.0052201767,0.008668083,0.00029350157,0.004233207,0.00011201328,0.00045467468,0.00017843665,0.002628482,0.9780042,0.00004126346],"about_ca_topic_score_codex":0.003968078,"about_ca_topic_score_gemma":0.007055058,"teacher_disagreement_score":0.004356947,"about_ca_system_score_codex":0.001265815,"about_ca_system_score_gemma":0.0018793565,"threshold_uncertainty_score":0.014575422},"labels":[],"label_agreement":null},{"id":"W4395040003","doi":"10.1002/ajh.27337","title":"Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Association Bordelaise pour l'Avancement des Sciences Pediatriques; Novartis; GlaxoSmithKline; Amgen","keywords":"Medicine; Immune thrombocytopenia; Refractory (planetary science); Outcome (game theory); Identification (biology); Immune system; Intensive care medicine; Pediatrics; Immunology; Platelet; Biology","score_opus":0.008462896752927128,"score_gpt":0.2827949769451584,"score_spread":0.2743320801922313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395040003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900407,0.00043076885,0.000085832864,0.00002865947,0.0000038371186,0.000005543052,0.00021454401,0.0000022184358,0.00022461388],"genre_scores_gemma":[0.9993647,0.00013581806,0.000049059287,0.000011752801,0.000009999941,0.000006610257,0.0003961616,0.0000013042189,0.000024679124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946684,0.00014846306,0.00007020889,0.000106196414,0.00009281628,0.00011548793],"domain_scores_gemma":[0.99784446,0.00056086446,0.0010423042,0.00007509388,0.00016357178,0.00031372387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007705916,0.00024390189,0.0004262355,0.00067821017,0.00028518113,0.00060442125,0.00025303353,0.00046643417,0.0010415368],"category_scores_gemma":[0.0032861053,0.00013795831,0.00039156928,0.0010299074,0.00028317593,0.00061712036,0.00040831472,0.0005382708,0.00016418968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011003768,0.000017213379,0.9984956,0.000006585244,0.000019948111,0.00025740423,0.000025650917,0.00006388079,0.000047454203,0.00001678757,0.00006370217,0.000875773],"study_design_scores_gemma":[0.00001460609,0.00022431895,0.9950014,0.000017000075,0.000034846445,0.0034615917,0.00020788136,0.0006244648,0.00009205767,0.000054189444,0.0002609312,0.00000664208],"about_ca_topic_score_codex":0.0011183268,"about_ca_topic_score_gemma":0.00067992747,"teacher_disagreement_score":0.0011183268,"about_ca_system_score_codex":0.0003722528,"about_ca_system_score_gemma":0.00038082784,"threshold_uncertainty_score":0.0040753484},"labels":[],"label_agreement":null},{"id":"W4395466827","doi":"10.1002/ajh.27345","title":"Management of post‐autologous transplant relapse in patients with T‐cell lymphomas","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lymphoma","score_opus":0.003466785784256579,"score_gpt":0.22099655403061624,"score_spread":0.21752976824635967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395466827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994873,0.0029833522,0.0003690508,0.00017289392,0.0000127075955,0.00002091539,0.000035761324,0.000018718616,0.0015136645],"genre_scores_gemma":[0.99884665,0.0006766701,0.00016247953,0.00006649863,0.000033471973,0.000010701571,0.00007477826,0.000002710329,0.00012601895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988866,0.00003360334,0.000015000479,0.000012072435,0.000021562284,0.000029067432],"domain_scores_gemma":[0.99979526,0.000042978347,0.00008803937,0.000011444743,0.000014587295,0.000047712496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022771087,0.0001031093,0.00019861589,0.0003288036,0.00027577454,0.00029745806,0.00022887757,0.00022043649,0.00043720854],"category_scores_gemma":[0.000674044,0.000041323023,0.000200683,0.00021518482,0.0001841389,0.00018314396,0.0001963286,0.00036010187,0.00012109962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015238716,0.00060171075,0.7830449,0.00016552492,0.000080311234,0.016995424,0.0005601388,0.00095841737,0.007908196,0.0002683595,0.0013288631,0.18656431],"study_design_scores_gemma":[0.00012130785,0.003863874,0.90714544,0.000118789234,0.00012876667,0.07441486,0.00064002257,0.0018702049,0.0063052434,0.00047660875,0.0048913327,0.00002356269],"about_ca_topic_score_codex":0.00025181935,"about_ca_topic_score_gemma":0.00043810092,"teacher_disagreement_score":0.00043720854,"about_ca_system_score_codex":0.00017786924,"about_ca_system_score_gemma":0.00019015442,"threshold_uncertainty_score":0.0014625788},"labels":[],"label_agreement":null},{"id":"W4396578328","doi":"10.1002/ajh.27352","title":"High prevalence of iron deficiency and socioeconomic disparities in laboratory screening of <scp>non‐pregnant</scp> females of reproductive age: A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Socioeconomic status; Retrospective cohort study; Cohort study; Cohort; Pregnancy; Demography; Obstetrics; Pediatrics; Environmental health; Internal medicine; Population; Biology; Genetics","score_opus":0.008281016965829545,"score_gpt":0.2688305231877425,"score_spread":0.2605495062219129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396578328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835795,0.00016879589,0.000023661343,0.000059777485,0.000003149837,0.000015138105,0.00097069395,0.0000017159879,0.00039919766],"genre_scores_gemma":[0.9992513,0.000115056755,0.000025291107,0.000034542943,0.000003054636,0.000010077122,0.00045163525,0.0000011402874,0.000107857224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956983,0.000040254217,0.00003575371,0.00010443978,0.00011495697,0.0001346955],"domain_scores_gemma":[0.9992704,0.00004519045,0.00034280127,0.000057125973,0.00011813556,0.00016630054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040461085,0.00020651835,0.00029986352,0.00061870104,0.0008210435,0.0005818027,0.0005819646,0.00033160285,0.0012462189],"category_scores_gemma":[0.0010729331,0.00035968743,0.0004699467,0.0014711693,0.00033896795,0.00031292532,0.00043217477,0.00045107707,0.00015663367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014023621,0.000008906283,0.99947006,0.000004680707,0.000017987995,0.000040224717,0.0000962721,0.0000047659896,0.000040766274,0.000008732771,0.000100319885,0.00019324095],"study_design_scores_gemma":[0.0000020448822,0.000013635572,0.99954224,0.00000699805,0.0000086952805,0.00007716374,0.00021680997,0.000031713513,0.000005833077,0.0000044870203,0.00008871851,0.0000015812328],"about_ca_topic_score_codex":0.50795543,"about_ca_topic_score_gemma":0.6456556,"teacher_disagreement_score":0.50795543,"about_ca_system_score_codex":0.002080736,"about_ca_system_score_gemma":0.002147562,"threshold_uncertainty_score":0.9898846},"labels":[],"label_agreement":null},{"id":"W4396705273","doi":"10.1002/ajh.27312","title":"Clinically meaningful improvements in patient‐reported outcomes in mitapivat‐treated patients with pyruvate kinase deficiency","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase; Clinical trial; Pyruvate kinase deficiency; Disease; Intensive care medicine; Internal medicine; Pediatrics","score_opus":0.013119453093576821,"score_gpt":0.27553756114615213,"score_spread":0.2624181080525753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396705273","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17926328,0.018602222,0.0019844952,0.7385245,0.010141936,0.0002136938,0.0011715107,0.00029216212,0.049806133],"genre_scores_gemma":[0.62102455,0.008947209,0.0018625882,0.3269746,0.021157531,0.00020672189,0.00097002555,0.000042206888,0.018814651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995609,0.00019876893,0.000056073157,0.000030639643,0.0000956824,0.000057873476],"domain_scores_gemma":[0.9986432,0.00076441996,0.00012204373,0.000039099443,0.00022152673,0.00020971888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008805224,0.00027422397,0.0007755776,0.00015900315,0.00049296906,0.0005837298,0.00034859646,0.0036142045,0.0018706715],"category_scores_gemma":[0.0033574335,0.00010847634,0.00030167177,0.00028147962,0.0003828988,0.0003205399,0.00013564322,0.0021471505,0.00084372575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007822918,0.0011317171,0.078284465,0.00047541838,0.00033114402,0.052440934,0.00031134364,0.0015400912,0.009736749,0.0033301106,0.6033383,0.24125674],"study_design_scores_gemma":[0.013135213,0.010443405,0.21648745,0.0009557436,0.0008036457,0.11670256,0.0007151707,0.013234704,0.01016432,0.015198927,0.6019445,0.00021442786],"about_ca_topic_score_codex":0.0009955671,"about_ca_topic_score_gemma":0.002519651,"teacher_disagreement_score":0.0036142045,"about_ca_system_score_codex":0.0007569174,"about_ca_system_score_gemma":0.00058324233,"threshold_uncertainty_score":0.006258011},"labels":[],"label_agreement":null},{"id":"W4396925099","doi":"10.1002/ajh.27364","title":"Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics","funders":"","keywords":"Oncology; Internal medicine; Medicine; Biomarker; Multiple myeloma; Risk stratification; Cohort; Predictive value; Correlation; Proportional hazards model; Biology; Genetics","score_opus":0.0180515829767489,"score_gpt":0.3237621007054432,"score_spread":0.3057105177286943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396925099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984206,0.00028585087,0.00082279596,0.000026378164,0.0000043072587,0.0000058225596,0.00017211339,0.000026204556,0.00023598185],"genre_scores_gemma":[0.99895203,0.00008562645,0.000505744,0.000008980668,0.0000062937493,0.0000054878724,0.0003121083,0.0000026346067,0.0001209719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998017,0.00005166897,0.000024354076,0.000039965387,0.000058830086,0.000023517261],"domain_scores_gemma":[0.9991974,0.00022914163,0.00031436954,0.00006452428,0.000109078304,0.00008549587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058656547,0.00031805382,0.00026354118,0.0010538478,0.00018559878,0.0006262583,0.00019424426,0.00048237084,0.0007778754],"category_scores_gemma":[0.0019751498,0.00013215534,0.00038303045,0.0005101147,0.00013915067,0.0002462737,0.00046178588,0.00041846404,0.00022535637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061004574,0.00005244233,0.9705101,0.00001852505,0.00008221519,0.00012441573,0.00006637733,0.0023101922,0.0078799855,0.000051599414,0.00019233055,0.018101787],"study_design_scores_gemma":[0.0000124350645,0.0002663416,0.9778205,0.000012004848,0.000053457843,0.00068019336,0.000080730475,0.016751429,0.0035215986,0.00018636532,0.00059446564,0.000020388963],"about_ca_topic_score_codex":0.0008894501,"about_ca_topic_score_gemma":0.0010457822,"teacher_disagreement_score":0.0010538478,"about_ca_system_score_codex":0.00015663965,"about_ca_system_score_gemma":0.000121949706,"threshold_uncertainty_score":0.0031021237},"labels":[],"label_agreement":null},{"id":"W4396972100","doi":"10.1002/ajh.27366","title":"Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in <i>IDH1</i>‐ or <i>IDH2</i>‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Daiichi-Sankyo; bluebird bio; Sarepta Therapeutics; Sierra Oncology; Jazz Pharmaceuticals; Dana-Farber Cancer Institute; Celgene","keywords":"Venetoclax; IDH1; Medicine; IDH2; Myeloid leukemia; Hypomethylating agent; Oncology; Internal medicine; Chemotherapy; Mutant; Leukemia; Biology; Gene; Genetics; DNA methylation","score_opus":0.023066902626930397,"score_gpt":0.3297877690618693,"score_spread":0.3067208664349389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396972100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997593,0.0014370981,0.00010378498,0.00006587004,0.000047542337,0.00021978952,0.00028359538,0.0000053598687,0.0002440212],"genre_scores_gemma":[0.996357,0.0012730492,0.00031167775,0.0002540029,0.00020251727,0.0002709864,0.00083136506,0.000007648951,0.00049159164],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990933,0.00035222652,0.00006661313,0.00021642695,0.00010910522,0.00016234769],"domain_scores_gemma":[0.9984773,0.00021766606,0.000460593,0.00018492821,0.00010482587,0.00055462884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018330737,0.0009023168,0.0018929761,0.0004141163,0.00058382633,0.0011847842,0.0008504798,0.00087020773,0.0020410838],"category_scores_gemma":[0.0017296622,0.0005040615,0.0021203847,0.0007403119,0.000531261,0.0009491709,0.0004851644,0.0017644202,0.0004139182],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5771872,0.037310954,0.30966842,0.00045144203,0.008630302,0.00070237427,0.0005737535,0.00094898744,0.009073866,0.00018606949,0.002156334,0.053110376],"study_design_scores_gemma":[0.079427786,0.4574512,0.43987697,0.0002134001,0.008958019,0.0014096515,0.00079794467,0.002657805,0.0020848832,0.0003501786,0.0066078515,0.00016432603],"about_ca_topic_score_codex":0.0016256092,"about_ca_topic_score_gemma":0.0019692332,"teacher_disagreement_score":0.0020410838,"about_ca_system_score_codex":0.00094441435,"about_ca_system_score_gemma":0.0011423397,"threshold_uncertainty_score":0.009694278},"labels":[],"label_agreement":null},{"id":"W4399245093","doi":"10.1002/ajh.27384","title":"Molecular landscape of mature B‐cell lymphoproliferative disorders with <i>BCL3</i>‐translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study","year":2024,"lang":"fr","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Ligue Contre le Cancer","keywords":"Chromosomal translocation; Leukemia; French; Lymphoproliferative disorders; Medicine; Immunology; Biology; Genetics; Humanities; Philosophy; Lymphoma; Gene","score_opus":0.003968826039970044,"score_gpt":0.24739581251065076,"score_spread":0.24342698647068073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399245093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890316,0.0004531764,0.00008797868,0.00003789163,0.000001842705,0.000006212763,0.0002722817,0.0000029310904,0.00023460401],"genre_scores_gemma":[0.99927694,0.00013490899,0.0000879096,0.000029111634,0.000010509783,0.000005606533,0.000385908,0.000002505446,0.00006658719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997366,0.000049958868,0.000022322713,0.00009595318,0.000035187346,0.00006005112],"domain_scores_gemma":[0.99955755,0.00008571915,0.0001448734,0.000049043912,0.000064124986,0.00009871663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004641991,0.00025068244,0.00027596919,0.00088673807,0.00044330212,0.00062593014,0.00028198003,0.000358672,0.0017095747],"category_scores_gemma":[0.0007435873,0.00017028741,0.00027595027,0.0007873861,0.00026423056,0.00031323635,0.00041044556,0.00024490972,0.00024330383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024734339,0.000027124488,0.99165255,0.00001507251,0.00005619998,0.00057962094,0.00011079204,0.000059684666,0.0032924216,0.00005920184,0.00025157363,0.0036484385],"study_design_scores_gemma":[0.000013572025,0.00009131308,0.9944107,0.000010702967,0.000050787094,0.0034496365,0.00018958857,0.00027951077,0.00026717232,0.00006663428,0.0011644051,0.0000059312147],"about_ca_topic_score_codex":0.002970976,"about_ca_topic_score_gemma":0.0030427391,"teacher_disagreement_score":0.002970976,"about_ca_system_score_codex":0.0004041003,"about_ca_system_score_gemma":0.000262913,"threshold_uncertainty_score":0.0059073567},"labels":[],"label_agreement":null},{"id":"W4399676872","doi":"10.1002/ajh.27419","title":"Still high risk? A review of translocation t(14;16) in multiple myeloma","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Hamilton Health Sciences Foundation; Hamilton Health Sciences","keywords":"Multiple myeloma; Presentation (obstetrics); Chromosomal translocation; Medicine; Biomarker; Disease; Internal medicine; Oncology; Intensive care medicine; Bioinformatics; Biology; Surgery; Genetics; Gene","score_opus":0.04152078225076134,"score_gpt":0.379898403241376,"score_spread":0.3383776209906147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399676872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038142236,0.9991672,0.000030343359,0.00030653688,0.00021841658,0.0000021793717,0.000011529217,0.0000028511297,0.00022296076],"genre_scores_gemma":[0.00020587903,0.99914527,0.00006243897,0.0002345083,0.0002182294,0.0000030451793,0.00001780475,7.4458126e-7,0.000111992995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999666,0.00007199863,0.000081022445,0.0000566819,0.000100959725,0.000023341094],"domain_scores_gemma":[0.9990527,0.00055653654,0.00012463803,0.0000133971525,0.00018712773,0.00006561814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008718054,0.00092695217,0.0017819953,0.0040858556,0.0003798393,0.0011202268,0.0011358806,0.0014166428,0.0030493955],"category_scores_gemma":[0.0020126118,0.00036062082,0.00076031004,0.0038494328,0.00045937946,0.0017642053,0.0007625598,0.0018987139,0.001202933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009802548,0.000054799115,0.0003226521,0.045887206,0.00018301663,0.00032537468,0.00013168335,0.00028886646,0.00044698126,0.0021730966,0.07456942,0.87551886],"study_design_scores_gemma":[0.000025192216,0.00011690608,0.0013945095,0.025239738,0.00038106955,0.0026480523,0.00012966488,0.00008917322,0.00013421844,0.0015219585,0.96828675,0.000032886594],"about_ca_topic_score_codex":0.0016564693,"about_ca_topic_score_gemma":0.002722563,"teacher_disagreement_score":0.0040858556,"about_ca_system_score_codex":0.00081240875,"about_ca_system_score_gemma":0.001520148,"threshold_uncertainty_score":0.010201275},"labels":[],"label_agreement":null},{"id":"W4401376323","doi":"10.1002/ajh.27436","title":"Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A <scp>STELLAR</scp> interim analysis","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Interim; Hematopoietic stem cell transplantation; Term (time); Quality of life (healthcare); Disease; Medicine; Pediatrics; Internal medicine; Haematopoiesis; Stem cell; Genetics; Biology","score_opus":0.008603079502140853,"score_gpt":0.26369086692839655,"score_spread":0.2550877874262557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401376323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732424,0.0005872078,0.00074861996,0.00083600375,0.00006306308,0.0002357036,0.021918014,0.000028055529,0.002340916],"genre_scores_gemma":[0.9574115,0.00030852435,0.0009013199,0.00085063715,0.00014495506,0.0006802858,0.03796642,0.000016169355,0.0017201682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969374,0.0014101857,0.0003796086,0.00023308164,0.00064243685,0.00039732707],"domain_scores_gemma":[0.9926863,0.0018861125,0.002443361,0.00081460783,0.001397478,0.00077221345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005943283,0.00033643426,0.0007795162,0.0010922072,0.00050126604,0.0009222012,0.000585283,0.00069452485,0.0018813699],"category_scores_gemma":[0.0072739734,0.0002517795,0.0017071319,0.0015293857,0.0002570964,0.0007309542,0.0006542756,0.0010717803,0.00047844727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002978294,0.00023115105,0.986238,0.000053713815,0.00050110056,0.00010280789,0.000043853906,0.00028282838,0.00012273552,0.00007082519,0.003194597,0.0061800056],"study_design_scores_gemma":[0.00023528485,0.0008411952,0.996029,0.00003393853,0.0003453518,0.00012975644,0.00009815767,0.0006060635,0.00018549054,0.00007016036,0.0014109082,0.0000146475395],"about_ca_topic_score_codex":0.0047063236,"about_ca_topic_score_gemma":0.006815048,"teacher_disagreement_score":0.005943283,"about_ca_system_score_codex":0.00083252083,"about_ca_system_score_gemma":0.0009792104,"threshold_uncertainty_score":0.031431437},"labels":[],"label_agreement":null},{"id":"W4401548384","doi":"10.1002/ajh.27458","title":"The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University of British Columbia; St. Michael's Hospital; Vancouver Coastal Health","funders":"","keywords":"Southern Hemisphere; Thrombotic thrombocytopenic purpura; Medicine; Etiology; Northern Hemisphere; Climatology; Demography; Internal medicine; Platelet","score_opus":0.012238776473041613,"score_gpt":0.2924952732071757,"score_spread":0.2802564967341341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401548384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956375,0.00015098417,0.00008747965,0.000011916222,0.0000014084978,0.0000026942928,0.00011126154,0.000001790109,0.000068580055],"genre_scores_gemma":[0.9996954,0.0000921798,0.00005626762,0.000006498441,0.0000039562847,0.0000030404528,0.00012254971,0.0000011291132,0.000019122836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992792,0.0002874477,0.000106236235,0.00015240963,0.000089413654,0.000085244275],"domain_scores_gemma":[0.9980599,0.00035364722,0.0010254517,0.00019435125,0.00015863666,0.00020801232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000715074,0.00018445696,0.00031949466,0.0007033206,0.0003657837,0.00051920634,0.00028613274,0.0002347069,0.0005078839],"category_scores_gemma":[0.0017848806,0.00029881444,0.0004093036,0.0013188287,0.0003251471,0.00044562054,0.00047272354,0.0002515,0.00009794312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037736583,0.000005735577,0.9989704,0.0000046974706,0.00003947808,0.00005153889,0.00007207331,0.000033216715,0.00011899311,0.000004153117,0.000023873637,0.0006381241],"study_design_scores_gemma":[0.0000023179582,0.00003053614,0.9994005,0.000002465351,0.000016830672,0.00020730225,0.00013193127,0.00011041283,0.000024145156,0.000004583692,0.00006711794,0.0000019747574],"about_ca_topic_score_codex":0.0070270873,"about_ca_topic_score_gemma":0.0067411475,"teacher_disagreement_score":0.0070270873,"about_ca_system_score_codex":0.00029258514,"about_ca_system_score_gemma":0.00023520218,"threshold_uncertainty_score":0.013972402},"labels":[],"label_agreement":null},{"id":"W4401586147","doi":"10.1002/ajh.27455","title":"Imatinib versus newer generation <scp>TKIs</scp> for upfront therapy in chronic phase <scp>chronic myeloid leukemia</scp>: What is the rationale for paying more to get the same survival benefit?","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Imatinib; Hematology; Internal medicine; Transplantation; Imatinib mesylate; Disease; Oncology; Immunology","score_opus":0.0374721474033498,"score_gpt":0.32962715616823646,"score_spread":0.29215500876488665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401586147","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020442596,0.033391807,0.00031361444,0.6557222,0.304211,0.000069973335,0.00026519338,0.000086273714,0.0038956653],"genre_scores_gemma":[0.011769583,0.023269989,0.00051926024,0.42010143,0.53702456,0.000080210695,0.00013902017,0.00007236743,0.007023598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799025,0.00076496333,0.0002781519,0.00019965578,0.00060129765,0.00016573734],"domain_scores_gemma":[0.986453,0.0074497056,0.0011365243,0.00018687976,0.0034830763,0.0012908034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050027664,0.00091107166,0.0023260908,0.00087074406,0.0010633487,0.0029034768,0.0028124847,0.0063464437,0.0055197394],"category_scores_gemma":[0.019972615,0.00039552728,0.0013812832,0.00082107796,0.0011408835,0.0028134878,0.00042372133,0.013967329,0.002637835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008212336,0.000088717374,0.00060531765,0.0006841352,0.000094001916,0.0003673309,0.000046239613,0.000111017456,0.00019400271,0.00071218767,0.9678944,0.028381353],"study_design_scores_gemma":[0.0012926701,0.0006926338,0.0037528833,0.0019943954,0.0006843976,0.0014332529,0.00029180472,0.001457266,0.0009866662,0.003981057,0.9833213,0.00011182706],"about_ca_topic_score_codex":0.0011575547,"about_ca_topic_score_gemma":0.002948158,"teacher_disagreement_score":0.0063464437,"about_ca_system_score_codex":0.0016667077,"about_ca_system_score_gemma":0.0022187023,"threshold_uncertainty_score":0.026457489},"labels":[],"label_agreement":null},{"id":"W4401656522","doi":"10.1002/ajh.27459","title":"Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; Astellas Pharma; Irish Research Council; University of Queensland; National Cancer Institute; National Research Foundation; Cancer Australia; Leukaemia Foundation; EUSA Pharma; Mater Foundation; National Research Foundation Singapore; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; BeiGene; Daiichi Sankyo Europe; Sanofi; Amgen; American Association for Cancer Research; Bristol-Myers Squibb; National Health and Medical Research Council; American Society of Hematology","keywords":"TIGIT; CD8; Immune system; Cancer research; Lymphoma; Immunophenotyping; Biology; Hodgkin's lymphoma; T cell; Lymphocyte; Immunology; Tumor microenvironment; Flow cytometry","score_opus":0.005422366018276542,"score_gpt":0.24567511970297534,"score_spread":0.2402527536846988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401656522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880064,0.00048658758,0.0003834073,0.000011711951,0.000001999216,0.0000063935504,0.000096742086,0.000010466784,0.0002019488],"genre_scores_gemma":[0.99882704,0.00014093872,0.0006305256,0.000020782396,0.000004779495,0.00001248046,0.00021091229,0.0000032007508,0.00014925387],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998253,0.00005088416,0.000008471994,0.000047481655,0.000040458774,0.000027451853],"domain_scores_gemma":[0.99983513,0.00004547633,0.000055224027,0.000013943366,0.00002089338,0.000029356852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004634033,0.00020753019,0.00022932865,0.00083356624,0.00009679192,0.00058770983,0.000110503024,0.0002098917,0.00029773326],"category_scores_gemma":[0.00037239055,0.00013090267,0.00014395975,0.00037582623,0.00026598037,0.00019325574,0.00030312015,0.00028857673,0.00008146275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024422903,0.00012362821,0.42773646,0.00010000333,0.00018065522,0.00031520444,0.0002569419,0.0015061359,0.53086317,0.00016749659,0.00021694996,0.036091052],"study_design_scores_gemma":[0.000029044719,0.00084700575,0.9212471,0.00001935875,0.00016118445,0.0012456039,0.0002906654,0.009478872,0.06478202,0.00032228237,0.0015614287,0.000015439515],"about_ca_topic_score_codex":0.00047604964,"about_ca_topic_score_gemma":0.00049642264,"teacher_disagreement_score":0.00083356624,"about_ca_system_score_codex":0.00021559681,"about_ca_system_score_gemma":0.00009390042,"threshold_uncertainty_score":0.0024507046},"labels":[],"label_agreement":null},{"id":"W4401701543","doi":"10.1002/ajh.27451","title":"Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (<scp>WBMT</scp>)","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"Medac; JCR Pharmaceuticals; National Cancer Institute; Prothena; Hamilton Health Sciences; Celgene; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Medicine; Multiple myeloma; Internal medicine; Cumulative incidence; Transplantation; Lenalidomide; Hematopoietic stem cell transplantation; Clinical endpoint; Oncology; Multivariate analysis; Surgery; Clinical trial","score_opus":0.011718091949148926,"score_gpt":0.28239324345271366,"score_spread":0.27067515150356475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401701543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863106,0.0004631422,0.00005695988,0.00005661712,0.0000063726648,0.0000071190516,0.0005286605,0.0000021688081,0.00024790852],"genre_scores_gemma":[0.99890316,0.00013280814,0.000027458647,0.000038056914,0.000010379871,0.000007481269,0.0008127013,0.000002321095,0.00006559079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910176,0.00025781657,0.00013056713,0.00022583098,0.00015679133,0.00012730985],"domain_scores_gemma":[0.9971621,0.00033704593,0.0015944353,0.0002234179,0.00024053395,0.00044254298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022008396,0.0002605608,0.0004708082,0.0006676634,0.00032801525,0.000844908,0.00039609423,0.00041619284,0.0007537043],"category_scores_gemma":[0.0031953051,0.0002399871,0.00083151273,0.0015131177,0.0003232839,0.0008692589,0.0008293047,0.0006439961,0.00017514601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009845575,0.000015395035,0.99910706,0.000005615633,0.00006775786,0.000016749127,0.000029705228,0.000025936111,0.000021645501,0.000010330779,0.000063735955,0.0005376499],"study_design_scores_gemma":[0.000012690458,0.00009433694,0.99931645,0.0000059967033,0.00006259439,0.00010610482,0.00010192514,0.00008579733,0.00001741349,0.000017354718,0.00017625334,0.0000030140784],"about_ca_topic_score_codex":0.0045752926,"about_ca_topic_score_gemma":0.005708754,"teacher_disagreement_score":0.0045752926,"about_ca_system_score_codex":0.00053611054,"about_ca_system_score_gemma":0.0006248206,"threshold_uncertainty_score":0.011639297},"labels":[],"label_agreement":null},{"id":"W4402415968","doi":"10.1002/ajh.27473","title":"Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quadruplets; Multiple myeloma; Medicine; MEDLINE; Oncology; Internal medicine; Biology; Pregnancy; Genetics","score_opus":0.01985682815134042,"score_gpt":0.3086462158474822,"score_spread":0.28878938769614176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402415968","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036880118,0.04472849,0.00062120246,0.6482766,0.2983224,0.000078636054,0.0005224045,0.000132823,0.0036293818],"genre_scores_gemma":[0.022120181,0.024503933,0.00059787143,0.42225912,0.524496,0.00007539536,0.00018837437,0.000072617106,0.0056864773],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983552,0.00056668645,0.00034285284,0.00023340397,0.00036204208,0.0001397688],"domain_scores_gemma":[0.9893777,0.0059288875,0.0013648611,0.00020415276,0.0018289848,0.0012955173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037303094,0.0006224971,0.0014382653,0.0008424701,0.00094641215,0.0017228813,0.0020781455,0.006305123,0.005913507],"category_scores_gemma":[0.02231761,0.00046966746,0.0007229311,0.0007782755,0.001003141,0.0023029505,0.00064513227,0.010106607,0.0016142221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006670897,0.00008852289,0.0014504682,0.0017560503,0.00014943647,0.0020324055,0.000096345604,0.00012698326,0.00018297312,0.0008047685,0.94031066,0.052334204],"study_design_scores_gemma":[0.0009685652,0.00058358035,0.005053666,0.0036447223,0.00054300786,0.008523456,0.0003713058,0.0013241873,0.0008328662,0.0033252034,0.9747251,0.00010430947],"about_ca_topic_score_codex":0.0010655832,"about_ca_topic_score_gemma":0.0020379808,"teacher_disagreement_score":0.006305123,"about_ca_system_score_codex":0.00122233,"about_ca_system_score_gemma":0.0017872882,"threshold_uncertainty_score":0.019782603},"labels":[],"label_agreement":null},{"id":"W4402484136","doi":"10.1002/ajh.27479","title":"Cybersecurity and the blood supply: The vulnerabilities of the technological revolution","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Business; Computer security; Computer science","score_opus":0.005361818181300017,"score_gpt":0.2295723148160244,"score_spread":0.22421049663472437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402484136","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04341069,0.23673545,0.024325402,0.5021099,0.003914463,0.0000762324,0.00039672924,0.00047911948,0.18855204],"genre_scores_gemma":[0.7481441,0.16462037,0.0067762206,0.05828991,0.0058965716,0.000114482995,0.00021199544,0.00014815964,0.015798176],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737406,0.001104255,0.00007328772,0.00021320918,0.00083560473,0.0003995984],"domain_scores_gemma":[0.9892145,0.00717073,0.0009402129,0.00089071575,0.0009854108,0.0007985079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036746191,0.0006394175,0.0005000467,0.0017855953,0.0027674406,0.008017631,0.00087060337,0.004921672,0.007237744],"category_scores_gemma":[0.009569445,0.00029922323,0.000393542,0.0015001913,0.011125527,0.01491701,0.005233003,0.0071528736,0.0011464619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074564094,0.000060727285,0.0036056822,0.00037625336,0.000043903543,0.0006848667,0.0039258488,0.0016577425,0.00040739178,0.797054,0.08409676,0.10801227],"study_design_scores_gemma":[0.000009898375,0.000070984424,0.002649708,0.001957928,0.000016069207,0.0015365698,0.004548617,0.0022113712,0.0004972244,0.6450159,0.3414252,0.000060453134],"about_ca_topic_score_codex":0.0016803313,"about_ca_topic_score_gemma":0.001505003,"teacher_disagreement_score":0.008017631,"about_ca_system_score_codex":0.0026254985,"about_ca_system_score_gemma":0.0022064531,"threshold_uncertainty_score":0.024212599},"labels":[],"label_agreement":null},{"id":"W4402868174","doi":"10.1002/ajh.27487","title":"Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Dell Medical School, University of Texas at Austin; Terumo BCT; U.S. Food and Drug Administration; National Institutes of Health; Grifols; McGovern Medical School; Vanderbilt University Medical Center; Omeros Corporation; Swedish Orphan Biovitrum; University of Texas at Austin; Janssen Pharmaceuticals; Vanderbilt University; Gilead Sciences; Momenta Pharmaceuticals; Sanofi; AstraZeneca; Amgen","keywords":"Neonatal Fc receptor; Medicine; Immunology; Antibody; Immune system; Adverse effect; Hematology; Thrombocytopenic purpura; Immunoglobulin G; Clinical trial; In vivo; Pharmacology; Biology; Internal medicine","score_opus":0.01407092375757604,"score_gpt":0.3413138708524309,"score_spread":0.3272429470948549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402868174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008705679,0.99899966,0.000057487105,0.0001481975,0.00010544143,0.0000037905718,0.000010352204,0.000005005679,0.00058300863],"genre_scores_gemma":[0.000448195,0.9988632,0.000116953226,0.00013683407,0.000105032435,0.000006065489,0.000022368777,0.0000011209974,0.0003001095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998173,0.000035406676,0.000031888063,0.000026905298,0.00007030454,0.000018126868],"domain_scores_gemma":[0.9996259,0.00020895553,0.000052863077,0.000009618089,0.00007310908,0.000029423632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072363694,0.0008371725,0.0012798547,0.002461392,0.00024346326,0.0009315046,0.0010028529,0.0009990718,0.0044002193],"category_scores_gemma":[0.0009129446,0.00027558714,0.00073086197,0.0018466382,0.0003439498,0.0010628272,0.0005609377,0.0016607194,0.0016422811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010958262,0.000088298155,0.0001393888,0.020229027,0.00011806216,0.00016308218,0.000056915433,0.00035294666,0.0011245407,0.0025037634,0.0226606,0.9524538],"study_design_scores_gemma":[0.000049117083,0.00012874242,0.00078066986,0.0061393376,0.00027858347,0.0012148141,0.00006009526,0.00014057787,0.0005072489,0.001817419,0.98886555,0.000017876067],"about_ca_topic_score_codex":0.0008427575,"about_ca_topic_score_gemma":0.0015018422,"teacher_disagreement_score":0.0044002193,"about_ca_system_score_codex":0.00049441966,"about_ca_system_score_gemma":0.00087406364,"threshold_uncertainty_score":0.0147202015},"labels":[],"label_agreement":null},{"id":"W4403184720","doi":"10.1002/ajh.27499","title":"The invisible lifeline: Intricacies of the global plasma supply","year":2024,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Anarchism and Radical Politics","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Business; Political science","score_opus":0.005786884733839829,"score_gpt":0.3112073898392508,"score_spread":0.30542050510541097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403184720","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009585221,0.10273531,0.010743881,0.7219068,0.015667427,0.000049858154,0.0005586552,0.00038305364,0.13836978],"genre_scores_gemma":[0.33463714,0.22942276,0.014675954,0.3044751,0.025584593,0.0002657753,0.0013167682,0.0013767672,0.08824516],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728227,0.0008671572,0.00011121497,0.00039129806,0.0010057688,0.00034229335],"domain_scores_gemma":[0.99514896,0.0017025598,0.00034609417,0.00039803216,0.0010034058,0.0014010906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053993072,0.00075812364,0.0006122636,0.00144413,0.00402463,0.013558717,0.00181605,0.0058614416,0.027951732],"category_scores_gemma":[0.009054395,0.00039170688,0.00046531594,0.0019616624,0.008711644,0.023653876,0.008485448,0.009186786,0.0067397235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099865705,0.00004818017,0.0013855188,0.0005477069,0.00002227173,0.00061929284,0.00301897,0.00040799472,0.0006468901,0.5330329,0.28807378,0.17209677],"study_design_scores_gemma":[0.0000064335527,0.000035549805,0.00041874868,0.0005460507,0.0000064128353,0.0003052205,0.0016265716,0.0001586798,0.00015994172,0.079984255,0.91673464,0.000017480806],"about_ca_topic_score_codex":0.003206259,"about_ca_topic_score_gemma":0.0034067738,"teacher_disagreement_score":0.027951732,"about_ca_system_score_codex":0.0054575973,"about_ca_system_score_gemma":0.007208921,"threshold_uncertainty_score":0.093507886},"labels":[],"label_agreement":null},{"id":"W4403406073","doi":"10.1002/ajh.27506","title":"Characterizing coagulation responses in humans and nonhuman primates following kidney xenotransplantation—A narrative review","year":2024,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Queen's University; University of Ottawa; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; American Society of Nephrology; U.S. Department of Health and Human Services","keywords":"Xenotransplantation; Thrombomodulin; Coagulation; Immunology; Thrombotic microangiopathy; Medicine; Von Willebrand factor; Coagulopathy; Kidney; Transplantation; Platelet; Thrombin; Internal medicine; Disease","score_opus":0.033210962994010544,"score_gpt":0.3926634263194095,"score_spread":0.35945246332539893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403406073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066263565,0.9993352,0.0000450056,0.00015525933,0.00011427717,0.000004832544,0.00001292113,0.0000022763213,0.00026392602],"genre_scores_gemma":[0.00039274056,0.99923384,0.00006428923,0.00012455555,0.000089985115,0.0000073677566,0.000013270615,5.7529485e-7,0.00007346543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997055,0.000070828355,0.000075068085,0.000051492032,0.0000792734,0.000017839231],"domain_scores_gemma":[0.99853384,0.0010401745,0.00017451012,0.000024140558,0.00018718008,0.000040259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010443258,0.0007050443,0.0014994658,0.002499527,0.00028127225,0.001424218,0.00081003836,0.0012282828,0.0023652383],"category_scores_gemma":[0.0025952838,0.00025554746,0.0007514681,0.0022479733,0.00050927466,0.0016310922,0.00065073837,0.0012480804,0.0006361539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014149043,0.00006854113,0.00035842665,0.09597966,0.0002948925,0.0003118948,0.00021276034,0.00028148934,0.0009863368,0.003530228,0.023198899,0.8746353],"study_design_scores_gemma":[0.000028367123,0.00023275007,0.0016400348,0.04239711,0.00076189643,0.002577048,0.00024494776,0.0001027965,0.0005842838,0.002614516,0.94877315,0.000043202832],"about_ca_topic_score_codex":0.0011459045,"about_ca_topic_score_gemma":0.0015565531,"teacher_disagreement_score":0.002499527,"about_ca_system_score_codex":0.0005822603,"about_ca_system_score_gemma":0.0016354161,"threshold_uncertainty_score":0.007912517},"labels":[],"label_agreement":null},{"id":"W4405323708","doi":"10.1002/ajh.27555","title":"Effect of Ferric Derisomaltose on Fatigue in Iron Deficiency Anemia Associated With Abnormal Uterine Bleeding","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Iron-deficiency anemia; Context (archaeology); Anemia; Iron deficiency; Population; Internal medicine; Post-hoc analysis; Etiology; Pediatrics; Gynecology","score_opus":0.011077726736898262,"score_gpt":0.2951890012336696,"score_spread":0.2841112744967713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405323708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91499895,0.07403459,0.00069794734,0.0011721274,0.0007812693,0.0012790485,0.0009819486,0.000106268926,0.00594781],"genre_scores_gemma":[0.98072815,0.01399672,0.0010794548,0.0008961994,0.00039098543,0.00040211336,0.0004612689,0.000015200381,0.0020299084],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997483,0.0001434212,0.00002387344,0.000028917952,0.000025304724,0.000030278252],"domain_scores_gemma":[0.9992581,0.00041328976,0.00013616604,0.000028226654,0.000055590936,0.000108542714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010108935,0.00039044247,0.0013630242,0.0003374498,0.00014622534,0.0003306003,0.00034577248,0.00046947523,0.0056024236],"category_scores_gemma":[0.0022321546,0.00014552167,0.0012692314,0.00017723927,0.00023577045,0.0004005263,0.0002567138,0.001357031,0.00030975055],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.677992,0.017090721,0.0021418184,0.00873442,0.0039827297,0.00013656956,0.00021298681,0.0011583155,0.010076278,0.0003489013,0.0026866845,0.27543852],"study_design_scores_gemma":[0.235682,0.705778,0.030061305,0.0021855484,0.0069078295,0.00038085828,0.00027788844,0.0019786905,0.0055155815,0.00079987885,0.010372388,0.000059977472],"about_ca_topic_score_codex":0.00075824035,"about_ca_topic_score_gemma":0.002471867,"teacher_disagreement_score":0.0056024236,"about_ca_system_score_codex":0.00027358756,"about_ca_system_score_gemma":0.00037026356,"threshold_uncertainty_score":0.018741965},"labels":[],"label_agreement":null},{"id":"W4405584069","doi":"10.1002/ajh.27563","title":"Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Pharmacyclics; Genentech; Grifols; Galápagos; MEI Pharma; BeiGene; National Cancer Institute; AbbVie; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Discontinuation; Ibrutinib; Internal medicine; Oncology; Clinical trial; Idelalisib; Leukemia","score_opus":0.018615806460144102,"score_gpt":0.34243286789192356,"score_spread":0.32381706143177946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405584069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218275,0.06701722,0.0005746703,0.001126774,0.0002487676,0.000921318,0.0030693295,0.000025422374,0.005189006],"genre_scores_gemma":[0.9787839,0.014727698,0.00061355165,0.0010364577,0.00047523182,0.0007300295,0.0029894677,0.000015946176,0.0006277429],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961204,0.0021453078,0.0003665516,0.00053836755,0.0005596861,0.00026970706],"domain_scores_gemma":[0.9925816,0.002248787,0.0031663391,0.00055890216,0.0004800476,0.0009642644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006751836,0.0005547698,0.0013255241,0.00072396355,0.0004094297,0.0018030643,0.0006439409,0.001153643,0.0030312887],"category_scores_gemma":[0.006504649,0.00019731554,0.0018589312,0.0018197214,0.0013160155,0.0011224471,0.0005305983,0.0019408374,0.0004506284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49053618,0.020973342,0.14558622,0.005427317,0.011365266,0.0003676988,0.0011163186,0.002699211,0.0038963498,0.001266878,0.008398597,0.30836672],"study_design_scores_gemma":[0.13772266,0.23162179,0.5616823,0.0032205577,0.01534941,0.0013177635,0.0014461597,0.0020487867,0.0018977106,0.0008831248,0.04250904,0.000300778],"about_ca_topic_score_codex":0.0012374846,"about_ca_topic_score_gemma":0.0014188436,"teacher_disagreement_score":0.006751836,"about_ca_system_score_codex":0.0017268125,"about_ca_system_score_gemma":0.0010152197,"threshold_uncertainty_score":0.035707533},"labels":[],"label_agreement":null},{"id":"W4405708568","doi":"10.1002/ajh.27565","title":"Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: <scp>EPICOVIDEHA</scp>‐<scp>EPIFLUEHA</scp> Report","year":2024,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Instituto de Salud Carlos III; Universitätsklinikum Köln; Universität Innsbruck; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Szegedi Tudományegyetem; European Hematology Association; Università degli Studi di Roma Tor Vergata; Universität zu Köln; National and Kapodistrian University of Athens; Masarykova Univerzita; Università degli Studi di Genova; Medizinische Universität Innsbruck; Fakultní nemocnice Hradec Králové; Deutsches Zentrum für Infektionsforschung; Ostravská Univerzita v Ostravě; Eskişehir Osmangazi Üniversitesi; Univerzita Komenského v Bratislave","keywords":"Boreal; Malignancy; Respiratory system; Medicine; Internal medicine; Biology; Ecology","score_opus":0.02920221971966039,"score_gpt":0.3447772890787328,"score_spread":0.3155750693590724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405708568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852425,0.00021678217,0.000047538142,0.00004624093,0.000012934924,0.000012482127,0.00072534825,0.00000335875,0.00041105694],"genre_scores_gemma":[0.99894005,0.0000791526,0.000037933634,0.000038224738,0.000016973258,0.000010768424,0.0007842571,0.0000012603756,0.00009137251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964035,0.000079528945,0.00004898725,0.00007060053,0.000056833305,0.00010365499],"domain_scores_gemma":[0.99945134,0.000056527664,0.00026533616,0.000033407385,0.000050926963,0.00014249895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056360976,0.00024475777,0.00024050179,0.00046717346,0.00044227557,0.00060242787,0.0003062708,0.000321118,0.0009030939],"category_scores_gemma":[0.0007613197,0.00020209685,0.0003753783,0.00076560705,0.00022237332,0.00033690012,0.0004993158,0.00031595517,0.00015055692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004125517,0.000010131817,0.9992207,0.000005274838,0.0000128203565,0.0000595893,0.00003742363,0.000018388462,0.00008527572,0.000002855062,0.00011455529,0.00039167266],"study_design_scores_gemma":[0.0000055984333,0.00004157529,0.99915695,0.000005233005,0.000009359817,0.00021691395,0.00022546039,0.000077240446,0.00003163729,0.000005348067,0.0002226285,0.0000020590398],"about_ca_topic_score_codex":0.030979821,"about_ca_topic_score_gemma":0.03762228,"teacher_disagreement_score":0.030979821,"about_ca_system_score_codex":0.00065545953,"about_ca_system_score_gemma":0.0007249336,"threshold_uncertainty_score":0.061598957},"labels":[],"label_agreement":null},{"id":"W4406679947","doi":"10.1002/ajh.27588","title":"Association Between Anticoagulant‐Related Bleeding and Mortality in Patients With Solid Tumors and Cancer‐Associated Venous Thromboembolism","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; American Society of Hematology","keywords":"Medicine; Cancer; Case fatality rate; Internal medicine; Mortality rate; Diagnosis code; Disease; Surgery; Epidemiology; Population","score_opus":0.009192973311584213,"score_gpt":0.27500349730888773,"score_spread":0.26581052399730354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406679947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934661,0.0029735132,0.00016798642,0.00018447306,0.00003455815,0.000016752352,0.0024819507,0.000006654575,0.00066811213],"genre_scores_gemma":[0.9968407,0.0006648221,0.00014689921,0.000068440466,0.00006666684,0.000019314944,0.0020524664,0.0000028747456,0.00013783542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940073,0.00011919672,0.00012709788,0.00013854358,0.00012652643,0.00008782755],"domain_scores_gemma":[0.99813217,0.00036695367,0.0009547318,0.0000992771,0.00021723627,0.00022958162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000580592,0.00022480164,0.00047004502,0.0009534554,0.00030386582,0.00044726342,0.00045656456,0.00046078025,0.001527773],"category_scores_gemma":[0.0026020699,0.00019714517,0.00084223493,0.0016243189,0.000189021,0.00045744673,0.0004485319,0.0009598666,0.00016037431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008858685,0.000014553605,0.9989598,0.000022346863,0.00010190859,0.00001792871,0.000008945035,0.000029617973,0.000029864423,0.000012519409,0.000109921406,0.0006041107],"study_design_scores_gemma":[0.000011879226,0.000064912674,0.99907815,0.000014765887,0.0000887196,0.00015908318,0.000040958537,0.00028318696,0.000023172008,0.000038927312,0.00019212459,0.0000041115454],"about_ca_topic_score_codex":0.0038994725,"about_ca_topic_score_gemma":0.0059984787,"teacher_disagreement_score":0.0038994725,"about_ca_system_score_codex":0.00036220485,"about_ca_system_score_gemma":0.0003965926,"threshold_uncertainty_score":0.007753551},"labels":[],"label_agreement":null},{"id":"W4406775014","doi":"10.1002/ajh.27539","title":"Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Chugai Pharmaceutical; Genentech; Grifols; AOP Orphan; Novo Nordisk; Argenx; Regeneron Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; Celgene; CTI Biopharma; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; BioCryst; Alnylam Pharmaceuticals; Sanofi; Alexion Pharmaceuticals; Amgen; Pfizer","keywords":"Immune thrombocytopenia; Bruton's tyrosine kinase; Medicine; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Immunology; Gastroenterology; Antibody; Receptor; Cancer","score_opus":0.011007295989296182,"score_gpt":0.3249805975566005,"score_spread":0.31397330156730435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406775014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738736,0.0052120625,0.0007020214,0.0004907716,0.00007166753,0.0013433915,0.0023841122,0.000098079516,0.0023105908],"genre_scores_gemma":[0.98566157,0.0029024621,0.0012935835,0.0012102626,0.00018314156,0.0017662415,0.0049778908,0.000044383112,0.001960536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994154,0.00031266102,0.000032672935,0.00007183609,0.00006861305,0.00009890404],"domain_scores_gemma":[0.9994624,0.00008914683,0.00013511005,0.000051791718,0.00004989332,0.00021158575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021465304,0.0013432724,0.0015351248,0.00037559198,0.00038108585,0.0009934022,0.0005635236,0.0010860261,0.003141768],"category_scores_gemma":[0.0008253283,0.00044359104,0.0012955662,0.00034423894,0.0005054717,0.00065006426,0.00026806362,0.0024089336,0.0008610611],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.599368,0.08334192,0.017358247,0.0011901027,0.002838364,0.0005824481,0.00038186513,0.0035517672,0.09856459,0.00031646804,0.01412634,0.17837995],"study_design_scores_gemma":[0.46132457,0.46036884,0.059789754,0.000102026344,0.0012803875,0.000720073,0.000083763225,0.0022341195,0.0073994393,0.00024331071,0.0063784295,0.00007524192],"about_ca_topic_score_codex":0.0008724993,"about_ca_topic_score_gemma":0.0011670792,"teacher_disagreement_score":0.003141768,"about_ca_system_score_codex":0.0006567633,"about_ca_system_score_gemma":0.0009790498,"threshold_uncertainty_score":0.011352062},"labels":[],"label_agreement":null},{"id":"W4406963855","doi":"10.1002/ajh.27621","title":"Non‐Transfusion‐Dependent Thalassemia: An Image Gallery Worth a Thousand Words","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Swedish Orphan Biovitrum; Novo Nordisk; Argenx; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; Agios Pharmaceuticals; Bristol-Myers Squibb; Vertex Pharmaceuticals; Amgen","keywords":"Medicine; Thalassemia; Ineffective erythropoiesis; Anemia; Splenectomy; Pediatrics; Internal medicine; Intensive care medicine; Erythropoiesis","score_opus":0.0043185632314264285,"score_gpt":0.26813236606553603,"score_spread":0.2638138028341096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406963855","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022772953,0.27463827,0.005524871,0.11807222,0.42074484,0.00020547186,0.0009716079,0.0019658706,0.17559956],"genre_scores_gemma":[0.011720884,0.16283923,0.0048113056,0.06765102,0.41611052,0.00020536526,0.00094846124,0.000636404,0.33507693],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9993424,0.00011768628,0.00009059016,0.00012233412,0.00025156306,0.000075385404],"domain_scores_gemma":[0.9971746,0.0012010733,0.00019207314,0.00016698573,0.00077839056,0.00048677044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007179336,0.0017721241,0.0015680738,0.0026604598,0.0005936538,0.0028436359,0.00139656,0.004260573,0.17219947],"category_scores_gemma":[0.0040294034,0.0005168188,0.0011940462,0.0011140943,0.0013054775,0.0048390124,0.0017446397,0.0055915266,0.081648715],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088144014,0.00002805629,0.00024028035,0.0004740612,0.000011775702,0.0014054466,0.000032588505,0.000106904976,0.0005731646,0.0013200298,0.8844599,0.11125961],"study_design_scores_gemma":[0.000019024694,0.00003339511,0.00042190583,0.0009457613,0.000013656998,0.0064122775,0.00007358435,0.00012741632,0.00012284245,0.0015197883,0.99029446,0.000015978712],"about_ca_topic_score_codex":0.00077767606,"about_ca_topic_score_gemma":0.0007279356,"teacher_disagreement_score":0.17219947,"about_ca_system_score_codex":0.0010773758,"about_ca_system_score_gemma":0.00084968033,"threshold_uncertainty_score":0.5760646},"labels":[],"label_agreement":null},{"id":"W4407592569","doi":"10.1002/ajh.27642","title":"Moving the Therapeutic Needle in Immunoglobulin Light Chain and <scp>TTR</scp> Cardiac Amyloidosis","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiac amyloidosis; Medicine; Amyloidosis; Restrictive cardiomyopathy; AL amyloidosis; Internal medicine; Cardiomyopathy; Heart failure; Cardiology; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Pathology; Immunoglobulin light chain; Monoclonal; Antibody; Immunology","score_opus":0.005749001782372957,"score_gpt":0.2396141922997072,"score_spread":0.23386519051733426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407592569","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01175076,0.08422629,0.025441414,0.8214364,0.033653818,0.0001249284,0.000071681934,0.00059751666,0.022697141],"genre_scores_gemma":[0.11976925,0.08581497,0.048208687,0.53113407,0.19741629,0.00025154962,0.0002336194,0.0005492792,0.016622238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689376,0.0012422933,0.00039398833,0.0004045567,0.000731749,0.00033370536],"domain_scores_gemma":[0.98656505,0.0070262887,0.0009478581,0.00072753784,0.002355233,0.0023780477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009322274,0.0004953865,0.0010113462,0.0017657905,0.0013517258,0.003225072,0.0013714639,0.007936413,0.0043339008],"category_scores_gemma":[0.017305706,0.00047652065,0.0012387577,0.0006612543,0.0038458763,0.006882673,0.0032406622,0.018904181,0.003841688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064755837,0.00041868485,0.007403725,0.00057898305,0.00012657138,0.016285695,0.0009803853,0.0007465256,0.0031581663,0.02147614,0.38497016,0.5632074],"study_design_scores_gemma":[0.00037754647,0.0011191785,0.011201444,0.0046584746,0.00017440025,0.051207393,0.002561681,0.0025823317,0.0016622837,0.0721458,0.85209036,0.000219068],"about_ca_topic_score_codex":0.002199844,"about_ca_topic_score_gemma":0.00483492,"teacher_disagreement_score":0.009322274,"about_ca_system_score_codex":0.0022324433,"about_ca_system_score_gemma":0.0023974276,"threshold_uncertainty_score":0.049301445},"labels":[],"label_agreement":null},{"id":"W4407714303","doi":"10.1002/ajh.27636","title":"Steady‐State Ratio of <scp>von</scp> Willebrand Factor Antigen to <scp>ADAMTS13</scp> Activity Predicts Low Platelet Count at Hospitalization for Sickle Cell Disease Vaso‐Occlusive Episodes","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of Illinois at Chicago; University of Illinois at Urbana-Champaign; National Institutes of Health","keywords":"Von Willebrand factor; ADAMTS13; Platelet; Antigen; Medicine; Immunology","score_opus":0.005413511609739836,"score_gpt":0.23603778055631724,"score_spread":0.23062426894657742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407714303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998396,0.00046244802,0.00016103128,0.00006246032,0.00001824822,0.0000064776023,0.0001769568,0.000012849686,0.00070352113],"genre_scores_gemma":[0.99930596,0.000112165035,0.00010277796,0.000023814313,0.00003023174,0.000004436971,0.0002972034,0.0000025736047,0.000120843375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997683,0.000041740772,0.00004321223,0.000049472288,0.0000512636,0.000045996854],"domain_scores_gemma":[0.997445,0.0006546876,0.0008741714,0.000093410046,0.0002128156,0.000719904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005284789,0.00045359478,0.00032626776,0.0010126045,0.00027366268,0.0008714429,0.0004243881,0.0009770809,0.0024724538],"category_scores_gemma":[0.0034699847,0.00020921517,0.0004330315,0.00058022805,0.0003374141,0.00048144686,0.00034890033,0.0007666825,0.00054254115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014137969,0.000025529933,0.9985752,0.0000041855033,0.00001618753,0.00009218256,0.000012229191,0.000048276972,0.00036292776,0.000013926845,0.00008104077,0.00062694086],"study_design_scores_gemma":[0.000008211248,0.0001886062,0.9973212,0.00000835014,0.000034858338,0.0012295227,0.000058366604,0.00078137266,0.00021636164,0.000050627586,0.00009735122,0.0000051464376],"about_ca_topic_score_codex":0.0010543274,"about_ca_topic_score_gemma":0.00089840835,"teacher_disagreement_score":0.0024724538,"about_ca_system_score_codex":0.00017480749,"about_ca_system_score_gemma":0.00021899935,"threshold_uncertainty_score":0.008271217},"labels":[],"label_agreement":null},{"id":"W4407908356","doi":"10.1002/ajh.27637","title":"Five‐Year Real‐World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B‐Cell Precursor Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; Pfizer","keywords":"Lymphoblastic Leukemia; Hematopoietic stem cell transplantation; Hematopoietic cell; Medicine; Transplantation; Leukemia; Stem cell; Immunology; Haematopoiesis; Oncology; Internal medicine; Biology; Genetics","score_opus":0.00682411759801206,"score_gpt":0.2611636252635529,"score_spread":0.25433950766554086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407908356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778826,0.006220248,0.0011243623,0.00055931933,0.00015239166,0.00015306809,0.0018195937,0.00008244625,0.0021003704],"genre_scores_gemma":[0.9973309,0.00070813694,0.00015676947,0.00036525854,0.000069894006,0.00006370608,0.0010058956,0.000009081046,0.00029027867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974948,0.00095552264,0.00024350669,0.00036050766,0.0007250014,0.00022063247],"domain_scores_gemma":[0.9942107,0.0011884557,0.002653382,0.0004912974,0.000685269,0.0007708846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043745935,0.0003441822,0.0008974292,0.00033952622,0.00036780495,0.0015019716,0.00035059062,0.00067850435,0.0016790527],"category_scores_gemma":[0.007777482,0.00013449887,0.00097431993,0.0005096081,0.00047704694,0.00080115045,0.00057903165,0.0017362275,0.0004955052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27770218,0.010498196,0.24855445,0.0011022195,0.0034329726,0.00088502065,0.0008747208,0.0049978285,0.010267238,0.0013329863,0.01094805,0.42940414],"study_design_scores_gemma":[0.016902693,0.28846064,0.62406385,0.0005557649,0.005353572,0.0023232012,0.0007026692,0.0093995035,0.011413456,0.0018772241,0.03877557,0.00017189543],"about_ca_topic_score_codex":0.00071611704,"about_ca_topic_score_gemma":0.0006579809,"teacher_disagreement_score":0.0043745935,"about_ca_system_score_codex":0.0010393928,"about_ca_system_score_gemma":0.0007690261,"threshold_uncertainty_score":0.023135364},"labels":[],"label_agreement":null},{"id":"W4408337415","doi":"10.1002/ajh.27655","title":"<scp><i>TP53</i></scp>‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma; Celgene; AbbVie Canada; Kura Oncology","keywords":"Myeloid leukemia; Medicine; Venetoclax; Cancer; Oncology; Myelodysplastic syndromes; Internal medicine; Myeloid; Population; Bioinformatics; Cancer research; Immunology; Leukemia; Biology; Bone marrow","score_opus":0.01547931291521099,"score_gpt":0.3319085732240816,"score_spread":0.31642926030887064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408337415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045680007,0.9885895,0.0011304951,0.0046667582,0.00182596,0.000021640964,0.00022906896,0.00008331508,0.0029964796],"genre_scores_gemma":[0.002343067,0.9872988,0.0020325677,0.0029674447,0.0031420528,0.000028971961,0.0006850054,0.000018758867,0.0014834356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965644,0.00008999699,0.00006772248,0.000033611494,0.0001249282,0.000027402677],"domain_scores_gemma":[0.9982508,0.0006833284,0.00019977172,0.000032249853,0.00069964345,0.0001341498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00139824,0.00067384524,0.0012270364,0.0025796623,0.0002060921,0.00091420644,0.0009648725,0.00097110786,0.0035250143],"category_scores_gemma":[0.0029103444,0.00028724296,0.00074988685,0.0014156321,0.00031356383,0.0013345947,0.0006218502,0.0023748993,0.0026107347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093009156,0.000038978116,0.00074351963,0.004730937,0.000121219724,0.00025643158,0.000042411903,0.0003547061,0.0007840975,0.0010485128,0.13027176,0.8615144],"study_design_scores_gemma":[0.00003818108,0.00013513007,0.0018987859,0.009365669,0.00036902033,0.0023609882,0.000048284324,0.00032573694,0.00032868207,0.001125443,0.98397696,0.000026978016],"about_ca_topic_score_codex":0.001759653,"about_ca_topic_score_gemma":0.0042398656,"teacher_disagreement_score":0.0035250143,"about_ca_system_score_codex":0.0008789904,"about_ca_system_score_gemma":0.001181431,"threshold_uncertainty_score":0.011792362},"labels":[],"label_agreement":null},{"id":"W4408460398","doi":"10.1002/ajh.27665","title":"Topics of Interest in Women With Myeloproliferative Neoplasms","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Polycythemia vera; Medicine; Myelofibrosis; Internal medicine; Myeloproliferative neoplasm; Disease; Oncology; Gynecology; Bone marrow","score_opus":0.040912619085824165,"score_gpt":0.3393716473534898,"score_spread":0.2984590282676656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408460398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003940867,0.9461266,0.00041211088,0.017744947,0.006423409,0.00009315132,0.001181178,0.000057656456,0.0240201],"genre_scores_gemma":[0.021974344,0.93933004,0.0006968438,0.010016457,0.014796589,0.00018918265,0.0011350824,0.00003489007,0.011826568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997075,0.00010588499,0.000039745137,0.000038398517,0.00006380268,0.000044596236],"domain_scores_gemma":[0.99936455,0.00030118445,0.00012842205,0.00000875159,0.00009357598,0.00010354212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042266198,0.00031509754,0.0005330162,0.0010612822,0.0003243947,0.00092999707,0.0002177532,0.00080047286,0.021783164],"category_scores_gemma":[0.0020078162,0.00010638879,0.0004103696,0.0012228219,0.00023128033,0.00085460936,0.00070187805,0.0008072305,0.0032607552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028348103,0.000056663124,0.00536164,0.016052179,0.00009862528,0.00091857754,0.00086710363,0.000064975495,0.0008331426,0.0020157064,0.3024777,0.67097026],"study_design_scores_gemma":[0.000039316725,0.00008337627,0.0126634,0.011258411,0.00011436381,0.0044238423,0.00069670985,0.000028771175,0.00011829245,0.0011528771,0.9694045,0.000016180174],"about_ca_topic_score_codex":0.0006879633,"about_ca_topic_score_gemma":0.0012175455,"teacher_disagreement_score":0.021783164,"about_ca_system_score_codex":0.00032769676,"about_ca_system_score_gemma":0.0008583823,"threshold_uncertainty_score":0.07287198},"labels":[],"label_agreement":null},{"id":"W4409964068","doi":"10.1002/ajh.27688","title":"Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Workflow; Identification (biology); Computational biology; Computer science; Bioinformatics; Biology; Database","score_opus":0.05738899509302728,"score_gpt":0.343285930744665,"score_spread":0.28589693565163776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409964068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034878189,0.44104722,0.10116711,0.40053418,0.016404258,0.001654703,0.0018101714,0.002258271,0.031636298],"genre_scores_gemma":[0.03164945,0.35909382,0.42119765,0.15299943,0.010562179,0.003010996,0.005121847,0.0013055934,0.01505903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96411693,0.01563352,0.0060468023,0.0023968183,0.010428222,0.0013777441],"domain_scores_gemma":[0.8977961,0.032246694,0.0050401543,0.00542691,0.05537472,0.0041154595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.071041346,0.0018445968,0.0022089772,0.0068425494,0.0016465427,0.0047697937,0.0068693548,0.008077312,0.0031264233],"category_scores_gemma":[0.07912886,0.001080414,0.0031243805,0.0036133754,0.0041261194,0.0046236245,0.0050285757,0.011992793,0.004948535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002496314,0.00019076398,0.005640452,0.0056219297,0.00023113238,0.00088148157,0.0012936703,0.0012240633,0.0049900515,0.014057173,0.35706708,0.6085525],"study_design_scores_gemma":[0.00007395296,0.00010491365,0.004226668,0.012647348,0.00035520343,0.0015114967,0.00078371004,0.0009102795,0.003271052,0.01248979,0.9634805,0.00014523983],"about_ca_topic_score_codex":0.011221152,"about_ca_topic_score_gemma":0.010564332,"teacher_disagreement_score":0.071041346,"about_ca_system_score_codex":0.0032582206,"about_ca_system_score_gemma":0.015444499,"threshold_uncertainty_score":0.37570703},"labels":[],"label_agreement":null},{"id":"W4410004675","doi":"10.1002/ajh.27691","title":"Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital; McMaster University","funders":"McMaster University","keywords":"Medicine; Cardiac surgery; Cardiology; Internal medicine; Surgery","score_opus":0.014011126601404677,"score_gpt":0.2914392502934344,"score_spread":0.27742812369202974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410004675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94938606,0.0126493005,0.0031918364,0.013325128,0.0014137063,0.00040131249,0.0010608725,0.0002596186,0.018312301],"genre_scores_gemma":[0.99246395,0.002272235,0.00050274277,0.0025809093,0.00061495055,0.000027835806,0.00030817793,0.000012877549,0.0012163353],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999635,0.000042259195,0.000041325875,0.000116667805,0.000055264863,0.000109472654],"domain_scores_gemma":[0.9994332,0.000083692474,0.00007821243,0.000022903476,0.00005913471,0.0003229352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002046856,0.0009998941,0.0010425146,0.000929578,0.0016104318,0.00066111906,0.00047564137,0.001924931,0.0015208777],"category_scores_gemma":[0.0012103503,0.0004222047,0.0005758741,0.00070673955,0.00043937797,0.00093004043,0.0007043962,0.0031275204,0.0004093752],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014433944,0.00013272403,0.0475159,0.000052874384,0.000028335513,0.9457693,0.00037758265,0.00009332924,0.00090399076,0.00021702203,0.0016540211,0.0031104959],"study_design_scores_gemma":[0.00003212096,0.00050850975,0.07521826,0.000116950396,0.00003570931,0.920106,0.00049110164,0.0004379836,0.00027913682,0.00035451594,0.0023799634,0.000039737464],"about_ca_topic_score_codex":0.002412945,"about_ca_topic_score_gemma":0.004101304,"teacher_disagreement_score":0.002412945,"about_ca_system_score_codex":0.00087060384,"about_ca_system_score_gemma":0.0005292794,"threshold_uncertainty_score":0.006316662},"labels":[],"label_agreement":null},{"id":"W4410036934","doi":"10.1002/ajh.27696","title":"Thrombocytopenia and Anemia After Cardiac Surgery","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Medicine; Anemia; Cardiac surgery; Surgery; Internal medicine; Cardiology","score_opus":0.011611686637571771,"score_gpt":0.28732023212119845,"score_spread":0.27570854548362667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410036934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487223,0.0062439786,0.0009131572,0.0025989832,0.00034035044,0.00014498674,0.0002932119,0.00007939392,0.014513636],"genre_scores_gemma":[0.99660826,0.0010376484,0.00015098357,0.0009939751,0.0003365057,0.0000138051955,0.00012664053,0.00000481599,0.0007274237],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99977773,0.00003809543,0.000029393264,0.000048618414,0.00003645628,0.00006966285],"domain_scores_gemma":[0.99949753,0.0001414795,0.000098351564,0.000034238692,0.00004459418,0.00018384814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024283708,0.00058465713,0.00058799813,0.0009912627,0.0010950821,0.0005185968,0.00036028697,0.0013475515,0.001851432],"category_scores_gemma":[0.001602636,0.00028363283,0.00037130914,0.00068313675,0.00035800447,0.0005255558,0.00032014408,0.0012149244,0.0003956389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032788794,0.00028315105,0.18418512,0.00005161917,0.000044468732,0.8055766,0.00019459333,0.000101079604,0.00106274,0.00023903431,0.0015198054,0.006413826],"study_design_scores_gemma":[0.00006023512,0.0006974767,0.18705423,0.00007235332,0.00006818747,0.80870616,0.00021335295,0.00045585542,0.0002953243,0.00032687036,0.0020264538,0.000023498982],"about_ca_topic_score_codex":0.0015078139,"about_ca_topic_score_gemma":0.0017321883,"teacher_disagreement_score":0.001851432,"about_ca_system_score_codex":0.00045556054,"about_ca_system_score_gemma":0.00034985077,"threshold_uncertainty_score":0.0061936975},"labels":[],"label_agreement":null},{"id":"W4410251140","doi":"10.1002/ajh.27710","title":"Hypoferremic Response to Chronic Inflammation Is Controlled via the Hemojuvelin/Hepcidin/Ferroportin Axis and Does Not Involve Hepcidin‐Independent Regulation of <i>Fpn</i><scp>mRNA</scp>","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Hepcidin; Ferroportin; Inflammation; Endocrinology; Internal medicine; Medicine; Anemia; Kidney disease","score_opus":0.006159806434292575,"score_gpt":0.26187840857365774,"score_spread":0.25571860213936515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410251140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963636,0.00063334435,0.001466123,0.00008229163,0.000031464348,0.00002324773,0.00042641436,0.0001009378,0.0008724903],"genre_scores_gemma":[0.9953908,0.00027179642,0.0011025558,0.00007893096,0.000015261694,0.000041601987,0.0003835679,0.000037811584,0.0026776602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981827,0.000021532614,0.000016669068,0.000049132177,0.000044177592,0.000050222738],"domain_scores_gemma":[0.99967134,0.000016334146,0.00014044189,0.000030092613,0.000026578073,0.000115328505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001420984,0.00027850454,0.00025566592,0.000281887,0.0001723065,0.00033946795,0.00014882359,0.0003242905,0.0017828089],"category_scores_gemma":[0.00010316693,0.00017508374,0.00023550671,0.00011038916,0.0004881011,0.00022336503,0.00020895002,0.0007375336,0.00035222532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030030982,0.000016992954,0.00030797877,0.00001627639,0.0000028902114,0.00003375696,0.00000994711,0.000007669726,0.99886584,0.000046256835,0.000026794161,0.0003653735],"study_design_scores_gemma":[0.00009336527,0.0009651287,0.052658048,0.000016644437,0.00003543925,0.00070225226,0.00013580344,0.00073542603,0.94153404,0.00015984107,0.0029468765,0.00001707728],"about_ca_topic_score_codex":0.00047556908,"about_ca_topic_score_gemma":0.0008100032,"teacher_disagreement_score":0.0017828089,"about_ca_system_score_codex":0.00030195777,"about_ca_system_score_gemma":0.00018399287,"threshold_uncertainty_score":0.0059641004},"labels":[],"label_agreement":null},{"id":"W4410543268","doi":"10.1002/ajh.27721","title":"Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rituximab; Autoimmune hemolytic anemia; Anemia; Epidemiology; Etiology; Disease; Intensive care medicine; Therapeutic approach; Internal medicine; Autoantibody; Pediatrics; Immunology; Lymphoma; Antibody","score_opus":0.05142610830383273,"score_gpt":0.39577066878111417,"score_spread":0.34434456047728146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410543268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058374717,0.9987729,0.000049429775,0.00010106172,0.00003594608,0.000032501408,0.00028262107,0.0000036760653,0.0001380049],"genre_scores_gemma":[0.004353049,0.9950015,0.00017183425,0.00012538736,0.00003994563,0.000053670818,0.00021150372,0.0000018438376,0.000041321866],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979292,0.00046826596,0.00093908404,0.00023138749,0.00035204302,0.00008002329],"domain_scores_gemma":[0.99145764,0.0058033857,0.0016787617,0.00010925478,0.0008290817,0.000121825105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002836991,0.001087158,0.004415426,0.009642154,0.00036859524,0.0014346022,0.0012168249,0.00085448404,0.0034225204],"category_scores_gemma":[0.01144979,0.0005364057,0.0037823892,0.012150741,0.00040035075,0.0012468077,0.00083195977,0.00061092677,0.00026216081],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026231605,0.000034038694,0.0033396215,0.84020966,0.0077469195,0.00019910996,0.00019108667,0.00019912171,0.00020310617,0.00038701456,0.006062165,0.14116584],"study_design_scores_gemma":[0.00026096,0.00037327077,0.026627582,0.79344374,0.089346156,0.0022771596,0.0004743076,0.00021255025,0.00032219055,0.00071660156,0.085863024,0.000082506645],"about_ca_topic_score_codex":0.005523088,"about_ca_topic_score_gemma":0.01337527,"teacher_disagreement_score":0.009642154,"about_ca_system_score_codex":0.0014254724,"about_ca_system_score_gemma":0.0051819813,"threshold_uncertainty_score":0.015003622},"labels":[],"label_agreement":null},{"id":"W4411255343","doi":"10.1002/ajh.27736","title":"Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; Norges Forskningsråd; Leukemia and Lymphoma Society","keywords":"Angioimmunoblastic T-cell lymphoma; Transcriptome; Lymphoma; Medicine; Cancer research; Computational biology; Oncology; Internal medicine; Biology; Immunology; T cell; Gene; Genetics; Gene expression","score_opus":0.004244613251270105,"score_gpt":0.24985277281071286,"score_spread":0.24560815955944276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411255343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619824,0.00031893785,0.0017880924,0.000040951236,0.0000043605396,0.000011280616,0.0010904658,0.000058044465,0.0004895912],"genre_scores_gemma":[0.99740237,0.00013046208,0.0011233555,0.000040009723,0.0000047636245,0.000012541398,0.0009751517,0.000010775755,0.00030062144],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993527,0.00000717277,0.000003121156,0.00002361604,0.000016421862,0.000014337777],"domain_scores_gemma":[0.99994326,0.000018247832,0.000017446844,0.000005787963,0.0000055375485,0.000009855295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009561165,0.00013579139,0.00013268314,0.00044243078,0.00009273382,0.00019764091,0.00009857078,0.00014354332,0.00090184447],"category_scores_gemma":[0.00015105547,0.00007327202,0.00016007196,0.00030786838,0.00011145714,0.000055408287,0.0001538404,0.00012995931,0.00015182716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002626456,0.000026098254,0.016025137,0.000040745057,0.000036662597,0.0006125854,0.000051528783,0.00032777424,0.9752371,0.00014108127,0.00013933472,0.0070993686],"study_design_scores_gemma":[0.000083473016,0.0006899626,0.6927686,0.000018347995,0.00032916636,0.0062189447,0.00024947146,0.00942698,0.28310564,0.0009831742,0.006107509,0.000018704613],"about_ca_topic_score_codex":0.00042344112,"about_ca_topic_score_gemma":0.00078284775,"teacher_disagreement_score":0.00090184447,"about_ca_system_score_codex":0.00015083353,"about_ca_system_score_gemma":0.00008127032,"threshold_uncertainty_score":0.0030170083},"labels":[],"label_agreement":null},{"id":"W4411960460","doi":"10.1002/ajh.27761","title":"Addressing Anemia in High‐Altitude Populations: Global Impact, Prevalence, Challenges, and Potential Solutions","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Université de Poitiers; Fondation Université Grenoble Alpes","keywords":"Anemia; Population; Medicine; Socioeconomic status; Psychological intervention; Global health; Environmental health; Altitude (triangle); Effects of high altitude on humans; Demography; Public health; Pathology; Internal medicine","score_opus":0.05229311928526361,"score_gpt":0.37027671570567594,"score_spread":0.31798359642041235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411960460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008458016,0.99715143,0.000107523774,0.0015738048,0.00048913056,0.0000041182316,0.000019875353,0.000009685088,0.0005599078],"genre_scores_gemma":[0.00059469586,0.9977379,0.0001915584,0.0006197627,0.00044120304,0.0000065520994,0.00003808662,0.0000018385397,0.00036847024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997136,0.0000727767,0.000038858496,0.00004421798,0.00009576357,0.000034756777],"domain_scores_gemma":[0.99907887,0.00044206812,0.00007414546,0.000018351866,0.00029506712,0.00009150513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010163714,0.00070308306,0.0013068028,0.0016136988,0.00032404668,0.0012419458,0.0011532772,0.0017399606,0.003901312],"category_scores_gemma":[0.0021013,0.00019669022,0.0006252603,0.0012087345,0.00043346765,0.0014235555,0.0008438315,0.0025771435,0.0013894698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007343669,0.00006827293,0.00038622666,0.013320373,0.00012606365,0.00017999532,0.00007956455,0.0002379158,0.00043520937,0.0033194427,0.06479041,0.9169832],"study_design_scores_gemma":[0.000025420988,0.000103658145,0.001356846,0.010305296,0.00019515825,0.0010572515,0.00015137623,0.00013512095,0.000199199,0.0029938067,0.9834546,0.00002216556],"about_ca_topic_score_codex":0.0018159153,"about_ca_topic_score_gemma":0.003013611,"teacher_disagreement_score":0.003901312,"about_ca_system_score_codex":0.00070707774,"about_ca_system_score_gemma":0.0017027354,"threshold_uncertainty_score":0.013051152},"labels":[],"label_agreement":null},{"id":"W4412422543","doi":"10.1002/ajh.70011","title":"Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Cure HHT","keywords":"Medicine; Terminology; Clinical trial; MEDLINE; Intensive care medicine; Guideline; Evidence-based medicine; Disease; Telangiectasia; Medical literature; Alternative medicine; Pathology","score_opus":0.06010240532466238,"score_gpt":0.39932953119228115,"score_spread":0.3392271258676188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412422543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0125005115,0.77782696,0.01985328,0.012130849,0.0017583489,0.082868956,0.073874876,0.00046916475,0.018717116],"genre_scores_gemma":[0.094708666,0.5848989,0.04905389,0.012730013,0.0012432234,0.18613239,0.06782454,0.00042183194,0.0029865846],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9320631,0.017038418,0.04031431,0.0028088654,0.006818364,0.0009568333],"domain_scores_gemma":[0.87925816,0.07212391,0.030566303,0.0034137515,0.013625125,0.001012896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053685,0.0019584936,0.010534433,0.039578278,0.0011595732,0.0038820454,0.005318412,0.0038977172,0.008462607],"category_scores_gemma":[0.14538209,0.0010910949,0.0077874414,0.033714022,0.0022479144,0.004674509,0.0035984018,0.0015640439,0.0015684293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009988768,0.00006420999,0.009599395,0.8160246,0.0065502874,0.00047265427,0.001003855,0.0007463294,0.00081804727,0.0050027547,0.03977713,0.11894191],"study_design_scores_gemma":[0.0015602754,0.00034179082,0.024664318,0.82260126,0.024928693,0.001126096,0.0009712184,0.0008484333,0.000770178,0.0052279285,0.11676791,0.00019188128],"about_ca_topic_score_codex":0.008314315,"about_ca_topic_score_gemma":0.013934067,"teacher_disagreement_score":0.053685,"about_ca_system_score_codex":0.0056762346,"about_ca_system_score_gemma":0.022105383,"threshold_uncertainty_score":0.28391677},"labels":[],"label_agreement":null},{"id":"W4412690814","doi":"10.1002/ajh.70015","title":"Practical Guidance on Clinical Management of Belantamab Mafodotin‐Associated Ocular Events","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"GlaxoSmithKline","keywords":"Medicine; MEDLINE; Intensive care medicine; Political science","score_opus":0.09633654355105074,"score_gpt":0.501464673043311,"score_spread":0.40512812949226024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412690814","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004127255,0.26885605,0.038429704,0.5684554,0.016628224,0.0036474764,0.005449931,0.002240238,0.09216567],"genre_scores_gemma":[0.050337758,0.3439098,0.3239437,0.20954926,0.016127903,0.008562534,0.00755677,0.0005898245,0.03942242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870661,0.0063981763,0.0032413248,0.0005641755,0.002280906,0.0004493896],"domain_scores_gemma":[0.9527295,0.02006103,0.0037207513,0.0012339003,0.019938527,0.0023162412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012334526,0.0015767509,0.00234108,0.005027314,0.0014280621,0.0036770552,0.0032945245,0.0099421805,0.022391403],"category_scores_gemma":[0.06012415,0.00076445256,0.0038984555,0.002681117,0.0014508857,0.0056502693,0.0026036222,0.007793519,0.010880763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016187031,0.0002323173,0.0019733997,0.009949709,0.0001338344,0.0012468339,0.0009252588,0.00055546616,0.00080517423,0.0041708243,0.68669957,0.29314572],"study_design_scores_gemma":[0.00039242973,0.00018036031,0.00430357,0.040216014,0.00035290883,0.002383622,0.0014344603,0.0006992475,0.00060557545,0.014842488,0.9344353,0.00015407876],"about_ca_topic_score_codex":0.008017673,"about_ca_topic_score_gemma":0.01718667,"teacher_disagreement_score":0.022391403,"about_ca_system_score_codex":0.002246171,"about_ca_system_score_gemma":0.01174733,"threshold_uncertainty_score":0.07490671},"labels":[],"label_agreement":null},{"id":"W4413753180","doi":"10.1002/ajh.70048","title":"Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With <scp> <i>KMT2A</i> </scp> Rearrangements Treated With Immunotherapy‐Based Regimens","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Blinatumomab; Internal medicine; Oncology; Acute lymphocytic leukemia; Cyclophosphamide; Vincristine; Retrospective cohort study; Chemotherapy; Leukemia; Lymphoblastic Leukemia","score_opus":0.008947255443592646,"score_gpt":0.25648859713857014,"score_spread":0.2475413416949775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413753180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977301,0.00072817696,0.00006690977,0.00007496885,0.0000074491672,0.000013025421,0.0007310304,0.0000037150178,0.0006446231],"genre_scores_gemma":[0.99751294,0.00068299135,0.00006515114,0.000060714796,0.000034367287,0.00001597301,0.0015212329,0.000003304053,0.00010333935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968374,0.000041078216,0.000060351653,0.000070423506,0.00006584689,0.000078574645],"domain_scores_gemma":[0.9989863,0.000102210695,0.00056524406,0.00003427576,0.00010012704,0.00021187012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000289336,0.00017580959,0.00033594435,0.00061717944,0.00036661403,0.00063505565,0.00026999324,0.00029433236,0.00080814795],"category_scores_gemma":[0.0011159361,0.00012077879,0.00030450238,0.001019358,0.00025056323,0.00049067585,0.00043892066,0.00047447826,0.00020230663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001902001,0.000047424488,0.9952122,0.0000146245875,0.000035194993,0.0002845703,0.000082162216,0.00007775335,0.00029126616,0.00003297368,0.00021532034,0.0035162016],"study_design_scores_gemma":[0.000012399104,0.00030664337,0.99669206,0.000013771784,0.00004208591,0.001593566,0.00028686947,0.00014313243,0.00011694412,0.000032377415,0.0007556484,0.00000452935],"about_ca_topic_score_codex":0.0025394715,"about_ca_topic_score_gemma":0.0035926516,"teacher_disagreement_score":0.0025394715,"about_ca_system_score_codex":0.00049545756,"about_ca_system_score_gemma":0.0003899186,"threshold_uncertainty_score":0.005049348},"labels":[],"label_agreement":null},{"id":"W4413826493","doi":"10.1002/ajh.70042","title":"Real‐World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population‐Based Retrospective Cohort Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; Hamilton Health Sciences","keywords":"Multiple myeloma; Retrospective cohort study; Medicine; Cohort; Population; Cohort study; Internal medicine; Oncology; Environmental health","score_opus":0.011374241173232678,"score_gpt":0.29021689182726296,"score_spread":0.2788426506540303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413826493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187213,0.0025036677,0.0004330728,0.00016264596,0.000042854546,0.00014464058,0.0037892582,0.000009146248,0.0010425063],"genre_scores_gemma":[0.994695,0.000833427,0.00029877308,0.00021976343,0.00008786342,0.000134816,0.0035269065,0.00001045523,0.00019300304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869007,0.0002525711,0.00024310866,0.00043966668,0.00021709314,0.00015762204],"domain_scores_gemma":[0.99805886,0.0002181279,0.00087870925,0.00027662658,0.0003018303,0.00026585572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016303383,0.00043808715,0.0010272245,0.0008750236,0.0007130981,0.0013170425,0.0007301668,0.0008046696,0.002478229],"category_scores_gemma":[0.0029209144,0.00045755226,0.0016353879,0.0017981475,0.00043573545,0.0012443572,0.0011579865,0.0014425926,0.0005798692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001042491,0.00016048343,0.9936546,0.00014993464,0.0009060982,0.00014201972,0.00023588659,0.00008465605,0.00017578805,0.00012805633,0.0008538725,0.0024661857],"study_design_scores_gemma":[0.0002181165,0.00079103734,0.99318343,0.00013042665,0.0011843028,0.0007727078,0.0006755752,0.0005740002,0.00006746362,0.00017976681,0.00217782,0.000045429584],"about_ca_topic_score_codex":0.0042769797,"about_ca_topic_score_gemma":0.004793485,"teacher_disagreement_score":0.0042769797,"about_ca_system_score_codex":0.0007626052,"about_ca_system_score_gemma":0.00067112816,"threshold_uncertainty_score":0.0086221695},"labels":[],"label_agreement":null},{"id":"W4413954079","doi":"10.1002/ajh.70065","title":"Triple A Plus ( <scp>AAA</scp> <sup>+</sup> ) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Internal medicine; Essential thrombocythemia; Gastroenterology; Confidence interval; Cohort; Survival analysis; Platelet","score_opus":0.012702881087114148,"score_gpt":0.28619297085756173,"score_spread":0.2734900897704476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413954079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714977,0.00023033393,0.001077892,0.0001256697,0.000026749785,0.000012021022,0.0011748729,0.00002670388,0.00017588932],"genre_scores_gemma":[0.9977475,0.00006306404,0.0003931455,0.00002078428,0.000028176806,0.000016360727,0.0014374523,0.0000066514544,0.00028690364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930227,0.0003830654,0.00003816151,0.00013005071,0.000073286974,0.00007327161],"domain_scores_gemma":[0.9983987,0.00076274126,0.00025818462,0.00018653838,0.00016768748,0.00022609558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031008788,0.0006748565,0.00072862406,0.0004558186,0.00023544383,0.0006751099,0.00058828713,0.0003740794,0.0021482029],"category_scores_gemma":[0.0024712004,0.00029174087,0.0018724201,0.00044287406,0.00016657858,0.0003460569,0.000507453,0.0008777931,0.00033725682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003641935,0.00013004425,0.97914255,0.00003119366,0.001671472,0.00018990022,0.000026961077,0.0058716475,0.00032932652,0.00012224034,0.0019834584,0.006859282],"study_design_scores_gemma":[0.00048859994,0.0017164373,0.757109,0.000047743335,0.0028800552,0.0006816723,0.00020874842,0.23415251,0.0004825777,0.00063121197,0.0015538888,0.000047508063],"about_ca_topic_score_codex":0.006735231,"about_ca_topic_score_gemma":0.0044223233,"teacher_disagreement_score":0.006735231,"about_ca_system_score_codex":0.00038682233,"about_ca_system_score_gemma":0.0006747497,"threshold_uncertainty_score":0.016399145},"labels":[],"label_agreement":null},{"id":"W4414083471","doi":"10.1002/ajh.70071","title":"Spirometry Interpretation in Children With Sickle Cell Disease: <scp>GLI</scp> Global Versus Race‐Specific Normative Equations","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Spirometry; Normative; Population; Cohort; Pulmonary function testing; Generalized estimating equation; Interpretation (philosophy)","score_opus":0.004574226025516468,"score_gpt":0.25455177657776257,"score_spread":0.2499775505522461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414083471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94800436,0.0066963593,0.025224928,0.0017924565,0.00027360214,0.00031682063,0.0049644187,0.00054623163,0.012180778],"genre_scores_gemma":[0.976082,0.0013502579,0.018318688,0.00051924936,0.00008986309,0.0003262956,0.0026854365,0.00010577539,0.00052243134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667346,0.00097056734,0.0006565859,0.0004341623,0.0011301056,0.00013513776],"domain_scores_gemma":[0.9959298,0.0011687938,0.0013447935,0.0002413928,0.001129927,0.00018530535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005355559,0.00056689465,0.0006229337,0.0015307553,0.00021277694,0.0010266355,0.00071775547,0.0006105266,0.00083008816],"category_scores_gemma":[0.013677817,0.00017470702,0.00040751018,0.0009905541,0.0004646914,0.0007498144,0.0008479434,0.0009396865,0.0004420807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002749675,0.00007183067,0.95496386,0.00013137552,0.00006765213,0.00027242446,0.00050008274,0.00075830874,0.0011582744,0.0004986289,0.0029690743,0.038333464],"study_design_scores_gemma":[0.000033911478,0.00028805356,0.9809039,0.0002538023,0.00008652847,0.0025453994,0.0005099124,0.0076112747,0.0027397778,0.00062247517,0.0043748803,0.000030045736],"about_ca_topic_score_codex":0.0042815735,"about_ca_topic_score_gemma":0.005448244,"teacher_disagreement_score":0.005355559,"about_ca_system_score_codex":0.00068702566,"about_ca_system_score_gemma":0.00052499375,"threshold_uncertainty_score":0.028323233},"labels":[],"label_agreement":null},{"id":"W4414554914","doi":"10.1002/ajh.70081","title":"Ferritin, C‐Reactive Protein, and Soluble <scp>CD25</scp> Distinguish <scp>TAFRO</scp> From <scp>HLH</scp>","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia; Hospital for Sick Children; Dalhousie University; Memorial University of Newfoundland","funders":"Recordati Rare Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Clinton Foundation; University of Pennsylvania","keywords":"Cytokine; Cytokine storm; Antibody; Interleukin 6","score_opus":0.010724883894434187,"score_gpt":0.2841429791099243,"score_spread":0.2734180952154901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414554914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816876,0.0019747273,0.0023681636,0.0004451978,0.00006253842,0.0000742427,0.00033804742,0.00014972858,0.012899842],"genre_scores_gemma":[0.9965898,0.0003097765,0.0014316682,0.0001593875,0.000040478775,0.000016386628,0.00022755885,0.000012325436,0.0012126638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998616,0.000014611766,0.000015409834,0.000022091259,0.00004134794,0.000044910765],"domain_scores_gemma":[0.99972063,0.00005314612,0.000066871566,0.000021480428,0.000060665723,0.000077181416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035538644,0.0003139042,0.00021038539,0.0014834702,0.00025387303,0.0005112521,0.00020495725,0.0005896543,0.0025720764],"category_scores_gemma":[0.0007788234,0.00009581618,0.00027155742,0.00029044983,0.00040355138,0.0003444522,0.00021551995,0.00042821193,0.0004898592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015551548,0.00014997668,0.62142843,0.00013343185,0.000117194715,0.014475571,0.00028847152,0.00028926358,0.28925407,0.0015398748,0.0034564976,0.06731198],"study_design_scores_gemma":[0.00011336133,0.0008417039,0.856557,0.0001798101,0.0001806313,0.05921119,0.0008355398,0.0027490985,0.06943734,0.0019765017,0.0078784935,0.000039319762],"about_ca_topic_score_codex":0.0038178968,"about_ca_topic_score_gemma":0.0056678625,"teacher_disagreement_score":0.0038178968,"about_ca_system_score_codex":0.00029244932,"about_ca_system_score_gemma":0.00017894484,"threshold_uncertainty_score":0.008604467},"labels":[],"label_agreement":null},{"id":"W4414889454","doi":"10.1002/ajh.70101","title":"Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia—A Retrospective, Dual‐Center Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Young adult; Cumulative incidence; Hematopoietic stem cell transplantation; Incidence (geometry); Transplantation; Minimal residual disease; Comorbidity; Retrospective cohort study","score_opus":0.0048947925967025374,"score_gpt":0.25414679212259195,"score_spread":0.24925199952588942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414889454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946123,0.00019904616,0.000028879971,0.000011226461,0.0000025377526,0.000009190249,0.00016494647,8.9145186e-7,0.00012215163],"genre_scores_gemma":[0.9993543,0.00016874004,0.000040341452,0.000025513571,0.0000075586822,0.000012367303,0.00034276472,9.426811e-7,0.000047578473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996018,0.00010952007,0.000060765396,0.00009906807,0.00006715937,0.000061710656],"domain_scores_gemma":[0.99903154,0.00012500392,0.00045837215,0.00006692228,0.00008936166,0.00022889153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006474646,0.00028329232,0.00041602747,0.00075978384,0.00042195828,0.00060142507,0.0002495897,0.0003509359,0.00069313135],"category_scores_gemma":[0.0009709478,0.00034222737,0.00045185778,0.0010203826,0.00030354297,0.00044967662,0.0004544898,0.000555927,0.00018628189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008544366,0.000023435643,0.99931705,0.000004815315,0.000029234663,0.000070359616,0.000034913177,0.000009517517,0.00008205055,0.000005932566,0.00002613849,0.00031126177],"study_design_scores_gemma":[0.00003347233,0.0003456758,0.99765694,0.000011415561,0.000083444196,0.000893974,0.0004140077,0.00012058139,0.00008308194,0.000014635899,0.00033899775,0.0000037880702],"about_ca_topic_score_codex":0.0038146207,"about_ca_topic_score_gemma":0.004188693,"teacher_disagreement_score":0.0038146207,"about_ca_system_score_codex":0.0003396863,"about_ca_system_score_gemma":0.0003858592,"threshold_uncertainty_score":0.0075848103},"labels":[],"label_agreement":null},{"id":"W4415432833","doi":"10.1002/ajh.70118","title":"<i>JAK2</i> Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management","year":2025,"lang":"en","type":"review","venue":"American Journal of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hematology; MEDLINE; Prospective cohort study; Hematologic tests","score_opus":0.02068847504912243,"score_gpt":0.3436894408646349,"score_spread":0.32300096581551246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415432833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009766251,0.9752586,0.0014053072,0.00760036,0.0025343257,0.000033388682,0.00052279193,0.00017999814,0.011488563],"genre_scores_gemma":[0.0056978306,0.9709165,0.0027533676,0.0070385686,0.0055099167,0.000060398008,0.0023175236,0.000057221874,0.0056486465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997191,0.00004927812,0.00006118378,0.000038084625,0.00009840001,0.00003399718],"domain_scores_gemma":[0.99891734,0.00040279597,0.0001523148,0.000019409043,0.0003877221,0.00012047127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057023496,0.0007989598,0.0011148566,0.0025884435,0.00033396037,0.001011415,0.001054379,0.0011499702,0.009115312],"category_scores_gemma":[0.0021651129,0.00026650098,0.00075336074,0.0013841308,0.0003764329,0.0015733158,0.0006890883,0.0024501067,0.005145205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010574507,0.00003673786,0.0010928125,0.0029198125,0.000065002365,0.0010155579,0.000048052672,0.00040681762,0.00075840275,0.0012611143,0.22876385,0.763526],"study_design_scores_gemma":[0.00003790411,0.0000819936,0.0021604868,0.0075976467,0.00018703536,0.011949426,0.00007433476,0.0003148443,0.00030692364,0.001679036,0.9755796,0.000030877247],"about_ca_topic_score_codex":0.002235863,"about_ca_topic_score_gemma":0.0046141054,"teacher_disagreement_score":0.009115312,"about_ca_system_score_codex":0.0009767564,"about_ca_system_score_gemma":0.00092113874,"threshold_uncertainty_score":0.030493736},"labels":[],"label_agreement":null},{"id":"W4416070382","doi":"10.1002/ajh.70127","title":"A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The <scp>WAVe</scp> Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; University of Alberta; McMaster University; Hôpital Saint-François d'Assise; Dalhousie University; University Health Network; University of Toronto; Centre Hospitalier de l’Université de Montréal; McGill University; Ottawa Hospital","funders":"University of Ottawa; Pfizer","keywords":"Prospective cohort study; Dosing; Cumulative incidence; Incidence (geometry); Low molecular weight heparin; Cohort study; Thrombosis; Venous thrombosis","score_opus":0.017557711373158515,"score_gpt":0.2849356814790295,"score_spread":0.26737797010587094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416070382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979545,0.00056396466,0.00016619325,0.000056742327,0.000024195495,0.000063618856,0.00080038095,0.0000042332085,0.00036613212],"genre_scores_gemma":[0.9979693,0.00027315566,0.0001511216,0.00011150757,0.00005702548,0.00006446569,0.0011897702,0.000005604742,0.00017812283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857426,0.0005649393,0.00016817728,0.00036180668,0.0001671761,0.00016362587],"domain_scores_gemma":[0.99626863,0.0005507088,0.0013505974,0.0006837732,0.0003581721,0.00078809855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027933363,0.00067144324,0.0008143096,0.00057750655,0.0005214093,0.0011698183,0.00059226324,0.0009185572,0.0012774142],"category_scores_gemma":[0.0033931518,0.0006516591,0.001329722,0.001250964,0.0002989632,0.0011491418,0.0006848051,0.0011577719,0.00032980982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005334484,0.00025277742,0.9903819,0.00004692723,0.0011879792,0.00013871153,0.00010596505,0.00006491094,0.0005908693,0.00006601141,0.00030861376,0.001520873],"study_design_scores_gemma":[0.0009341663,0.0018336413,0.99468815,0.000020201645,0.0007946575,0.00035385793,0.00015431202,0.0003569933,0.00008828033,0.0000488475,0.00070617534,0.000020918325],"about_ca_topic_score_codex":0.002331005,"about_ca_topic_score_gemma":0.0022551161,"teacher_disagreement_score":0.0027933363,"about_ca_system_score_codex":0.00027700939,"about_ca_system_score_gemma":0.00040617603,"threshold_uncertainty_score":0.014772773},"labels":[],"label_agreement":null},{"id":"W4416297626","doi":"10.1002/ajh.70141","title":"<scp>DNA</scp> Methylation Episignature as a Novel Diagnostic Tool for Diamond‐Blackfan Anemia Syndrome","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca; European Commission; Ontario Genomics; Ontario Genomics Institute; Genome Canada","keywords":"dNaM; DNA methylation; Epigenetics; Biomarker; Fanconi anemia; Erythropoiesis; Human genetics; Disease; Diagnostic biomarker","score_opus":0.005634187898551996,"score_gpt":0.26930857024350763,"score_spread":0.2636743823449556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416297626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918012,0.001404332,0.0041049914,0.00025025688,0.000035028836,0.000031923268,0.0005577245,0.00013108851,0.0016834651],"genre_scores_gemma":[0.99540675,0.00029869276,0.0034102204,0.00008045633,0.00003847,0.000019053477,0.00035079033,0.0000111967,0.00038449332],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996209,0.000082386214,0.000034509485,0.00010841719,0.00011941676,0.000034346238],"domain_scores_gemma":[0.9994461,0.00018084273,0.00015885336,0.0000289123,0.00009900626,0.000086298816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060802174,0.0004496728,0.0002729443,0.0017162134,0.00015188321,0.00045890134,0.00025235605,0.00044885182,0.0010710297],"category_scores_gemma":[0.0015303297,0.00014456625,0.0001918578,0.00044945595,0.00026728577,0.00019830064,0.00039740303,0.00040349134,0.00031474626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095760374,0.000059663795,0.7520585,0.000119074924,0.00013857055,0.002926546,0.00022091369,0.0009618574,0.17600675,0.00030967695,0.0012696112,0.06497121],"study_design_scores_gemma":[0.00007389031,0.00074341125,0.85624653,0.00010584631,0.00025162735,0.022007447,0.00032410538,0.025843503,0.085269585,0.0011606948,0.007922039,0.000051357514],"about_ca_topic_score_codex":0.0007928923,"about_ca_topic_score_gemma":0.0009568253,"teacher_disagreement_score":0.0017162134,"about_ca_system_score_codex":0.00022204916,"about_ca_system_score_gemma":0.0001454921,"threshold_uncertainty_score":0.0035829544},"labels":[],"label_agreement":null},{"id":"W4416953116","doi":"10.1002/ajh.70155","title":"Albuminuria Predicts a Rapid Decline in Kidney Function in 2 International, Longitudinal Cohorts of Adults With Sickle Cell Anemia","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Novartis Pharma; National Institutes of Health; Novartis","keywords":"Renal function; Albuminuria; Kidney disease; Creatinine; Anemia; Cystatin C; Sickle cell anemia","score_opus":0.0037885926527832844,"score_gpt":0.236623730938176,"score_spread":0.23283513828539273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416953116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992175,0.0001143566,0.00016254977,0.000047538586,0.000008634529,0.000008139038,0.00029224073,0.0000050623835,0.0001440158],"genre_scores_gemma":[0.99909496,0.000050601295,0.00015714219,0.000038810424,0.000012589678,0.000010976818,0.0005050637,0.0000024403898,0.0001274285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932516,0.00029791627,0.000046417383,0.00016486234,0.00007543344,0.00009024043],"domain_scores_gemma":[0.9971398,0.00053945405,0.0011470709,0.00036502004,0.000313633,0.0004951239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026061495,0.00048389792,0.00037965627,0.00068207376,0.0005048713,0.00083821017,0.00046684584,0.00077115063,0.00095435424],"category_scores_gemma":[0.004033838,0.00031528538,0.0009773797,0.00048823742,0.00028459635,0.0005369185,0.0008370625,0.0011415412,0.00021164387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029227705,0.000058883157,0.99881387,0.0000032347614,0.00008154568,0.000025271791,0.000046565445,0.0000443379,0.00011952706,0.000009910706,0.00009331887,0.000411325],"study_design_scores_gemma":[0.000017710554,0.00020427647,0.9986603,0.0000045128822,0.00007025782,0.000112913134,0.00007733181,0.0006916689,0.000043539654,0.000025870375,0.000086638094,0.000004774943],"about_ca_topic_score_codex":0.0064083315,"about_ca_topic_score_gemma":0.0058635063,"teacher_disagreement_score":0.0064083315,"about_ca_system_score_codex":0.00026299598,"about_ca_system_score_gemma":0.000342992,"threshold_uncertainty_score":0.013782799},"labels":[],"label_agreement":null},{"id":"W4417488423","doi":"10.1002/ajh.70169","title":"Basiliximab in the Prophylaxis of <scp>aGVHD</scp> for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Guangxi Medical University; Natural Science Foundation of Guangxi Province","keywords":"Basiliximab; Transplantation; Busulfan; Alemtuzumab; Hematopoietic stem cell transplantation; Randomized controlled trial; Fludarabine; Thalassemia","score_opus":0.008739896312929008,"score_gpt":0.2631857706983192,"score_spread":0.25444587438539024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417488423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90968996,0.079417534,0.0010139814,0.0016245076,0.0013511755,0.0037392566,0.00076892274,0.00009279946,0.0023018136],"genre_scores_gemma":[0.97185284,0.019831954,0.0015021566,0.0018947055,0.0010437007,0.002389973,0.0005373526,0.000014108764,0.00093324325],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984145,0.0010023856,0.00018657568,0.00014956646,0.00013978432,0.00010711994],"domain_scores_gemma":[0.998648,0.00049799064,0.0004482707,0.0000803214,0.000097357166,0.0002280684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030891895,0.0010029357,0.0025154937,0.00051741104,0.00037775314,0.0012186198,0.00074875046,0.0015448087,0.004615652],"category_scores_gemma":[0.0021997269,0.00045334277,0.0024684314,0.00069921423,0.0008550179,0.0008369959,0.0002997272,0.0022645742,0.00043467814],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9392395,0.006460092,0.0015505736,0.004358444,0.0049468786,0.000057565325,0.00005530177,0.00020685988,0.0022798316,0.00013880845,0.0007042699,0.040001787],"study_design_scores_gemma":[0.90450615,0.08611766,0.0030006776,0.00028747576,0.0040892405,0.000047340614,0.000029908051,0.00029724432,0.00038273213,0.00011875568,0.0011049677,0.000017791663],"about_ca_topic_score_codex":0.0005088722,"about_ca_topic_score_gemma":0.0011838294,"teacher_disagreement_score":0.004615652,"about_ca_system_score_codex":0.00047663355,"about_ca_system_score_gemma":0.0009067727,"threshold_uncertainty_score":0.016337395},"labels":[],"label_agreement":null},{"id":"W7117123621","doi":"10.1002/ajh.70166","title":"Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Köln; National Cancer Institute; Marmara Üniversitesi; Mansoura University; Universität zu Köln; Universitat de Barcelona; NIH Clinical Center; Università degli Studi di Parma; Università Cattolica del Sacro Cuore; Rigshospitalet; AstraZeneca; Gentofte Hospital; Aristotle University of Thessaloniki; King Faisal Specialist Hospital and Research Centre; Deutsches Zentrum für Infektionsforschung","keywords":"Malignancy; Asymptomatic; Hematological malignancy; Population; Human metapneumovirus; Respiratory system; Respiratory infection; Comorbidity","score_opus":0.034223667055211175,"score_gpt":0.3682761180429798,"score_spread":0.33405245098776865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117123621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650307,0.008527665,0.00045573188,0.0009275025,0.00016244012,0.0001940536,0.019663772,0.000027887558,0.005010267],"genre_scores_gemma":[0.9854564,0.0021395357,0.00034592897,0.00042374185,0.00020977102,0.00013783331,0.011004809,0.000009629472,0.00027230888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899143,0.0002473685,0.0002539525,0.00020161767,0.00019787783,0.00010775085],"domain_scores_gemma":[0.99840087,0.00030502616,0.00076787884,0.00011175182,0.00021579381,0.00019869018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00109847,0.00015475215,0.00038805,0.00093710655,0.0003692424,0.00068300916,0.00030951793,0.00031713303,0.0011811436],"category_scores_gemma":[0.003062,0.00012966656,0.0003478155,0.0015584216,0.00014545812,0.0006024247,0.00075191696,0.00047590942,0.00029810308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034950464,0.00002782861,0.9912152,0.00012792947,0.000077238394,0.00031457187,0.00010938985,0.000037285023,0.000099564604,0.000101664475,0.002671925,0.0048678606],"study_design_scores_gemma":[0.000043265234,0.00015183086,0.992031,0.00021304465,0.00011443888,0.0017880992,0.00055754493,0.00019165051,0.0000766332,0.00009621742,0.0047224998,0.0000137986535],"about_ca_topic_score_codex":0.004752461,"about_ca_topic_score_gemma":0.0051359623,"teacher_disagreement_score":0.004752461,"about_ca_system_score_codex":0.00033973748,"about_ca_system_score_gemma":0.00068009266,"threshold_uncertainty_score":0.009449601},"labels":[],"label_agreement":null},{"id":"W7117712244","doi":"10.1002/ajh.70181","title":"Factor <scp>XIII</scp> Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation","year":2025,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Observational study; Fibrin; Factor XIII; Fibrinogen; Randomized controlled trial; Coagulation; Clinical trial; Pregnancy","score_opus":0.037164312564713,"score_gpt":0.37611391521101306,"score_spread":0.3389496026463001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117712244","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03732746,0.8475068,0.0030875627,0.09899644,0.0025519065,0.0002383949,0.00025120276,0.0000816839,0.009958427],"genre_scores_gemma":[0.31053513,0.637975,0.010313359,0.032943748,0.0047072954,0.0006090197,0.00033671712,0.00004341633,0.0025362808],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.998638,0.000826399,0.00015533503,0.00010822592,0.00020155654,0.00007053121],"domain_scores_gemma":[0.9970247,0.0018586793,0.00038428293,0.00014246374,0.00042661082,0.0001632788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043600923,0.0003113416,0.00072465383,0.00031208337,0.00020424889,0.0014149891,0.000625897,0.0011855029,0.0028410354],"category_scores_gemma":[0.009793767,0.00016166522,0.0004885482,0.00028694983,0.0009025412,0.0007269141,0.000527056,0.002498158,0.0004855266],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009280664,0.00067962497,0.003297072,0.00826636,0.00041253984,0.0002779823,0.00020671802,0.00041650742,0.003032826,0.012129111,0.020331778,0.9416688],"study_design_scores_gemma":[0.018096821,0.031971436,0.040770657,0.10569037,0.004380298,0.002320323,0.0015161678,0.004519856,0.014067459,0.08285751,0.6935773,0.0002317007],"about_ca_topic_score_codex":0.0009391973,"about_ca_topic_score_gemma":0.0012311003,"teacher_disagreement_score":0.0043600923,"about_ca_system_score_codex":0.0007538674,"about_ca_system_score_gemma":0.0014434666,"threshold_uncertainty_score":0.023058653},"labels":[],"label_agreement":null},{"id":"W7485085","doi":"10.1002/ajh.2830500312","title":"Platform Regulation on Seller Heterogeneity","year":2013,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Digital Platforms and Economics","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quality (philosophy); Incentive; Monopoly; Microeconomics; Profit (economics); Industrial organization; Strategic complements; Business; Economics","score_opus":0.014955614930410489,"score_gpt":0.21064237595853041,"score_spread":0.19568676102811994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7485085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66441554,0.001622395,0.042739518,0.007036242,0.00016815298,0.00012144232,0.0005472005,0.0002707429,0.28307882],"genre_scores_gemma":[0.9932287,0.00018315438,0.00053766184,0.00019027104,0.000057066347,0.00001758038,0.000028512812,0.000014114516,0.005742911],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99831676,0.0005169982,0.000064016065,0.00036337264,0.000284395,0.0004544537],"domain_scores_gemma":[0.98726046,0.007225962,0.0024770608,0.0013448345,0.00073703885,0.00095457217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003353772,0.00029298515,0.0008695369,0.0011361992,0.0013769271,0.0041183634,0.0009689221,0.001857958,0.028601963],"category_scores_gemma":[0.014565342,0.0003196086,0.00084617175,0.0008788619,0.0025883375,0.0045208912,0.0026677193,0.0016619184,0.0013512444],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005404077,0.00017625485,0.024450492,0.00015079831,0.00010939781,0.0007192241,0.000708688,0.012154977,0.004759656,0.91739875,0.0048200935,0.034011148],"study_design_scores_gemma":[0.00036034116,0.00031388146,0.043502677,0.00013365723,0.00022137901,0.00058767974,0.0017888589,0.05225594,0.0025562127,0.87500226,0.02314789,0.00012922384],"about_ca_topic_score_codex":0.0033469573,"about_ca_topic_score_gemma":0.0016353755,"teacher_disagreement_score":0.028601963,"about_ca_system_score_codex":0.0024683527,"about_ca_system_score_gemma":0.0015192725,"threshold_uncertainty_score":0.09568316},"labels":[],"label_agreement":null}]}